data_2khl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2khl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -82.9 133.29 35.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.545 1.164 . . . . 0.0 113.496 -173.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.536 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 31.6 m-20 -78.53 155.21 29.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.339 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.56 176.23 8.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.443 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.46 146.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.687 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 2.4 tp -99.43 120.74 40.1 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.265 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.776 ' HB2' ' HB2' ' A' ' 46' ' ' ARG . 53.1 mtp180 -88.72 157.16 18.61 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.469 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 11.9 t70 -102.35 -151.8 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.739 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 51.1 mm-40 -83.48 -20.37 34.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.868 0.366 . . . . 0.0 110.917 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.25 -6.88 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.477 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.91 50.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.315 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 12.4 m120 -54.63 178.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.653 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.37 160.15 34.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.272 0.558 . . . . 0.0 111.994 -169.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 77.9 m-70 -142.58 -159.59 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.172 -171.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' A' ' 16' ' ' HIS . . . -59.65 161.2 17.4 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.448 0.467 . . . . 0.0 112.84 -172.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 p -84.25 110.9 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.898 0.856 . . . . 0.0 110.521 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 2.7 m-85 -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.111 175.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.511 HG22 ' OD1' ' A' ' 5' ' ' ASN . 74.2 p -148.24 175.34 11.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.999 0.428 . . . . 0.0 109.865 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 154.69 142.93 3.55 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.565 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -14.41 48.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.241 0.544 . . . . 0.0 110.39 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 36.4 tt0 -153.83 142.86 14.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.802 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 72.3 Cg_exo -46.96 -18.74 0.61 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.485 3.457 . . . . 0.0 115.492 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.425 ' HA ' ' HB1' ' A' ' 28' ' ' ALA . 59.6 ttt180 -82.81 -12.7 57.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . 23.1 mm-40 -77.37 -65.01 1.01 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.914 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -34.46 -37.46 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 164.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.523 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -77.34 -38.97 49.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.34 177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.791 HD12 HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -63.24 -39.19 93.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 14.2 mmmm -80.87 -1.03 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.943 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.588 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . . . -99.06 -20.3 16.78 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.772 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -72.81 -66.33 0.68 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.658 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -35.06 8.13 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 162.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 14.8 mmm180 -91.37 -48.27 6.99 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.4 1.0 . . . . 0.0 110.272 -167.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -81.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.142 -1.504 . . . . 0.0 115.055 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -87.26 36.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 0.0 110.204 -168.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 61' ' ' TRP . . . -72.73 92.65 0.62 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.078 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -133.72 144.07 48.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.221 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HD2' ' CD ' ' A' ' 63' ' ' GLU . 68.9 tttt -81.4 -12.81 58.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.256 0.55 . . . . 0.0 110.365 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.6 64.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.047 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.9 81.06 1.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.059 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.427 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.8 Cg_exo -51.8 140.05 48.26 Favored 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.712 2.941 . . . . 0.0 112.826 -174.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -57.32 99.29 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.992 HD11 ' HE3' ' A' ' 59' ' ' LYS . 19.6 mm -54.9 126.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.355 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 58' ' ' PHE . 2.6 pp -135.27 140.93 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.776 ' HB2' ' HB2' ' A' ' 9' ' ' ARG . 72.5 mtp180 -117.29 124.83 49.96 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.521 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.423 ' CD2' HD13 ' A' ' 45' ' ' ILE . 1.7 mm? -106.2 158.11 17.08 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -142.5 115.73 8.93 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.8 tt0 -69.3 130.7 43.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 11.2 mtp180 -77.81 8.05 5.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.63 0.729 . . . . 0.0 109.077 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' GLU . . . -112.78 -64.36 0.46 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.607 174.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 p -91.7 146.66 23.59 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.189 0.519 . . . . 0.0 112.224 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -84.03 55.65 3.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.229 1.014 . . . . 0.0 109.808 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -127.98 111.54 13.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.345 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.943 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.7 t -78.68 99.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.568 ' HA ' HD11 ' A' ' 89' ' ' ILE . 51.1 m-70 -69.68 135.51 49.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.431 HG13 ' HG2' ' A' ' 90' ' ' GLU . 4.2 p -140.34 104.98 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 122.682 1.23 . . . . 0.0 109.471 -172.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.792 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -104.61 177.54 4.82 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.599 -1.637 . . . . 0.0 107.78 -177.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.992 ' HE3' HD11 ' A' ' 44' ' ' ILE . 45.6 mtpt -123.9 127.44 48.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.515 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -127.47 123.79 36.82 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.954 -159.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.571 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . 29.3 p90 -134.64 179.84 6.05 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 48.2 mtmt -133.84 140.36 46.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.338 174.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.605 ' HB2' ' HE2' ' A' ' 83' ' ' PHE . 38.8 mt-10 -129.56 112.81 14.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.478 173.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 32.9 mm -79.93 77.97 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.639 ' HA ' ' CB ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -152.24 153.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.873 -177.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.696 ' N ' ' HA ' ' A' ' 78' ' ' LYS . 8.8 t70 157.9 66.44 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.279 1.612 . . . . 0.0 107.932 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -60.59 133.86 91.58 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.266 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 1.02 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 61.6 Cg_endo -70.37 128.86 16.04 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.853 2.369 . . . . 0.0 115.781 -166.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -95.96 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.322 -1.763 . . . . 0.0 107.621 163.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.35 33.83 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.791 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 1.02 ' HD3' ' HA ' ' A' ' 68' ' ' PRO . 36.9 mtp85 -84.96 163.85 44.24 Favored Pre-proline 0 N--CA 1.464 0.235 0 O-C-N 121.916 -0.49 . . . . 0.0 111.033 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 75' ' ' MET . 18.5 Cg_exo -67.72 160.25 49.05 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.383 2.722 . . . . 0.0 111.458 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.34 -50.15 72.75 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.986 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -59.79 -20.48 57.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.626 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 13.2 ttm -90.18 111.07 44.83 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 24.9 Cg_exo -65.24 -135.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 124.19 3.26 . . . . 0.0 115.052 -170.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.773 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.4 mt-10 -117.46 8.47 13.0 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.696 ' HA ' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -160.26 169.43 23.22 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.804 -1.998 . . . . 0.0 106.51 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 1.001 HD13 ' HD3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -162.7 164.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 169.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.481 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 74.9 m -65.3 117.8 8.39 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.765 0.793 . . . . 0.0 111.416 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 1.001 ' HD3' HD13 ' A' ' 79' ' ' ILE . 4.3 mptp? -142.1 112.71 6.23 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 114.077 -1.42 . . . . 0.0 112.181 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.536 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 2.4 Cg_endo -86.54 124.59 2.34 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 123.28 2.653 . . . . 0.0 109.219 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.698 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 89.1 m-85 -120.82 134.73 55.28 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.792 HG12 ' HB3' ' A' ' 58' ' ' PHE . 1.5 t -138.81 137.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.926 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -122.45 154.67 37.47 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 27.3 ttmt -99.69 123.37 43.89 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.804 1.638 . . . . 0.0 109.195 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 2.4 pt-20 -89.15 -13.56 38.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.111 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 12.4 ptt-85 174.08 -173.01 0.06 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 56' ' ' HIS . 8.7 mm -138.85 136.22 42.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.784 0.326 . . . . 0.0 110.16 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.943 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.7 mm-40 -107.01 175.04 5.63 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.646 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 121.283 0.563 . . . . 0.0 112.407 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.391 0.615 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 1.006 HH22 ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -93.7 133.68 36.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.647 ' HA ' HG22 ' A' ' 20' ' ' THR . 60.6 m-80 -115.6 113.74 23.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.431 . . . . 0.0 111.05 -167.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.826 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -117.68 148.09 42.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -175.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 18' ' ' VAL . 3.3 t -113.66 -179.57 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.3 tp -106.56 149.63 26.96 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.579 ' HD3' ' HB2' ' A' ' 48' ' ' ARG . 24.7 mmm180 -111.05 162.36 14.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t70 -92.74 -162.56 0.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -92.35 -6.62 49.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.073 1.306 . . . . 0.0 108.039 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -110.43 -20.14 12.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.591 -170.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.93 36.53 1.23 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.596 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 65.4 m-80 -111.23 -173.05 2.15 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 87.7 mt-10 -135.9 145.31 46.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 111.092 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 73.9 m-70 -132.57 -166.09 1.69 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.182 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -21.59 130.07 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 125.034 1.459 . . . . 0.0 114.248 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.641 HG21 HG12 ' A' ' 7' ' ' VAL . 78.4 t -85.53 131.65 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 6' ' ' PHE . 81.5 m-85 -131.4 125.76 33.42 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.647 HG22 ' HA ' ' A' ' 5' ' ' ASN . 38.0 p -139.25 140.77 37.78 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.636 ' H ' ' NH1' ' A' ' 4' ' ' ARG . . . -140.78 -164.81 10.06 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.515 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -8.85 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 23' ' ' GLN . 1.2 tt0 -157.12 139.21 10.25 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.654 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.606 ' CA ' HH21 ' A' ' 4' ' ' ARG . 80.4 Cg_exo -40.91 -47.88 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 124.335 3.356 . . . . 0.0 114.077 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.544 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 42.0 ttt180 -53.04 -22.9 6.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.074 0.95 . . . . 0.0 113.341 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 22.9 mm-40 -84.05 -50.62 7.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.509 0.671 . . . . 0.0 110.677 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 1.006 ' HB1' HH22 ' A' ' 4' ' ' ARG . . . -59.07 -31.95 69.34 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.214 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -83.58 -26.24 30.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.876 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.787 ' HG ' ' HG2' ' A' ' 82' ' ' PRO . 3.7 tt -65.24 -65.52 0.66 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -43.75 -31.29 0.78 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.458 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.88 -39.65 69.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.166 0.507 . . . . 0.0 110.311 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -70.56 -21.37 62.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.367 0.603 . . . . 0.0 111.184 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.816 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 71.3 m-20 -68.34 -2.83 9.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.965 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.419 ' NH2' ' HE1' ' A' ' 19' ' ' PHE . 8.2 mmt180 -100.06 -13.27 19.09 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.09 82.85 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.84 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 13.0 p -100.18 -49.52 4.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -126.92 8.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.909 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 160.83 40.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.105 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -62.12 -20.87 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.589 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.64 -25.43 67.36 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.969 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.462 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.0 OUTLIER -161.85 67.82 2.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.442 0.639 . . . . 0.0 110.353 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.3 Cg_exo -65.16 130.95 26.95 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.085 1.857 . . . . 0.0 111.592 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.18 139.39 52.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.61 HD11 HG11 ' A' ' 57' ' ' VAL . 5.6 tp -82.97 105.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.824 0.821 . . . . 0.0 111.249 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 58' ' ' PHE . 2.7 pp -95.94 123.27 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 122.351 1.072 . . . . 0.0 110.345 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' HD22 ' A' ' 47' ' ' LEU . 77.5 mtp180 -91.79 173.26 7.96 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.446 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.553 ' CB ' ' HB2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -147.47 148.23 31.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.579 ' HB2' ' HD3' ' A' ' 9' ' ' ARG . 11.6 tpt180 -124.18 111.27 15.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.106 0.479 . . . . 0.0 110.169 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.79 ' HB3' ' HG1' ' A' ' 52' ' ' THR . 8.4 tp10 -86.27 104.57 15.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.547 ' HD3' ' HB3' ' A' ' 5' ' ' ASN . 2.8 ptm180 -73.05 25.66 0.06 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.434 0.635 . . . . 0.0 111.429 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 49' ' ' GLU . . . -128.63 0.99 6.39 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.325 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.79 ' HG1' ' HB3' ' A' ' 49' ' ' GLU . 44.6 p -146.65 169.78 18.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.411 0.605 . . . . 0.0 109.825 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -95.21 38.21 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -127.94 132.19 49.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.923 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.822 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 49.1 t -92.47 119.7 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.129 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 47' ' ' LEU . 95.2 m-70 -81.42 131.74 35.3 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 44' ' ' ILE . 71.3 t -123.15 116.23 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -170.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -132.25 134.78 45.7 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 87.5 mttt -70.56 170.26 12.52 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 162.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -163.08 133.99 4.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -166.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' SER . 29.9 p90 -150.03 -172.57 4.19 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.816 ' HZ1' ' HA ' ' A' ' 33' ' ' ASN . 35.3 mttp -132.2 136.51 47.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.11 0.481 . . . . 0.0 111.108 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HB3' ' HE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -137.66 137.8 38.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 -178.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 16.0 tt -83.67 94.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.147 1.451 . . . . 0.0 113.877 -166.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 81' ' ' LYS . 35.2 m -112.09 -174.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.523 170.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.965 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 7.3 p-10 -98.88 178.06 5.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 119.453 1.024 . . . . 0.0 110.985 169.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.685 ' HB1' HD12 ' A' ' 79' ' ' ILE . . . -125.23 163.87 35.44 Favored Pre-proline 0 C--O 1.239 0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.375 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 82.7 Cg_exo -46.3 149.31 2.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.979 2.453 . . . . 0.0 112.636 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -83.83 12.11 6.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.486 0.66 . . . . 0.0 110.309 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -117.31 22.84 12.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.013 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.419 ' NH1' ' HB3' ' A' ' 77' ' ' GLU . 31.3 ptt-85 -63.89 170.2 3.57 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.618 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -56.57 168.95 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.68 2.254 . . . . 0.0 113.108 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.44 -14.87 32.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.265 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.553 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 35.8 p-90 -91.37 -24.36 19.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.111 0.482 . . . . 0.0 111.151 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.553 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 28.6 ttp -101.28 147.46 33.8 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.279 -172.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -83.84 177.4 6.16 Favored 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.499 2.132 . . . . 0.0 110.026 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 12.8 pt-20 -74.07 -43.46 57.67 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.145 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.965 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 29.7 mmmt -79.71 114.99 19.06 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.685 HD12 ' HB1' ' A' ' 67' ' ' ALA . 1.4 pp -153.54 153.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.355 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 5.3 p -76.33 104.24 6.75 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.226 0.536 . . . . 0.0 110.053 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 21.6 tptt -62.9 136.9 96.75 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.763 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.787 ' HG2' ' HG ' ' A' ' 29' ' ' LEU . 37.9 Cg_endo -68.43 98.32 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.221 1.948 . . . . 0.0 110.491 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 42.3 m-85 -94.31 173.0 7.85 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.751 HG12 ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -162.59 174.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -162.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' H ' HG11 ' A' ' 84' ' ' VAL . 49.5 tptt -175.63 98.23 0.07 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 111.146 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 36.4 ttmt -55.96 93.16 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.825 0.821 . . . . 0.0 111.954 166.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.579 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -82.23 -11.88 58.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.657 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.579 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 7.7 ptm180 -176.84 177.12 1.37 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.347 0.594 . . . . 0.0 111.907 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.519 HD12 ' HE2' ' A' ' 86' ' ' LYS . 20.9 mm -135.83 136.96 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.527 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.822 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 30.4 mt-10 -107.2 151.29 25.62 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.023 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.462 ' HD3' ' C ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -93.93 126.67 39.27 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.429 0.633 . . . . 0.0 110.557 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.613 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 12.4 m120 -78.78 143.87 35.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.673 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 66.0 m-85 -131.89 142.09 49.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.411 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 61.7 t -105.17 122.32 58.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.76 133.17 43.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.061 -177.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.856 ' HB3' ' CA ' ' A' ' 13' ' ' GLY . 60.3 mtp180 -85.36 138.84 32.02 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.607 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -59.2 -146.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.691 170.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.61 -56.46 4.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -167.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.25 -42.32 68.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 109.088 162.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.856 ' CA ' ' HB3' ' A' ' 9' ' ' ARG . . . 139.36 48.01 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 116.263 -2.875 . . . . 0.0 113.671 169.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.5 m120 -74.01 -152.44 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -97.41 146.67 24.97 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.691 0.758 . . . . 0.0 112.295 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 15.5 m-70 -138.52 -164.56 1.66 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 167.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.95 162.87 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 119.058 -1.544 . . . . 0.0 112.317 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' A' ' 5' ' ' ASN . 2.7 p -99.22 110.77 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.093 0.949 . . . . 0.0 111.179 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -78.95 178.43 8.0 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.794 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.1 p -135.09 151.97 51.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.417 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -172.35 160.42 31.76 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.462 ' C ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -84.04 -10.21 58.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.446 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 17.1 mt-30 -151.58 165.5 17.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 10.8 Cg_endo -60.63 -53.3 2.88 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 CA-C-N 120.283 1.137 . . . . 0.0 111.278 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 75.5 ttt180 -39.9 -36.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.129 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 8.2 mm100 -84.44 -10.79 57.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.988 0.423 . . . . 0.0 111.535 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.98 -57.07 2.99 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 47' ' ' LEU . . . -45.08 -32.95 1.94 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 165.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 25' ' ' ARG . 7.2 tt -61.41 -19.23 61.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.282 0.563 . . . . 0.0 110.565 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 30' ' ' LYS . 18.4 mtpp -77.85 -53.39 7.53 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -68.37 -16.59 63.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . . . -64.44 -20.46 66.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.317 0.579 . . . . 0.0 110.838 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.36 7.1 0.65 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 56.6 mtp180 -99.64 -54.95 2.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.931 -163.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 36' ' ' SER . . . -105.76 -20.8 9.1 Favored Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.164 167.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 61' ' ' TRP . 68.5 m 76.15 -63.95 0.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.54 -160.8 54.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.235 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -160.93 157.14 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.61 ' HB3' ' HZ3' ' A' ' 39' ' ' LYS . 4.8 ttpm? -63.65 -12.86 37.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.984 0.513 . . . . 0.0 112.065 -171.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.63 -29.92 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.699 0.762 . . . . 0.0 110.162 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.29 70.18 2.95 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.556 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -56.98 166.13 4.34 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.901 2.401 . . . . 0.0 112.84 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.32 118.04 35.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.764 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.699 HD13 ' HZ1' ' A' ' 59' ' ' LYS . 7.0 tp -55.87 158.0 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.04 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -159.19 179.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.785 ' CB ' ' HB2' ' A' ' 9' ' ' ARG . 24.1 mmm-85 -158.29 143.01 16.23 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.826 0.704 . . . . 0.0 109.761 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -139.84 125.4 19.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.802 0.81 . . . . 0.0 110.567 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 45.3 tpt85 -105.36 114.48 28.68 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.994 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HB3' ' HG1' ' A' ' 52' ' ' THR . 57.4 tt0 -85.58 78.24 9.68 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -46.47 104.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.997 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.93 -19.47 4.4 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.042 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.512 ' HG1' ' HB3' ' A' ' 49' ' ' GLU . 26.1 p -127.62 178.48 6.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -115.59 37.26 3.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.929 0.871 . . . . 0.0 109.87 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -127.03 149.09 50.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.906 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 1.011 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 20.9 t -103.92 136.47 36.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.25 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.665 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 90.9 m-70 -103.73 105.99 16.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 43.7 t -95.32 122.38 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.504 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.665 ' CE1' ' HB3' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -128.44 162.11 27.91 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.932 176.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.699 ' HZ1' HD13 ' A' ' 44' ' ' ILE . 40.2 mmtm -103.44 133.28 48.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.926 158.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.651 ' HB2' HD12 ' A' ' 45' ' ' ILE . . . -110.96 146.26 36.93 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.732 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 32.0 p90 -168.87 151.36 4.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.604 ' HE2' ' HG3' ' A' ' 82' ' ' PRO . 77.5 mttt -103.18 122.95 45.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.367 0.604 . . . . 0.0 109.932 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.732 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.1 mm-40 -107.71 143.14 36.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.961 172.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 20.7 tt -86.24 143.31 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 163.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 m -141.0 -172.82 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.793 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.3 p-10 -121.16 -179.41 4.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.158 0.504 . . . . 0.0 111.272 -165.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB1' ' HA ' ' A' ' 77' ' ' GLU . . . -110.74 116.59 52.01 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.369 -172.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 71' ' ' ARG . 7.4 Cg_exo -69.0 -173.66 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.3 2.667 . . . . 0.0 111.383 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.48 -51.2 4.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.417 0.627 . . . . 0.0 109.334 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.4 t30 -83.97 18.05 2.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.44 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.629 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 9.8 ptt-85 -59.26 158.01 21.15 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.695 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.5 173.58 10.53 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.517 2.811 . . . . 0.0 114.015 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.15 10.66 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.833 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -123.21 -15.48 7.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.808 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 32.8 ttm -103.05 121.81 47.7 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.532 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 20.4 Cg_endo -88.7 -152.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.124 2.549 . . . . 0.0 112.444 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.719 ' HA ' ' HB1' ' A' ' 67' ' ' ALA . 16.6 mm-40 -69.53 -42.04 75.19 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.793 ' HD3' ' HA ' ' A' ' 66' ' ' ASP . 31.9 mmtp -150.03 129.76 13.24 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.565 HD12 HG21 ' A' ' 65' ' ' VAL . 1.2 pp -147.46 147.87 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 118.721 0.691 . . . . 0.0 111.074 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 71.5 p -94.14 153.83 17.9 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 4.4 tptp -157.38 133.67 6.2 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -168.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.604 ' HG3' ' HE2' ' A' ' 62' ' ' LYS . 14.0 Cg_exo -65.22 89.79 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 CA-C-N 120.651 1.268 . . . . 0.0 111.663 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.619 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 27.3 m-85 -83.68 157.78 22.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.517 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.538 HG13 ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -145.92 162.84 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.079 177.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.54 ' HB3' ' CZ3' ' A' ' 61' ' ' TRP . 5.2 tmtt? -151.72 115.56 4.91 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.316 0.579 . . . . 0.0 110.874 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.509 ' HE2' HD13 ' A' ' 89' ' ' ILE . 33.9 ttmt -60.2 125.65 24.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.463 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 20.6 pt-20 -135.41 -13.54 2.03 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.41 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.403 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 32.1 ttp85 -157.16 165.83 34.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.509 HD13 ' HE2' ' A' ' 86' ' ' LYS . 22.2 mm -147.1 140.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 1.011 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 52.6 mt-10 -119.93 153.11 36.39 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.06 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt . . . . . 0 N--CA 1.443 -0.807 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 -174.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.402 0.62 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 20' ' ' THR . 12.4 mmm180 -88.52 137.47 32.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.336 1.065 . . . . 0.0 111.796 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 36.8 m-80 -104.68 118.05 35.62 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.228 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.474 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 30.3 m-85 -119.27 165.0 14.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.282 1.039 . . . . 0.0 111.599 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.88 130.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.524 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 1.109 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 13.9 tp -81.26 156.06 25.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD2' ' HD3' ' A' ' 48' ' ' ARG . 47.9 mtp180 -135.47 143.03 45.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.491 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . 6.7 t70 -87.15 -165.04 1.18 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.475 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 4.7 mm-40 -83.74 -52.5 6.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.547 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -75.61 0.6 16.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.2 35.94 3.02 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 118.637 -1.744 . . . . 0.0 113.768 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.491 ' HB2' ' CB ' ' A' ' 10' ' ' ASP . 61.5 m-80 -101.75 178.67 4.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -122.72 152.52 40.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.858 0.837 . . . . 0.0 112.255 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 1.109 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 97.3 m-70 -132.18 -158.92 0.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.993 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.78 -172.67 46.55 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 117.84 -2.124 . . . . 0.0 110.936 -158.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 87.1 t -94.23 109.06 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.692 0.758 . . . . 0.0 110.851 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.816 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 77.6 m-85 -94.66 111.94 23.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.389 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.8 p -91.08 113.95 26.34 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.74 166.51 21.88 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.423 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.692 ' HG2' ' HG3' ' A' ' 26' ' ' GLN . 8.9 ptpp? -77.66 -27.25 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.517 0.675 . . . . 0.0 109.58 174.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.573 ' HG2' ' HG3' ' A' ' 22' ' ' LYS . 11.0 pt20 -160.4 163.99 20.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.454 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 33.0 Cg_exo -40.02 -53.3 2.51 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.476 2.784 . . . . 0.0 113.956 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.98 -40.0 69.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.692 ' HG3' ' HG2' ' A' ' 22' ' ' LYS . 21.5 mm-40 -78.56 -31.54 47.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 122.001 -0.437 . . . . 0.0 111.324 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.32 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.588 0.709 . . . . 0.0 109.207 173.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.743 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -70.51 -38.73 74.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.68 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -56.4 -62.29 1.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 32.1 mmtp -34.81 -48.05 0.37 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.186 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.816 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -66.98 -30.36 70.45 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.162 -0.336 . . . . 0.0 111.512 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -84.7 -18.34 35.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.79 -34.65 20.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 34' ' ' ARG . 28.4 ptt85 -92.21 -20.9 20.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.68 89.75 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.787 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -67.49 -17.1 64.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 31.91 -135.65 0.13 Allowed Glycine 0 C--N 1.344 0.987 0 O-C-N 124.332 1.02 . . . . 0.0 112.843 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -149.46 168.69 22.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 164.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -58.37 -33.64 69.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.41 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -81.06 -42.31 21.25 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.294 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.66 65.5 72.32 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.811 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 22.9 Cg_exo -64.45 146.17 89.06 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.485 2.124 . . . . 0.0 112.543 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.92 110.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 44' ' ' ILE . 30.0 mm -64.1 122.82 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.066 0.46 . . . . 0.0 111.584 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.796 HD11 ' HB2' ' A' ' 60' ' ' ALA . 8.0 pt -117.5 132.47 67.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.842 0.83 . . . . 0.0 111.925 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 1.066 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 69.4 mtp180 -122.37 116.47 24.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.866 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.809 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.9 mm? -108.11 123.16 48.29 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.343 0.592 . . . . 0.0 109.922 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 16.9 ttp180 -112.03 97.29 6.57 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.769 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' A' ' 4' ' ' ARG . 2.7 tm-20 -61.97 144.14 55.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.07 13.73 7.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -172.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.24 -9.5 2.38 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.408 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.5 p -99.33 172.79 7.12 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.835 -0.215 . . . . 0.0 110.647 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 63.4 tttp -111.76 11.77 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 110.339 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -121.57 142.88 49.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 90.6 t -111.34 101.16 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.809 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 18.6 p80 -86.48 140.31 30.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.28 0.562 . . . . 0.0 111.359 -174.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 1.066 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -125.36 114.57 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.258 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.604 ' O ' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -115.92 147.81 40.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HE3' HD11 ' A' ' 44' ' ' ILE . 1.5 mmmm -66.29 169.57 7.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.986 160.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.796 ' HB2' HD11 ' A' ' 45' ' ' ILE . . . -165.31 134.31 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.413 0.149 . . . . 0.0 110.769 -173.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.518 ' HD1' ' HG2' ' A' ' 63' ' ' GLU . 20.1 p90 -161.18 172.74 16.19 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 120.449 0.166 . . . . 0.0 111.15 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.678 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 42.2 mtmt -144.32 124.03 13.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.525 0.203 . . . . 0.0 110.706 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.537 ' HG3' ' CG1' ' A' ' 65' ' ' VAL . 7.7 pt-20 -174.09 155.9 2.57 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -69.99 125.99 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.885 0.766 . . . . 0.0 110.288 173.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.601 HG23 ' N ' ' A' ' 66' ' ' ASP . 4.2 m -150.75 -167.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -167.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.601 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.3 OUTLIER 101.16 -174.65 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 125.395 1.685 . . . . 0.0 110.638 168.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.674 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . . . -121.53 179.85 0.88 Allowed Pre-proline 0 N--CA 1.437 -1.099 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.324 -165.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.674 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 98.1 Cg_exo -50.94 -175.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 123.705 2.937 . . . . 0.0 115.051 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HZ2' ' CD ' ' A' ' 77' ' ' GLU . 4.1 mptp? -56.93 -13.05 2.33 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.456 -166.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -76.01 32.67 0.12 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.04 0.447 . . . . 0.0 111.317 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 68' ' ' PRO . 20.3 mmm180 -84.5 167.16 28.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.524 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.6 162.72 30.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.097 1.865 . . . . 0.0 111.191 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.98 62.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.118 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.693 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 56.3 p-90 -103.92 -37.51 7.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.895 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.693 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 16.6 ttp -104.57 136.46 19.17 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.706 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 42.7 Cg_endo -92.38 -164.69 0.13 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 122.696 2.264 . . . . 0.0 113.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.452 ' CD ' ' HZ2' ' A' ' 69' ' ' LYS . 25.3 mt-10 -86.07 -2.02 57.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.552 -1.658 . . . . 0.0 112.531 -168.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 72.5 mmtt -155.42 119.25 4.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.8 OUTLIER -155.71 144.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.552 0.615 . . . . 0.0 110.087 177.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.0 p -120.71 81.22 1.73 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.004 0.907 . . . . 0.0 111.616 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.829 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -124.74 168.32 13.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.197 176.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.713 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 52.2 Cg_exo -57.24 94.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.483 2.122 . . . . 0.0 111.875 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.829 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-85 -86.53 175.6 8.26 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.602 HG11 ' CB ' ' A' ' 58' ' ' PHE . 1.4 t -166.22 173.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -166.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.55 ' HE2' ' O ' ' A' ' 86' ' ' LYS . 16.8 tptm -176.51 99.11 0.06 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.119 0.485 . . . . 0.0 110.7 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.55 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 34.4 ttmt -57.25 134.3 55.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.38 169.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.426 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 11.3 pt-20 -167.19 23.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.168 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.487 ' O ' HG12 ' A' ' 57' ' ' VAL . 23.7 ttp180 -168.2 157.03 9.08 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.1 mm -140.58 136.31 35.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.534 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.69 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -119.36 166.21 13.33 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.452 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt . . . . . 0 CA--C 1.501 -0.911 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.818 176.753 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.444 ' HG1' ' C ' ' A' ' 21' ' ' GLY . 4.1 t . . . . . 0 N--CA 1.449 -0.525 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.498 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.0 ptm180 -89.34 151.74 21.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.261 1.029 . . . . 0.0 112.642 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.8 OUTLIER -105.08 136.55 44.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.531 -166.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.498 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 28.0 m-85 -127.32 122.18 33.07 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.384 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 1.027 HG11 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -97.31 128.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.5 tp -66.19 139.84 58.14 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.788 -171.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -92.03 171.73 8.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.136 0.97 . . . . 0.0 111.777 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.482 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 21.2 t70 -128.43 169.98 13.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.038 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.74 -36.33 80.68 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.744 0.652 . . . . 0.0 111.094 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.09 -39.3 25.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.862 0.839 . . . . 0.0 109.439 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.03 31.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.173 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.482 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -77.22 -170.09 1.59 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.773 173.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.29 108.86 9.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.512 0.672 . . . . 0.0 111.083 -170.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.896 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 72.3 m-70 -89.88 -162.17 0.86 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.52 144.11 7.21 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 123.398 0.436 . . . . 0.0 113.434 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.64 143.82 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -126.71 143.11 51.34 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 p -121.89 135.16 54.87 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.444 ' C ' ' HG1' ' A' ' 3' ' ' THR . . . -137.57 -78.59 0.08 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.27 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt 173.36 -33.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.437 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 11.1 pt20 -159.68 166.68 15.57 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.312 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 72.5 Cg_exo -45.8 -22.29 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.507 2.805 . . . . 0.0 114.038 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.59 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 21.2 ttm-85 -88.1 -35.09 17.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.657 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.594 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -86.34 -14.66 42.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.598 -178.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.0 -47.78 7.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HA ' HD23 ' A' ' 47' ' ' LEU . . . -57.12 -37.36 71.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.476 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.671 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -49.5 -65.92 0.48 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.426 172.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 74.5 mmtt -35.33 -48.31 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . . . -68.13 -26.78 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.752 0.706 . . . . 0.0 112.067 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.974 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -70.11 -22.95 62.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.226 1.012 . . . . 0.0 111.007 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.636 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 6.2 m-80 -62.45 -0.29 0.57 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -73.54 -63.92 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 116.6 -2.04 . . . . 0.0 109.651 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.13 -50.25 0.25 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 115.282 -3.342 . . . . 0.0 116.622 143.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.561 ' O ' HG21 ' A' ' 38' ' ' THR . 15.2 m -53.77 -25.35 18.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.488 0.644 . . . . 0.0 109.405 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.94 100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.945 164.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 36' ' ' SER . 25.5 p -135.49 -177.97 4.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.143 0.577 . . . . 0.0 110.461 -171.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.659 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 23.4 mtmm -65.42 -29.77 70.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.646 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.87 -38.03 79.44 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.157 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.38 71.7 32.27 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.21 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.8 Cg_exo -67.25 130.44 22.63 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.043 1.162 . . . . 0.0 109.42 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -72.2 107.17 4.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.727 ' HB ' ' HZ1' ' A' ' 59' ' ' LYS . 2.9 tp -71.07 96.75 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 122.316 1.055 . . . . 0.0 110.038 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 5.3 pt -103.62 152.13 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.107 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HG2' HG21 ' A' ' 57' ' ' VAL . 30.0 mtp180 -125.85 102.95 7.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 28' ' ' ALA . 2.6 mm? -87.62 137.62 32.17 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -122.13 112.26 17.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.87 144.26 56.83 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 1.027 ' HG2' HG11 ' A' ' 7' ' ' VAL . 61.7 mtp180 -74.98 -18.96 60.29 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.446 -166.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 -9.62 60.33 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.806 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.3 p -111.86 149.44 31.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.894 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -95.63 18.22 13.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -100.39 139.97 35.31 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.653 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.02 117.37 48.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.696 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.605 ' HA ' HD11 ' A' ' 89' ' ' ILE . 42.3 m-70 -96.85 99.55 11.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.888 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.576 HG21 ' HG2' ' A' ' 46' ' ' ARG . 7.5 p -98.32 127.27 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 1.4 m-85 -137.68 124.02 20.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.01 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.727 ' HZ1' ' HB ' ' A' ' 44' ' ' ILE . 26.7 mtpp -71.13 107.62 4.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.996 160.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.974 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -95.24 145.98 24.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.659 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 19.8 p90 -158.68 143.25 15.88 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.335 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.638 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 30.5 mtmt -103.62 124.51 48.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.577 ' HG2' ' CG ' ' A' ' 39' ' ' LYS . 3.6 tp10 -150.89 154.78 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.297 0.57 . . . . 0.0 111.392 -166.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.724 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 92.1 mt -118.44 121.18 66.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.626 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.56 HG22 ' NH2' ' A' ' 71' ' ' ARG . 34.7 m -122.93 151.05 26.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -79.91 -175.56 5.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -48.5 160.07 0.48 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 125.771 1.628 . . . . 0.0 114.791 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 71' ' ' ARG . 42.1 Cg_endo -67.08 67.49 0.59 Allowed 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 124.116 3.211 . . . . 0.0 116.167 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -93.1 -7.78 44.56 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 161.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -133.51 2.01 3.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.067 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.937 HH22 HD12 ' A' ' 79' ' ' ILE . 67.0 mtt-85 -118.23 167.73 10.84 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -158.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.55 ' HD2' ' HE2' ' A' ' 75' ' ' MET . 25.4 Cg_exo -67.39 149.88 80.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.207 2.605 . . . . 0.0 109.364 154.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.01 19.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -167.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.622 ' CH2' ' HE3' ' A' ' 75' ' ' MET . 65.2 p-90 -95.27 -21.48 18.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.693 ' HB3' ' HD3' ' A' ' 71' ' ' ARG . 10.3 ttm -81.87 130.6 60.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.336 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HD2' HG21 ' A' ' 79' ' ' ILE . 3.0 Cg_endo -74.48 177.47 8.34 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.839 2.36 . . . . 0.0 112.448 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.91 ' HA ' ' HA ' ' A' ' 67' ' ' ALA . 1.9 mp0 -51.81 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.876 0.735 . . . . 0.0 109.036 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -89.54 130.0 35.92 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.436 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.937 HD12 HH22 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.21 151.12 15.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.598 ' HB3' HG12 ' A' ' 64' ' ' ILE . 9.1 p -124.88 125.74 44.44 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.833 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 73.0 mmtt -159.28 144.26 11.55 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.671 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 3.0 Cg_exo -73.18 96.1 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 0.0 110.493 163.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.503 ' O ' HG11 ' A' ' 84' ' ' VAL . 80.2 m-85 -78.66 172.72 13.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.691 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -173.08 117.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.23 -173.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 118.14 34.56 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.875 157.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 3.6 ptpp? -55.13 139.57 41.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.236 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.9 -31.98 31.18 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.69 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 173.63 -174.68 0.06 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.097 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 56' ' ' HIS . 31.2 mm -127.84 110.02 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.873 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.89 -176.34 2.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.335 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 21.4 mtmt . . . . . 0 C--N 1.312 -1.065 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.69 ' NH1' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -95.76 156.11 16.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.877 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -121.61 132.4 54.65 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.229 -0.295 . . . . 0.0 110.532 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.575 ' HD1' ' NH2' ' A' ' 4' ' ' ARG . 61.2 m-85 -143.74 134.07 24.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.76 133.89 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.774 ' HB2' ' HE2' ' A' ' 19' ' ' PHE . 2.4 tp -66.17 149.36 50.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.44 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.668 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 76.9 mtp180 -118.77 124.16 46.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 163.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -87.03 175.5 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.668 -169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -44.42 -44.77 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 124.122 0.889 . . . . 0.0 112.965 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -41.54 89.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.456 0.646 . . . . 0.0 110.89 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.05 25.78 2.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.96 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 p30 -110.55 170.37 8.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -95.82 141.89 28.73 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.051 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 -132.4 -178.99 5.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.823 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -20.26 126.27 0.01 OUTLIER Glycine 0 C--N 1.328 0.135 0 O-C-N 125.876 1.985 . . . . 0.0 114.884 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.09 125.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.253 0.549 . . . . 0.0 109.939 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.774 ' HE2' ' HB2' ' A' ' 8' ' ' LEU . 6.9 m-85 -112.72 149.37 33.04 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -135.8 141.98 44.81 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.3 -175.37 27.19 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.624 -1.275 . . . . 0.0 112.814 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -87.01 -31.79 20.38 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.57 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.603 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 18.6 pt20 -154.15 155.94 31.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 9.3 Cg_endo -50.84 -23.37 11.54 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.154 3.236 . . . . 0.0 114.398 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -58.01 -54.28 48.73 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 123.168 0.292 . . . . 0.0 110.858 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.475 HE21 HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -43.97 77.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.263 0.554 . . . . 0.0 111.106 175.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.69 ' HB1' ' NH1' ' A' ' 4' ' ' ARG . . . -55.96 -35.41 66.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.704 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.967 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -89.25 -21.49 23.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.349 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 1.3 mp -64.63 -63.55 1.1 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -39.62 -16.87 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.323 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 29' ' ' LEU . . . -95.53 -50.95 4.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.219 0.533 . . . . 0.0 110.421 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.735 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -63.76 -29.46 70.67 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.412 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -4.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 32' ' ' ALA . 60.9 ttt180 -87.2 -59.92 2.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.69 -130.86 6.11 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.043 150.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.3 m 68.05 19.71 9.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.465 0.706 . . . . 0.0 111.886 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.14 146.55 17.84 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.186 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -125.37 176.28 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -58.8 -36.0 73.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.195 0.521 . . . . 0.0 110.783 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.92 -25.08 61.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.626 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.57 82.44 3.02 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.764 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.4 Cg_exo -84.8 136.28 6.06 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.245 2.63 . . . . 0.0 111.245 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.62 173.27 9.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.781 HD11 ' HE3' ' A' ' 59' ' ' LYS . 28.9 mm -111.04 118.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.113 0.482 . . . . 0.0 111.125 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.595 ' O ' HD11 ' A' ' 45' ' ' ILE . 2.9 pp -122.9 130.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.977 0.894 . . . . 0.0 111.622 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.807 ' HG2' HG23 ' A' ' 57' ' ' VAL . 48.1 mtm180 -105.89 114.32 28.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.961 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 28' ' ' ALA . 3.3 mm? -82.2 164.0 21.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.691 0.758 . . . . 0.0 109.781 168.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.668 ' HD2' ' HD2' ' A' ' 9' ' ' ARG . 51.1 ttt180 -132.22 140.32 48.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.483 ' HB3' ' CG2' ' A' ' 52' ' ' THR . 17.5 tt0 -83.62 72.26 10.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 47.21 -64.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 111.456 -2.611 . . . . 0.0 113.612 -166.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.94 52.71 0.58 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.993 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.483 ' CG2' ' HB3' ' A' ' 49' ' ' GLU . 8.2 p -95.21 160.16 14.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.556 -0.379 . . . . 0.0 111.417 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.98 -21.95 58.84 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -100.94 111.71 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.062 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.562 HG21 HH11 ' A' ' 9' ' ' ARG . 98.1 t -86.6 132.36 32.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.246 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.445 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 90.0 m-70 -84.82 138.73 32.4 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.807 HG23 ' HG2' ' A' ' 46' ' ' ARG . 86.3 t -130.79 117.34 37.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.101 -171.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.787 ' HB3' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -129.11 139.94 51.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.781 ' HE3' HD11 ' A' ' 44' ' ' ILE . 24.0 mttp -70.32 161.32 30.63 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 162.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.735 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -153.47 142.52 21.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.59 -171.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 35.8 p90 -162.01 -166.88 1.52 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 87.3 mttt -143.34 136.69 28.14 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 80' ' ' SER . 30.9 mm-40 -145.39 171.39 14.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.979 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.53 74.58 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 122.292 1.044 . . . . 0.0 108.223 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 78' ' ' LYS . 27.5 m -85.6 -167.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.691 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.465 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 16.9 t70 -131.76 125.05 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.734 -171.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.816 ' HB1' ' HE2' ' A' ' 78' ' ' LYS . . . -120.34 141.24 31.51 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.073 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.95 -165.71 0.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.434 2.756 . . . . 0.0 113.519 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -51.63 -19.78 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.78 7.4 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 0.0 110.768 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.481 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 8.5 ptt180 -81.22 163.25 55.9 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.323 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 12.6 Cg_exo -68.03 166.1 25.96 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.355 2.037 . . . . 0.0 112.071 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.02 -22.51 20.75 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.467 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 60.8 p-90 -74.33 -29.38 61.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.403 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 18.4 ttp -99.3 145.94 30.9 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.417 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.4 175.5 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 110.028 168.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.4 mp0 -41.02 -62.68 0.78 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.816 ' HE2' ' HB1' ' A' ' 67' ' ' ALA . 65.8 mmtt -152.01 -173.93 4.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.169 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.649 HD13 ' CG ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -161.56 160.79 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.49 -160.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -73.34 79.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.756 0.788 . . . . 0.0 109.977 -176.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.649 ' CG ' HD13 ' A' ' 79' ' ' ILE . 66.2 mmtt -113.03 162.08 23.59 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.477 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.515 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 25.7 Cg_endo -62.44 119.07 6.0 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.982 2.455 . . . . 0.0 110.903 170.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.549 ' HE2' ' HB2' ' A' ' 63' ' ' GLU . 23.2 m-85 -107.61 176.25 5.21 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.967 HG11 ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -165.55 173.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -162.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 179.47 99.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.565 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 18.1 ttpp -68.86 103.81 1.89 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.627 0.727 . . . . 0.0 112.225 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 12.4 pt-20 -106.05 2.15 27.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.998 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.507 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 10.1 ptm180 -174.77 175.54 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.288 0.566 . . . . 0.0 111.672 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.461 HD12 ' HD2' ' A' ' 86' ' ' LYS . 23.2 mm -132.56 145.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.561 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -113.95 177.64 4.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 91' ' ' LYS . 1.6 mtmt . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.517 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 29.8 m . . . . . 0 N--CA 1.446 -0.632 0 CA-C-O 121.378 0.608 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -83.76 144.99 28.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.02 0.914 . . . . 0.0 112.182 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -96.14 134.97 38.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.19 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.509 ' HB3' HD13 ' A' ' 47' ' ' LEU . 70.6 m-85 -130.51 146.43 52.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.736 0.779 . . . . 0.0 111.004 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.811 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 9.5 t -96.01 149.01 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.804 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 10.5 tp -113.54 147.79 37.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.99 162.9 37.84 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 170.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 11' ' ' GLU . 3.4 m-20 -84.83 -160.58 0.5 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 171.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.639 ' OE1' ' HD3' ' A' ' 46' ' ' ARG . 5.3 mm-40 -91.05 0.53 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.79 -16.45 13.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.741 -168.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.442 ' HA2' ' NH2' ' A' ' 9' ' ' ARG . . . 104.62 35.44 3.29 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.472 -1.347 . . . . 0.0 112.249 -176.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 18.4 m120 -107.74 101.71 10.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.94 122.54 27.9 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.064 0.459 . . . . 0.0 110.859 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 92.3 m-70 -110.05 -167.01 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.864 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 16' ' ' HIS . . . -52.27 166.33 1.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.873 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 94.6 t -95.36 110.81 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.493 0.664 . . . . 0.0 110.185 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.497 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 m-85 -86.55 120.05 27.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.549 1.166 . . . . 0.0 112.225 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.517 ' HB ' ' CG2' ' A' ' 3' ' ' THR . 21.3 p -86.9 142.23 28.17 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.383 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.21 139.23 4.27 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -63.64 -20.18 65.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.846 0.823 . . . . 0.0 110.568 -175.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.523 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 13.5 pt20 -161.1 165.5 16.94 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.3 Cg_exo -43.85 -51.8 6.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.967 2.445 . . . . 0.0 112.97 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.426 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 39.2 ttt180 -51.0 -41.93 60.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.5 HE22 HD21 ' A' ' 29' ' ' LEU . 14.5 mm100 -78.29 -33.56 49.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 0.0 111.26 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.15 79.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.502 0.667 . . . . 0.0 109.635 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.576 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -69.82 -32.73 71.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.215 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.5 HD21 HE22 ' A' ' 26' ' ' GLN . 0.8 OUTLIER -55.88 -59.51 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -50.71 -24.34 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.138 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.497 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -90.47 -25.11 20.48 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.713 -0.617 . . . . 0.0 110.246 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -88.63 -16.28 32.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.292 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -15.39 56.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.592 -173.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.51 -28.92 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 110.673 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.38 102.8 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 m -59.12 -41.66 88.73 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.098 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.23 -139.6 0.41 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 123.931 0.77 . . . . 0.0 111.788 -170.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -147.29 171.18 15.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HZ2' ' HZ2' ' A' ' 61' ' ' TRP . 8.1 tppt? -62.14 -28.2 69.48 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.094 0.474 . . . . 0.0 110.679 173.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.53 -24.17 25.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.45 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.1 p-10 -143.93 64.6 13.1 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.425 0.631 . . . . 0.0 110.238 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.707 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 19.7 Cg_exo -64.81 150.17 88.53 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.634 2.223 . . . . 0.0 112.599 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.71 124.46 28.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.6 HD11 ' HE2' ' A' ' 59' ' ' LYS . 17.5 mm -74.6 117.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.785 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.441 HD11 HG13 ' A' ' 84' ' ' VAL . 17.7 pt -107.16 139.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.696 0.76 . . . . 0.0 111.397 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.643 ' O ' HD21 ' A' ' 47' ' ' LEU . 33.7 mmm-85 -94.89 171.54 8.71 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.948 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -154.56 94.74 1.72 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.656 -177.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.811 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.2 ttp180 -78.9 143.39 35.91 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 131.74 54.09 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.01 19.03 7.13 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.279 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.75 -18.05 1.81 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.703 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.2 p -124.32 179.64 4.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.239 0.52 . . . . 0.0 111.326 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -108.11 33.64 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.527 0.68 . . . . 0.0 109.513 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -133.4 123.66 25.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.492 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 48' ' ' ARG . 50.0 t -94.37 125.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.088 0.47 . . . . 0.0 109.918 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.414 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 33.7 m-70 -81.13 146.79 30.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.516 ' C ' ' HD1' ' A' ' 58' ' ' PHE . 8.3 p -135.13 127.33 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.422 0.629 . . . . 0.0 111.042 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HD1' ' C ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -129.55 143.09 50.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 175.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.707 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -68.53 171.68 7.19 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.565 159.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.634 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -171.63 133.05 0.76 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.132 0.491 . . . . 0.0 109.823 -161.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.455 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 41.4 p90 -158.28 -177.48 6.58 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 55.0 mtmt -131.7 142.75 49.89 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.931 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.686 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 34.0 mt-10 -131.06 175.01 9.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.548 -0.751 . . . . 0.0 108.983 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.867 HD11 ' HB3' ' A' ' 78' ' ' LYS . 9.5 tt -95.53 134.9 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.411 1.1 . . . . 0.0 112.234 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.802 HG23 ' HG3' ' A' ' 81' ' ' LYS . 32.1 m -135.15 -174.4 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.166 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 4.2 p-10 -99.88 165.53 11.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 77' ' ' GLU . . . -142.05 -177.16 0.63 Allowed Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -167.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.731 ' HD2' ' HD2' ' A' ' 71' ' ' ARG . 58.9 Cg_endo -83.94 148.7 12.19 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.812 1.675 . . . . 0.0 111.236 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -78.29 2.55 18.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.692 -172.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.439 ' OD1' ' HB2' ' A' ' 68' ' ' PRO . 26.1 p-10 -92.07 7.85 40.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.315 0.579 . . . . 0.0 110.825 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.731 ' HD2' ' HD2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -69.24 171.64 6.39 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.633 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.849 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 68.6 Cg_exo -53.15 178.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.403 2.735 . . . . 0.0 114.297 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.38 81.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.834 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CH2' ' HE1' ' A' ' 75' ' ' MET . 42.5 p-90 -81.37 -39.48 24.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.849 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 44.9 ttm -77.04 115.47 48.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.534 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 74' ' ' TRP . 76.9 Cg_endo -109.3 -155.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.678 2.919 . . . . 0.0 112.026 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.723 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 4.6 pt-20 -52.11 -59.65 4.12 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.769 167.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.867 ' HB3' HD11 ' A' ' 64' ' ' ILE . 18.6 mmtp -76.64 114.0 14.9 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.195 -172.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -163.79 -178.42 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.29 -175.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' ILE . 2.8 p -73.75 158.54 34.43 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.177 0.513 . . . . 0.0 111.968 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.802 ' HG3' HG23 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -162.23 136.15 4.87 Favored Pre-proline 0 C--O 1.22 -0.486 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -171.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.63 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 76.3 Cg_exo -52.4 153.98 12.4 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.87 2.38 . . . . 0.0 113.9 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.686 ' CE1' ' HB2' ' A' ' 63' ' ' GLU . 70.2 m-85 -165.93 157.41 13.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.576 HG12 ' HB3' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -165.21 169.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -166.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.416 ' H ' HG11 ' A' ' 84' ' ' VAL . 59.4 tttp -171.17 98.93 0.21 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.599 0.238 . . . . 0.0 110.519 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.463 ' HE3' HD13 ' A' ' 89' ' ' ILE . 67.2 tttt -53.02 128.26 26.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.523 170.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.532 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 3.4 pm0 -130.85 -5.78 4.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.562 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.469 ' HB3' HG13 ' A' ' 57' ' ' VAL . 8.6 ttp180 -171.24 174.56 4.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.37 -166.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.463 HD13 ' HE3' ' A' ' 86' ' ' LYS . 17.4 mm -136.1 137.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.41 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -111.14 176.82 4.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.798 0.809 . . . . 0.0 111.579 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt . . . . . 0 C--N 1.313 -0.984 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.894 -176.032 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 121.163 0.506 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 27.7 mmm180 -92.76 137.5 32.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.343 1.068 . . . . 0.0 111.208 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.414 ' HB3' ' HG3' ' A' ' 50' ' ' ARG . 1.1 m-80 -106.73 116.65 32.3 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.85 -1.977 . . . . 0.0 111.301 -175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 91.0 m-85 -129.99 177.32 7.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.567 1.175 . . . . 0.0 112.422 -174.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.865 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 35.2 t -147.68 149.94 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.521 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.8 tp -96.83 158.33 15.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.623 HH11 HG23 ' A' ' 55' ' ' VAL . 49.4 mtp180 -124.79 147.19 48.84 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 12.8 t70 -69.65 -167.65 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.9 0.318 . . . . 0.0 111.015 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 26.3 mm-40 -61.83 -39.59 92.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 111.435 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.79 -37.61 22.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.474 0.654 . . . . 0.0 109.702 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 9' ' ' ARG . . . 132.51 45.0 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 118.721 -1.705 . . . . 0.0 112.063 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.4 -97.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -173.95 137.23 0.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 88.1 m-70 -144.6 166.25 25.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.154 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 34.53 -171.86 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.86 110.89 7.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.792 -1.704 . . . . 0.0 106.638 163.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.04 106.11 16.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.871 1.319 . . . . 0.0 113.364 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.0 p -91.08 117.29 29.48 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.877 170.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.66 169.5 24.59 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 113.776 -1.557 . . . . 0.0 111.947 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.82 -11.28 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.655 0.741 . . . . 0.0 110.293 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -160.82 147.12 11.52 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.391 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 53.8 Cg_exo -43.51 -42.56 11.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.904 . . . . 0.0 113.02 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -60.31 -35.22 75.1 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 86.2 mm-40 -75.92 -39.03 57.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.631 0.729 . . . . 0.0 109.969 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.5 -33.05 75.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.259 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.807 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -83.26 -26.78 30.4 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.39 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 8.3 tt -64.05 -63.9 1.03 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 172.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 66.6 mmtt -31.99 -27.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.058 164.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.91 -37.67 12.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.54 0.686 . . . . 0.0 110.527 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . . . -69.71 -8.66 49.77 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.716 1.206 . . . . 0.0 113.237 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.693 ' ND2' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m-80 -61.96 -51.71 66.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.656 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -63.83 -56.79 12.77 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.914 174.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.425 ' H ' ' HG2' ' A' ' 34' ' ' ARG . . . 83.19 -94.19 1.76 Allowed Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.289 151.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.4 m 63.66 36.77 10.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.217 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.9 159.34 25.98 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.663 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.5 p -125.27 -177.55 3.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.714 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.7 mtmm -72.12 -25.96 61.94 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.62 -28.32 56.06 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.975 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.78 64.53 8.47 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.31 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.645 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 7.1 Cg_exo -64.03 134.94 45.17 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.967 1.778 . . . . 0.0 111.182 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 5.9 p-10 -72.56 176.7 5.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.523 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.543 HG12 ' HE3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -123.77 136.65 59.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -176.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -138.27 136.71 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.739 172.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 57' ' ' VAL . 66.8 ttt180 -112.08 113.05 25.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.922 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.538 HD12 ' CA ' ' A' ' 28' ' ' ALA . 23.3 mt -101.36 104.52 15.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.153 0.978 . . . . 0.0 112.205 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.865 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 68.7 ttt180 -69.93 153.77 42.83 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.25 172.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 51' ' ' GLY . 50.4 tt0 -122.07 129.47 52.42 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -94.61 18.74 10.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.51 0.671 . . . . 0.0 110.507 176.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -110.98 -58.1 0.48 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.408 HG23 ' CD ' ' A' ' 49' ' ' GLU . 6.4 p -93.06 175.34 6.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 0.0 110.877 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -93.72 11.3 29.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.542 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 91' ' ' LYS . 94.7 mttt -108.52 133.67 52.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.837 -174.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.857 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 93.6 t -101.59 128.27 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.504 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.425 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 22.8 m-70 -94.51 128.63 41.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.555 HG21 ' HG3' ' A' ' 46' ' ' ARG . 39.7 t -111.7 123.54 67.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.043 0.449 . . . . 0.0 110.686 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.98 ' HB3' HG12 ' A' ' 84' ' ' VAL . 34.6 m-85 -131.03 126.86 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.266 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 19.4 mttp -71.13 154.93 41.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.392 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.597 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . . . -135.35 147.06 48.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.494 -170.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.714 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 18.9 p90 -161.51 -179.38 7.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 45.0 mtmt -138.28 136.05 36.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.737 ' O ' ' HA ' ' A' ' 80' ' ' SER . 56.1 mm-40 -151.42 173.15 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.409 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.463 HG23 ' HA ' ' A' ' 79' ' ' ILE . 4.1 mp -109.37 83.34 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.973 0.892 . . . . 0.0 108.609 168.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.697 ' C ' ' HB2' ' A' ' 78' ' ' LYS . 27.2 m -88.59 -162.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.452 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 14.6 t70 -134.02 90.6 2.71 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.898 -168.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 77' ' ' GLU . . . -70.79 154.12 94.47 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.048 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 15.3 Cg_exo -70.71 -158.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.411 2.741 . . . . 0.0 113.565 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -75.05 -23.41 58.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -84.22 17.2 2.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.616 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 18.0 ptt-85 -72.89 170.56 13.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.121 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.66 168.45 24.79 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.899 2.399 . . . . 0.0 112.437 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.7 -20.82 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.379 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.94 -27.09 33.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.498 ' HG2' ' HD2' ' A' ' 76' ' ' PRO . 29.7 ttm -94.56 145.02 28.9 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.498 ' HD2' ' HG2' ' A' ' 75' ' ' MET . 14.0 Cg_exo -67.87 -176.96 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.923 1.748 . . . . 0.0 109.849 167.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.616 ' HA ' ' CD ' ' A' ' 71' ' ' ARG . 34.9 mt-10 -44.99 -67.37 0.29 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.697 ' HB2' ' C ' ' A' ' 65' ' ' VAL . 20.8 mmtp -151.1 -177.18 5.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.247 167.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.679 HD11 ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -157.45 173.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.292 -161.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.737 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 12.4 p -64.59 85.53 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.828 1.33 . . . . 0.0 110.855 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.898 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -117.84 167.13 11.79 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.03 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.693 ' HG2' ' ND2' ' A' ' 33' ' ' ASN . 7.4 Cg_exo -77.73 128.19 9.21 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.523 2.815 . . . . 0.0 110.57 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 20.5 m-85 -126.47 123.56 38.11 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.98 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -119.38 128.8 75.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.344 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.9 pttt -106.05 169.9 8.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.6 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -109.44 106.43 16.18 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -171.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG2' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.57 -6.82 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.829 -172.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -176.4 161.94 2.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 mm -131.81 141.37 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.512 0.673 . . . . 0.0 110.407 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.857 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 69.3 mm-40 -128.1 178.6 6.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.603 -173.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 53.3 mtmt . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.163 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.789 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 5.0 ptm180 -93.86 125.47 38.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.26 1.029 . . . . 0.0 111.766 -171.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.482 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.9 OUTLIER -87.8 145.75 25.95 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.389 -178.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.649 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 39.7 m-85 -128.9 170.86 12.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.889 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 50' ' ' ARG . 15.9 t -130.1 142.41 43.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.614 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 4.0 tp -76.68 124.95 28.42 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.889 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.737 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 6.8 mmm180 -96.62 130.17 43.87 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 14' ' ' ASN . 42.7 p30 -88.34 -171.61 3.43 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.788 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -42.36 -46.69 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.58 -37.23 25.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 111.174 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 9' ' ' ARG . . . 123.0 36.55 0.66 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.731 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 27.2 m-80 -85.98 -178.21 6.5 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.809 0.337 . . . . 0.0 110.294 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' HG13 ' A' ' 7' ' ' VAL . 43.7 mt-10 -105.13 117.99 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.527 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.613 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 79.6 m-70 -137.57 104.27 5.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.911 0.862 . . . . 0.0 111.278 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.75 147.22 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.59 161.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 80.7 m-85 -150.71 159.59 44.42 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -170.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.4 ' OG1' ' HE3' ' A' ' 30' ' ' LYS . 32.0 p -141.25 158.2 44.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.777 0.323 . . . . 0.0 111.254 -176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.789 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.86 162.61 27.68 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.707 ' H ' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -87.78 0.41 55.8 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.919 0.866 . . . . 0.0 108.889 173.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.669 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 27.0 tt0 -161.33 151.58 14.58 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.273 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 7.9 Cg_exo -43.12 -60.35 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.559 2.173 . . . . 0.0 112.756 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.571 ' HB3' HE21 ' A' ' 23' ' ' GLN . 38.5 ttt180 -33.89 -42.29 0.11 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.249 167.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.668 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.68 -30.35 59.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 117.938 0.336 . . . . 0.0 111.592 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . -63.01 -63.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.903 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -41.05 -39.02 1.12 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.567 165.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 26' ' ' GLN . 1.6 tp -61.78 -14.59 34.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.106 0.479 . . . . 0.0 111.228 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 60.0 mmtt -87.33 -55.45 3.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.61 -30.05 29.27 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -61.52 -29.5 70.03 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.663 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.82 2.15 0.33 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -110.12 -55.02 2.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.564 -162.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.03 -33.8 5.9 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 118.963 -1.589 . . . . 0.0 112.944 165.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 t 73.68 -3.86 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.023 0.529 . . . . 0.0 111.371 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.7 -140.39 0.42 Allowed Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 0.0 112.901 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -150.08 167.72 25.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 165.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -58.79 -31.5 68.47 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.4 0.619 . . . . 0.0 110.4 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.43 27.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.363 -173.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.91 70.42 8.61 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.441 0.639 . . . . 0.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.722 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 25.9 Cg_exo -62.15 166.87 11.82 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.712 2.275 . . . . 0.0 111.477 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -97.2 150.06 21.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.689 HD13 ' HD3' ' A' ' 59' ' ' LYS . 23.0 mm -96.17 102.45 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.895 0.855 . . . . 0.0 112.215 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.418 ' O ' HD11 ' A' ' 45' ' ' ILE . 2.7 pp -118.98 142.05 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.076 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.633 ' HB3' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -129.32 131.72 46.98 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.773 165.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.902 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.4 mm? -90.3 161.12 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.735 0.779 . . . . 0.0 112.118 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.737 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . 18.7 ttp85 -125.01 133.23 53.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.35 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -82.66 72.9 9.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.203 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.695 ' HG2' HG22 ' A' ' 7' ' ' VAL . 35.8 mtp180 30.78 -90.14 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.884 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.61 3.01 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.198 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.833 HG22 ' HE2' ' A' ' 54' ' ' LYS . 54.7 p -138.35 166.29 24.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 110.171 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -112.44 36.46 3.39 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.833 ' HE2' HG22 ' A' ' 52' ' ' THR . 61.0 pttt -124.82 141.23 52.26 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.637 -176.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.593 HG23 ' HE ' ' A' ' 9' ' ' ARG . 10.8 t -124.83 144.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.759 0.314 . . . . 0.0 111.71 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.902 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 7.7 p80 -122.53 118.99 29.58 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.887 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . 60.8 t -85.1 119.83 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.925 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.97 ' HB3' HG12 ' A' ' 84' ' ' VAL . 8.1 m-85 -131.6 124.98 31.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.722 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 16.9 ttpt -85.57 122.57 29.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.807 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -119.57 144.55 47.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -164.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 9.3 p90 -162.55 175.2 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 14.2 mtpp -142.0 107.47 5.05 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.915 173.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 63' ' ' GLU . 7.0 pt-20 177.4 89.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.039 0.936 . . . . 0.0 112.169 159.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.588 HG21 ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -170.28 102.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.242 -1.536 . . . . 0.0 111.951 167.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.791 HG11 ' HE3' ' A' ' 81' ' ' LYS . 2.1 m -142.97 148.51 19.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 120.706 1.594 . . . . 0.0 110.823 164.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.13 72.15 1.64 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.63 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' HB1' ' HG2' ' A' ' 71' ' ' ARG . . . -54.13 135.71 58.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.495 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.3 Cg_exo -78.28 -148.97 0.03 OUTLIER 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 123.915 3.077 . . . . 0.0 113.078 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -94.81 -42.03 8.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.461 173.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -71.02 31.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.913 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.498 ' HG2' ' HB1' ' A' ' 67' ' ' ALA . 97.9 mtt180 -62.91 162.67 20.35 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.449 0.642 . . . . 0.0 111.981 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.615 ' HG2' ' HE3' ' A' ' 75' ' ' MET . 14.1 Cg_exo -72.61 151.11 52.12 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.463 2.775 . . . . 0.0 109.768 163.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.33 64.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.62 -171.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -88.42 -25.38 22.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.637 ' CG ' HG23 ' A' ' 79' ' ' ILE . 41.1 ttm -84.99 125.62 70.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -169.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 79' ' ' ILE . 60.2 Cg_endo -91.07 -162.48 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.253 2.635 . . . . 0.0 112.362 173.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -51.84 -68.84 0.14 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.924 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.5 mmmt -118.38 138.69 52.26 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.637 HG23 ' CG ' ' A' ' 75' ' ' MET . 0.7 OUTLIER -148.01 169.15 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-O 121.21 0.529 . . . . 0.0 109.645 -169.033 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 33.8 p -99.16 155.49 17.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.155 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.791 ' HE3' HG11 ' A' ' 65' ' ' VAL . 12.5 mmtp -158.34 150.14 17.12 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HA ' ' CG ' ' A' ' 62' ' ' LYS . 52.3 Cg_exo -53.83 91.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 CA-C-N 121.455 1.555 . . . . 0.0 112.899 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 64' ' ' ILE . 14.4 m-85 -89.78 142.58 27.55 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.267 1.032 . . . . 0.0 111.342 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.97 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -146.51 151.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.08 178.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -135.63 103.07 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.717 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 82.8 tttt -66.99 120.37 13.52 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.136 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.64 -15.05 7.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 2.6 ttm180 -166.95 171.61 11.03 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -170.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.608 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 10.4 mm -137.66 136.2 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.7 mm-40 -116.93 140.02 49.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt . . . . . 0 C--N 1.311 -1.078 0 CA-C-O 121.357 0.598 . . . . 0.0 111.399 -176.122 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.502 ' O ' ' HD2' ' A' ' 4' ' ' ARG . 26.3 m . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.549 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 11.8 mmm180 -126.68 171.51 11.1 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 108.62 7.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 120.973 0.416 . . . . 0.0 110.42 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.549 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 13.8 m-85 -113.16 149.29 33.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.71 0.767 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.02 141.54 19.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.92 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 19.0 tp -92.59 156.37 17.16 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.426 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.537 ' HG3' ' HD2' ' A' ' 48' ' ' ARG . 16.7 mtp85 -143.76 113.77 7.26 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.7 t70 -105.79 170.0 8.16 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.291 -170.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -27.7 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 O-C-N 125.197 1.561 . . . . 0.0 113.048 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.88 -39.36 62.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.636 0.732 . . . . 0.0 111.236 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 94.05 33.94 6.71 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.485 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 84.8 m-20 -142.5 -174.7 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -82.02 154.19 25.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.583 0.706 . . . . 0.0 110.831 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 9.6 m-70 -135.06 -165.18 1.63 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.404 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -46.3 157.64 0.42 Allowed Glycine 0 CA--C 1.518 0.266 0 O-C-N 123.983 0.802 . . . . 0.0 114.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.55 105.71 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.639 0.733 . . . . 0.0 109.481 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 61.6 m-85 -87.28 113.96 23.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.548 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -95.56 141.88 28.56 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.082 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 164.76 37.97 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -74.0 -19.29 60.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 118.616 1.208 . . . . 0.0 111.259 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 26.6 pt20 -157.94 168.89 11.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.7 Cg_exo -45.8 -60.76 0.74 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.686 2.257 . . . . 0.0 112.724 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -39.66 -49.66 2.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.239 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.558 ' HG2' ' HG2' ' A' ' 23' ' ' GLN . 13.1 mm100 -73.12 -24.42 60.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.701 0.286 . . . . 0.0 111.401 -174.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 30' ' ' LYS . . . -74.37 -41.12 61.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.415 0.626 . . . . 0.0 109.666 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 45' ' ' ILE . . . -68.98 -35.72 77.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.008 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 9.7 tt -53.78 -55.39 26.91 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 69.6 mmtt -43.7 -43.48 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -73.32 -23.43 60.25 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.85 -0.531 . . . . 0.0 111.549 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.957 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -68.0 -11.88 59.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.602 0.715 . . . . 0.0 110.686 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.4 m-80 -78.88 3.0 18.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.658 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.4 mmp_? -89.59 -28.37 19.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.93 38.18 49.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.677 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.609 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . 13.8 m -97.48 5.27 49.9 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.173 0.511 . . . . 0.0 109.932 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.25 157.07 26.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.178 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 p -128.45 -177.47 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 12.8 tptm -61.16 -31.8 71.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.997 0.427 . . . . 0.0 110.732 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -38.51 25.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.68 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.24 75.1 75.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 121.116 0.484 . . . . 0.0 110.636 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.669 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 23.3 Cg_exo -67.29 158.12 58.47 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.71 2.274 . . . . 0.0 113.333 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.609 ' OD1' ' HB2' ' A' ' 36' ' ' SER . 15.8 m-20 -71.91 94.12 1.41 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.847 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 tp -72.92 95.65 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.983 0.897 . . . . 0.0 109.372 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 28' ' ' ALA . 6.2 pt -109.58 152.23 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.914 -172.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.697 ' HB3' HG12 ' A' ' 55' ' ' VAL . 74.3 mtp180 -114.55 118.53 34.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 6' ' ' PHE . 2.4 mm? -111.13 130.87 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.637 0.653 . . . . 0.0 109.412 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.652 ' HG2' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -122.3 118.76 29.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -77.97 107.19 10.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -47.37 102.61 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.296 0 O-C-N 124.019 0.824 . . . . 0.0 111.481 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.4 -25.26 3.01 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.102 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.8 p -92.49 167.47 11.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 24.7 ttmm -111.77 8.97 20.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.216 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -136.89 145.16 44.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.183 0.516 . . . . 0.0 110.96 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.729 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.1 t -101.71 136.41 33.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.958 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 4.4 m-70 -101.0 128.71 46.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 88' ' ' ARG . 12.8 p -114.31 130.55 68.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.549 0.69 . . . . 0.0 110.45 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.746 ' CB ' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -143.13 136.26 28.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.13 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 53.3 mttp -71.15 109.45 5.21 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.231 163.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.957 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -94.6 145.85 24.54 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 83' ' ' PHE . 13.6 p90 -170.15 146.61 3.02 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.847 ' HE3' ' HG3' ' A' ' 82' ' ' PRO . 11.8 mtpt -101.47 136.23 41.67 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.702 ' O ' ' HA ' ' A' ' 80' ' ' SER . 3.7 tp10 -163.73 158.95 20.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 112.036 -166.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 39.3 mt -103.54 130.61 53.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.42 150.47 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.484 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.94 93.82 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.914 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.475 ' HB1' ' HD3' ' A' ' 72' ' ' PRO . . . -51.25 136.27 30.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.404 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HG2' ' HG3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -4.9 -148.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 1 C-N-CA 127.836 5.69 . . . . 0.0 118.22 -165.4 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -51.88 -57.57 8.99 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.503 173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -132.85 -42.83 0.9 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.304 168.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ARG . 8.4 mmt180 -144.68 148.04 38.15 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.217 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 1.004 ' HG2' ' HB3' ' A' ' 75' ' ' MET . 5.5 Cg_exo -90.98 166.58 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.434 2.756 . . . . 0.0 108.31 147.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.78 58.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.636 0.731 . . . . 0.0 111.198 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.549 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 58.3 p-90 -109.29 -33.71 6.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.389 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 1.004 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttp -99.44 144.39 28.18 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -167.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' HD2' HG21 ' A' ' 79' ' ' ILE . 7.0 Cg_exo -73.52 157.18 49.28 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.338 2.692 . . . . 0.0 112.115 169.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -44.19 -48.38 9.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.629 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -138.4 153.67 48.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 175.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.783 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -159.66 -178.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -169.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.702 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 23.1 t -150.72 84.66 1.35 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.394 168.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 26.2 mmtt -97.67 158.16 33.49 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.274 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.847 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 19.9 Cg_exo -63.38 92.44 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.704 1.603 . . . . 0.0 109.31 159.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HE2' ' O ' ' A' ' 63' ' ' GLU . 35.2 m-85 -78.27 -179.52 6.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.571 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' CB ' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -160.92 162.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 79.1 tttt -159.23 98.51 1.43 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.851 0.834 . . . . 0.0 110.709 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.593 ' HB2' ' HD2' ' A' ' 58' ' ' PHE . 11.9 tmtt? -58.75 113.55 2.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.379 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.434 ' CD ' ' HZ3' ' A' ' 59' ' ' LYS . 12.0 pt-20 -119.63 5.97 11.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.029 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.468 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 39.2 ttp-105 176.24 170.15 0.43 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.015 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -120.24 141.12 41.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.729 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.2 mm-40 -112.14 166.66 11.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.293 0.568 . . . . 0.0 111.174 -173.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.256 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.984 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 91.5 m . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 120.782 0.325 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.586 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 1.3 ptm180 -132.77 155.48 48.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -107.15 145.15 32.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.409 0.55 . . . . 0.0 110.306 -174.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.497 ' HB3' HD13 ' A' ' 47' ' ' LEU . 58.5 m-85 -126.49 158.82 35.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.157 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 1.009 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -127.85 125.12 64.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.742 0.782 . . . . 0.0 109.166 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.732 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.5 OUTLIER -69.67 142.86 53.33 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.923 -1.489 . . . . 0.0 111.581 -168.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.05 142.1 28.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.225 171.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -88.87 -162.07 0.82 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.24 -38.65 66.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.345 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -86.19 -38.95 17.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 9' ' ' ARG . . . 121.25 30.26 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.705 171.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 47.8 m-80 -70.92 128.67 36.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.239 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.41 107.18 2.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.695 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.732 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 78.9 m-70 -103.11 -162.8 0.94 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.558 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.56 157.1 10.99 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.9 t -80.62 140.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 12.9 m-85 -124.24 159.25 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 p -128.61 145.75 51.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.092 0.472 . . . . 0.0 110.919 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -178.57 144.01 6.16 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.9 ptmt -70.09 -7.88 44.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.054 0.927 . . . . 0.0 111.549 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HA ' ' HD3' ' A' ' 4' ' ' ARG . 10.0 pt20 -159.29 149.71 15.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.14 174.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.29 -8.46 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.661 3.574 . . . . 0.0 115.079 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 23' ' ' GLN . 55.9 ttt180 -96.69 -25.26 15.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.603 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 25.3 mm-40 -86.84 -8.29 57.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.883 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.69 -48.69 7.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.49 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.275 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 82' ' ' PRO . 1.5 tp -57.2 -56.08 26.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.184 173.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 73.7 mmtt -61.54 -5.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.779 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.34 -40.15 9.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 1.036 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -72.97 -11.18 60.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.162 0.982 . . . . 0.0 109.738 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -83.75 -2.22 55.82 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.37 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -107.43 15.62 24.71 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.12 -167.53 24.76 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -172.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 22.9 m -106.04 -33.21 7.96 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.512 0.156 . . . . 0.0 111.291 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 59.16 171.24 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.11 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.4 m -156.66 128.33 7.17 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.21 -16.88 64.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.145 0.498 . . . . 0.0 111.965 -172.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.26 -22.04 28.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.71 71.96 2.45 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 121.637 0.732 . . . . 0.0 110.283 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.6 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 69.8 Cg_exo -54.77 170.0 0.71 Allowed 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.771 2.981 . . . . 0.0 113.943 -176.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.72 123.14 36.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.469 ' HA ' HD12 ' A' ' 44' ' ' ILE . 21.1 mm -81.55 120.53 33.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.147 0.499 . . . . 0.0 111.211 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.25 141.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 81.6 mtp180 -113.54 122.56 47.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -91.69 127.53 37.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 70.0 ttt-85 -116.66 99.79 7.37 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 85.1 tt0 -70.69 112.23 6.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 1.009 ' HG2' HG12 ' A' ' 7' ' ' VAL . 27.0 mtp180 -47.46 -15.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.05 -38.25 6.48 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.755 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 75.1 p -93.85 165.25 12.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.107 0.48 . . . . 0.0 111.561 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -98.85 7.68 45.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.535 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.776 ' HA ' ' CB ' ' A' ' 91' ' ' LYS . 44.9 mtpt -125.24 148.11 48.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 111.215 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.808 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 26.7 t -93.16 135.73 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.713 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.682 ' HA ' HD11 ' A' ' 89' ' ' ILE . 31.7 m-70 -104.18 100.33 10.07 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.664 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.601 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -93.03 134.85 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CE2' ' HA ' ' A' ' 25' ' ' ARG . 2.8 m-85 -142.56 118.93 10.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.044 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 15.3 ptpt -67.31 114.57 6.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.531 -1.268 . . . . 0.0 112.251 159.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 1.036 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -103.07 151.95 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.46 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.554 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 29.0 p90 -161.29 -172.68 3.5 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.691 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 44.8 mtmt -136.81 136.39 38.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.669 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 80' ' ' SER . 20.4 mm-40 -137.64 129.38 28.52 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.586 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.824 ' HB ' ' HB3' ' A' ' 80' ' ' SER . 3.3 tt -100.41 109.17 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.843 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.08 144.64 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.767 0.794 . . . . 0.0 110.382 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.576 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 21.7 t70 -74.72 103.56 5.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.936 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.584 ' HB1' ' CB ' ' A' ' 71' ' ' ARG . . . -70.19 133.75 87.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.856 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 58.1 Cg_endo -95.47 -160.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.314 3.343 . . . . 0.0 113.333 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -54.61 -56.29 20.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.281 0.562 . . . . 0.0 110.304 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.02 36.26 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.808 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.584 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 17.5 ptt180 -94.09 144.5 28.17 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.766 -0.584 . . . . 0.0 109.553 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 49.7 Cg_exo -59.16 159.83 21.03 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.965 2.444 . . . . 0.0 112.2 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.79 8.26 1.59 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.128 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -121.96 -36.44 3.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.552 ' CG ' HD11 ' A' ' 79' ' ' ILE . 36.8 ttm -72.41 114.99 34.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.987 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.602 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 81.6 Cg_endo -89.69 -177.91 1.54 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 123.138 2.559 . . . . 0.0 113.704 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 4.3 mm-40 -37.12 -52.42 1.0 Allowed 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 112.235 -2.257 . . . . 0.0 114.015 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.558 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -155.34 113.14 3.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.87 0.843 . . . . 0.0 112.059 176.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.602 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -150.0 160.04 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.175 175.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.824 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 14.1 p -110.03 93.41 4.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 160.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.653 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 21.2 mmmt -77.36 156.1 81.47 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.23 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.691 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 4.6 Cg_exo -68.32 90.79 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.254 1.302 . . . . 0.0 110.2 169.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 23.0 m-85 -75.45 175.09 8.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 122.048 0.928 . . . . 0.0 112.081 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 1.8 m -165.16 158.68 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.325 -169.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 6.7 tmtm? -148.83 114.15 5.55 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -75.39 123.67 25.79 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.609 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -101.16 -25.92 13.85 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.609 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 8.6 ptt180 -175.73 -173.11 0.58 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.315 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.682 HD11 ' HA ' ' A' ' 56' ' ' HIS . 16.2 mm -131.96 103.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.808 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 30.8 mt-10 -118.24 112.66 20.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 118.868 -1.133 . . . . 0.0 113.863 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.776 ' CB ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 mmmt . . . . . 0 N--CA 1.436 -1.155 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.359 163.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 21' ' ' GLY . 5.3 t . . . . . 0 N--CA 1.445 -0.687 0 CA-C-O 121.349 0.595 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.421 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.7 ptm180 -85.67 145.88 27.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.452 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.472 ' ND2' HG22 ' A' ' 20' ' ' THR . 7.6 m120 -84.96 147.09 26.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.554 -172.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 67.2 m-85 -135.59 150.32 49.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.89 136.47 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.1 tp -82.25 124.94 30.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HD3' ' HE ' ' A' ' 46' ' ' ARG . 2.6 mtp180 -101.21 166.92 10.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.513 1.149 . . . . 0.0 114.031 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -134.46 178.1 7.25 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.326 -2.215 . . . . 0.0 108.349 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.02 -35.84 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.62 -39.87 11.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -172.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.44 32.83 1.08 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.845 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.04 -173.57 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.293 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.88 107.8 16.52 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.289 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 85.4 m-70 -102.35 75.99 1.52 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.761 0.791 . . . . 0.0 110.053 175.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.65 153.01 0.98 Allowed Glycine 0 C--N 1.302 -1.348 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.865 -172.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.43 139.08 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 32.6 m-85 -123.89 151.02 43.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.472 HG22 ' ND2' ' A' ' 5' ' ' ASN . 22.1 p -114.04 145.42 41.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.5 ' HA3' ' HB1' ' A' ' 27' ' ' ALA . . . -154.81 135.71 4.81 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.893 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -71.83 -9.08 57.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.69 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 5.4 tt0 -160.23 149.01 13.64 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.79 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.69 ' HD2' ' HG2' ' A' ' 23' ' ' GLN . 75.0 Cg_exo -43.85 -9.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.956 3.771 . . . . 0.0 115.514 173.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 26.0 ttt-85 -96.52 -45.2 6.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 43.7 mm-40 -70.02 -16.86 63.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.979 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HB1' ' HA3' ' A' ' 21' ' ' GLY . . . -89.02 -19.08 26.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' A' ' 47' ' ' LEU . . . -94.37 -27.83 15.86 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 26' ' ' GLN . 7.8 tt -64.89 -46.6 81.08 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.642 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 3.4 mmmp? -62.78 -13.02 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.618 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -88.32 -23.79 23.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.622 0.725 . . . . 0.0 109.046 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.908 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -68.1 -10.47 54.28 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.752 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -92.75 2.77 56.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.339 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 34' ' ' ARG . 11.8 mmt85 -100.41 15.17 28.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -173.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 174.5 -147.12 8.96 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -170.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 72.1 m -149.01 -41.87 0.15 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.008 -1.096 . . . . 0.0 109.166 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.79 5.32 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -168.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.1 p -151.99 177.58 10.32 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' A' ' 63' ' ' GLU . 20.5 ttmt -67.44 -31.89 72.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.702 0.763 . . . . 0.0 109.859 172.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.02 -39.47 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.503 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.62 75.42 73.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.79 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 35.9 Cg_exo -63.53 158.54 45.12 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.37 2.047 . . . . 0.0 111.549 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.69 72.68 8.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -54.61 130.59 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.396 -174.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.531 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -128.15 152.98 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.84 0.828 . . . . 0.0 110.867 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.751 ' NH1' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.59 127.46 53.05 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.751 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -118.18 132.55 56.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.623 ' HB2' HH21 ' A' ' 46' ' ' ARG . 41.4 ttt180 -131.03 127.81 39.02 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 30.7 tt0 -71.3 149.77 45.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -67.89 116.18 8.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.351 0.596 . . . . 0.0 111.182 -165.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -8.84 78.92 Favored Glycine 0 C--N 1.318 -0.437 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.247 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 23.1 p -96.86 170.96 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.926 0.393 . . . . 0.0 111.479 -174.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 -8.19 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.229 171.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 57.3 mttp -49.28 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 111.784 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.751 HG12 ' NH1' ' A' ' 46' ' ' ARG . 14.3 t -110.1 101.9 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.751 ' CE1' ' HB3' ' A' ' 47' ' ' LEU . 4.0 p80 -111.3 128.03 55.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.365 172.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.726 HG21 ' HG2' ' A' ' 46' ' ' ARG . 43.0 t -109.17 115.76 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.782 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.96 131.82 53.37 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HG2' HG12 ' A' ' 44' ' ' ILE . 30.8 mtpt -72.83 117.83 15.02 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.688 1.131 . . . . 0.0 110.869 164.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.908 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -108.61 137.81 45.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.247 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -149.99 -174.43 4.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 32' ' ' ALA . 25.0 mtpt -143.04 122.63 13.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.633 ' HG2' ' CE2' ' A' ' 83' ' ' PHE . 12.1 pt-20 -149.62 174.03 13.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.784 HD11 ' HB3' ' A' ' 78' ' ' LYS . 8.2 tt -115.47 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.33 145.94 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.268 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.64 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 11.2 p-10 -80.3 113.54 18.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.967 170.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 77' ' ' GLU . . . -77.41 129.99 75.8 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.073 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -79.81 -177.33 3.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.955 2.437 . . . . 0.0 111.511 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -49.94 -58.64 5.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 110.04 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.51 31.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 75' ' ' MET . 14.7 ptt85 -64.59 151.14 92.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 118.654 0.661 . . . . 0.0 110.068 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.52 147.07 95.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 111.601 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.68 5.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.449 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.0 p-90 -113.87 -24.72 8.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.655 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.579 ' HG2' HG12 ' A' ' 79' ' ' ILE . 22.8 ttp -101.68 118.94 58.58 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.517 ' HD2' HG21 ' A' ' 79' ' ' ILE . 12.8 Cg_exo -65.87 144.91 78.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.565 2.177 . . . . 0.0 113.344 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.727 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 31.0 mp0 -31.43 -54.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.805 1.316 . . . . 0.0 112.322 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HB3' HD11 ' A' ' 64' ' ' ILE . 29.5 mmtp -112.22 134.63 53.65 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.462 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.579 HG12 ' HG2' ' A' ' 75' ' ' MET . 1.1 pp -155.22 146.73 13.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.826 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 t -122.5 121.73 37.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.742 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 6.2 tppt? -154.64 145.76 16.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.472 -168.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HA ' ' CG ' ' A' ' 62' ' ' LYS . 51.0 Cg_exo -52.63 146.86 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.558 1.505 . . . . 0.0 109.474 156.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.742 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 11.2 m-85 -144.44 149.37 35.91 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -169.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.782 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -153.01 150.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 19.4 tptm -141.79 105.97 4.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.215 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.475 ' HE3' HD13 ' A' ' 89' ' ' ILE . 86.8 tttt -73.32 101.89 3.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.514 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 4.5 pt-20 -109.63 -36.73 5.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.705 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 23.9 ttt180 -128.35 152.94 47.57 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.235 0.54 . . . . 0.0 110.455 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.475 HD13 ' HE3' ' A' ' 86' ' ' LYS . 25.5 mm -143.98 159.56 15.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.442 -176.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 20.0 mm-40 -142.26 179.17 7.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 9.9 ptpt . . . . . 0 C--N 1.31 -1.112 0 CA-C-O 122.148 0.975 . . . . 0.0 112.322 -171.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 14.3 m . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.742 0.306 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.664 HH22 ' HG3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -148.94 154.46 39.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -96.76 136.5 37.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.84 0.352 . . . . 0.0 111.759 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HZ ' ' NH2' ' A' ' 4' ' ' ARG . 96.7 m-85 -133.14 129.72 38.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.428 0.632 . . . . 0.0 111.73 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.775 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 3.1 t -103.53 100.83 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.978 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.496 ' HB2' HD22 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -61.89 144.8 54.4 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.921 173.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 9.6 ptm85 -132.49 132.53 42.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 170.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -115.92 169.44 9.23 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.788 -165.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -23.62 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 O-C-N 126.452 2.345 . . . . 0.0 114.38 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.87 -37.19 86.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.62 35.15 2.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 m120 -138.36 170.54 15.84 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -86.65 156.17 20.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.262 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.475 ' HB2' HD23 ' A' ' 8' ' ' LEU . 27.1 m-70 -142.52 -164.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -38.87 128.11 1.95 Allowed Glycine 0 C--N 1.339 0.697 0 O-C-N 124.473 1.108 . . . . 0.0 113.52 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -80.92 104.52 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.278 1.037 . . . . 0.0 108.231 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -88.46 113.11 23.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.501 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -88.39 136.15 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.531 -1.668 . . . . 0.0 107.945 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.62 140.66 6.3 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -76.96 -1.27 27.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.476 0.638 . . . . 0.0 111.144 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.678 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 25.2 tt0 -155.61 146.68 16.53 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.678 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 85.3 Cg_exo -47.07 -55.12 4.17 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.456 2.104 . . . . 0.0 112.383 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -45.16 -28.29 0.73 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.579 ' HG2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 mm100 -82.23 -26.22 33.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.14 -40.85 26.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.685 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -58.57 -36.2 73.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.363 169.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.44 -53.0 40.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -50.31 -19.44 0.82 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.903 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.705 ' O ' ' HG2' ' A' ' 34' ' ' ARG . . . -95.49 -41.09 9.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.475 0.58 . . . . 0.0 109.73 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . . . -59.79 -20.11 54.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.267 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -56.84 -40.15 75.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.991 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 7.4 ptm180 -84.55 -23.61 29.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.89 0.376 . . . . 0.0 110.937 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.98 70.69 2.87 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.305 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 m -76.67 60.36 1.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.091 0.472 . . . . 0.0 112.196 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.72 40.43 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.3 p -132.09 166.79 20.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.503 0.651 . . . . 0.0 109.74 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -66.54 -14.27 62.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 0.0 111.55 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.97 -18.56 21.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.343 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -151.78 63.48 5.36 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.939 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 13.3 Cg_exo -68.45 151.98 75.44 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.704 2.269 . . . . 0.0 112.621 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -77.54 122.11 24.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.719 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.814 HD11 ' HE3' ' A' ' 59' ' ' LYS . 17.5 mm -71.22 109.61 3.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.42 0.629 . . . . 0.0 111.064 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 58' ' ' PHE . 2.7 pp -113.75 137.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.515 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.509 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 24.1 mtp180 -124.38 104.87 9.02 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.01 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.57 HD11 ' N ' ' A' ' 28' ' ' ALA . 86.0 mt -88.65 131.0 35.17 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.327 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.775 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -84.27 154.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.452 0.644 . . . . 0.0 109.547 174.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.808 ' HB3' ' HG1' ' A' ' 52' ' ' THR . 34.6 tt0 -116.96 76.98 1.07 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.623 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.656 ' HG2' HG22 ' A' ' 7' ' ' VAL . 6.3 mtp180 -30.66 119.18 0.18 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.059 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.65 -24.21 24.38 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.127 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.808 ' HG1' ' HB3' ' A' ' 49' ' ' GLU . 10.6 p -114.25 -172.21 2.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.182 0.491 . . . . 0.0 110.201 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -123.17 27.22 7.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 109.534 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 9.8 mtmp? -110.08 138.18 46.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.411 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.509 ' CG1' ' HB3' ' A' ' 46' ' ' ARG . 39.9 t -109.8 127.47 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.476 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.644 ' HA ' HD11 ' A' ' 89' ' ' ILE . 62.9 m-70 -88.49 111.71 22.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.711 0.291 . . . . 0.0 110.784 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.438 HG23 ' HG2' ' A' ' 46' ' ' ARG . 38.5 t -97.09 108.12 21.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.479 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -120.06 122.48 41.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.155 172.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.939 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 44.1 mttp -68.76 111.77 5.07 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.1 163.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.613 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -92.92 134.88 34.65 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.011 174.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 41.6 p90 -144.46 -172.32 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 47.8 mttp -133.8 139.77 46.5 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.208 0.527 . . . . 0.0 110.387 174.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.755 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 18.1 mm-40 -133.09 140.04 47.45 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.365 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.78 143.08 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 79' ' ' ILE . 5.5 m -145.96 -175.35 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.141 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.9 p-10 -162.91 124.17 2.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 168.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -131.74 150.01 75.05 Favored Pre-proline 0 C--N 1.315 -0.925 0 O-C-N 121.613 -0.68 . . . . 0.0 110.675 -167.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.4 Cg_exo -78.0 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.294 1.996 . . . . 0.0 113.833 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 71' ' ' ARG . 59.6 mmtt -93.98 -51.23 4.96 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.64 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 77' ' ' GLU . 22.8 mtm105 -83.04 167.11 31.55 Favored Pre-proline 0 C--N 1.316 -0.885 0 O-C-N 121.219 -0.926 . . . . 0.0 109.998 166.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 15.7 Cg_exo -69.85 170.83 15.77 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 122.197 1.932 . . . . 0.0 110.312 163.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.59 1.33 34.29 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.585 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -120.77 -38.71 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.187 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.591 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 10.1 ttp -74.82 126.93 87.87 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.71 151.44 46.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.274 2.649 . . . . 0.0 111.861 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 7.2 pt-20 -25.58 -58.57 0.07 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.465 1.506 . . . . 0.0 114.726 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -100.39 119.06 37.88 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.343 -164.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.599 ' O ' HG21 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -165.36 164.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.053 -174.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 38.2 p -109.06 95.64 5.77 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 20.5 mttt -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.457 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 4.1 Cg_exo -80.87 96.33 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.642 2.228 . . . . 0.0 111.913 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.755 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 47.4 m-85 -94.36 120.82 35.17 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.371 0.605 . . . . 0.0 110.553 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.856 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -99.29 178.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.422 175.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.708 ' HE2' ' HB3' ' A' ' 87' ' ' GLU . 5.1 tttt -166.18 104.39 0.65 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.125 -173.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.597 ' HE2' HD13 ' A' ' 89' ' ' ILE . 65.8 tttm -61.62 127.7 32.71 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 171.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.708 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 13.5 pt-20 -127.41 -34.03 2.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.271 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 88' ' ' ARG . 15.4 ttp180 -151.74 159.5 43.93 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.712 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 56' ' ' HIS . 21.0 mm -123.23 107.96 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.741 173.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -92.5 -177.46 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.122 0.963 . . . . 0.0 113.286 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.882 170.937 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.693 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -93.06 125.3 37.58 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.85 0.833 . . . . 0.0 110.966 -178.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -88.82 145.0 25.85 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.858 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.773 ' CE2' ' HG3' ' A' ' 49' ' ' GLU . 82.5 m-85 -130.98 144.59 51.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.536 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.574 HG21 ' HB3' ' A' ' 50' ' ' ARG . 47.1 t -112.83 127.92 69.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 16' ' ' HIS . 3.9 tp -66.63 130.01 41.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.216 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 67.1 mtp180 -106.82 128.03 53.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 166.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -87.62 -169.78 2.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -37.57 -48.24 0.99 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.589 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -80.2 -35.07 36.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.595 0.712 . . . . 0.0 110.258 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.6 31.41 1.81 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.641 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.69 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -96.89 148.1 23.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -173.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.77 130.42 38.6 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.784 0.677 . . . . 0.0 111.013 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.544 ' HB2' HD21 ' A' ' 8' ' ' LEU . 92.0 m-70 -138.22 -171.47 3.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.737 -176.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -12.2 130.45 0.01 OUTLIER Glycine 0 N--CA 1.461 0.331 0 O-C-N 126.736 2.522 . . . . 0.0 113.366 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.79 156.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.685 0.278 . . . . 0.0 111.077 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE1' ' HB1' ' A' ' 31' ' ' ALA . 92.6 m-85 -151.43 156.82 41.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -139.71 158.36 44.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.581 0.229 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.693 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.71 150.63 8.38 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.103 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 2.7 tppp? -72.79 -6.33 44.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.487 0.643 . . . . 0.0 110.767 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.835 ' HG3' ' HG2' ' A' ' 26' ' ' GLN . 5.5 pt20 -160.46 158.62 25.61 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 11.6 Cg_endo -56.84 -13.48 11.49 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 123.329 2.686 . . . . 0.0 115.233 -171.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.547 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 19.4 ttt180 -94.14 -13.67 26.5 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -174.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.835 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 16.9 mm100 -88.21 -18.08 29.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.061 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 -59.05 2.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.722 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -35.92 -45.58 0.42 Allowed 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 159.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.74 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -57.48 -26.07 60.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.425 0.631 . . . . 0.0 111.076 177.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 27.2 mmmt -80.94 -47.89 13.06 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -69.4 -21.56 63.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.772 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -67.47 -12.85 61.28 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.82 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.658 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -66.06 -47.66 73.59 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.82 17.71 2.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.977 170.028 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.29 90.68 1.42 Allowed Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -77.09 49.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 110.281 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.32 -165.62 11.94 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.32 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.464 HG21 ' ND2' ' A' ' 41' ' ' ASN . 9.5 t -162.35 171.62 16.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -62.12 -16.42 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.941 0.791 . . . . 0.0 111.029 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.85 -30.08 40.24 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.769 . . . . 0.0 110.63 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.464 ' ND2' HG21 ' A' ' 38' ' ' THR . 0.3 OUTLIER -165.15 72.74 1.43 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.182 -176.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.497 ' HB2' ' HD2' ' A' ' 59' ' ' LYS . 49.4 Cg_exo -56.19 -169.44 0.02 OUTLIER 'Trans proline' 0 CA--C 1.526 0.082 0 C-N-CA 123.386 2.724 . . . . 0.0 114.008 -174.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -119.4 104.14 10.09 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.05 101.52 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.781 0.8 . . . . 0.0 112.391 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 28' ' ' ALA . 2.4 pp -119.12 129.08 75.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.09 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.824 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 42.2 ttm105 -109.44 118.04 35.59 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.453 HD11 ' HA ' ' A' ' 8' ' ' LEU . 3.4 mm? -84.88 161.69 19.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.916 0.865 . . . . 0.0 112.687 175.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.643 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 49.5 ttp180 -133.2 130.46 39.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.003 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.773 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 2.4 mt-10 -80.18 88.2 5.47 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.574 ' HB3' HG21 ' A' ' 7' ' ' VAL . 3.4 ptm180 -51.56 -9.12 0.07 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.86 -32.47 9.96 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.748 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 p -117.99 -169.75 1.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.002 0.43 . . . . 0.0 110.872 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -108.91 41.62 1.57 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.464 0.65 . . . . 0.0 109.599 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -101.32 138.9 37.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.32 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 81.4 t -124.34 129.07 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.589 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 89' ' ' ILE . 71.2 m-70 -134.84 107.93 7.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -172.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.824 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 14.9 p -97.0 138.75 21.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.836 ' HB3' HG12 ' A' ' 84' ' ' VAL . 2.9 m-85 -141.52 138.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.966 0.412 . . . . 0.0 110.321 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 55.3 mmtt -71.66 128.5 35.99 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 161.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.772 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -126.02 133.01 51.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.489 ' HZ3' ' HG2' ' A' ' 85' ' ' LYS . 26.9 p90 -151.93 156.37 39.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 6.7 mtpm? -131.58 124.17 29.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.724 0.773 . . . . 0.0 110.943 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.478 ' HG3' ' HE2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 139.87 31.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.003 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -82.23 145.78 8.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.755 ' H ' HD13 ' A' ' 64' ' ' ILE . 1.5 t -130.19 176.51 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -167.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 25.4 t0 176.79 50.39 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -133.87 118.71 14.45 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.38 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 7.3 Cg_exo -74.14 -19.81 19.72 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 C-N-CA 123.697 2.931 . . . . 0.0 113.822 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -71.54 -36.09 70.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.458 -171.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.431 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 42.9 m-80 -114.82 33.39 5.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.852 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.876 ' HG3' HH11 ' A' ' 71' ' ' ARG . 5.5 mmt85 -76.21 111.95 18.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.178 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.743 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 10.0 Cg_exo -73.76 174.47 12.24 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 123.838 3.025 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.24 8.69 20.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.479 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.2 p-90 -123.49 -31.79 3.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.319 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.743 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.4 ttp -97.78 141.46 23.02 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.325 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.481 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 11.7 Cg_endo -79.68 -148.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.63 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.653 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 35.7 mt-10 -91.37 -40.54 11.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.213 -0.304 . . . . 0.0 111.745 -169.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -144.79 118.38 9.15 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -175.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.19 159.15 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 CA-C-O 120.934 0.397 . . . . 0.0 110.266 -176.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 44.5 t -112.31 126.48 55.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.748 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 14.0 tppt? -146.64 135.57 11.22 Favored Pre-proline 0 N--CA 1.438 -1.05 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -164.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.74 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 22.3 Cg_exo -64.67 89.97 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 CA-C-N 119.747 0.945 . . . . 0.0 110.389 172.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.748 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 18.3 m-85 -75.42 139.28 42.22 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.985 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.836 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -150.43 155.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.739 -177.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.489 ' HG2' ' HZ3' ' A' ' 61' ' ' TRP . 3.7 ptmm? -151.78 138.97 19.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.11 0.481 . . . . 0.0 111.637 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.522 ' HD3' ' CG1' ' A' ' 89' ' ' ILE . 35.9 ttmt -88.98 89.85 8.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.424 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.519 ' OE2' ' HG2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -55.03 -54.63 40.57 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 165.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.465 ' HG2' HG12 ' A' ' 57' ' ' VAL . 5.0 ptt180 -143.61 171.62 13.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.445 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.534 ' CD1' ' HA ' ' A' ' 56' ' ' HIS . 15.8 mm -145.37 131.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.747 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 32.4 mt-10 -87.77 -158.01 0.44 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.934 1.293 . . . . 0.0 109.17 175.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.658 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -87.05 124.24 33.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.266 0.555 . . . . 0.0 111.369 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.63 135.48 38.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.187 174.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CE2' ' HG3' ' A' ' 24' ' ' PRO . 9.2 m-85 -120.3 160.82 22.24 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 50' ' ' ARG . 3.5 t -118.5 138.22 49.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 16' ' ' HIS . 11.5 tp -79.28 134.74 36.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.528 ' HG3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -136.31 121.18 18.66 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.426 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 1.9 t70 -65.32 179.03 0.81 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.371 0.605 . . . . 0.0 112.273 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.32 -32.4 71.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -83.37 -38.97 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.689 0.756 . . . . 0.0 109.211 175.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.43 21.12 2.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.878 172.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 40.0 mt-10 -81.88 121.31 26.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.737 ' HB2' HD23 ' A' ' 8' ' ' LEU . 62.0 m-70 -114.61 99.5 7.58 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.376 0.607 . . . . 0.0 111.461 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.46 175.92 27.7 Favored Glycine 0 C--N 1.294 -1.787 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.207 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.17 138.69 50.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 55.0 m-85 -126.69 148.52 49.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.5 p -132.33 144.38 50.52 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.195 -0.316 . . . . 0.0 111.688 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.15 33.69 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.945 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -54.97 -40.43 70.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.529 0.681 . . . . 0.0 109.719 171.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.75 177.68 1.73 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.75 -53.33 7.2 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.925 1.75 . . . . 0.0 112.113 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 34.2 ttm180 -32.28 -53.38 0.3 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -74.86 -17.41 60.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.114 0.483 . . . . 0.0 111.169 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.01 23.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.629 0.728 . . . . 0.0 109.132 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.83 -32.63 12.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.791 HD22 HG22 ' A' ' 84' ' ' VAL . 4.3 mt -57.3 -40.32 77.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.382 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -70.19 -7.07 38.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.724 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -100.48 -48.25 4.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.636 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . . . -73.58 -11.21 60.36 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.237 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.38 -2.19 55.19 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.407 -166.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.6 ptp180 -114.99 15.79 17.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.0 -119.36 2.66 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.661 -171.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m 176.32 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -172.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 46.37 -164.69 0.1 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.539 -175.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 37' ' ' GLY . 11.9 p -157.01 141.46 16.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.082 0.553 . . . . 0.0 109.618 176.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -66.45 -22.47 66.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.761 0.791 . . . . 0.0 110.37 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.03 -43.03 88.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.658 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.51 74.41 4.2 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.621 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.835 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 50.4 Cg_exo -52.83 125.57 18.54 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.377 2.718 . . . . 0.0 113.519 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -42.15 127.47 3.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.105 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 44' ' ' ILE . 11.7 mm -80.65 115.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 1.012 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.8 pp -106.05 154.62 7.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.101 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.532 ' NE ' ' HB ' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -129.71 101.72 6.02 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.034 -178.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.69 HD23 HD12 ' A' ' 45' ' ' ILE . 4.4 mm? -96.25 135.65 37.8 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 55' ' ' VAL . 45.0 ttt180 -132.85 113.04 12.43 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.437 -175.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 33.6 mt-10 -59.56 108.92 0.79 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.665 0.386 . . . . 0.0 110.059 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.56 ' HG2' HG22 ' A' ' 7' ' ' VAL . 12.8 mtp180 -34.08 -43.97 0.16 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 174.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.28 -26.5 71.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.728 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 ' HZ3' ' A' ' 54' ' ' LYS . 6.9 p -103.43 -177.12 3.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.276 0.56 . . . . 0.0 110.989 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -121.1 4.04 10.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.792 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 25.7 pttm -90.86 133.31 35.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.264 0.554 . . . . 0.0 110.313 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 19.0 t -103.61 153.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.759 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -128.9 112.29 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.094 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.532 ' HB ' ' NE ' ' A' ' 46' ' ' ARG . 2.5 p -98.07 126.11 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 122.602 1.191 . . . . 0.0 113.251 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 1.012 ' HB2' HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -114.13 -173.11 2.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.602 -1.636 . . . . 0.0 107.547 174.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.835 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 13.7 ptpt -141.25 121.13 13.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . . . -108.87 140.9 41.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.659 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 10.2 p90 -160.78 -174.33 4.37 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.104 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 88.0 mttt -127.27 153.34 46.26 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 110.542 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.485 ' CG ' ' HE1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -163.77 177.36 8.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -164.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.674 ' HB ' ' HG2' ' A' ' 76' ' ' PRO . 18.2 pt -62.37 137.28 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.109 0.957 . . . . 0.0 110.669 167.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 1.042 HG22 HG21 ' A' ' 79' ' ' ILE . 1.4 m -99.75 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 -165.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.481 ' N ' HG21 ' A' ' 65' ' ' VAL . 36.0 t70 -33.35 -94.18 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 112.02 -2.355 . . . . 0.0 115.945 -166.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 76' ' ' PRO . . . -50.26 150.17 4.68 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -166.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 71.7 Cg_endo -110.34 -102.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 1 C-N-CA 125.963 4.442 . . . . 0.0 115.225 -172.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -83.04 -23.6 33.15 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.33 -168.155 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -64.49 -8.13 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.567 1.175 . . . . 0.0 110.461 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 76' ' ' PRO . 24.3 mmm180 -117.14 170.78 5.6 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.378 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 52.9 Cg_exo -57.69 169.03 2.71 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.778 1.652 . . . . 0.0 112.167 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.45 -47.72 84.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.284 0.564 . . . . 0.0 110.46 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.624 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 43.7 p-90 -82.62 -33.22 27.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.434 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.604 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.8 ttm -94.88 112.0 56.55 Favored Pre-proline 0 C--O 1.223 -0.317 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -170.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.752 ' HG2' HG22 ' A' ' 79' ' ' ILE . 47.0 Cg_exo -65.69 -72.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 123.612 2.875 . . . . 0.0 112.976 169.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.55 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 4.7 mm-40 -135.79 -80.44 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.55 ' HD2' ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -159.92 115.25 2.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 166.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 1.042 HG21 HG22 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -120.22 117.16 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 N-CA-C 119.294 3.072 . . . . 0.0 119.294 -150.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -168.69 88.75 0.21 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 110.451 -3.068 . . . . 0.0 109.351 159.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.764 ' HG2' HG11 ' A' ' 65' ' ' VAL . 23.5 mmtt -122.55 155.7 62.29 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 120.113 1.324 . . . . 0.0 111.546 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 95.4 Cg_endo -76.14 123.05 6.99 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.255 2.637 . . . . 0.0 111.363 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 33.8 m-85 -124.51 149.41 46.94 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.791 HG22 HD22 ' A' ' 29' ' ' LEU . 1.1 t -122.3 163.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.315 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 86' ' ' LYS . 1.6 tmmm? -148.67 132.71 17.22 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 51.8 tttm -72.99 113.5 10.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.832 0.825 . . . . 0.0 109.116 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.435 ' OE1' ' HE3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -97.52 -45.02 6.58 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.804 -169.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.555 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 27.0 ttp-105 -156.79 -175.73 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.363 0.601 . . . . 0.0 111.048 -171.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.555 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 14.7 mm -128.12 154.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.605 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.897 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -120.28 -171.29 2.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.051 0.94 . . . . 0.0 110.783 -169.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 53.6 mtmt . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.35 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.574 0.226 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -91.0 149.0 22.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.052 0.454 . . . . 0.0 110.829 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.3 t -121.58 130.23 53.37 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -82.9 133.29 35.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.545 1.164 . . . . 0.0 113.496 -173.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.536 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 31.6 m-20 -78.53 155.21 29.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.339 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.56 176.23 8.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.443 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.46 146.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.687 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 2.4 tp -99.43 120.74 40.1 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.265 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.776 ' HB2' ' HB2' ' A' ' 46' ' ' ARG . 53.1 mtp180 -88.72 157.16 18.61 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.469 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.49 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 11.9 t70 -102.35 -151.8 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.739 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 51.1 mm-40 -83.48 -20.37 34.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.868 0.366 . . . . 0.0 110.917 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.25 -6.88 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.477 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.91 50.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.315 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 12.4 m120 -54.63 178.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.653 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.37 160.15 34.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.272 0.558 . . . . 0.0 111.994 -169.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 77.9 m-70 -142.58 -159.59 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.172 -171.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.444 ' H ' ' HB3' ' A' ' 16' ' ' HIS . . . -59.65 161.2 17.4 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.448 0.467 . . . . 0.0 112.84 -172.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 p -84.25 110.9 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.898 0.856 . . . . 0.0 110.521 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 2.7 m-85 -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.111 175.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.511 HG22 ' OD1' ' A' ' 5' ' ' ASN . 74.2 p -148.24 175.34 11.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.999 0.428 . . . . 0.0 109.865 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 154.69 142.93 3.55 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.565 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -14.41 48.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.241 0.544 . . . . 0.0 110.39 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 36.4 tt0 -153.83 142.86 14.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.802 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 72.3 Cg_exo -46.96 -18.74 0.61 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.485 3.457 . . . . 0.0 115.492 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.425 ' HA ' ' HB1' ' A' ' 28' ' ' ALA . 59.6 ttt180 -82.81 -12.7 57.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . 23.1 mm-40 -77.37 -65.01 1.01 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.914 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -34.46 -37.46 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 164.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.523 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -77.34 -38.97 49.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.34 177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.791 HD12 HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -63.24 -39.19 93.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 14.2 mmmm -80.87 -1.03 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.943 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.588 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . . . -99.06 -20.3 16.78 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.772 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -72.81 -66.33 0.68 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.658 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -35.06 8.13 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 162.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.588 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 14.8 mmm180 -91.37 -48.27 6.99 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.4 1.0 . . . . 0.0 110.272 -167.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -81.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.142 -1.504 . . . . 0.0 115.055 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -87.26 36.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 0.0 110.204 -168.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' CA ' ' HA ' ' A' ' 61' ' ' TRP . . . -72.73 92.65 0.62 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.078 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -133.72 144.07 48.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.221 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.485 ' HD2' ' CD ' ' A' ' 63' ' ' GLU . 68.9 tttt -81.4 -12.81 58.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.256 0.55 . . . . 0.0 110.365 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.6 64.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.047 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.9 81.06 1.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.059 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.427 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.8 Cg_exo -51.8 140.05 48.26 Favored 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.712 2.941 . . . . 0.0 112.826 -174.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -57.32 99.29 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.992 HD11 ' HE3' ' A' ' 59' ' ' LYS . 19.6 mm -54.9 126.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.355 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.601 HD12 ' HB2' ' A' ' 58' ' ' PHE . 2.6 pp -135.27 140.93 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.776 ' HB2' ' HB2' ' A' ' 9' ' ' ARG . 72.5 mtp180 -117.29 124.83 49.96 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.521 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.423 ' CD2' HD13 ' A' ' 45' ' ' ILE . 1.7 mm? -106.2 158.11 17.08 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -142.5 115.73 8.93 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 51' ' ' GLY . 7.8 tt0 -69.3 130.7 43.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.536 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 11.2 mtp180 -77.81 8.05 5.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.63 0.729 . . . . 0.0 109.077 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 49' ' ' GLU . . . -112.78 -64.36 0.46 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.607 174.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 p -91.7 146.66 23.59 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.189 0.519 . . . . 0.0 112.224 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 1.085 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 53.3 pttt -84.03 55.65 3.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.229 1.014 . . . . 0.0 109.808 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -127.98 111.54 13.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.345 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.943 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.7 t -78.68 99.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.568 ' HA ' HD11 ' A' ' 89' ' ' ILE . 51.1 m-70 -69.68 135.51 49.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.431 HG13 ' HG2' ' A' ' 90' ' ' GLU . 4.2 p -140.34 104.98 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 122.682 1.23 . . . . 0.0 109.471 -172.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.792 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -104.61 177.54 4.82 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.599 -1.637 . . . . 0.0 107.78 -177.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.992 ' HE3' HD11 ' A' ' 44' ' ' ILE . 45.6 mtpt -123.9 127.44 48.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.515 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -127.47 123.79 36.82 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.954 -159.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.571 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . 29.3 p90 -134.64 179.84 6.05 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 48.2 mtmt -133.84 140.36 46.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.338 174.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.605 ' HB2' ' HE2' ' A' ' 83' ' ' PHE . 38.8 mt-10 -129.56 112.81 14.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.478 173.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 32.9 mm -79.93 77.97 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.639 ' HA ' ' CB ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -152.24 153.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.873 -177.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.696 ' N ' ' HA ' ' A' ' 78' ' ' LYS . 8.8 t70 157.9 66.44 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.279 1.612 . . . . 0.0 107.932 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -60.59 133.86 91.58 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.266 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 1.02 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 61.6 Cg_endo -70.37 128.86 16.04 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.853 2.369 . . . . 0.0 115.781 -166.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -95.96 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.322 -1.763 . . . . 0.0 107.621 163.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.35 33.83 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.791 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 1.02 ' HD3' ' HA ' ' A' ' 68' ' ' PRO . 36.9 mtp85 -84.96 163.85 44.24 Favored Pre-proline 0 N--CA 1.464 0.235 0 O-C-N 121.916 -0.49 . . . . 0.0 111.033 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 75' ' ' MET . 18.5 Cg_exo -67.72 160.25 49.05 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.383 2.722 . . . . 0.0 111.458 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.34 -50.15 72.75 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.986 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -59.79 -20.48 57.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.626 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 13.2 ttm -90.18 111.07 44.83 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 24.9 Cg_exo -65.24 -135.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 124.19 3.26 . . . . 0.0 115.052 -170.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.773 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.4 mt-10 -117.46 8.47 13.0 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.696 ' HA ' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -160.26 169.43 23.22 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.804 -1.998 . . . . 0.0 106.51 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 1.001 HD13 ' HD3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -162.7 164.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 169.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.481 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 74.9 m -65.3 117.8 8.39 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.765 0.793 . . . . 0.0 111.416 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 1.001 ' HD3' HD13 ' A' ' 79' ' ' ILE . 4.3 mptp? -142.1 112.71 6.23 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 114.077 -1.42 . . . . 0.0 112.181 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.536 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 2.4 Cg_endo -86.54 124.59 2.34 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 123.28 2.653 . . . . 0.0 109.219 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.698 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 89.1 m-85 -120.82 134.73 55.28 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.792 HG12 ' HB3' ' A' ' 58' ' ' PHE . 1.5 t -138.81 137.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.926 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -122.45 154.67 37.47 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 27.3 ttmt -99.69 123.37 43.89 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.804 1.638 . . . . 0.0 109.195 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.489 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 2.4 pt-20 -89.15 -13.56 38.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.111 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.489 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 12.4 ptt-85 174.08 -173.01 0.06 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.568 HD11 ' HA ' ' A' ' 56' ' ' HIS . 8.7 mm -138.85 136.22 42.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.784 0.326 . . . . 0.0 110.16 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.943 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.7 mm-40 -107.01 175.04 5.63 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.646 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -126.27 140.17 52.74 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.283 0.563 . . . . 0.0 112.407 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 1.085 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 13.8 tp -80.85 175.81 10.36 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 164.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.475 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 13.2 mm-40 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.996 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.7 t . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -167.82 135.06 2.22 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.1 m -83.12 131.94 35.12 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.391 0.615 . . . . 0.0 111.934 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 1.006 HH22 ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -93.7 133.68 36.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.647 ' HA ' HG22 ' A' ' 20' ' ' THR . 60.6 m-80 -115.6 113.74 23.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.431 . . . . 0.0 111.05 -167.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.826 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -117.68 148.09 42.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -175.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.641 HG12 HG21 ' A' ' 18' ' ' VAL . 3.3 t -113.66 -179.57 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.3 tp -106.56 149.63 26.96 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.579 ' HD3' ' HB2' ' A' ' 48' ' ' ARG . 24.7 mmm180 -111.05 162.36 14.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t70 -92.74 -162.56 0.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -92.35 -6.62 49.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.073 1.306 . . . . 0.0 108.039 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -110.43 -20.14 12.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.591 -170.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.93 36.53 1.23 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.596 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.577 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 65.4 m-80 -111.23 -173.05 2.15 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 87.7 mt-10 -135.9 145.31 46.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 111.092 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 73.9 m-70 -132.57 -166.09 1.69 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.182 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -21.59 130.07 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 125.034 1.459 . . . . 0.0 114.248 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.641 HG21 HG12 ' A' ' 7' ' ' VAL . 78.4 t -85.53 131.65 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 6' ' ' PHE . 81.5 m-85 -131.4 125.76 33.42 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.647 HG22 ' HA ' ' A' ' 5' ' ' ASN . 38.0 p -139.25 140.77 37.78 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.636 ' H ' ' NH1' ' A' ' 4' ' ' ARG . . . -140.78 -164.81 10.06 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.515 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -8.85 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.429 HE21 ' HB3' ' A' ' 23' ' ' GLN . 1.2 tt0 -157.12 139.21 10.25 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.654 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.606 ' CA ' HH21 ' A' ' 4' ' ' ARG . 80.4 Cg_exo -40.91 -47.88 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 124.335 3.356 . . . . 0.0 114.077 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.544 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 42.0 ttt180 -53.04 -22.9 6.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.074 0.95 . . . . 0.0 113.341 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 22.9 mm-40 -84.05 -50.62 7.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.509 0.671 . . . . 0.0 110.677 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 1.006 ' HB1' HH22 ' A' ' 4' ' ' ARG . . . -59.07 -31.95 69.34 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.214 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.751 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -83.58 -26.24 30.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.876 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.787 ' HG ' ' HG2' ' A' ' 82' ' ' PRO . 3.7 tt -65.24 -65.52 0.66 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -43.75 -31.29 0.78 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.458 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.88 -39.65 69.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.166 0.507 . . . . 0.0 110.311 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -70.56 -21.37 62.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.367 0.603 . . . . 0.0 111.184 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.816 ' HA ' ' HZ1' ' A' ' 62' ' ' LYS . 71.3 m-20 -68.34 -2.83 9.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.965 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.419 ' NH2' ' HE1' ' A' ' 19' ' ' PHE . 8.2 mmt180 -100.06 -13.27 19.09 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.09 82.85 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.84 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.541 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 13.0 p -100.18 -49.52 4.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -126.92 8.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.909 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 160.83 40.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.105 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -62.12 -20.87 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.589 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.64 -25.43 67.36 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.969 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.462 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.0 OUTLIER -161.85 67.82 2.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.442 0.639 . . . . 0.0 110.353 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.3 Cg_exo -65.16 130.95 26.95 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.085 1.857 . . . . 0.0 111.592 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.18 139.39 52.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.61 HD11 HG11 ' A' ' 57' ' ' VAL . 5.6 tp -82.97 105.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.824 0.821 . . . . 0.0 111.249 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 58' ' ' PHE . 2.7 pp -95.94 123.27 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 122.351 1.072 . . . . 0.0 110.345 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.404 ' O ' HD22 ' A' ' 47' ' ' LEU . 77.5 mtp180 -91.79 173.26 7.96 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.446 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.553 ' CB ' ' HB2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -147.47 148.23 31.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.579 ' HB2' ' HD3' ' A' ' 9' ' ' ARG . 11.6 tpt180 -124.18 111.27 15.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.106 0.479 . . . . 0.0 110.169 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.79 ' HB3' ' HG1' ' A' ' 52' ' ' THR . 8.4 tp10 -86.27 104.57 15.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.547 ' HD3' ' HB3' ' A' ' 5' ' ' ASN . 2.8 ptm180 -73.05 25.66 0.06 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.434 0.635 . . . . 0.0 111.429 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 49' ' ' GLU . . . -128.63 0.99 6.39 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.325 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.79 ' HG1' ' HB3' ' A' ' 49' ' ' GLU . 44.6 p -146.65 169.78 18.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.411 0.605 . . . . 0.0 109.825 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -95.21 38.21 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -127.94 132.19 49.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.923 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.822 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 49.1 t -92.47 119.7 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.129 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.553 ' HB2' ' CB ' ' A' ' 47' ' ' LEU . 95.2 m-70 -81.42 131.74 35.3 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.61 HG11 HD11 ' A' ' 44' ' ' ILE . 71.3 t -123.15 116.23 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -170.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.631 ' CB ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -132.25 134.78 45.7 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 87.5 mttt -70.56 170.26 12.52 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 162.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -163.08 133.99 4.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -166.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 36' ' ' SER . 29.9 p90 -150.03 -172.57 4.19 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.816 ' HZ1' ' HA ' ' A' ' 33' ' ' ASN . 35.3 mttp -132.2 136.51 47.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.11 0.481 . . . . 0.0 111.108 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.434 ' HB3' ' HE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -137.66 137.8 38.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 -178.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.702 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 16.0 tt -83.67 94.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.147 1.451 . . . . 0.0 113.877 -166.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 81' ' ' LYS . 35.2 m -112.09 -174.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.523 170.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.965 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 7.3 p-10 -98.88 178.06 5.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 119.453 1.024 . . . . 0.0 110.985 169.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.685 ' HB1' HD12 ' A' ' 79' ' ' ILE . . . -125.23 163.87 35.44 Favored Pre-proline 0 C--O 1.239 0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.375 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 82.7 Cg_exo -46.3 149.31 2.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.979 2.453 . . . . 0.0 112.636 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -83.83 12.11 6.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.486 0.66 . . . . 0.0 110.309 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -117.31 22.84 12.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.013 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.419 ' NH1' ' HB3' ' A' ' 77' ' ' GLU . 31.3 ptt-85 -63.89 170.2 3.57 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.618 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -56.57 168.95 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.68 2.254 . . . . 0.0 113.108 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.44 -14.87 32.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.265 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.553 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 35.8 p-90 -91.37 -24.36 19.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.111 0.482 . . . . 0.0 111.151 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.553 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 28.6 ttp -101.28 147.46 33.8 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.279 -172.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -83.84 177.4 6.16 Favored 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.499 2.132 . . . . 0.0 110.026 172.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.559 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 12.8 pt-20 -74.07 -43.46 57.67 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.145 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.965 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 29.7 mmmt -79.71 114.99 19.06 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.685 HD12 ' HB1' ' A' ' 67' ' ' ALA . 1.4 pp -153.54 153.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.355 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 5.3 p -76.33 104.24 6.75 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.226 0.536 . . . . 0.0 110.053 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 21.6 tptt -62.9 136.9 96.75 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.763 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.787 ' HG2' ' HG ' ' A' ' 29' ' ' LEU . 37.9 Cg_endo -68.43 98.32 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.221 1.948 . . . . 0.0 110.491 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 42.3 m-85 -94.31 173.0 7.85 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.751 HG12 ' HB3' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -162.59 174.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -162.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' H ' HG11 ' A' ' 84' ' ' VAL . 49.5 tptt -175.63 98.23 0.07 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 111.146 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 36.4 ttmt -55.96 93.16 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.825 0.821 . . . . 0.0 111.954 166.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.579 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -82.23 -11.88 58.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.657 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.579 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 7.7 ptm180 -176.84 177.12 1.37 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.347 0.594 . . . . 0.0 111.907 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.519 HD12 ' HE2' ' A' ' 86' ' ' LYS . 20.9 mm -135.83 136.96 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.527 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.822 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 30.4 mt-10 -107.2 151.29 25.62 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.023 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -111.29 166.35 11.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.7 mt -119.44 142.2 48.45 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.161 -171.905 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 120.872 0.368 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -131.75 149.98 52.3 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.491 0.662 . . . . 0.0 110.961 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.9 m -71.38 137.61 48.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.935 170.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.462 ' HD3' ' C ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -93.93 126.67 39.27 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.429 0.633 . . . . 0.0 110.557 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.613 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 12.4 m120 -78.78 143.87 35.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.673 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.447 ' CE2' ' HB3' ' A' ' 24' ' ' PRO . 66.0 m-85 -131.89 142.09 49.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.411 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 61.7 t -105.17 122.32 58.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.76 133.17 43.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.061 -177.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.856 ' HB3' ' CA ' ' A' ' 13' ' ' GLY . 60.3 mtp180 -85.36 138.84 32.02 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.607 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -59.2 -146.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.691 170.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.61 -56.46 4.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -167.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.25 -42.32 68.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 109.088 162.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.856 ' CA ' ' HB3' ' A' ' 9' ' ' ARG . . . 139.36 48.01 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 116.263 -2.875 . . . . 0.0 113.671 169.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.5 m120 -74.01 -152.44 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -97.41 146.67 24.97 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.691 0.758 . . . . 0.0 112.295 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 15.5 m-70 -138.52 -164.56 1.66 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 167.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.95 162.87 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 119.058 -1.544 . . . . 0.0 112.317 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.613 ' CG2' ' HB3' ' A' ' 5' ' ' ASN . 2.7 p -99.22 110.77 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.093 0.949 . . . . 0.0 111.179 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -78.95 178.43 8.0 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.794 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 33.1 p -135.09 151.97 51.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.417 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -172.35 160.42 31.76 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.462 ' C ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -84.04 -10.21 58.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.446 ' HB3' ' HD2' ' A' ' 24' ' ' PRO . 17.1 mt-30 -151.58 165.5 17.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 10.8 Cg_endo -60.63 -53.3 2.88 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 CA-C-N 120.283 1.137 . . . . 0.0 111.278 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 75.5 ttt180 -39.9 -36.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.129 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 8.2 mm100 -84.44 -10.79 57.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.988 0.423 . . . . 0.0 111.535 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.98 -57.07 2.99 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.569 ' HB2' HD23 ' A' ' 47' ' ' LEU . . . -45.08 -32.95 1.94 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 165.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 25' ' ' ARG . 7.2 tt -61.41 -19.23 61.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.282 0.563 . . . . 0.0 110.565 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 30' ' ' LYS . 18.4 mtpp -77.85 -53.39 7.53 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -68.37 -16.59 63.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' A' ' 82' ' ' PRO . . . -64.44 -20.46 66.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.317 0.579 . . . . 0.0 110.838 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.36 7.1 0.65 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 56.6 mtp180 -99.64 -54.95 2.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.931 -163.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 36' ' ' SER . . . -105.76 -20.8 9.1 Favored Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.164 167.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.644 ' O ' ' HA ' ' A' ' 61' ' ' TRP . 68.5 m 76.15 -63.95 0.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.54 -160.8 54.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.235 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -160.93 157.14 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' HB3' ' HZ3' ' A' ' 39' ' ' LYS . 4.8 ttpm? -63.65 -12.86 37.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.984 0.513 . . . . 0.0 112.065 -171.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.63 -29.92 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.699 0.762 . . . . 0.0 110.162 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.29 70.18 2.95 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.556 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -56.98 166.13 4.34 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.901 2.401 . . . . 0.0 112.84 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.32 118.04 35.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.764 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.699 HD13 ' HZ1' ' A' ' 59' ' ' LYS . 7.0 tp -55.87 158.0 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.04 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -159.19 179.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.785 ' CB ' ' HB2' ' A' ' 9' ' ' ARG . 24.1 mmm-85 -158.29 143.01 16.23 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.826 0.704 . . . . 0.0 109.761 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -139.84 125.4 19.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.802 0.81 . . . . 0.0 110.567 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.438 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 45.3 tpt85 -105.36 114.48 28.68 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.994 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HB3' ' HG1' ' A' ' 52' ' ' THR . 57.4 tt0 -85.58 78.24 9.68 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -46.47 104.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.997 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.93 -19.47 4.4 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.042 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.512 ' HG1' ' HB3' ' A' ' 49' ' ' GLU . 26.1 p -127.62 178.48 6.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -115.59 37.26 3.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.929 0.871 . . . . 0.0 109.87 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -127.03 149.09 50.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.906 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 1.011 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 20.9 t -103.92 136.47 36.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.25 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.665 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 90.9 m-70 -103.73 105.99 16.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 43.7 t -95.32 122.38 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.504 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.665 ' CE1' ' HB3' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -128.44 162.11 27.91 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.932 176.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.699 ' HZ1' HD13 ' A' ' 44' ' ' ILE . 40.2 mmtm -103.44 133.28 48.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.926 158.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.651 ' HB2' HD12 ' A' ' 45' ' ' ILE . . . -110.96 146.26 36.93 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.732 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 32.0 p90 -168.87 151.36 4.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.604 ' HE2' ' HG3' ' A' ' 82' ' ' PRO . 77.5 mttt -103.18 122.95 45.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.367 0.604 . . . . 0.0 109.932 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.732 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.1 mm-40 -107.71 143.14 36.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.961 172.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 20.7 tt -86.24 143.31 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 163.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 m -141.0 -172.82 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.793 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.3 p-10 -121.16 -179.41 4.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.158 0.504 . . . . 0.0 111.272 -165.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.719 ' HB1' ' HA ' ' A' ' 77' ' ' GLU . . . -110.74 116.59 52.01 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.369 -172.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 71' ' ' ARG . 7.4 Cg_exo -69.0 -173.66 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.3 2.667 . . . . 0.0 111.383 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.48 -51.2 4.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.417 0.627 . . . . 0.0 109.334 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.4 t30 -83.97 18.05 2.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.44 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.629 ' HD3' ' HB2' ' A' ' 67' ' ' ALA . 9.8 ptt-85 -59.26 158.01 21.15 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.695 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.5 173.58 10.53 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.517 2.811 . . . . 0.0 114.015 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.15 10.66 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.833 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -123.21 -15.48 7.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.808 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 32.8 ttm -103.05 121.81 47.7 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.532 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 20.4 Cg_endo -88.7 -152.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.124 2.549 . . . . 0.0 112.444 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.719 ' HA ' ' HB1' ' A' ' 67' ' ' ALA . 16.6 mm-40 -69.53 -42.04 75.19 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.793 ' HD3' ' HA ' ' A' ' 66' ' ' ASP . 31.9 mmtp -150.03 129.76 13.24 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.565 HD12 HG21 ' A' ' 65' ' ' VAL . 1.2 pp -147.46 147.87 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 118.721 0.691 . . . . 0.0 111.074 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 71.5 p -94.14 153.83 17.9 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 4.4 tptp -157.38 133.67 6.2 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -168.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.604 ' HG3' ' HE2' ' A' ' 62' ' ' LYS . 14.0 Cg_exo -65.22 89.79 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 CA-C-N 120.651 1.268 . . . . 0.0 111.663 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.619 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 27.3 m-85 -83.68 157.78 22.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.517 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.538 HG13 ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -145.92 162.84 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.079 177.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.54 ' HB3' ' CZ3' ' A' ' 61' ' ' TRP . 5.2 tmtt? -151.72 115.56 4.91 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.316 0.579 . . . . 0.0 110.874 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.509 ' HE2' HD13 ' A' ' 89' ' ' ILE . 33.9 ttmt -60.2 125.65 24.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.463 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 20.6 pt-20 -135.41 -13.54 2.03 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.41 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.403 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 32.1 ttp85 -157.16 165.83 34.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.509 HD13 ' HE2' ' A' ' 86' ' ' LYS . 22.2 mm -147.1 140.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 1.011 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 52.6 mt-10 -119.93 153.11 36.39 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.06 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -115.67 130.16 56.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD23 HG21 ' A' ' 55' ' ' VAL . 2.1 mm? -109.82 174.71 5.74 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.658 -169.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.249 1.061 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.275 -179.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.66 0.267 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -83.0 140.86 32.49 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.4 m -67.16 125.6 26.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.402 0.62 . . . . 0.0 112.123 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 20' ' ' THR . 12.4 mmm180 -88.52 137.47 32.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.336 1.065 . . . . 0.0 111.796 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 36.8 m-80 -104.68 118.05 35.62 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.228 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 30.3 m-85 -119.27 165.0 14.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.282 1.039 . . . . 0.0 111.599 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.88 130.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.524 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 1.109 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 13.9 tp -81.26 156.06 25.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HD2' ' HD3' ' A' ' 48' ' ' ARG . 47.9 mtp180 -135.47 143.03 45.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.491 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . 6.7 t70 -87.15 -165.04 1.18 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.475 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 4.7 mm-40 -83.74 -52.5 6.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.547 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -75.61 0.6 16.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.2 35.94 3.02 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 118.637 -1.744 . . . . 0.0 113.768 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.491 ' HB2' ' CB ' ' A' ' 10' ' ' ASP . 61.5 m-80 -101.75 178.67 4.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -122.72 152.52 40.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.858 0.837 . . . . 0.0 112.255 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 1.109 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 97.3 m-70 -132.18 -158.92 0.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.993 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.78 -172.67 46.55 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 117.84 -2.124 . . . . 0.0 110.936 -158.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 87.1 t -94.23 109.06 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.692 0.758 . . . . 0.0 110.851 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.816 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 77.6 m-85 -94.66 111.94 23.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.389 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.8 p -91.08 113.95 26.34 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.74 166.51 21.88 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.423 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.692 ' HG2' ' HG3' ' A' ' 26' ' ' GLN . 8.9 ptpp? -77.66 -27.25 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.517 0.675 . . . . 0.0 109.58 174.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.573 ' HG2' ' HG3' ' A' ' 22' ' ' LYS . 11.0 pt20 -160.4 163.99 20.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.454 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 33.0 Cg_exo -40.02 -53.3 2.51 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.476 2.784 . . . . 0.0 113.956 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.98 -40.0 69.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.692 ' HG3' ' HG2' ' A' ' 22' ' ' LYS . 21.5 mm-40 -78.56 -31.54 47.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 122.001 -0.437 . . . . 0.0 111.324 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.32 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.588 0.709 . . . . 0.0 109.207 173.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.743 ' HB3' HD13 ' A' ' 45' ' ' ILE . . . -70.51 -38.73 74.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.68 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -56.4 -62.29 1.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 32.1 mmtp -34.81 -48.05 0.37 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.186 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.816 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -66.98 -30.36 70.45 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.162 -0.336 . . . . 0.0 111.512 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -84.7 -18.34 35.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.79 -34.65 20.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 34' ' ' ARG . 28.4 ptt85 -92.21 -20.9 20.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.68 89.75 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.787 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -67.49 -17.1 64.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 31.91 -135.65 0.13 Allowed Glycine 0 C--N 1.344 0.987 0 O-C-N 124.332 1.02 . . . . 0.0 112.843 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -149.46 168.69 22.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 164.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -58.37 -33.64 69.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.41 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -81.06 -42.31 21.25 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.294 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.66 65.5 72.32 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.811 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 22.9 Cg_exo -64.45 146.17 89.06 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.485 2.124 . . . . 0.0 112.543 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.92 110.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.51 ' HA ' HD12 ' A' ' 44' ' ' ILE . 30.0 mm -64.1 122.82 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.066 0.46 . . . . 0.0 111.584 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.796 HD11 ' HB2' ' A' ' 60' ' ' ALA . 8.0 pt -117.5 132.47 67.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.842 0.83 . . . . 0.0 111.925 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 1.066 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 69.4 mtp180 -122.37 116.47 24.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.866 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.809 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.9 mm? -108.11 123.16 48.29 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.343 0.592 . . . . 0.0 109.922 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.557 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 16.9 ttp180 -112.03 97.29 6.57 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.769 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' CD ' HH21 ' A' ' 4' ' ' ARG . 2.7 tm-20 -61.97 144.14 55.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.07 13.73 7.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -172.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.24 -9.5 2.38 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.408 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.5 p -99.33 172.79 7.12 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.835 -0.215 . . . . 0.0 110.647 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.676 ' HA ' HD22 ' A' ' 92' ' ' LEU . 63.4 tttp -111.76 11.77 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 110.339 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -121.57 142.88 49.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 90.6 t -111.34 101.16 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.809 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 18.6 p80 -86.48 140.31 30.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.28 0.562 . . . . 0.0 111.359 -174.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 1.066 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -125.36 114.57 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.258 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.604 ' O ' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -115.92 147.81 40.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.425 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.46 ' HE3' HD11 ' A' ' 44' ' ' ILE . 1.5 mmmm -66.29 169.57 7.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.986 160.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.796 ' HB2' HD11 ' A' ' 45' ' ' ILE . . . -165.31 134.31 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.413 0.149 . . . . 0.0 110.769 -173.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.518 ' HD1' ' HG2' ' A' ' 63' ' ' GLU . 20.1 p90 -161.18 172.74 16.19 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 120.449 0.166 . . . . 0.0 111.15 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.678 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 42.2 mtmt -144.32 124.03 13.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.525 0.203 . . . . 0.0 110.706 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.537 ' HG3' ' CG1' ' A' ' 65' ' ' VAL . 7.7 pt-20 -174.09 155.9 2.57 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -69.99 125.99 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.885 0.766 . . . . 0.0 110.288 173.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.601 HG23 ' N ' ' A' ' 66' ' ' ASP . 4.2 m -150.75 -167.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -167.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.601 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.3 OUTLIER 101.16 -174.65 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 125.395 1.685 . . . . 0.0 110.638 168.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.674 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . . . -121.53 179.85 0.88 Allowed Pre-proline 0 N--CA 1.437 -1.099 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.324 -165.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.674 ' HD2' ' HB2' ' A' ' 67' ' ' ALA . 98.1 Cg_exo -50.94 -175.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 123.705 2.937 . . . . 0.0 115.051 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.452 ' HZ2' ' CD ' ' A' ' 77' ' ' GLU . 4.1 mptp? -56.93 -13.05 2.33 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.456 -166.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -76.01 32.67 0.12 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.04 0.447 . . . . 0.0 111.317 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 68' ' ' PRO . 20.3 mmm180 -84.5 167.16 28.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.524 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.6 162.72 30.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.097 1.865 . . . . 0.0 111.191 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.98 62.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.118 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.693 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 56.3 p-90 -103.92 -37.51 7.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.895 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.693 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 16.6 ttp -104.57 136.46 19.17 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.706 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 42.7 Cg_endo -92.38 -164.69 0.13 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 122.696 2.264 . . . . 0.0 113.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.452 ' CD ' ' HZ2' ' A' ' 69' ' ' LYS . 25.3 mt-10 -86.07 -2.02 57.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.552 -1.658 . . . . 0.0 112.531 -168.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 72.5 mmtt -155.42 119.25 4.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.696 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.8 OUTLIER -155.71 144.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.552 0.615 . . . . 0.0 110.087 177.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.0 p -120.71 81.22 1.73 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.004 0.907 . . . . 0.0 111.616 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.829 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -124.74 168.32 13.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.197 176.203 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.713 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 52.2 Cg_exo -57.24 94.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.483 2.122 . . . . 0.0 111.875 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.829 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-85 -86.53 175.6 8.26 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.602 HG11 ' CB ' ' A' ' 58' ' ' PHE . 1.4 t -166.22 173.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -166.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.55 ' HE2' ' O ' ' A' ' 86' ' ' LYS . 16.8 tptm -176.51 99.11 0.06 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.119 0.485 . . . . 0.0 110.7 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.55 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 34.4 ttmt -57.25 134.3 55.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.38 169.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.426 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 11.3 pt-20 -167.19 23.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.168 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.487 ' O ' HG12 ' A' ' 57' ' ' VAL . 23.7 ttp180 -168.2 157.03 9.08 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.1 mm -140.58 136.31 35.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.534 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.69 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -119.36 166.21 13.33 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.452 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -95.16 170.15 9.6 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.818 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.676 HD22 ' HA ' ' A' ' 53' ' ' LYS . 13.3 tp -72.76 157.59 37.21 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.897 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.62 -174.741 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -81.59 74.45 8.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.858 0.837 . . . . 0.0 109.522 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.444 ' HG1' ' C ' ' A' ' 21' ' ' GLY . 4.1 t -75.8 149.61 37.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.08 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.498 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.0 ptm180 -89.34 151.74 21.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.261 1.029 . . . . 0.0 112.642 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.8 OUTLIER -105.08 136.55 44.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.531 -166.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.498 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 28.0 m-85 -127.32 122.18 33.07 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.384 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.027 HG11 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -97.31 128.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.896 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.5 tp -66.19 139.84 58.14 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.788 -171.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -92.03 171.73 8.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.136 0.97 . . . . 0.0 111.777 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.482 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 21.2 t70 -128.43 169.98 13.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.038 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.74 -36.33 80.68 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.744 0.652 . . . . 0.0 111.094 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.09 -39.3 25.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.862 0.839 . . . . 0.0 109.439 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.03 31.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.173 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.482 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -77.22 -170.09 1.59 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.773 173.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.29 108.86 9.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.512 0.672 . . . . 0.0 111.083 -170.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.896 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 72.3 m-70 -89.88 -162.17 0.86 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.52 144.11 7.21 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 123.398 0.436 . . . . 0.0 113.434 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.6 t -83.64 143.82 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -126.71 143.11 51.34 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 p -121.89 135.16 54.87 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.444 ' C ' ' HG1' ' A' ' 3' ' ' THR . . . -137.57 -78.59 0.08 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.27 -177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt 173.36 -33.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.437 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 11.1 pt20 -159.68 166.68 15.57 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.312 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 72.5 Cg_exo -45.8 -22.29 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.507 2.805 . . . . 0.0 114.038 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.59 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 21.2 ttm-85 -88.1 -35.09 17.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.657 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.594 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -86.34 -14.66 42.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.598 -178.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.0 -47.78 7.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.405 ' HA ' HD23 ' A' ' 47' ' ' LEU . . . -57.12 -37.36 71.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.476 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.671 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -49.5 -65.92 0.48 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.426 172.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 74.5 mmtt -35.33 -48.31 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.445 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . . . -68.13 -26.78 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.752 0.706 . . . . 0.0 112.067 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.974 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -70.11 -22.95 62.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.226 1.012 . . . . 0.0 111.007 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.636 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 6.2 m-80 -62.45 -0.29 0.57 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -73.54 -63.92 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 116.6 -2.04 . . . . 0.0 109.651 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.13 -50.25 0.25 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 115.282 -3.342 . . . . 0.0 116.622 143.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.561 ' O ' HG21 ' A' ' 38' ' ' THR . 15.2 m -53.77 -25.35 18.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.488 0.644 . . . . 0.0 109.405 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.94 100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.945 164.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 36' ' ' SER . 25.5 p -135.49 -177.97 4.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.143 0.577 . . . . 0.0 110.461 -171.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.659 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 23.4 mtmm -65.42 -29.77 70.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.646 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.87 -38.03 79.44 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.157 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.38 71.7 32.27 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.21 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.626 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.8 Cg_exo -67.25 130.44 22.63 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.043 1.162 . . . . 0.0 109.42 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -72.2 107.17 4.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.727 ' HB ' ' HZ1' ' A' ' 59' ' ' LYS . 2.9 tp -71.07 96.75 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 122.316 1.055 . . . . 0.0 110.038 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 5.3 pt -103.62 152.13 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.107 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HG2' HG21 ' A' ' 57' ' ' VAL . 30.0 mtp180 -125.85 102.95 7.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 28' ' ' ALA . 2.6 mm? -87.62 137.62 32.17 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -122.13 112.26 17.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.87 144.26 56.83 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.027 ' HG2' HG11 ' A' ' 7' ' ' VAL . 61.7 mtp180 -74.98 -18.96 60.29 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.446 -166.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 -9.62 60.33 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.806 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.3 p -111.86 149.44 31.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.894 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -95.63 18.22 13.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -100.39 139.97 35.31 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.653 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.02 117.37 48.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.696 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.605 ' HA ' HD11 ' A' ' 89' ' ' ILE . 42.3 m-70 -96.85 99.55 11.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.888 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.576 HG21 ' HG2' ' A' ' 46' ' ' ARG . 7.5 p -98.32 127.27 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 1.4 m-85 -137.68 124.02 20.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.01 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.727 ' HZ1' ' HB ' ' A' ' 44' ' ' ILE . 26.7 mtpp -71.13 107.62 4.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.996 160.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.974 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -95.24 145.98 24.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.659 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 19.8 p90 -158.68 143.25 15.88 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.335 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.638 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 30.5 mtmt -103.62 124.51 48.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.577 ' HG2' ' CG ' ' A' ' 39' ' ' LYS . 3.6 tp10 -150.89 154.78 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.297 0.57 . . . . 0.0 111.392 -166.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.724 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 92.1 mt -118.44 121.18 66.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.626 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.56 HG22 ' NH2' ' A' ' 71' ' ' ARG . 34.7 m -122.93 151.05 26.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -79.91 -175.56 5.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.91 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -48.5 160.07 0.48 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 125.771 1.628 . . . . 0.0 114.791 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.749 ' HB3' ' HB2' ' A' ' 71' ' ' ARG . 42.1 Cg_endo -67.08 67.49 0.59 Allowed 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 124.116 3.211 . . . . 0.0 116.167 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -93.1 -7.78 44.56 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 161.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -133.51 2.01 3.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.067 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.937 HH22 HD12 ' A' ' 79' ' ' ILE . 67.0 mtt-85 -118.23 167.73 10.84 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -158.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.55 ' HD2' ' HE2' ' A' ' 75' ' ' MET . 25.4 Cg_exo -67.39 149.88 80.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.207 2.605 . . . . 0.0 109.364 154.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.01 19.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -167.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.622 ' CH2' ' HE3' ' A' ' 75' ' ' MET . 65.2 p-90 -95.27 -21.48 18.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.693 ' HB3' ' HD3' ' A' ' 71' ' ' ARG . 10.3 ttm -81.87 130.6 60.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.336 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.529 ' HD2' HG21 ' A' ' 79' ' ' ILE . 3.0 Cg_endo -74.48 177.47 8.34 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.839 2.36 . . . . 0.0 112.448 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.91 ' HA ' ' HA ' ' A' ' 67' ' ' ALA . 1.9 mp0 -51.81 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.876 0.735 . . . . 0.0 109.036 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -89.54 130.0 35.92 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.436 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.937 HD12 HH22 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.21 151.12 15.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.608 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.598 ' HB3' HG12 ' A' ' 64' ' ' ILE . 9.1 p -124.88 125.74 44.44 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.833 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 73.0 mmtt -159.28 144.26 11.55 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.671 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 3.0 Cg_exo -73.18 96.1 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 0.0 110.493 163.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.503 ' O ' HG11 ' A' ' 84' ' ' VAL . 80.2 m-85 -78.66 172.72 13.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.691 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -173.08 117.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.23 -173.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 118.14 34.56 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.875 157.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 3.6 ptpp? -55.13 139.57 41.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.236 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.9 -31.98 31.18 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.69 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 173.63 -174.68 0.06 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.097 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.605 HD11 ' HA ' ' A' ' 56' ' ' HIS . 31.2 mm -127.84 110.02 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.873 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.89 -176.34 2.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.335 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.436 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 21.4 mtmt -110.63 171.06 7.68 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.64 150.37 48.84 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.365 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--N 1.314 -0.96 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.13 -171.767 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.5 t30 62.03 91.1 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.844 0.83 . . . . 0.0 111.307 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.9 m -108.14 108.74 19.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.225 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.69 ' NH1' ' HB1' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -95.76 156.11 16.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.877 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -121.61 132.4 54.65 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.229 -0.295 . . . . 0.0 110.532 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.575 ' HD1' ' NH2' ' A' ' 4' ' ' ARG . 61.2 m-85 -143.74 134.07 24.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -115.76 133.89 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.774 ' HB2' ' HE2' ' A' ' 19' ' ' PHE . 2.4 tp -66.17 149.36 50.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.44 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.668 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 76.9 mtp180 -118.77 124.16 46.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 163.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -87.03 175.5 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.668 -169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -44.42 -44.77 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 124.122 0.889 . . . . 0.0 112.965 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -41.54 89.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.456 0.646 . . . . 0.0 110.89 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.05 25.78 2.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.96 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 p30 -110.55 170.37 8.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -95.82 141.89 28.73 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.051 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 39.9 m-70 -132.4 -178.99 5.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.823 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -20.26 126.27 0.01 OUTLIER Glycine 0 C--N 1.328 0.135 0 O-C-N 125.876 1.985 . . . . 0.0 114.884 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.09 125.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.253 0.549 . . . . 0.0 109.939 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.774 ' HE2' ' HB2' ' A' ' 8' ' ' LEU . 6.9 m-85 -112.72 149.37 33.04 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -135.8 141.98 44.81 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.3 -175.37 27.19 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.624 -1.275 . . . . 0.0 112.814 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -87.01 -31.79 20.38 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.57 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.603 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 18.6 pt20 -154.15 155.94 31.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 9.3 Cg_endo -50.84 -23.37 11.54 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.154 3.236 . . . . 0.0 114.398 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -58.01 -54.28 48.73 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 123.168 0.292 . . . . 0.0 110.858 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.475 HE21 HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -43.97 77.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.263 0.554 . . . . 0.0 111.106 175.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.69 ' HB1' ' NH1' ' A' ' 4' ' ' ARG . . . -55.96 -35.41 66.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.704 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.967 ' HB3' HG11 ' A' ' 84' ' ' VAL . . . -89.25 -21.49 23.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.349 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 1.3 mp -64.63 -63.55 1.1 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -39.62 -16.87 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.323 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' H ' ' C ' ' A' ' 29' ' ' LEU . . . -95.53 -50.95 4.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.219 0.533 . . . . 0.0 110.421 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.735 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -63.76 -29.46 70.67 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.412 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -4.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 32' ' ' ALA . 60.9 ttt180 -87.2 -59.92 2.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.69 -130.86 6.11 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.043 150.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.3 m 68.05 19.71 9.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.465 0.706 . . . . 0.0 111.886 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.14 146.55 17.84 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.186 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -125.37 176.28 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -58.8 -36.0 73.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.195 0.521 . . . . 0.0 110.783 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.92 -25.08 61.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.626 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.57 82.44 3.02 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.764 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.639 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.4 Cg_exo -84.8 136.28 6.06 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.245 2.63 . . . . 0.0 111.245 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.62 173.27 9.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.781 HD11 ' HE3' ' A' ' 59' ' ' LYS . 28.9 mm -111.04 118.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.113 0.482 . . . . 0.0 111.125 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.595 ' O ' HD11 ' A' ' 45' ' ' ILE . 2.9 pp -122.9 130.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.977 0.894 . . . . 0.0 111.622 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.807 ' HG2' HG23 ' A' ' 57' ' ' VAL . 48.1 mtm180 -105.89 114.32 28.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.961 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.639 HD22 ' HA ' ' A' ' 28' ' ' ALA . 3.3 mm? -82.2 164.0 21.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.691 0.758 . . . . 0.0 109.781 168.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.668 ' HD2' ' HD2' ' A' ' 9' ' ' ARG . 51.1 ttt180 -132.22 140.32 48.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.483 ' HB3' ' CG2' ' A' ' 52' ' ' THR . 17.5 tt0 -83.62 72.26 10.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mtm180 47.21 -64.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 111.456 -2.611 . . . . 0.0 113.612 -166.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.94 52.71 0.58 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.993 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.483 ' CG2' ' HB3' ' A' ' 49' ' ' GLU . 8.2 p -95.21 160.16 14.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.556 -0.379 . . . . 0.0 111.417 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.98 -21.95 58.84 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -100.94 111.71 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.062 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.562 HG21 HH11 ' A' ' 9' ' ' ARG . 98.1 t -86.6 132.36 32.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.246 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.445 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 90.0 m-70 -84.82 138.73 32.4 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.807 HG23 ' HG2' ' A' ' 46' ' ' ARG . 86.3 t -130.79 117.34 37.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.101 -171.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.787 ' HB3' HG13 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -129.11 139.94 51.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.781 ' HE3' HD11 ' A' ' 44' ' ' ILE . 24.0 mttp -70.32 161.32 30.63 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 162.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.735 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -153.47 142.52 21.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.59 -171.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 35.8 p90 -162.01 -166.88 1.52 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 87.3 mttt -143.34 136.69 28.14 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 80' ' ' SER . 30.9 mm-40 -145.39 171.39 14.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.979 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.53 74.58 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 122.292 1.044 . . . . 0.0 108.223 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 78' ' ' LYS . 27.5 m -85.6 -167.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.691 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.465 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 16.9 t70 -131.76 125.05 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.734 -171.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.816 ' HB1' ' HE2' ' A' ' 78' ' ' LYS . . . -120.34 141.24 31.51 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.073 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.95 -165.71 0.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.434 2.756 . . . . 0.0 113.519 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -51.63 -19.78 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.78 7.4 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 0.0 110.768 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.481 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 8.5 ptt180 -81.22 163.25 55.9 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.323 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 12.6 Cg_exo -68.03 166.1 25.96 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.355 2.037 . . . . 0.0 112.071 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.02 -22.51 20.75 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.467 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 60.8 p-90 -74.33 -29.38 61.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.403 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 74' ' ' TRP . 18.4 ttp -99.3 145.94 30.9 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.417 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.4 175.5 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 110.028 168.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.4 mp0 -41.02 -62.68 0.78 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.816 ' HE2' ' HB1' ' A' ' 67' ' ' ALA . 65.8 mmtt -152.01 -173.93 4.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.169 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.649 HD13 ' CG ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -161.56 160.79 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.49 -160.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.743 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -73.34 79.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.756 0.788 . . . . 0.0 109.977 -176.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.649 ' CG ' HD13 ' A' ' 79' ' ' ILE . 66.2 mmtt -113.03 162.08 23.59 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.477 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.515 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 25.7 Cg_endo -62.44 119.07 6.0 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.982 2.455 . . . . 0.0 110.903 170.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.549 ' HE2' ' HB2' ' A' ' 63' ' ' GLU . 23.2 m-85 -107.61 176.25 5.21 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.967 HG11 ' HB3' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -165.55 173.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -162.183 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' H ' HG13 ' A' ' 84' ' ' VAL . 0.0 OUTLIER 179.47 99.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.565 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 18.1 ttpp -68.86 103.81 1.89 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.627 0.727 . . . . 0.0 112.225 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 12.4 pt-20 -106.05 2.15 27.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.998 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.507 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 10.1 ptm180 -174.77 175.54 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.288 0.566 . . . . 0.0 111.672 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.461 HD12 ' HD2' ' A' ' 86' ' ' LYS . 23.2 mm -132.56 145.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.561 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -113.95 177.64 4.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 91' ' ' LYS . 1.6 mtmt -110.5 162.91 14.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -59.95 159.55 9.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.329 173.195 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.545 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 34.5 tt0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.728 -1.129 . . . . 0.0 110.147 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.0 m . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.957 0.408 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -107.38 132.83 52.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.942 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.517 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 29.8 m -82.2 98.41 8.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.378 0.608 . . . . 0.0 109.858 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -83.76 144.99 28.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.02 0.914 . . . . 0.0 112.182 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -96.14 134.97 38.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.19 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.509 ' HB3' HD13 ' A' ' 47' ' ' LEU . 70.6 m-85 -130.51 146.43 52.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.736 0.779 . . . . 0.0 111.004 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.811 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 9.5 t -96.01 149.01 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.804 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.652 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 10.5 tp -113.54 147.79 37.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.99 162.9 37.84 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 170.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.447 ' HB3' ' H ' ' A' ' 11' ' ' GLU . 3.4 m-20 -84.83 -160.58 0.5 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 171.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.639 ' OE1' ' HD3' ' A' ' 46' ' ' ARG . 5.3 mm-40 -91.05 0.53 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.79 -16.45 13.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.741 -168.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.442 ' HA2' ' NH2' ' A' ' 9' ' ' ARG . . . 104.62 35.44 3.29 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.472 -1.347 . . . . 0.0 112.249 -176.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 18.4 m120 -107.74 101.71 10.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.94 122.54 27.9 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.064 0.459 . . . . 0.0 110.859 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.652 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 92.3 m-70 -110.05 -167.01 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.864 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 16' ' ' HIS . . . -52.27 166.33 1.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.873 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 94.6 t -95.36 110.81 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.493 0.664 . . . . 0.0 110.185 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.497 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 m-85 -86.55 120.05 27.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.549 1.166 . . . . 0.0 112.225 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.517 ' HB ' ' CG2' ' A' ' 3' ' ' THR . 21.3 p -86.9 142.23 28.17 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.383 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.21 139.23 4.27 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -63.64 -20.18 65.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.846 0.823 . . . . 0.0 110.568 -175.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.523 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 13.5 pt20 -161.1 165.5 16.94 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.3 Cg_exo -43.85 -51.8 6.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.967 2.445 . . . . 0.0 112.97 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.426 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 39.2 ttt180 -51.0 -41.93 60.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.5 HE22 HD21 ' A' ' 29' ' ' LEU . 14.5 mm100 -78.29 -33.56 49.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 0.0 111.26 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.15 79.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.502 0.667 . . . . 0.0 109.635 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.576 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -69.82 -32.73 71.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.215 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.5 HD21 HE22 ' A' ' 26' ' ' GLN . 0.8 OUTLIER -55.88 -59.51 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -50.71 -24.34 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.138 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.497 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -90.47 -25.11 20.48 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.713 -0.617 . . . . 0.0 110.246 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -88.63 -16.28 32.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.292 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -15.39 56.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.592 -173.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.51 -28.92 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 110.673 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.38 102.8 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 m -59.12 -41.66 88.73 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.098 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.23 -139.6 0.41 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 123.931 0.77 . . . . 0.0 111.788 -170.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -147.29 171.18 15.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HZ2' ' HZ2' ' A' ' 61' ' ' TRP . 8.1 tppt? -62.14 -28.2 69.48 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.094 0.474 . . . . 0.0 110.679 173.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.53 -24.17 25.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.45 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.1 p-10 -143.93 64.6 13.1 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.425 0.631 . . . . 0.0 110.238 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.707 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 19.7 Cg_exo -64.81 150.17 88.53 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.634 2.223 . . . . 0.0 112.599 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.71 124.46 28.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.6 HD11 ' HE2' ' A' ' 59' ' ' LYS . 17.5 mm -74.6 117.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.785 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.441 HD11 HG13 ' A' ' 84' ' ' VAL . 17.7 pt -107.16 139.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.696 0.76 . . . . 0.0 111.397 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.643 ' O ' HD21 ' A' ' 47' ' ' LEU . 33.7 mmm-85 -94.89 171.54 8.71 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.948 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.643 HD21 ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -154.56 94.74 1.72 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.656 -177.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.811 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.2 ttp180 -78.9 143.39 35.91 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 131.74 54.09 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.01 19.03 7.13 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.279 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.75 -18.05 1.81 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.703 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.2 p -124.32 179.64 4.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.239 0.52 . . . . 0.0 111.326 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.511 ' HA ' HD12 ' A' ' 92' ' ' LEU . 64.1 pttt -108.11 33.64 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.527 0.68 . . . . 0.0 109.513 173.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -133.4 123.66 25.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.492 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.548 HG22 ' HG3' ' A' ' 48' ' ' ARG . 50.0 t -94.37 125.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.088 0.47 . . . . 0.0 109.918 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.414 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 33.7 m-70 -81.13 146.79 30.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.516 ' C ' ' HD1' ' A' ' 58' ' ' PHE . 8.3 p -135.13 127.33 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.422 0.629 . . . . 0.0 111.042 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' HD1' ' C ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -129.55 143.09 50.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 175.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.707 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -68.53 171.68 7.19 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.565 159.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.634 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -171.63 133.05 0.76 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.132 0.491 . . . . 0.0 109.823 -161.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.455 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 41.4 p90 -158.28 -177.48 6.58 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.63 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 55.0 mtmt -131.7 142.75 49.89 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.931 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.686 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 34.0 mt-10 -131.06 175.01 9.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.548 -0.751 . . . . 0.0 108.983 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.867 HD11 ' HB3' ' A' ' 78' ' ' LYS . 9.5 tt -95.53 134.9 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.411 1.1 . . . . 0.0 112.234 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.802 HG23 ' HG3' ' A' ' 81' ' ' LYS . 32.1 m -135.15 -174.4 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.166 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 4.2 p-10 -99.88 165.53 11.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 77' ' ' GLU . . . -142.05 -177.16 0.63 Allowed Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -167.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.731 ' HD2' ' HD2' ' A' ' 71' ' ' ARG . 58.9 Cg_endo -83.94 148.7 12.19 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.812 1.675 . . . . 0.0 111.236 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -78.29 2.55 18.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.692 -172.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.439 ' OD1' ' HB2' ' A' ' 68' ' ' PRO . 26.1 p-10 -92.07 7.85 40.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.315 0.579 . . . . 0.0 110.825 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.731 ' HD2' ' HD2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -69.24 171.64 6.39 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.633 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.849 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 68.6 Cg_exo -53.15 178.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.403 2.735 . . . . 0.0 114.297 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.38 81.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.834 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.506 ' CH2' ' HE1' ' A' ' 75' ' ' MET . 42.5 p-90 -81.37 -39.48 24.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.849 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 44.9 ttm -77.04 115.47 48.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.534 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 74' ' ' TRP . 76.9 Cg_endo -109.3 -155.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.678 2.919 . . . . 0.0 112.026 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.723 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 4.6 pt-20 -52.11 -59.65 4.12 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.769 167.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.867 ' HB3' HD11 ' A' ' 64' ' ' ILE . 18.6 mmtp -76.64 114.0 14.9 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.195 -172.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.698 HD12 ' O ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -163.79 -178.42 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.29 -175.018 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' ILE . 2.8 p -73.75 158.54 34.43 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.177 0.513 . . . . 0.0 111.968 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.802 ' HG3' HG23 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -162.23 136.15 4.87 Favored Pre-proline 0 C--O 1.22 -0.486 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -171.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.63 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 76.3 Cg_exo -52.4 153.98 12.4 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.87 2.38 . . . . 0.0 113.9 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.686 ' CE1' ' HB2' ' A' ' 63' ' ' GLU . 70.2 m-85 -165.93 157.41 13.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.576 HG12 ' HB3' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -165.21 169.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -166.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' H ' HG11 ' A' ' 84' ' ' VAL . 59.4 tttp -171.17 98.93 0.21 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.599 0.238 . . . . 0.0 110.519 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.463 ' HE3' HD13 ' A' ' 89' ' ' ILE . 67.2 tttt -53.02 128.26 26.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.523 170.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.532 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 3.4 pm0 -130.85 -5.78 4.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.562 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.469 ' HB3' HG13 ' A' ' 57' ' ' VAL . 8.6 ttp180 -171.24 174.56 4.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.37 -166.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.463 HD13 ' HE3' ' A' ' 86' ' ' LYS . 17.4 mm -136.1 137.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.41 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -111.14 176.82 4.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.798 0.809 . . . . 0.0 111.579 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -103.29 169.09 8.75 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.894 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 53' ' ' LYS . 13.7 mt -76.85 162.09 27.9 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.48 ' HB3' HH12 ' A' ' 9' ' ' ARG . 5.8 tp10 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 120.838 0.351 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.51 147.76 26.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m -64.67 126.62 28.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.163 0.506 . . . . 0.0 110.649 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 27.7 mmm180 -92.76 137.5 32.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.343 1.068 . . . . 0.0 111.208 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.414 ' HB3' ' HG3' ' A' ' 50' ' ' ARG . 1.1 m-80 -106.73 116.65 32.3 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.85 -1.977 . . . . 0.0 111.301 -175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 91.0 m-85 -129.99 177.32 7.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.567 1.175 . . . . 0.0 112.422 -174.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.865 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 35.2 t -147.68 149.94 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.521 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.71 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.8 tp -96.83 158.33 15.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.623 HH11 HG23 ' A' ' 55' ' ' VAL . 49.4 mtp180 -124.79 147.19 48.84 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.512 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 12.8 t70 -69.65 -167.65 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.9 0.318 . . . . 0.0 111.015 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.512 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 26.3 mm-40 -61.83 -39.59 92.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 111.435 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.79 -37.61 22.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.474 0.654 . . . . 0.0 109.702 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' A' ' 9' ' ' ARG . . . 132.51 45.0 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 118.721 -1.705 . . . . 0.0 112.063 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.4 -97.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -173.95 137.23 0.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 88.1 m-70 -144.6 166.25 25.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.154 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 34.53 -171.86 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.86 110.89 7.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.792 -1.704 . . . . 0.0 106.638 163.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.04 106.11 16.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.871 1.319 . . . . 0.0 113.364 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.0 p -91.08 117.29 29.48 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.877 170.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.66 169.5 24.59 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 113.776 -1.557 . . . . 0.0 111.947 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.82 -11.28 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.655 0.741 . . . . 0.0 110.293 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -160.82 147.12 11.52 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.391 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 53.8 Cg_exo -43.51 -42.56 11.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.904 . . . . 0.0 113.02 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -60.31 -35.22 75.1 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.449 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 86.2 mm-40 -75.92 -39.03 57.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.631 0.729 . . . . 0.0 109.969 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.5 -33.05 75.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.259 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.807 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -83.26 -26.78 30.4 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.39 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 8.3 tt -64.05 -63.9 1.03 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 172.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 66.6 mmtt -31.99 -27.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.058 164.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.91 -37.67 12.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.54 0.686 . . . . 0.0 110.527 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.472 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . . . -69.71 -8.66 49.77 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.716 1.206 . . . . 0.0 113.237 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.693 ' ND2' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m-80 -61.96 -51.71 66.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.656 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -63.83 -56.79 12.77 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.914 174.677 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.425 ' H ' ' HG2' ' A' ' 34' ' ' ARG . . . 83.19 -94.19 1.76 Allowed Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.289 151.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.4 m 63.66 36.77 10.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.217 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.9 159.34 25.98 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.663 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.5 p -125.27 -177.55 3.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.714 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.7 mtmm -72.12 -25.96 61.94 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.62 -28.32 56.06 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.975 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.78 64.53 8.47 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.31 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.645 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 7.1 Cg_exo -64.03 134.94 45.17 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.967 1.778 . . . . 0.0 111.182 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 5.9 p-10 -72.56 176.7 5.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.523 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.543 HG12 ' HE3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -123.77 136.65 59.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -176.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -138.27 136.71 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.739 172.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 57' ' ' VAL . 66.8 ttt180 -112.08 113.05 25.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.922 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.538 HD12 ' CA ' ' A' ' 28' ' ' ALA . 23.3 mt -101.36 104.52 15.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.153 0.978 . . . . 0.0 112.205 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.865 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 68.7 ttt180 -69.93 153.77 42.83 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.25 172.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.585 ' HG2' ' H ' ' A' ' 51' ' ' GLY . 50.4 tt0 -122.07 129.47 52.42 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HG3' ' HB3' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -94.61 18.74 10.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.51 0.671 . . . . 0.0 110.507 176.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.585 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -110.98 -58.1 0.48 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.408 HG23 ' CD ' ' A' ' 49' ' ' GLU . 6.4 p -93.06 175.34 6.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 0.0 110.877 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -93.72 11.3 29.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.542 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 91' ' ' LYS . 94.7 mttt -108.52 133.67 52.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.837 -174.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.857 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 93.6 t -101.59 128.27 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.504 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.425 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 22.8 m-70 -94.51 128.63 41.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.555 HG21 ' HG3' ' A' ' 46' ' ' ARG . 39.7 t -111.7 123.54 67.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.043 0.449 . . . . 0.0 110.686 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.98 ' HB3' HG12 ' A' ' 84' ' ' VAL . 34.6 m-85 -131.03 126.86 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.266 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 19.4 mttp -71.13 154.93 41.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.392 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.597 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . . . -135.35 147.06 48.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.494 -170.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.714 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 18.9 p90 -161.51 -179.38 7.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 45.0 mtmt -138.28 136.05 36.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.737 ' O ' ' HA ' ' A' ' 80' ' ' SER . 56.1 mm-40 -151.42 173.15 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.409 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.463 HG23 ' HA ' ' A' ' 79' ' ' ILE . 4.1 mp -109.37 83.34 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.973 0.892 . . . . 0.0 108.609 168.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.697 ' C ' ' HB2' ' A' ' 78' ' ' LYS . 27.2 m -88.59 -162.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.452 ' H ' ' HB ' ' A' ' 65' ' ' VAL . 14.6 t70 -134.02 90.6 2.71 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.898 -168.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.555 ' HB2' ' O ' ' A' ' 77' ' ' GLU . . . -70.79 154.12 94.47 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.048 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 15.3 Cg_exo -70.71 -158.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.411 2.741 . . . . 0.0 113.565 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -75.05 -23.41 58.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -84.22 17.2 2.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.616 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 18.0 ptt-85 -72.89 170.56 13.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.121 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.66 168.45 24.79 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.899 2.399 . . . . 0.0 112.437 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.7 -20.82 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.379 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.94 -27.09 33.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.498 ' HG2' ' HD2' ' A' ' 76' ' ' PRO . 29.7 ttm -94.56 145.02 28.9 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.498 ' HD2' ' HG2' ' A' ' 75' ' ' MET . 14.0 Cg_exo -67.87 -176.96 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.923 1.748 . . . . 0.0 109.849 167.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.616 ' HA ' ' CD ' ' A' ' 71' ' ' ARG . 34.9 mt-10 -44.99 -67.37 0.29 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.697 ' HB2' ' C ' ' A' ' 65' ' ' VAL . 20.8 mmtp -151.1 -177.18 5.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.247 167.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.679 HD11 ' N ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -157.45 173.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.292 -161.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.737 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 12.4 p -64.59 85.53 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.828 1.33 . . . . 0.0 110.855 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.898 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -117.84 167.13 11.79 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.03 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.693 ' HG2' ' ND2' ' A' ' 33' ' ' ASN . 7.4 Cg_exo -77.73 128.19 9.21 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.523 2.815 . . . . 0.0 110.57 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.898 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 20.5 m-85 -126.47 123.56 38.11 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.98 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -119.38 128.8 75.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.344 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.9 pttt -106.05 169.9 8.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.6 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -109.44 106.43 16.18 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -171.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG2' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.57 -6.82 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.829 -172.259 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -176.4 161.94 2.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 mm -131.81 141.37 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.512 0.673 . . . . 0.0 110.407 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.857 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 69.3 mm-40 -128.1 178.6 6.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.603 -173.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 53.3 mtmt -144.53 169.17 18.48 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.163 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt -84.96 168.12 15.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--N 1.315 -0.93 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.581 -179.223 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 121.306 0.574 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -134.91 -178.2 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 t -63.99 159.31 20.31 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.789 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 5.0 ptm180 -93.86 125.47 38.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.26 1.029 . . . . 0.0 111.766 -171.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.482 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.9 OUTLIER -87.8 145.75 25.95 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.389 -178.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.649 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 39.7 m-85 -128.9 170.86 12.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.889 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.695 HG22 ' HG2' ' A' ' 50' ' ' ARG . 15.9 t -130.1 142.41 43.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.614 ' HB2' ' CE1' ' A' ' 19' ' ' PHE . 4.0 tp -76.68 124.95 28.42 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.889 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.737 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 6.8 mmm180 -96.62 130.17 43.87 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 14' ' ' ASN . 42.7 p30 -88.34 -171.61 3.43 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.788 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -42.36 -46.69 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.58 -37.23 25.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 111.174 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 9' ' ' ARG . . . 123.0 36.55 0.66 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.731 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 27.2 m-80 -85.98 -178.21 6.5 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.809 0.337 . . . . 0.0 110.294 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' HG13 ' A' ' 7' ' ' VAL . 43.7 mt-10 -105.13 117.99 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.527 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.613 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 79.6 m-70 -137.57 104.27 5.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.911 0.862 . . . . 0.0 111.278 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.75 147.22 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.59 161.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 80.7 m-85 -150.71 159.59 44.42 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -170.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.4 ' OG1' ' HE3' ' A' ' 30' ' ' LYS . 32.0 p -141.25 158.2 44.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.777 0.323 . . . . 0.0 111.254 -176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.789 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.86 162.61 27.68 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.707 ' H ' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -87.78 0.41 55.8 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.919 0.866 . . . . 0.0 108.889 173.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.669 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 27.0 tt0 -161.33 151.58 14.58 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.273 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 7.9 Cg_exo -43.12 -60.35 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.559 2.173 . . . . 0.0 112.756 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.571 ' HB3' HE21 ' A' ' 23' ' ' GLN . 38.5 ttt180 -33.89 -42.29 0.11 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.249 167.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.668 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.68 -30.35 59.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 117.938 0.336 . . . . 0.0 111.592 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . -63.01 -63.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.903 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -41.05 -39.02 1.12 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.567 165.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.668 ' HB2' ' HA ' ' A' ' 26' ' ' GLN . 1.6 tp -61.78 -14.59 34.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.106 0.479 . . . . 0.0 111.228 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 60.0 mmtt -87.33 -55.45 3.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.61 -30.05 29.27 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -61.52 -29.5 70.03 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.663 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.82 2.15 0.33 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -110.12 -55.02 2.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.564 -162.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.03 -33.8 5.9 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 118.963 -1.589 . . . . 0.0 112.944 165.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.441 ' OG ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 t 73.68 -3.86 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.023 0.529 . . . . 0.0 111.371 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.7 -140.39 0.42 Allowed Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 0.0 112.901 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -150.08 167.72 25.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 165.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -58.79 -31.5 68.47 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.4 0.619 . . . . 0.0 110.4 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.43 27.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.363 -173.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.91 70.42 8.61 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.441 0.639 . . . . 0.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.722 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 25.9 Cg_exo -62.15 166.87 11.82 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.712 2.275 . . . . 0.0 111.477 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -97.2 150.06 21.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.689 HD13 ' HD3' ' A' ' 59' ' ' LYS . 23.0 mm -96.17 102.45 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.895 0.855 . . . . 0.0 112.215 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.418 ' O ' HD11 ' A' ' 45' ' ' ILE . 2.7 pp -118.98 142.05 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.076 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.633 ' HB3' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -129.32 131.72 46.98 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.773 165.275 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.902 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.4 mm? -90.3 161.12 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.735 0.779 . . . . 0.0 112.118 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.737 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . 18.7 ttp85 -125.01 133.23 53.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.35 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -82.66 72.9 9.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.203 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.695 ' HG2' HG22 ' A' ' 7' ' ' VAL . 35.8 mtp180 30.78 -90.14 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.884 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.61 3.01 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.198 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.833 HG22 ' HE2' ' A' ' 54' ' ' LYS . 54.7 p -138.35 166.29 24.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 110.171 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 92' ' ' LEU . 36.0 ttpt -112.44 36.46 3.39 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.833 ' HE2' HG22 ' A' ' 52' ' ' THR . 61.0 pttt -124.82 141.23 52.26 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.637 -176.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.593 HG23 ' HE ' ' A' ' 9' ' ' ARG . 10.8 t -124.83 144.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.759 0.314 . . . . 0.0 111.71 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.902 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 7.7 p80 -122.53 118.99 29.58 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.887 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.633 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . 60.8 t -85.1 119.83 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.925 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.97 ' HB3' HG12 ' A' ' 84' ' ' VAL . 8.1 m-85 -131.6 124.98 31.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.722 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 16.9 ttpt -85.57 122.57 29.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.807 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -119.57 144.55 47.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -164.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 9.3 p90 -162.55 175.2 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.618 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 14.2 mtpp -142.0 107.47 5.05 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.915 173.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.612 ' HG3' ' O ' ' A' ' 63' ' ' GLU . 7.0 pt-20 177.4 89.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.039 0.936 . . . . 0.0 112.169 159.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.588 HG21 ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -170.28 102.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.242 -1.536 . . . . 0.0 111.951 167.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.791 HG11 ' HE3' ' A' ' 81' ' ' LYS . 2.1 m -142.97 148.51 19.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 120.706 1.594 . . . . 0.0 110.823 164.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.13 72.15 1.64 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.63 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' HB1' ' HG2' ' A' ' 71' ' ' ARG . . . -54.13 135.71 58.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.495 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.3 Cg_exo -78.28 -148.97 0.03 OUTLIER 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 123.915 3.077 . . . . 0.0 113.078 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -94.81 -42.03 8.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.461 173.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -71.02 31.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.913 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.498 ' HG2' ' HB1' ' A' ' 67' ' ' ALA . 97.9 mtt180 -62.91 162.67 20.35 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.449 0.642 . . . . 0.0 111.981 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.615 ' HG2' ' HE3' ' A' ' 75' ' ' MET . 14.1 Cg_exo -72.61 151.11 52.12 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.463 2.775 . . . . 0.0 109.768 163.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.33 64.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.62 -171.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -88.42 -25.38 22.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.637 ' CG ' HG23 ' A' ' 79' ' ' ILE . 41.1 ttm -84.99 125.62 70.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -169.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 79' ' ' ILE . 60.2 Cg_endo -91.07 -162.48 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.253 2.635 . . . . 0.0 112.362 173.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -51.84 -68.84 0.14 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.924 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.5 mmmt -118.38 138.69 52.26 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.637 HG23 ' CG ' ' A' ' 75' ' ' MET . 0.7 OUTLIER -148.01 169.15 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-O 121.21 0.529 . . . . 0.0 109.645 -169.033 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.618 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 33.8 p -99.16 155.49 17.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.155 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.791 ' HE3' HG11 ' A' ' 65' ' ' VAL . 12.5 mmtp -158.34 150.14 17.12 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HA ' ' CG ' ' A' ' 62' ' ' LYS . 52.3 Cg_exo -53.83 91.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 CA-C-N 121.455 1.555 . . . . 0.0 112.899 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.588 ' CE2' HG21 ' A' ' 64' ' ' ILE . 14.4 m-85 -89.78 142.58 27.55 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.267 1.032 . . . . 0.0 111.342 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.97 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -146.51 151.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.08 178.261 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -135.63 103.07 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.717 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 82.8 tttt -66.99 120.37 13.52 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.136 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.64 -15.05 7.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.608 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 2.6 ttm180 -166.95 171.61 11.03 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -170.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.608 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 10.4 mm -137.66 136.2 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.432 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.7 mm-40 -116.93 140.02 49.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -142.09 149.42 39.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.357 0.598 . . . . 0.0 111.399 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.412 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 40.6 mt -124.38 155.04 39.46 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 163.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.439 -0.977 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.417 -171.572 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 121.28 0.562 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.499 ' CG ' ' H ' ' A' ' 3' ' ' THR . 62.8 t30 -125.98 -158.92 0.88 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.222 -173.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.502 ' O ' ' HD2' ' A' ' 4' ' ' ARG . 26.3 m -60.6 162.25 6.71 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.941 0.496 . . . . 0.0 111.373 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.549 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 11.8 mmm180 -126.68 171.51 11.1 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 108.62 7.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 120.973 0.416 . . . . 0.0 110.42 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.549 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 13.8 m-85 -113.16 149.29 33.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.71 0.767 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.02 141.54 19.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.92 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 19.0 tp -92.59 156.37 17.16 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.426 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.537 ' HG3' ' HD2' ' A' ' 48' ' ' ARG . 16.7 mtp85 -143.76 113.77 7.26 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 13' ' ' GLY . 12.7 t70 -105.79 170.0 8.16 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.291 -170.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -27.7 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 O-C-N 125.197 1.561 . . . . 0.0 113.048 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.88 -39.36 62.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.636 0.732 . . . . 0.0 111.236 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 10' ' ' ASP . . . 94.05 33.94 6.71 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.485 177.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 84.8 m-20 -142.5 -174.7 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -82.02 154.19 25.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.583 0.706 . . . . 0.0 110.831 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 9.6 m-70 -135.06 -165.18 1.63 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.404 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -46.3 157.64 0.42 Allowed Glycine 0 CA--C 1.518 0.266 0 O-C-N 123.983 0.802 . . . . 0.0 114.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.55 105.71 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.639 0.733 . . . . 0.0 109.481 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.5 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 61.6 m-85 -87.28 113.96 23.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.548 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -95.56 141.88 28.56 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.082 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 164.76 37.97 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -174.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -74.0 -19.29 60.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 118.616 1.208 . . . . 0.0 111.259 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 26.6 pt20 -157.94 168.89 11.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.7 Cg_exo -45.8 -60.76 0.74 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.686 2.257 . . . . 0.0 112.724 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -39.66 -49.66 2.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.239 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.558 ' HG2' ' HG2' ' A' ' 23' ' ' GLN . 13.1 mm100 -73.12 -24.42 60.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.701 0.286 . . . . 0.0 111.401 -174.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 30' ' ' LYS . . . -74.37 -41.12 61.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.415 0.626 . . . . 0.0 109.666 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' HD11 ' A' ' 45' ' ' ILE . . . -68.98 -35.72 77.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.008 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 9.7 tt -53.78 -55.39 26.91 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 69.6 mmtt -43.7 -43.48 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -73.32 -23.43 60.25 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.85 -0.531 . . . . 0.0 111.549 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.957 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -68.0 -11.88 59.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.602 0.715 . . . . 0.0 110.686 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.4 m-80 -78.88 3.0 18.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.658 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.4 mmp_? -89.59 -28.37 19.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.93 38.18 49.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.677 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.609 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . 13.8 m -97.48 5.27 49.9 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.173 0.511 . . . . 0.0 109.932 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.25 157.07 26.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.178 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 p -128.45 -177.47 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 12.8 tptm -61.16 -31.8 71.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.997 0.427 . . . . 0.0 110.732 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -38.51 25.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.68 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.24 75.1 75.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 121.116 0.484 . . . . 0.0 110.636 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.669 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 23.3 Cg_exo -67.29 158.12 58.47 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.71 2.274 . . . . 0.0 113.333 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.609 ' OD1' ' HB2' ' A' ' 36' ' ' SER . 15.8 m-20 -71.91 94.12 1.41 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.847 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 tp -72.92 95.65 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.983 0.897 . . . . 0.0 109.372 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 28' ' ' ALA . 6.2 pt -109.58 152.23 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.914 -172.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.697 ' HB3' HG12 ' A' ' 55' ' ' VAL . 74.3 mtp180 -114.55 118.53 34.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 6' ' ' PHE . 2.4 mm? -111.13 130.87 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.637 0.653 . . . . 0.0 109.412 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.652 ' HG2' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -122.3 118.76 29.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -77.97 107.19 10.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -47.37 102.61 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.296 0 O-C-N 124.019 0.824 . . . . 0.0 111.481 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.4 -25.26 3.01 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.102 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.8 p -92.49 167.47 11.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.758 ' HA ' HD23 ' A' ' 92' ' ' LEU . 24.7 ttmm -111.77 8.97 20.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.216 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -136.89 145.16 44.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.183 0.516 . . . . 0.0 110.96 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.729 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.1 t -101.71 136.41 33.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.958 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 4.4 m-70 -101.0 128.71 46.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 88' ' ' ARG . 12.8 p -114.31 130.55 68.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.549 0.69 . . . . 0.0 110.45 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.746 ' CB ' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -143.13 136.26 28.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.13 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.669 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 53.3 mttp -71.15 109.45 5.21 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.231 163.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.957 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -94.6 145.85 24.54 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 83' ' ' PHE . 13.6 p90 -170.15 146.61 3.02 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.847 ' HE3' ' HG3' ' A' ' 82' ' ' PRO . 11.8 mtpt -101.47 136.23 41.67 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.702 ' O ' ' HA ' ' A' ' 80' ' ' SER . 3.7 tp10 -163.73 158.95 20.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 112.036 -166.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 39.3 mt -103.54 130.61 53.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.42 150.47 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.484 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.94 93.82 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.914 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.475 ' HB1' ' HD3' ' A' ' 72' ' ' PRO . . . -51.25 136.27 30.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.404 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.432 ' HG2' ' HG3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -4.9 -148.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 1 C-N-CA 127.836 5.69 . . . . 0.0 118.22 -165.4 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -51.88 -57.57 8.99 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.503 173.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -132.85 -42.83 0.9 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.304 168.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 71' ' ' ARG . 8.4 mmt180 -144.68 148.04 38.15 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.217 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 1.004 ' HG2' ' HB3' ' A' ' 75' ' ' MET . 5.5 Cg_exo -90.98 166.58 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.434 2.756 . . . . 0.0 108.31 147.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.78 58.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.636 0.731 . . . . 0.0 111.198 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.549 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 58.3 p-90 -109.29 -33.71 6.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.389 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 1.004 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttp -99.44 144.39 28.18 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -167.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' HD2' HG21 ' A' ' 79' ' ' ILE . 7.0 Cg_exo -73.52 157.18 49.28 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.338 2.692 . . . . 0.0 112.115 169.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -44.19 -48.38 9.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.629 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -138.4 153.67 48.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 175.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.783 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -159.66 -178.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -169.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.702 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 23.1 t -150.72 84.66 1.35 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.394 168.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.696 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 26.2 mmtt -97.67 158.16 33.49 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.274 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.847 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 19.9 Cg_exo -63.38 92.44 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.704 1.603 . . . . 0.0 109.31 159.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.48 ' HE2' ' O ' ' A' ' 63' ' ' GLU . 35.2 m-85 -78.27 -179.52 6.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.571 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.746 HG12 ' CB ' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -160.92 162.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 79.1 tttt -159.23 98.51 1.43 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.851 0.834 . . . . 0.0 110.709 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.593 ' HB2' ' HD2' ' A' ' 58' ' ' PHE . 11.9 tmtt? -58.75 113.55 2.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.379 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' CD ' ' HZ3' ' A' ' 59' ' ' LYS . 12.0 pt-20 -119.63 5.97 11.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.029 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.468 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 39.2 ttp-105 176.24 170.15 0.43 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.015 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -120.24 141.12 41.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.729 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.2 mm-40 -112.14 166.66 11.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.293 0.568 . . . . 0.0 111.174 -173.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -82.12 159.91 23.26 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.758 HD23 ' HA ' ' A' ' 53' ' ' LYS . 12.5 tp -80.65 140.4 35.69 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--N 1.305 -1.332 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -169.345 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 121.094 0.473 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -154.78 133.31 11.99 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.984 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 91.5 m -73.53 149.13 42.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.181 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.586 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 1.3 ptm180 -132.77 155.48 48.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -107.15 145.15 32.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.409 0.55 . . . . 0.0 110.306 -174.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.497 ' HB3' HD13 ' A' ' 47' ' ' LEU . 58.5 m-85 -126.49 158.82 35.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.157 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 1.009 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -127.85 125.12 64.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.742 0.782 . . . . 0.0 109.166 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.732 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.5 OUTLIER -69.67 142.86 53.33 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.923 -1.489 . . . . 0.0 111.581 -168.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.05 142.1 28.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.225 171.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -88.87 -162.07 0.82 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.24 -38.65 66.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.345 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -86.19 -38.95 17.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 9' ' ' ARG . . . 121.25 30.26 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.705 171.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 47.8 m-80 -70.92 128.67 36.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.239 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.41 107.18 2.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.695 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.732 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 78.9 m-70 -103.11 -162.8 0.94 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.558 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.56 157.1 10.99 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -170.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.9 t -80.62 140.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 12.9 m-85 -124.24 159.25 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 p -128.61 145.75 51.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.092 0.472 . . . . 0.0 110.919 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.571 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -178.57 144.01 6.16 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.984 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.9 ptmt -70.09 -7.88 44.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.054 0.927 . . . . 0.0 111.549 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HA ' ' HD3' ' A' ' 4' ' ' ARG . 10.0 pt20 -159.29 149.71 15.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.14 174.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.29 -8.46 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.661 3.574 . . . . 0.0 115.079 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 23' ' ' GLN . 55.9 ttt180 -96.69 -25.26 15.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.603 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 25.3 mm-40 -86.84 -8.29 57.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.883 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.69 -48.69 7.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.49 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.275 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 82' ' ' PRO . 1.5 tp -57.2 -56.08 26.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.184 173.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 73.7 mmtt -61.54 -5.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.779 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.34 -40.15 9.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 1.036 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -72.97 -11.18 60.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.162 0.982 . . . . 0.0 109.738 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -83.75 -2.22 55.82 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.37 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -107.43 15.62 24.71 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.12 -167.53 24.76 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -172.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 22.9 m -106.04 -33.21 7.96 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.512 0.156 . . . . 0.0 111.291 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 59.16 171.24 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.11 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.4 m -156.66 128.33 7.17 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -65.21 -16.88 64.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.145 0.498 . . . . 0.0 111.965 -172.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.26 -22.04 28.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.71 71.96 2.45 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 121.637 0.732 . . . . 0.0 110.283 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.6 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 69.8 Cg_exo -54.77 170.0 0.71 Allowed 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.771 2.981 . . . . 0.0 113.943 -176.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.72 123.14 36.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.469 ' HA ' HD12 ' A' ' 44' ' ' ILE . 21.1 mm -81.55 120.53 33.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.147 0.499 . . . . 0.0 111.211 -176.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.25 141.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 81.6 mtp180 -113.54 122.56 47.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.497 HD13 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -91.69 127.53 37.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 70.0 ttt-85 -116.66 99.79 7.37 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 85.1 tt0 -70.69 112.23 6.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 1.009 ' HG2' HG12 ' A' ' 7' ' ' VAL . 27.0 mtp180 -47.46 -15.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.05 -38.25 6.48 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.755 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 75.1 p -93.85 165.25 12.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.107 0.48 . . . . 0.0 111.561 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -98.85 7.68 45.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.535 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.776 ' HA ' ' CB ' ' A' ' 91' ' ' LYS . 44.9 mtpt -125.24 148.11 48.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 111.215 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.808 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 26.7 t -93.16 135.73 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.713 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.682 ' HA ' HD11 ' A' ' 89' ' ' ILE . 31.7 m-70 -104.18 100.33 10.07 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.664 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.601 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -93.03 134.85 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.404 ' CE2' ' HA ' ' A' ' 25' ' ' ARG . 2.8 m-85 -142.56 118.93 10.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.044 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 15.3 ptpt -67.31 114.57 6.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.531 -1.268 . . . . 0.0 112.251 159.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 1.036 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -103.07 151.95 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.46 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.554 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 29.0 p90 -161.29 -172.68 3.5 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.691 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 44.8 mtmt -136.81 136.39 38.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.669 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 80' ' ' SER . 20.4 mm-40 -137.64 129.38 28.52 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.586 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.824 ' HB ' ' HB3' ' A' ' 80' ' ' SER . 3.3 tt -100.41 109.17 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.843 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.08 144.64 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.767 0.794 . . . . 0.0 110.382 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.576 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 21.7 t70 -74.72 103.56 5.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.936 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.584 ' HB1' ' CB ' ' A' ' 71' ' ' ARG . . . -70.19 133.75 87.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.856 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 58.1 Cg_endo -95.47 -160.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.314 3.343 . . . . 0.0 113.333 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -54.61 -56.29 20.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.281 0.562 . . . . 0.0 110.304 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.02 36.26 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.808 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.584 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 17.5 ptt180 -94.09 144.5 28.17 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.766 -0.584 . . . . 0.0 109.553 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 49.7 Cg_exo -59.16 159.83 21.03 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.965 2.444 . . . . 0.0 112.2 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.79 8.26 1.59 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.128 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -121.96 -36.44 3.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.552 ' CG ' HD11 ' A' ' 79' ' ' ILE . 36.8 ttm -72.41 114.99 34.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.987 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.602 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 81.6 Cg_endo -89.69 -177.91 1.54 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 123.138 2.559 . . . . 0.0 113.704 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 4.3 mm-40 -37.12 -52.42 1.0 Allowed 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 112.235 -2.257 . . . . 0.0 114.015 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.558 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -155.34 113.14 3.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.87 0.843 . . . . 0.0 112.059 176.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.602 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -150.0 160.04 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.175 175.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.824 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 14.1 p -110.03 93.41 4.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 160.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.653 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 21.2 mmmt -77.36 156.1 81.47 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.23 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.691 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 4.6 Cg_exo -68.32 90.79 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.254 1.302 . . . . 0.0 110.2 169.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.653 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 23.0 m-85 -75.45 175.09 8.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 122.048 0.928 . . . . 0.0 112.081 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 1.8 m -165.16 158.68 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.325 -169.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 6.7 tmtm? -148.83 114.15 5.55 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -75.39 123.67 25.79 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.609 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -101.16 -25.92 13.85 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.609 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 8.6 ptt180 -175.73 -173.11 0.58 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.315 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.682 HD11 ' HA ' ' A' ' 56' ' ' HIS . 16.2 mm -131.96 103.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.808 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 30.8 mt-10 -118.24 112.66 20.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 118.868 -1.133 . . . . 0.0 113.863 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.776 ' CB ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 mmmt -144.73 170.75 15.5 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.359 163.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.519 ' H ' ' HD2' ' A' ' 91' ' ' LYS . 79.5 mt -119.88 175.11 6.05 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 112.822 -1.99 . . . . 0.0 110.462 -172.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.525 -176.193 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 121.225 0.536 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -104.57 6.41 34.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.078 0.942 . . . . 0.0 109.642 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.41 ' HG1' ' C ' ' A' ' 21' ' ' GLY . 5.3 t -78.1 121.28 24.08 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.749 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.421 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.7 ptm180 -85.67 145.88 27.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.452 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.472 ' ND2' HG22 ' A' ' 20' ' ' THR . 7.6 m120 -84.96 147.09 26.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.554 -172.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 67.2 m-85 -135.59 150.32 49.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.89 136.47 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.584 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.1 tp -82.25 124.94 30.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HD3' ' HE ' ' A' ' 46' ' ' ARG . 2.6 mtp180 -101.21 166.92 10.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.513 1.149 . . . . 0.0 114.031 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -134.46 178.1 7.25 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.326 -2.215 . . . . 0.0 108.349 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.02 -35.84 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.62 -39.87 11.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -172.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.44 32.83 1.08 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.845 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.04 -173.57 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.293 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.88 107.8 16.52 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.289 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.584 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 85.4 m-70 -102.35 75.99 1.52 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.761 0.791 . . . . 0.0 110.053 175.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.65 153.01 0.98 Allowed Glycine 0 C--N 1.302 -1.348 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.865 -172.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.43 139.08 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.512 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 32.6 m-85 -123.89 151.02 43.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.472 HG22 ' ND2' ' A' ' 5' ' ' ASN . 22.1 p -114.04 145.42 41.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.5 ' HA3' ' HB1' ' A' ' 27' ' ' ALA . . . -154.81 135.71 4.81 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.893 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -71.83 -9.08 57.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.69 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 5.4 tt0 -160.23 149.01 13.64 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.79 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.69 ' HD2' ' HG2' ' A' ' 23' ' ' GLN . 75.0 Cg_exo -43.85 -9.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.956 3.771 . . . . 0.0 115.514 173.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.569 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 26.0 ttt-85 -96.52 -45.2 6.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 43.7 mm-40 -70.02 -16.86 63.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.979 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.5 ' HB1' ' HA3' ' A' ' 21' ' ' GLY . . . -89.02 -19.08 26.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.463 ' HB2' HD23 ' A' ' 47' ' ' LEU . . . -94.37 -27.83 15.86 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 26' ' ' GLN . 7.8 tt -64.89 -46.6 81.08 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.642 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.538 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 3.4 mmmp? -62.78 -13.02 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.618 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.512 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -88.32 -23.79 23.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.622 0.725 . . . . 0.0 109.046 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.908 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -68.1 -10.47 54.28 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.752 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -92.75 2.77 56.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.339 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 34' ' ' ARG . 11.8 mmt85 -100.41 15.17 28.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -173.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 174.5 -147.12 8.96 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -170.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 72.1 m -149.01 -41.87 0.15 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.008 -1.096 . . . . 0.0 109.166 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.79 5.32 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -168.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.1 p -151.99 177.58 10.32 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' A' ' 63' ' ' GLU . 20.5 ttmt -67.44 -31.89 72.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.702 0.763 . . . . 0.0 109.859 172.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.02 -39.47 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.503 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.62 75.42 73.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.79 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 35.9 Cg_exo -63.53 158.54 45.12 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.37 2.047 . . . . 0.0 111.549 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -88.69 72.68 8.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.545 HG12 ' HG2' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -54.61 130.59 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.396 -174.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.531 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -128.15 152.98 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.84 0.828 . . . . 0.0 110.867 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.751 ' NH1' HG12 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.59 127.46 53.05 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.751 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -118.18 132.55 56.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.623 ' HB2' HH21 ' A' ' 46' ' ' ARG . 41.4 ttt180 -131.03 127.81 39.02 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.497 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 30.7 tt0 -71.3 149.77 45.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -67.89 116.18 8.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.351 0.596 . . . . 0.0 111.182 -165.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -8.84 78.92 Favored Glycine 0 C--N 1.318 -0.437 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.247 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.497 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 23.1 p -96.86 170.96 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.926 0.393 . . . . 0.0 111.479 -174.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.899 ' H ' ' HB3' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.55 -8.19 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.229 171.377 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.818 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 57.3 mttp -49.28 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 111.784 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.751 HG12 ' NH1' ' A' ' 46' ' ' ARG . 14.3 t -110.1 101.9 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.751 ' CE1' ' HB3' ' A' ' 47' ' ' LEU . 4.0 p80 -111.3 128.03 55.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.365 172.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.726 HG21 ' HG2' ' A' ' 46' ' ' ARG . 43.0 t -109.17 115.76 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.782 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.96 131.82 53.37 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.545 ' HG2' HG12 ' A' ' 44' ' ' ILE . 30.8 mtpt -72.83 117.83 15.02 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.688 1.131 . . . . 0.0 110.869 164.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.908 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -108.61 137.81 45.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.247 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -149.99 -174.43 4.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.615 ' HD3' ' O ' ' A' ' 32' ' ' ALA . 25.0 mtpt -143.04 122.63 13.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.633 ' HG2' ' CE2' ' A' ' 83' ' ' PHE . 12.1 pt-20 -149.62 174.03 13.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.784 HD11 ' HB3' ' A' ' 78' ' ' LYS . 8.2 tt -115.47 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.33 145.94 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.268 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.64 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 11.2 p-10 -80.3 113.54 18.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.967 170.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 77' ' ' GLU . . . -77.41 129.99 75.8 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.073 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -79.81 -177.33 3.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.955 2.437 . . . . 0.0 111.511 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -49.94 -58.64 5.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 110.04 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.51 31.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 75' ' ' MET . 14.7 ptt85 -64.59 151.14 92.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 118.654 0.661 . . . . 0.0 110.068 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.52 147.07 95.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 111.601 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.68 5.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.449 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.544 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.0 p-90 -113.87 -24.72 8.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.655 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.579 ' HG2' HG12 ' A' ' 79' ' ' ILE . 22.8 ttp -101.68 118.94 58.58 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.517 ' HD2' HG21 ' A' ' 79' ' ' ILE . 12.8 Cg_exo -65.87 144.91 78.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.565 2.177 . . . . 0.0 113.344 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.727 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 31.0 mp0 -31.43 -54.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.805 1.316 . . . . 0.0 112.322 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HB3' HD11 ' A' ' 64' ' ' ILE . 29.5 mmtp -112.22 134.63 53.65 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.462 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.579 HG12 ' HG2' ' A' ' 75' ' ' MET . 1.1 pp -155.22 146.73 13.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.826 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 t -122.5 121.73 37.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.742 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 6.2 tppt? -154.64 145.76 16.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.472 -168.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HA ' ' CG ' ' A' ' 62' ' ' LYS . 51.0 Cg_exo -52.63 146.86 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.558 1.505 . . . . 0.0 109.474 156.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.742 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 11.2 m-85 -144.44 149.37 35.91 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -169.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.782 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -153.01 150.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 19.4 tptm -141.79 105.97 4.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.215 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.475 ' HE3' HD13 ' A' ' 89' ' ' ILE . 86.8 tttt -73.32 101.89 3.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.514 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 4.5 pt-20 -109.63 -36.73 5.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.705 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 23.9 ttt180 -128.35 152.94 47.57 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.235 0.54 . . . . 0.0 110.455 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.475 HD13 ' HE3' ' A' ' 86' ' ' LYS . 25.5 mm -143.98 159.56 15.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.442 -176.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 20.0 mm-40 -142.26 179.17 7.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 9.9 ptpt -77.39 113.33 15.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.148 0.975 . . . . 0.0 112.322 -171.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.818 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 24.0 mt -76.25 171.59 14.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.616 -1.629 . . . . 0.0 112.239 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.899 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 7.4 tt0 . . . . . 0 C--O 1.244 0.808 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.102 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.542 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 8.6 p . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.156 0.503 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 66.3 t30 -115.56 178.73 4.2 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 14.3 m -61.72 144.26 54.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.742 0.306 . . . . 0.0 111.274 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.664 HH22 ' HG3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -148.94 154.46 39.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -96.76 136.5 37.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.84 0.352 . . . . 0.0 111.759 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HZ ' ' NH2' ' A' ' 4' ' ' ARG . 96.7 m-85 -133.14 129.72 38.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.428 0.632 . . . . 0.0 111.73 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.775 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 3.1 t -103.53 100.83 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.978 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.496 ' HB2' HD22 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -61.89 144.8 54.4 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.921 173.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 9.6 ptm85 -132.49 132.53 42.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 170.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -115.92 169.44 9.23 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.788 -165.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -23.62 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 O-C-N 126.452 2.345 . . . . 0.0 114.38 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.87 -37.19 86.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.62 35.15 2.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 m120 -138.36 170.54 15.84 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -86.65 156.17 20.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.262 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' HB2' HD23 ' A' ' 8' ' ' LEU . 27.1 m-70 -142.52 -164.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -38.87 128.11 1.95 Allowed Glycine 0 C--N 1.339 0.697 0 O-C-N 124.473 1.108 . . . . 0.0 113.52 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -80.92 104.52 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.278 1.037 . . . . 0.0 108.231 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -88.46 113.11 23.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.501 -176.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -88.39 136.15 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.531 -1.668 . . . . 0.0 107.945 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.62 140.66 6.3 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 1' ' ' SER . 30.3 mtmm -76.96 -1.27 27.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.476 0.638 . . . . 0.0 111.144 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.678 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 25.2 tt0 -155.61 146.68 16.53 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.678 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 85.3 Cg_exo -47.07 -55.12 4.17 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.456 2.104 . . . . 0.0 112.383 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -45.16 -28.29 0.73 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.579 ' HG2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 mm100 -82.23 -26.22 33.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.14 -40.85 26.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.685 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -58.57 -36.2 73.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.363 169.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 tt -66.44 -53.0 40.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -50.31 -19.44 0.82 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.903 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.705 ' O ' ' HG2' ' A' ' 34' ' ' ARG . . . -95.49 -41.09 9.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.475 0.58 . . . . 0.0 109.73 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . . . -59.79 -20.11 54.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.267 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' ND2' ' H ' ' A' ' 34' ' ' ARG . 0.1 OUTLIER -56.84 -40.15 75.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.991 179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.705 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 7.4 ptm180 -84.55 -23.61 29.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.89 0.376 . . . . 0.0 110.937 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.98 70.69 2.87 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.305 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 m -76.67 60.36 1.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.091 0.472 . . . . 0.0 112.196 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.72 40.43 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.3 p -132.09 166.79 20.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.503 0.651 . . . . 0.0 109.74 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -66.54 -14.27 62.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 0.0 111.55 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.97 -18.56 21.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.343 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.446 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -151.78 63.48 5.36 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.939 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 13.3 Cg_exo -68.45 151.98 75.44 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.704 2.269 . . . . 0.0 112.621 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -77.54 122.11 24.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.719 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.814 HD11 ' HE3' ' A' ' 59' ' ' LYS . 17.5 mm -71.22 109.61 3.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.42 0.629 . . . . 0.0 111.064 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 58' ' ' PHE . 2.7 pp -113.75 137.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.515 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.509 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 24.1 mtp180 -124.38 104.87 9.02 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.01 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.57 HD11 ' N ' ' A' ' 28' ' ' ALA . 86.0 mt -88.65 131.0 35.17 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.327 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.775 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -84.27 154.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.452 0.644 . . . . 0.0 109.547 174.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.808 ' HB3' ' HG1' ' A' ' 52' ' ' THR . 34.6 tt0 -116.96 76.98 1.07 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.623 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.656 ' HG2' HG22 ' A' ' 7' ' ' VAL . 6.3 mtp180 -30.66 119.18 0.18 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.059 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.65 -24.21 24.38 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.127 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.808 ' HG1' ' HB3' ' A' ' 49' ' ' GLU . 10.6 p -114.25 -172.21 2.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.182 0.491 . . . . 0.0 110.201 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.55 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 18.8 pttm -123.17 27.22 7.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 109.534 170.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HB2' ' HZ2' ' A' ' 54' ' ' LYS . 9.8 mtmp? -110.08 138.18 46.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.411 179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 92' ' ' LEU . 39.9 t -109.8 127.47 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.476 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.644 ' HA ' HD11 ' A' ' 89' ' ' ILE . 62.9 m-70 -88.49 111.71 22.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.711 0.291 . . . . 0.0 110.784 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG23 ' HG2' ' A' ' 46' ' ' ARG . 38.5 t -97.09 108.12 21.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.479 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.856 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -120.06 122.48 41.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.155 172.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.939 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 44.1 mttp -68.76 111.77 5.07 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.1 163.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.613 ' HB2' HG11 ' A' ' 84' ' ' VAL . . . -92.92 134.88 34.65 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.011 174.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 41.6 p90 -144.46 -172.32 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 47.8 mttp -133.8 139.77 46.5 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.208 0.527 . . . . 0.0 110.387 174.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.755 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 18.1 mm-40 -133.09 140.04 47.45 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.365 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.78 143.08 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 79' ' ' ILE . 5.5 m -145.96 -175.35 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.141 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.687 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.9 p-10 -162.91 124.17 2.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 168.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -131.74 150.01 75.05 Favored Pre-proline 0 C--N 1.315 -0.925 0 O-C-N 121.613 -0.68 . . . . 0.0 110.675 -167.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.4 Cg_exo -78.0 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.294 1.996 . . . . 0.0 113.833 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' C ' ' H ' ' A' ' 71' ' ' ARG . 59.6 mmtt -93.98 -51.23 4.96 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.64 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.461 ' HD3' ' HA ' ' A' ' 77' ' ' GLU . 22.8 mtm105 -83.04 167.11 31.55 Favored Pre-proline 0 C--N 1.316 -0.885 0 O-C-N 121.219 -0.926 . . . . 0.0 109.998 166.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.591 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 15.7 Cg_exo -69.85 170.83 15.77 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 122.197 1.932 . . . . 0.0 110.312 163.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.59 1.33 34.29 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.585 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -120.77 -38.71 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.187 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.591 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 10.1 ttp -74.82 126.93 87.87 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.71 151.44 46.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.274 2.649 . . . . 0.0 111.861 175.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 7.2 pt-20 -25.58 -58.57 0.07 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.465 1.506 . . . . 0.0 114.726 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -100.39 119.06 37.88 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.343 -164.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.599 ' O ' HG21 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -165.36 164.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.053 -174.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 38.2 p -109.06 95.64 5.77 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 20.5 mttt -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.457 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 4.1 Cg_exo -80.87 96.33 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.642 2.228 . . . . 0.0 111.913 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.755 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 47.4 m-85 -94.36 120.82 35.17 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.371 0.605 . . . . 0.0 110.553 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.856 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -99.29 178.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.422 175.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.708 ' HE2' ' HB3' ' A' ' 87' ' ' GLU . 5.1 tttt -166.18 104.39 0.65 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.125 -173.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.597 ' HE2' HD13 ' A' ' 89' ' ' ILE . 65.8 tttm -61.62 127.7 32.71 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 171.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.708 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 13.5 pt-20 -127.41 -34.03 2.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.271 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 88' ' ' ARG . 15.4 ttp180 -151.74 159.5 43.93 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.712 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.644 HD11 ' HA ' ' A' ' 56' ' ' HIS . 21.0 mm -123.23 107.96 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.741 173.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -92.5 -177.46 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.122 0.963 . . . . 0.0 113.286 179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -82.25 169.31 16.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.882 170.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.602 HD21 ' HD2' ' A' ' 48' ' ' ARG . 22.6 mt -53.26 151.25 5.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.54 0.686 . . . . 0.0 112.675 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.252 1.198 0 CA-C-N 113.49 -1.686 . . . . 0.0 109.466 -175.711 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.202 0.525 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -123.6 -169.08 1.88 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.367 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 t -70.96 170.37 12.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.989 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.693 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -93.06 125.3 37.58 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.85 0.833 . . . . 0.0 110.966 -178.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -88.82 145.0 25.85 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.858 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.773 ' CE2' ' HG3' ' A' ' 49' ' ' GLU . 82.5 m-85 -130.98 144.59 51.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.536 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.574 HG21 ' HB3' ' A' ' 50' ' ' ARG . 47.1 t -112.83 127.92 69.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.544 HD21 ' HB2' ' A' ' 16' ' ' HIS . 3.9 tp -66.63 130.01 41.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.216 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.69 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 67.1 mtp180 -106.82 128.03 53.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 166.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -87.62 -169.78 2.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -37.57 -48.24 0.99 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.589 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -80.2 -35.07 36.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.595 0.712 . . . . 0.0 110.258 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.6 31.41 1.81 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.641 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.69 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -96.89 148.1 23.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -173.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.77 130.42 38.6 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.784 0.677 . . . . 0.0 111.013 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.544 ' HB2' HD21 ' A' ' 8' ' ' LEU . 92.0 m-70 -138.22 -171.47 3.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.737 -176.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -12.2 130.45 0.01 OUTLIER Glycine 0 N--CA 1.461 0.331 0 O-C-N 126.736 2.522 . . . . 0.0 113.366 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.79 156.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.685 0.278 . . . . 0.0 111.077 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.581 ' CE1' ' HB1' ' A' ' 31' ' ' ALA . 92.6 m-85 -151.43 156.82 41.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -139.71 158.36 44.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.581 0.229 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.693 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.71 150.63 8.38 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.103 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.501 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 2.7 tppp? -72.79 -6.33 44.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.487 0.643 . . . . 0.0 110.767 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.835 ' HG3' ' HG2' ' A' ' 26' ' ' GLN . 5.5 pt20 -160.46 158.62 25.61 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 11.6 Cg_endo -56.84 -13.48 11.49 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 123.329 2.686 . . . . 0.0 115.233 -171.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.547 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 19.4 ttt180 -94.14 -13.67 26.5 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -174.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.835 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 16.9 mm100 -88.21 -18.08 29.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.061 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 -59.05 2.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.722 ' HB3' HG13 ' A' ' 84' ' ' VAL . . . -35.92 -45.58 0.42 Allowed 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 159.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.74 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -57.48 -26.07 60.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.425 0.631 . . . . 0.0 111.076 177.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.744 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 27.2 mmmt -80.94 -47.89 13.06 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -69.4 -21.56 63.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.772 ' HB1' ' HB3' ' A' ' 60' ' ' ALA . . . -67.47 -12.85 61.28 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.82 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.658 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -66.06 -47.66 73.59 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.82 17.71 2.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.977 170.028 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.29 90.68 1.42 Allowed Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -77.09 49.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 110.281 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.32 -165.62 11.94 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.32 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.464 HG21 ' ND2' ' A' ' 41' ' ' ASN . 9.5 t -162.35 171.62 16.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -62.12 -16.42 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.941 0.791 . . . . 0.0 111.029 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.85 -30.08 40.24 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.769 . . . . 0.0 110.63 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.464 ' ND2' HG21 ' A' ' 38' ' ' THR . 0.3 OUTLIER -165.15 72.74 1.43 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.182 -176.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.497 ' HB2' ' HD2' ' A' ' 59' ' ' LYS . 49.4 Cg_exo -56.19 -169.44 0.02 OUTLIER 'Trans proline' 0 CA--C 1.526 0.082 0 C-N-CA 123.386 2.724 . . . . 0.0 114.008 -174.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -119.4 104.14 10.09 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.7 tp -79.05 101.52 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.781 0.8 . . . . 0.0 112.391 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 28' ' ' ALA . 2.4 pp -119.12 129.08 75.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.09 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.824 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 42.2 ttm105 -109.44 118.04 35.59 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.453 HD11 ' HA ' ' A' ' 8' ' ' LEU . 3.4 mm? -84.88 161.69 19.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.916 0.865 . . . . 0.0 112.687 175.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.643 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 49.5 ttp180 -133.2 130.46 39.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.003 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.773 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 2.4 mt-10 -80.18 88.2 5.47 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.574 ' HB3' HG21 ' A' ' 7' ' ' VAL . 3.4 ptm180 -51.56 -9.12 0.07 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.86 -32.47 9.96 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.748 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 p -117.99 -169.75 1.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.002 0.43 . . . . 0.0 110.872 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -108.91 41.62 1.57 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.464 0.65 . . . . 0.0 109.599 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HD3' ' OXT' ' A' ' 93' ' ' GLU . 67.6 mttm -101.32 138.9 37.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.32 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 81.4 t -124.34 129.07 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.589 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 89' ' ' ILE . 71.2 m-70 -134.84 107.93 7.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -172.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.824 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 14.9 p -97.0 138.75 21.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.836 ' HB3' HG12 ' A' ' 84' ' ' VAL . 2.9 m-85 -141.52 138.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.966 0.412 . . . . 0.0 110.321 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 55.3 mmtt -71.66 128.5 35.99 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 161.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.772 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . . . -126.02 133.01 51.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.489 ' HZ3' ' HG2' ' A' ' 85' ' ' LYS . 26.9 p90 -151.93 156.37 39.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 6.7 mtpm? -131.58 124.17 29.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.724 0.773 . . . . 0.0 110.943 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.478 ' HG3' ' HE2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 139.87 31.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.003 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.758 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -82.23 145.78 8.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.755 ' H ' HD13 ' A' ' 64' ' ' ILE . 1.5 t -130.19 176.51 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -167.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.543 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 25.4 t0 176.79 50.39 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -133.87 118.71 14.45 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.38 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 7.3 Cg_exo -74.14 -19.81 19.72 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 C-N-CA 123.697 2.931 . . . . 0.0 113.822 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -71.54 -36.09 70.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.458 -171.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.431 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 42.9 m-80 -114.82 33.39 5.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.852 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.876 ' HG3' HH11 ' A' ' 71' ' ' ARG . 5.5 mmt85 -76.21 111.95 18.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.178 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.743 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 10.0 Cg_exo -73.76 174.47 12.24 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 123.838 3.025 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.24 8.69 20.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.479 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.2 p-90 -123.49 -31.79 3.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.319 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.743 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.4 ttp -97.78 141.46 23.02 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.325 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.481 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 11.7 Cg_endo -79.68 -148.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.63 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.653 ' HA ' ' NE ' ' A' ' 71' ' ' ARG . 35.7 mt-10 -91.37 -40.54 11.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.213 -0.304 . . . . 0.0 111.745 -169.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -144.79 118.38 9.15 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -175.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.19 159.15 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 CA-C-O 120.934 0.397 . . . . 0.0 110.266 -176.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 44.5 t -112.31 126.48 55.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.748 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 14.0 tppt? -146.64 135.57 11.22 Favored Pre-proline 0 N--CA 1.438 -1.05 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -164.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.74 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 22.3 Cg_exo -64.67 89.97 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 CA-C-N 119.747 0.945 . . . . 0.0 110.389 172.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.748 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 18.3 m-85 -75.42 139.28 42.22 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.985 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.836 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -150.43 155.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.739 -177.294 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.489 ' HG2' ' HZ3' ' A' ' 61' ' ' TRP . 3.7 ptmm? -151.78 138.97 19.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.11 0.481 . . . . 0.0 111.637 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.522 ' HD3' ' CG1' ' A' ' 89' ' ' ILE . 35.9 ttmt -88.98 89.85 8.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.424 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' OE2' ' HG2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -55.03 -54.63 40.57 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 165.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.465 ' HG2' HG12 ' A' ' 57' ' ' VAL . 5.0 ptt180 -143.61 171.62 13.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.445 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.601 HG22 ' HB2' ' A' ' 93' ' ' GLU . 15.8 mm -145.37 131.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.747 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 32.4 mt-10 -87.77 -158.01 0.44 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.934 1.293 . . . . 0.0 109.17 175.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -57.11 169.42 0.56 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.2 mt -34.6 156.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 117.749 2.5 . . . . 0.0 117.749 -126.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.601 ' HB2' HG22 ' A' ' 89' ' ' ILE . 44.0 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 112.731 -2.032 . . . . 0.0 109.364 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -93.67 98.07 10.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m -72.28 111.95 7.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.393 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -87.05 124.24 33.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.266 0.555 . . . . 0.0 111.369 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.63 135.48 38.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.187 174.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.526 ' CE2' ' HG3' ' A' ' 24' ' ' PRO . 9.2 m-85 -120.3 160.82 22.24 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 50' ' ' ARG . 3.5 t -118.5 138.22 49.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.737 HD23 ' HB2' ' A' ' 16' ' ' HIS . 11.5 tp -79.28 134.74 36.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.528 ' HG3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -136.31 121.18 18.66 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.426 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 1.9 t70 -65.32 179.03 0.81 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.371 0.605 . . . . 0.0 112.273 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.32 -32.4 71.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -83.37 -38.97 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.689 0.756 . . . . 0.0 109.211 175.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.43 21.12 2.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.878 172.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 40.0 mt-10 -81.88 121.31 26.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.737 ' HB2' HD23 ' A' ' 8' ' ' LEU . 62.0 m-70 -114.61 99.5 7.58 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.376 0.607 . . . . 0.0 111.461 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.46 175.92 27.7 Favored Glycine 0 C--N 1.294 -1.787 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.207 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.17 138.69 50.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 55.0 m-85 -126.69 148.52 49.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.5 p -132.33 144.38 50.52 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.195 -0.316 . . . . 0.0 111.688 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.15 33.69 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.945 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -54.97 -40.43 70.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.529 0.681 . . . . 0.0 109.719 171.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.75 177.68 1.73 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.526 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.75 -53.33 7.2 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.925 1.75 . . . . 0.0 112.113 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 34.2 ttm180 -32.28 -53.38 0.3 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -74.86 -17.41 60.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.114 0.483 . . . . 0.0 111.169 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.01 23.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.629 0.728 . . . . 0.0 109.132 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -95.83 -32.63 12.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.791 HD22 HG22 ' A' ' 84' ' ' VAL . 4.3 mt -57.3 -40.32 77.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.382 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -70.19 -7.07 38.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.724 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -100.48 -48.25 4.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.636 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . . . -73.58 -11.21 60.36 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.237 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.38 -2.19 55.19 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.407 -166.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.6 ptp180 -114.99 15.79 17.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.0 -119.36 2.66 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.661 -171.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m 176.32 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -172.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 46.37 -164.69 0.1 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.539 -175.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 37' ' ' GLY . 11.9 p -157.01 141.46 16.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.082 0.553 . . . . 0.0 109.618 176.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -66.45 -22.47 66.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.761 0.791 . . . . 0.0 110.37 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.03 -43.03 88.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.658 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.51 74.41 4.2 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.621 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.835 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 50.4 Cg_exo -52.83 125.57 18.54 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.377 2.718 . . . . 0.0 113.519 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -42.15 127.47 3.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.105 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 44' ' ' ILE . 11.7 mm -80.65 115.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 1.012 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.8 pp -106.05 154.62 7.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.101 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.532 ' NE ' ' HB ' ' A' ' 57' ' ' VAL . 0.8 OUTLIER -129.71 101.72 6.02 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.034 -178.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.69 HD23 HD12 ' A' ' 45' ' ' ILE . 4.4 mm? -96.25 135.65 37.8 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.403 ' HB2' HG21 ' A' ' 55' ' ' VAL . 45.0 ttt180 -132.85 113.04 12.43 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.437 -175.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.502 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 33.6 mt-10 -59.56 108.92 0.79 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.665 0.386 . . . . 0.0 110.059 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.56 ' HG2' HG22 ' A' ' 7' ' ' VAL . 12.8 mtp180 -34.08 -43.97 0.16 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 174.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.28 -26.5 71.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.728 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.538 HG23 ' HZ3' ' A' ' 54' ' ' LYS . 6.9 p -103.43 -177.12 3.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.276 0.56 . . . . 0.0 110.989 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.733 ' HB2' ' HA ' ' A' ' 93' ' ' GLU . 53.6 mtmt -121.1 4.04 10.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.792 169.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 25.7 pttm -90.86 133.31 35.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.264 0.554 . . . . 0.0 110.313 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.897 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 19.0 t -103.61 153.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.759 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -128.9 112.29 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.094 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.532 ' HB ' ' NE ' ' A' ' 46' ' ' ARG . 2.5 p -98.07 126.11 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 122.602 1.191 . . . . 0.0 113.251 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 1.012 ' HB2' HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -114.13 -173.11 2.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.602 -1.636 . . . . 0.0 107.547 174.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.835 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 13.7 ptpt -141.25 121.13 13.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB3' ' CB ' ' A' ' 32' ' ' ALA . . . -108.87 140.9 41.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.659 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 10.2 p90 -160.78 -174.33 4.37 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.104 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 88.0 mttt -127.27 153.34 46.26 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 110.542 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.485 ' CG ' ' HE1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -163.77 177.36 8.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -164.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.674 ' HB ' ' HG2' ' A' ' 76' ' ' PRO . 18.2 pt -62.37 137.28 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.109 0.957 . . . . 0.0 110.669 167.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 1.042 HG22 HG21 ' A' ' 79' ' ' ILE . 1.4 m -99.75 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 -165.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.481 ' N ' HG21 ' A' ' 65' ' ' VAL . 36.0 t70 -33.35 -94.18 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 112.02 -2.355 . . . . 0.0 115.945 -166.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 76' ' ' PRO . . . -50.26 150.17 4.68 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -166.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 71.7 Cg_endo -110.34 -102.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 1 C-N-CA 125.963 4.442 . . . . 0.0 115.225 -172.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -83.04 -23.6 33.15 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.33 -168.155 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -64.49 -8.13 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.567 1.175 . . . . 0.0 110.461 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 76' ' ' PRO . 24.3 mmm180 -117.14 170.78 5.6 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.378 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.604 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 52.9 Cg_exo -57.69 169.03 2.71 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.778 1.652 . . . . 0.0 112.167 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.45 -47.72 84.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.284 0.564 . . . . 0.0 110.46 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.624 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 43.7 p-90 -82.62 -33.22 27.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.434 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.604 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.8 ttm -94.88 112.0 56.55 Favored Pre-proline 0 C--O 1.223 -0.317 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -170.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.752 ' HG2' HG22 ' A' ' 79' ' ' ILE . 47.0 Cg_exo -65.69 -72.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 123.612 2.875 . . . . 0.0 112.976 169.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.55 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 4.7 mm-40 -135.79 -80.44 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.55 ' HD2' ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -159.92 115.25 2.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 166.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 1.042 HG21 HG22 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -120.22 117.16 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 N-CA-C 119.294 3.072 . . . . 0.0 119.294 -150.228 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -168.69 88.75 0.21 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 110.451 -3.068 . . . . 0.0 109.351 159.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.764 ' HG2' HG11 ' A' ' 65' ' ' VAL . 23.5 mmtt -122.55 155.7 62.29 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 120.113 1.324 . . . . 0.0 111.546 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 95.4 Cg_endo -76.14 123.05 6.99 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.255 2.637 . . . . 0.0 111.363 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.581 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 33.8 m-85 -124.51 149.41 46.94 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.791 HG22 HD22 ' A' ' 29' ' ' LEU . 1.1 t -122.3 163.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.315 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 86' ' ' LYS . 1.6 tmmm? -148.67 132.71 17.22 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 51.8 tttm -72.99 113.5 10.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.832 0.825 . . . . 0.0 109.116 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.435 ' OE1' ' HE3' ' A' ' 59' ' ' LYS . 0.4 OUTLIER -97.52 -45.02 6.58 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.804 -169.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.555 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 27.0 ttp-105 -156.79 -175.73 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.363 0.601 . . . . 0.0 111.048 -171.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.555 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 14.7 mm -128.12 154.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.605 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.897 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -120.28 -171.29 2.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.051 0.94 . . . . 0.0 110.783 -169.511 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 53.6 mtmt -69.02 173.98 4.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.35 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.78 155.56 39.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.088 -152.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.733 ' HA ' ' HB2' ' A' ' 53' ' ' LYS . 1.2 tm-20 . . . . . 0 C--O 1.249 1.044 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.345 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -82.9 133.29 35.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.545 1.164 . . . . 0.0 113.496 -173.633 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.54 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 31.6 m-20 -78.53 155.21 29.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.339 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.56 176.23 8.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.443 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.46 146.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 2.4 tp -99.43 120.74 40.1 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.265 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.795 ' HB2' ' HB2' ' A' ' 46' ' ' ARG . 53.1 mtp180 -88.72 157.16 18.61 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.469 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 11.9 t70 -102.35 -151.8 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.739 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.461 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 51.1 mm-40 -83.48 -20.37 34.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.868 0.366 . . . . 0.0 110.917 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.25 -6.88 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.477 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.91 50.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.315 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 12.4 m120 -54.63 178.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.653 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.37 160.15 34.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.272 0.558 . . . . 0.0 111.994 -169.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 77.9 m-70 -142.58 -159.59 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.172 -171.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.65 161.2 17.4 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.448 0.467 . . . . 0.0 112.84 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 p -84.25 110.9 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.898 0.856 . . . . 0.0 110.521 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 2.7 m-85 -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.111 175.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 74.2 p -148.24 175.34 11.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.999 0.428 . . . . 0.0 109.865 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 154.69 142.93 3.55 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.565 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -14.41 48.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.241 0.544 . . . . 0.0 110.39 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.428 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 36.4 tt0 -153.83 142.86 14.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.802 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 72.3 Cg_exo -46.96 -18.74 0.61 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.485 3.457 . . . . 0.0 115.492 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -82.81 -12.7 57.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . 13.8 mm100 -77.37 -65.01 1.01 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.914 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -34.46 -37.46 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 164.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.568 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -77.34 -38.97 49.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.34 177.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.856 HD12 HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -63.24 -39.19 93.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -80.87 -1.03 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.943 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . . . -99.06 -20.3 16.78 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.772 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 34' ' ' ARG . . . -72.81 -66.33 0.68 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.621 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -35.06 8.13 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 162.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.61 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 14.8 mmm180 -91.37 -48.27 6.99 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.4 1.0 . . . . 0.0 110.272 -167.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -81.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.142 -1.504 . . . . 0.0 115.055 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -87.26 36.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 0.0 110.204 -168.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 61' ' ' TRP . . . -72.73 92.65 0.62 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.078 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -133.72 144.07 48.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.221 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HD2' ' CD ' ' A' ' 63' ' ' GLU . 68.9 tttt -81.4 -12.81 58.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.256 0.55 . . . . 0.0 110.365 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.6 64.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.047 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -163.9 81.06 1.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.059 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.8 Cg_exo -51.8 140.05 48.26 Favored 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.712 2.941 . . . . 0.0 112.826 -174.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -57.32 99.29 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.924 HD11 ' HE3' ' A' ' 59' ' ' LYS . 19.6 mm -54.9 126.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.355 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.6 pp -135.27 140.93 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.795 ' HB2' ' HB2' ' A' ' 9' ' ' ARG . 72.5 mtp180 -117.29 124.83 49.96 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.521 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 45' ' ' ILE . 1.7 mm? -106.2 158.11 17.08 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -142.5 115.73 8.93 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.3 130.7 43.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 11.2 mtp180 -77.81 8.05 5.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.63 0.729 . . . . 0.0 109.077 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.78 -64.36 0.46 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.607 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 p -91.7 146.66 23.59 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.189 0.519 . . . . 0.0 112.224 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -84.03 55.65 3.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.229 1.014 . . . . 0.0 109.808 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -127.98 111.54 13.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.345 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.966 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.7 t -78.68 99.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.562 ' HA ' HD13 ' A' ' 89' ' ' ILE . 51.1 m-70 -69.68 135.51 49.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG11 ' HG2' ' A' ' 90' ' ' GLU . 4.2 p -140.34 104.98 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 122.682 1.23 . . . . 0.0 109.471 -172.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.838 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -104.61 177.54 4.82 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.599 -1.637 . . . . 0.0 107.78 -177.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.924 ' HE3' HD11 ' A' ' 44' ' ' ILE . 45.6 mtpt -123.9 127.44 48.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -127.47 123.79 36.82 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.954 -159.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.583 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . 29.3 p90 -134.64 179.84 6.05 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.621 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 48.2 mtmt -133.84 140.36 46.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.338 174.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.617 ' HB2' ' HE2' ' A' ' 83' ' ' PHE . 38.8 mt-10 -129.56 112.81 14.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.478 173.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 80' ' ' SER . 32.9 mm -79.93 77.97 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.65 ' HA ' ' CB ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -152.24 153.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.873 -177.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.696 ' N ' ' HA ' ' A' ' 78' ' ' LYS . 8.8 t70 157.9 66.44 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.279 1.612 . . . . 0.0 107.932 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -60.59 133.86 91.58 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.266 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.914 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 61.6 Cg_endo -70.37 128.86 16.04 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.853 2.369 . . . . 0.0 115.781 -166.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -95.96 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.322 -1.763 . . . . 0.0 107.621 163.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -124.35 33.83 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.791 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.914 ' HD3' ' HA ' ' A' ' 68' ' ' PRO . 36.9 mtp85 -84.96 163.85 44.24 Favored Pre-proline 0 N--CA 1.464 0.235 0 O-C-N 121.916 -0.49 . . . . 0.0 111.033 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 75' ' ' MET . 18.5 Cg_exo -67.72 160.25 49.05 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.383 2.722 . . . . 0.0 111.458 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.34 -50.15 72.75 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.986 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -59.79 -20.48 57.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.621 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 13.2 ttm -90.18 111.07 44.83 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.454 ' N ' HH21 ' A' ' 71' ' ' ARG . 24.9 Cg_exo -65.24 -135.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 124.19 3.26 . . . . 0.0 115.052 -170.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.827 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.4 mt-10 -117.46 8.47 13.0 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.696 ' HA ' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -160.26 169.43 23.22 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.804 -1.998 . . . . 0.0 106.51 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.083 HD13 ' HD3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -162.7 164.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 169.208 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 74.9 m -65.3 117.8 8.39 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.765 0.793 . . . . 0.0 111.416 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 1.083 ' HD3' HD13 ' A' ' 79' ' ' ILE . 4.3 mptp? -142.1 112.71 6.23 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 114.077 -1.42 . . . . 0.0 112.181 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.497 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 2.4 Cg_endo -86.54 124.59 2.34 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 123.28 2.653 . . . . 0.0 109.219 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.722 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 89.1 m-85 -120.82 134.73 55.28 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.856 HG23 HD12 ' A' ' 29' ' ' LEU . 1.5 t -138.81 137.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.926 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -122.45 154.67 37.47 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 27.3 ttmt -99.69 123.37 43.89 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.804 1.638 . . . . 0.0 109.195 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 2.4 pt-20 -89.15 -13.56 38.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.111 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 12.4 ptt-85 174.08 -173.01 0.06 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 56' ' ' HIS . 8.7 mm -138.85 136.22 42.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.784 0.326 . . . . 0.0 110.16 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.966 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.7 mm-40 -107.01 175.04 5.63 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.686 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 121.283 0.563 . . . . 0.0 112.407 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.391 0.615 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.833 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -93.7 133.68 36.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.623 ' HA ' HG22 ' A' ' 20' ' ' THR . 60.6 m-80 -115.6 113.74 23.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.431 . . . . 0.0 111.05 -167.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -117.68 148.09 42.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -175.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 18' ' ' VAL . 3.3 t -113.66 -179.57 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.3 tp -106.56 149.63 26.96 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HD3' ' HB2' ' A' ' 48' ' ' ARG . 24.7 mmm180 -111.05 162.36 14.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t70 -92.74 -162.56 0.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -92.35 -6.62 49.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.073 1.306 . . . . 0.0 108.039 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -110.43 -20.14 12.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.591 -170.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.93 36.53 1.23 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.596 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 65.4 m-80 -111.23 -173.05 2.15 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 87.7 mt-10 -135.9 145.31 46.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 111.092 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 73.9 m-70 -132.57 -166.09 1.69 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.182 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -21.59 130.07 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 125.034 1.459 . . . . 0.0 114.248 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 7' ' ' VAL . 78.4 t -85.53 131.65 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 6' ' ' PHE . 81.5 m-85 -131.4 125.76 33.42 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 5' ' ' ASN . 38.0 p -139.25 140.77 37.78 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.637 ' H ' ' NH1' ' A' ' 4' ' ' ARG . . . -140.78 -164.81 10.06 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.515 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -8.85 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -157.12 139.21 10.25 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.654 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HA ' HH21 ' A' ' 4' ' ' ARG . 80.4 Cg_exo -40.91 -47.88 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 124.335 3.356 . . . . 0.0 114.077 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 42.0 ttt180 -53.04 -22.9 6.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.074 0.95 . . . . 0.0 113.341 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 15.0 mm100 -84.05 -50.62 7.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.509 0.671 . . . . 0.0 110.677 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.752 ' CB ' HH22 ' A' ' 4' ' ' ARG . . . -59.07 -31.95 69.34 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.214 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.682 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -83.58 -26.24 30.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.876 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.783 ' HG ' ' HG2' ' A' ' 82' ' ' PRO . 3.7 tt -65.24 -65.52 0.66 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -43.75 -31.29 0.78 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.458 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.88 -39.65 69.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.166 0.507 . . . . 0.0 110.311 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.656 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -70.56 -21.37 62.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.367 0.603 . . . . 0.0 111.184 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' OD1' ' HG3' ' A' ' 82' ' ' PRO . 71.3 m-20 -68.34 -2.83 9.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.965 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.42 ' NH2' ' HE1' ' A' ' 19' ' ' PHE . 8.2 mmt180 -100.06 -13.27 19.09 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.09 82.85 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.84 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.507 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 13.0 p -100.18 -49.52 4.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -126.92 8.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.909 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 160.83 40.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.105 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -62.12 -20.87 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.589 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.64 -25.43 67.36 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.969 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -161.85 67.82 2.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.442 0.639 . . . . 0.0 110.353 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.3 Cg_exo -65.16 130.95 26.95 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.085 1.857 . . . . 0.0 111.592 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.18 139.39 52.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 57' ' ' VAL . 5.6 tp -82.97 105.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.824 0.821 . . . . 0.0 111.249 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.631 HD11 ' HB1' ' A' ' 28' ' ' ALA . 2.7 pp -95.94 123.27 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 122.351 1.072 . . . . 0.0 110.345 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' HD22 ' A' ' 47' ' ' LEU . 77.5 mtp180 -91.79 173.26 7.96 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.446 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.57 ' CB ' ' HB2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -147.47 148.23 31.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.58 ' HB2' ' HD3' ' A' ' 9' ' ' ARG . 11.6 tpt180 -124.18 111.27 15.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.106 0.479 . . . . 0.0 110.169 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 8.4 tp10 -86.27 104.57 15.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.568 ' HD3' ' HB3' ' A' ' 5' ' ' ASN . 2.8 ptm180 -73.05 25.66 0.06 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.434 0.635 . . . . 0.0 111.429 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 49' ' ' GLU . . . -128.63 0.99 6.39 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.325 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 44.6 p -146.65 169.78 18.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.411 0.605 . . . . 0.0 109.825 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -95.21 38.21 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -127.94 132.19 49.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.923 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.852 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 49.1 t -92.47 119.7 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.129 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 47' ' ' LEU . 95.2 m-70 -81.42 131.74 35.3 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.592 HG21 ' HG3' ' A' ' 90' ' ' GLU . 71.3 t -123.15 116.23 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -170.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.65 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -132.25 134.78 45.7 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 87.5 mttt -70.56 170.26 12.52 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 162.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -163.08 133.99 4.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -166.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 36' ' ' SER . 29.9 p90 -150.03 -172.57 4.19 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 35.3 mttp -132.2 136.51 47.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.11 0.481 . . . . 0.0 111.108 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -137.66 137.8 38.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 -178.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 16.0 tt -83.67 94.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.147 1.451 . . . . 0.0 113.877 -166.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 81' ' ' LYS . 35.2 m -112.09 -174.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.523 170.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.996 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 7.3 p-10 -98.88 178.06 5.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 119.453 1.024 . . . . 0.0 110.985 169.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.707 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -125.23 163.87 35.44 Favored Pre-proline 0 C--O 1.239 0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.375 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 67' ' ' ALA . 82.7 Cg_exo -46.3 149.31 2.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.979 2.453 . . . . 0.0 112.636 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -83.83 12.11 6.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.486 0.66 . . . . 0.0 110.309 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -117.31 22.84 12.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.013 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 77' ' ' GLU . 31.3 ptt-85 -63.89 170.2 3.57 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.618 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -56.57 168.95 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.68 2.254 . . . . 0.0 113.108 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.44 -14.87 32.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.265 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.558 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 35.8 p-90 -91.37 -24.36 19.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.111 0.482 . . . . 0.0 111.151 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.558 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 28.6 ttp -101.28 147.46 33.8 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.279 -172.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 75' ' ' MET . 56.1 Cg_endo -83.84 177.4 6.16 Favored 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.499 2.132 . . . . 0.0 110.026 172.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 12.8 pt-20 -74.07 -43.46 57.67 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.145 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.996 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 29.7 mmmt -79.71 114.99 19.06 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 67' ' ' ALA . 1.4 pp -153.54 153.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.355 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 5.3 p -76.33 104.24 6.75 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.226 0.536 . . . . 0.0 110.053 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 21.6 tptt -62.9 136.9 96.75 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.763 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.783 ' HG2' ' HG ' ' A' ' 29' ' ' LEU . 37.9 Cg_endo -68.43 98.32 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.221 1.948 . . . . 0.0 110.491 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 42.3 m-85 -94.31 173.0 7.85 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.682 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -162.59 174.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -162.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' H ' ' HB3' ' A' ' 58' ' ' PHE . 49.5 tptt -175.63 98.23 0.07 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 111.146 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 36.4 ttmt -55.96 93.16 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.825 0.821 . . . . 0.0 111.954 166.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.596 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -82.23 -11.88 58.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.657 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.596 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 7.7 ptm180 -176.84 177.12 1.37 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.347 0.594 . . . . 0.0 111.907 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.531 HD11 ' HE2' ' A' ' 86' ' ' LYS . 20.9 mm -135.83 136.96 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.527 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.852 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 30.4 mt-10 -107.2 151.29 25.62 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.023 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.959 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.425 HG21 ' HB ' ' A' ' 20' ' ' THR . 28.9 m . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HD3' ' C ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -93.93 126.67 39.27 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.429 0.633 . . . . 0.0 110.557 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.628 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 70.1 m-20 -78.78 143.87 35.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.673 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.844 ' HB3' HD12 ' A' ' 47' ' ' LEU . 66.0 m-85 -131.89 142.09 49.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.411 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 61.7 t -105.17 122.32 58.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.76 133.17 43.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.061 -177.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.866 ' HB3' ' CA ' ' A' ' 13' ' ' GLY . 60.3 mtp180 -85.36 138.84 32.02 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.607 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 5.4 t70 -59.2 -146.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.691 170.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.61 -56.46 4.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -167.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.25 -42.32 68.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 109.088 162.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.866 ' CA ' ' HB3' ' A' ' 9' ' ' ARG . . . 139.36 48.01 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 116.263 -2.875 . . . . 0.0 113.671 169.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.5 m120 -74.01 -152.44 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -97.41 146.67 24.97 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.691 0.758 . . . . 0.0 112.295 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 15.5 m-70 -138.52 -164.56 1.66 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 167.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.95 162.87 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 119.058 -1.544 . . . . 0.0 112.317 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.628 ' CG2' ' HB3' ' A' ' 5' ' ' ASN . 2.7 p -99.22 110.77 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.093 0.949 . . . . 0.0 111.179 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -78.95 178.43 8.0 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.794 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.425 ' HB ' HG21 ' A' ' 3' ' ' THR . 33.1 p -135.09 151.97 51.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.417 -175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -172.35 160.42 31.76 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -84.04 -10.21 58.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 26' ' ' GLN . 84.1 mt-30 -151.58 165.5 17.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 23' ' ' GLN . 10.8 Cg_endo -60.63 -53.3 2.88 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 CA-C-N 120.283 1.137 . . . . 0.0 111.278 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 75.5 ttt180 -39.9 -36.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.129 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 49.3 mm-40 -84.44 -10.79 57.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.988 0.423 . . . . 0.0 111.535 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.98 -57.07 2.99 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.672 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -45.08 -32.95 1.94 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 165.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' ARG . 7.2 tt -61.41 -19.23 61.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.282 0.563 . . . . 0.0 110.565 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 30' ' ' LYS . 18.4 mtpp -77.85 -53.39 7.53 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -68.37 -16.59 63.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -64.44 -20.46 66.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.317 0.579 . . . . 0.0 110.838 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -68.36 7.1 0.65 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 56.6 mtp180 -99.64 -54.95 2.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.931 -163.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 36' ' ' SER . . . -105.76 -20.8 9.1 Favored Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.164 167.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 61' ' ' TRP . 68.5 m 76.15 -63.95 0.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.54 -160.8 54.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.235 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -160.93 157.14 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.554 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 4.8 ttpm? -63.65 -12.86 37.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.984 0.513 . . . . 0.0 112.065 -171.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.63 -29.92 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.699 0.762 . . . . 0.0 110.162 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.29 70.18 2.95 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.556 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -56.98 166.13 4.34 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.901 2.401 . . . . 0.0 112.84 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.32 118.04 35.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.764 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 ' HZ2' ' A' ' 59' ' ' LYS . 7.0 tp -55.87 158.0 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.04 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -159.19 179.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.784 ' CB ' ' HB2' ' A' ' 9' ' ' ARG . 24.1 mmm-85 -158.29 143.01 16.23 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.826 0.704 . . . . 0.0 109.761 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.844 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -139.84 125.4 19.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.802 0.81 . . . . 0.0 110.567 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 45.3 tpt85 -105.36 114.48 28.68 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.994 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 57.4 tt0 -85.58 78.24 9.68 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -46.47 104.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.997 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.93 -19.47 4.4 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.042 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 26.1 p -127.62 178.48 6.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -115.59 37.26 3.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.929 0.871 . . . . 0.0 109.87 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -127.03 149.09 50.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.906 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 1.052 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 20.9 t -103.92 136.47 36.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.25 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.682 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 90.9 m-70 -103.73 105.99 16.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 43.7 t -95.32 122.38 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.504 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -128.44 162.11 27.91 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.932 176.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.424 ' HZ2' HD13 ' A' ' 44' ' ' ILE . 40.2 mmtm -103.44 133.28 48.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.926 158.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 45' ' ' ILE . . . -110.96 146.26 36.93 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.745 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 32.0 p90 -168.87 151.36 4.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HE2' ' HG3' ' A' ' 82' ' ' PRO . 77.5 mttt -103.18 122.95 45.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.367 0.604 . . . . 0.0 109.932 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.745 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.1 mm-40 -107.71 143.14 36.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.961 172.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 20.7 tt -86.24 143.31 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 163.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 m -141.0 -172.82 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.82 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.3 p-10 -121.16 -179.41 4.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.158 0.504 . . . . 0.0 111.272 -165.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.694 ' HB2' ' HA ' ' A' ' 77' ' ' GLU . . . -110.74 116.59 52.01 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.369 -172.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 71' ' ' ARG . 7.4 Cg_exo -69.0 -173.66 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.3 2.667 . . . . 0.0 111.383 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -95.48 -51.2 4.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.417 0.627 . . . . 0.0 109.334 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.4 t30 -83.97 18.05 2.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.44 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.631 ' HD3' ' HB1' ' A' ' 67' ' ' ALA . 9.8 ptt-85 -59.26 158.01 21.15 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.695 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.5 173.58 10.53 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.517 2.811 . . . . 0.0 114.015 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.15 10.66 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.833 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -123.21 -15.48 7.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.808 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 32.8 ttm -103.05 121.81 47.7 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.532 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 20.4 Cg_endo -88.7 -152.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.124 2.549 . . . . 0.0 112.444 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.694 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 16.6 mm-40 -69.53 -42.04 75.19 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.82 ' HD3' ' HA ' ' A' ' 66' ' ' ASP . 31.9 mmtp -150.03 129.76 13.24 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.613 HD12 HG22 ' A' ' 65' ' ' VAL . 1.2 pp -147.46 147.87 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 118.721 0.691 . . . . 0.0 111.074 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 71.5 p -94.14 153.83 17.9 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.58 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 4.4 tptp -157.38 133.67 6.2 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -168.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.611 ' HG3' ' HE2' ' A' ' 62' ' ' LYS . 14.0 Cg_exo -65.22 89.79 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 CA-C-N 120.651 1.268 . . . . 0.0 111.663 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 27.3 m-85 -83.68 157.78 22.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.517 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.672 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -145.92 162.84 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.079 177.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.557 ' HB3' ' CZ3' ' A' ' 61' ' ' TRP . 5.2 tmtt? -151.72 115.56 4.91 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.316 0.579 . . . . 0.0 110.874 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.52 ' HE2' HD11 ' A' ' 89' ' ' ILE . 33.9 ttmt -60.2 125.65 24.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 20.6 pt-20 -135.41 -13.54 2.03 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.41 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 32.1 ttp85 -157.16 165.83 34.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.52 HD11 ' HE2' ' A' ' 86' ' ' LYS . 22.2 mm -147.1 140.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 1.052 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 52.6 mt-10 -119.93 153.11 36.39 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.06 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt . . . . . 0 N--CA 1.443 -0.807 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 -174.957 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.402 0.62 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' THR . 12.4 mmm180 -88.52 137.47 32.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.336 1.065 . . . . 0.0 111.796 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 36.8 m-80 -104.68 118.05 35.62 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.228 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.501 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 30.3 m-85 -119.27 165.0 14.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.282 1.039 . . . . 0.0 111.599 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.88 130.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.524 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.132 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 13.9 tp -81.26 156.06 25.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.581 ' HD3' HG11 ' A' ' 55' ' ' VAL . 47.9 mtp180 -135.47 143.03 45.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . 6.7 t70 -87.15 -165.04 1.18 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 4.7 mm-40 -83.74 -52.5 6.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.547 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -75.61 0.6 16.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.2 35.94 3.02 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 118.637 -1.744 . . . . 0.0 113.768 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.5 ' HB2' ' CB ' ' A' ' 10' ' ' ASP . 61.5 m-80 -101.75 178.67 4.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -122.72 152.52 40.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.858 0.837 . . . . 0.0 112.255 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 1.132 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 97.3 m-70 -132.18 -158.92 0.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.993 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.78 -172.67 46.55 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 117.84 -2.124 . . . . 0.0 110.936 -158.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 87.1 t -94.23 109.06 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.692 0.758 . . . . 0.0 110.851 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 77.6 m-85 -94.66 111.94 23.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.389 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.8 p -91.08 113.95 26.34 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.74 166.51 21.88 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.423 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HG2' ' HG3' ' A' ' 26' ' ' GLN . 8.9 ptpp? -77.66 -27.25 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.517 0.675 . . . . 0.0 109.58 174.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.608 ' HG2' ' HG3' ' A' ' 22' ' ' LYS . 11.0 pt20 -160.4 163.99 20.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.454 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 33.0 Cg_exo -40.02 -53.3 2.51 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.476 2.784 . . . . 0.0 113.956 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.98 -40.0 69.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.707 ' HG3' ' HG2' ' A' ' 22' ' ' LYS . 21.5 mm-40 -78.56 -31.54 47.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 122.001 -0.437 . . . . 0.0 111.324 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.32 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.588 0.709 . . . . 0.0 109.207 173.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.547 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -70.51 -38.73 74.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.68 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.739 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -56.4 -62.29 1.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 32.1 mmtp -34.81 -48.05 0.37 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.186 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.821 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -66.98 -30.36 70.45 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.162 -0.336 . . . . 0.0 111.512 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -84.7 -18.34 35.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.79 -34.65 20.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 34' ' ' ARG . 28.4 ptt85 -92.21 -20.9 20.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.68 89.75 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.787 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -67.49 -17.1 64.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 31.91 -135.65 0.13 Allowed Glycine 0 C--N 1.344 0.987 0 O-C-N 124.332 1.02 . . . . 0.0 112.843 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -149.46 168.69 22.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 164.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -58.37 -33.64 69.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -81.06 -42.31 21.25 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.294 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.66 65.5 72.32 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.811 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 22.9 Cg_exo -64.45 146.17 89.06 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.485 2.124 . . . . 0.0 112.543 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.92 110.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.539 HD11 ' HE3' ' A' ' 59' ' ' LYS . 30.0 mm -64.1 122.82 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.066 0.46 . . . . 0.0 111.584 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 58' ' ' PHE . 8.0 pt -117.5 132.47 67.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.842 0.83 . . . . 0.0 111.925 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 1.09 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 69.4 mtp180 -122.37 116.47 24.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.866 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.822 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.9 mm? -108.11 123.16 48.29 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.343 0.592 . . . . 0.0 109.922 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.569 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 16.9 ttp180 -112.03 97.29 6.57 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.769 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 4' ' ' ARG . 2.7 tm-20 -61.97 144.14 55.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.07 13.73 7.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -172.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.24 -9.5 2.38 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.408 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.5 p -99.33 172.79 7.12 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.835 -0.215 . . . . 0.0 110.647 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 63.4 tttp -111.76 11.77 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 110.339 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -121.57 142.88 49.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 90.6 t -111.34 101.16 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.822 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 18.6 p80 -86.48 140.31 30.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.28 0.562 . . . . 0.0 111.359 -174.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 1.09 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -125.36 114.57 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.258 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.624 ' O ' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -115.92 147.81 40.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.425 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HE3' HD11 ' A' ' 44' ' ' ILE . 1.5 mmmm -66.29 169.57 7.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.986 160.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -165.31 134.31 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.413 0.149 . . . . 0.0 110.769 -173.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.532 ' HD1' ' HG2' ' A' ' 63' ' ' GLU . 20.1 p90 -161.18 172.74 16.19 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 120.449 0.166 . . . . 0.0 111.15 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 42.2 mtmt -144.32 124.03 13.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.525 0.203 . . . . 0.0 110.706 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.549 ' HG3' ' CG1' ' A' ' 65' ' ' VAL . 7.7 pt-20 -174.09 155.9 2.57 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.698 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -69.99 125.99 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.885 0.766 . . . . 0.0 110.288 173.389 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG23 ' N ' ' A' ' 66' ' ' ASP . 4.2 m -150.75 -167.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -167.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.3 OUTLIER 101.16 -174.65 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 125.395 1.685 . . . . 0.0 110.638 168.192 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 68' ' ' PRO . . . -121.53 179.85 0.88 Allowed Pre-proline 0 N--CA 1.437 -1.099 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.324 -165.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 67' ' ' ALA . 98.1 Cg_exo -50.94 -175.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 123.705 2.937 . . . . 0.0 115.051 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 4.1 mptp? -56.93 -13.05 2.33 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.456 -166.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -76.01 32.67 0.12 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.04 0.447 . . . . 0.0 111.317 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 68' ' ' PRO . 20.3 mmm180 -84.5 167.16 28.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.524 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.6 162.72 30.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.097 1.865 . . . . 0.0 111.191 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.98 62.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.118 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 56.3 p-90 -103.92 -37.51 7.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.895 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.699 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 16.6 ttp -104.57 136.46 19.17 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.706 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 42.7 Cg_endo -92.38 -164.69 0.13 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 122.696 2.264 . . . . 0.0 113.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -86.07 -2.02 57.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.552 -1.658 . . . . 0.0 112.531 -168.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 72.5 mmtt -155.42 119.25 4.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.8 OUTLIER -155.71 144.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.552 0.615 . . . . 0.0 110.087 177.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.0 p -120.71 81.22 1.73 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.004 0.907 . . . . 0.0 111.616 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.842 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -124.74 168.32 13.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.197 176.203 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.739 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 52.2 Cg_exo -57.24 94.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.483 2.122 . . . . 0.0 111.875 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.842 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-85 -86.53 175.6 8.26 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.597 HG12 ' CB ' ' A' ' 58' ' ' PHE . 1.4 t -166.22 173.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -166.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' A' ' 86' ' ' LYS . 16.8 tptm -176.51 99.11 0.06 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.119 0.485 . . . . 0.0 110.7 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.563 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 34.4 ttmt -57.25 134.3 55.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.38 169.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 11.3 pt-20 -167.19 23.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.168 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.488 ' C ' HG13 ' A' ' 57' ' ' VAL . 23.7 ttp180 -168.2 157.03 9.08 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.418 HD11 ' HE2' ' A' ' 86' ' ' LYS . 23.1 mm -140.58 136.31 35.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.534 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -119.36 166.21 13.33 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.452 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt . . . . . 0 CA--C 1.501 -0.911 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.818 176.753 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.449 -0.525 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.0 ptm180 -89.34 151.74 21.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.261 1.029 . . . . 0.0 112.642 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -105.08 136.55 44.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.531 -166.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 28.0 m-85 -127.32 122.18 33.07 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.384 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.985 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -97.31 128.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.918 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.5 tp -66.19 139.84 58.14 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.788 -171.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -92.03 171.73 8.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.136 0.97 . . . . 0.0 111.777 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 21.2 t70 -128.43 169.98 13.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.038 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.74 -36.33 80.68 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.744 0.652 . . . . 0.0 111.094 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.09 -39.3 25.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.862 0.839 . . . . 0.0 109.439 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.03 31.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.173 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 6.1 m-20 -77.22 -170.09 1.59 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.773 173.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.29 108.86 9.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.512 0.672 . . . . 0.0 111.083 -170.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.918 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 72.3 m-70 -89.88 -162.17 0.86 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.52 144.11 7.21 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 123.398 0.436 . . . . 0.0 113.434 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 50' ' ' ARG . 97.6 t -83.64 143.82 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -126.71 143.11 51.34 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 p -121.89 135.16 54.87 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.57 -78.59 0.08 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.27 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt 173.36 -33.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 11.1 pt20 -159.68 166.68 15.57 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.312 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 72.5 Cg_exo -45.8 -22.29 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.507 2.805 . . . . 0.0 114.038 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 21.2 ttm-85 -88.1 -35.09 17.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.657 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 20.6 mm-40 -86.34 -14.66 42.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.598 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.0 -47.78 7.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 47' ' ' LEU . . . -57.12 -37.36 71.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.476 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.696 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -49.5 -65.92 0.48 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.426 172.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 74.5 mmtt -35.33 -48.31 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . . . -68.13 -26.78 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.752 0.706 . . . . 0.0 112.067 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.056 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -70.11 -22.95 62.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.226 1.012 . . . . 0.0 111.007 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.665 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 6.2 m-80 -62.45 -0.29 0.57 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -73.54 -63.92 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 116.6 -2.04 . . . . 0.0 109.651 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.13 -50.25 0.25 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 115.282 -3.342 . . . . 0.0 116.622 143.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 38' ' ' THR . 15.2 m -53.77 -25.35 18.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.488 0.644 . . . . 0.0 109.405 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.94 100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.945 164.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 36' ' ' SER . 25.5 p -135.49 -177.97 4.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.143 0.577 . . . . 0.0 110.461 -171.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 23.4 mtmm -65.42 -29.77 70.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.646 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.87 -38.03 79.44 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.157 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -140.38 71.7 32.27 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.21 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.8 Cg_exo -67.25 130.44 22.63 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.043 1.162 . . . . 0.0 109.42 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -72.2 107.17 4.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 44' ' ' ILE . 2.9 tp -71.07 96.75 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 122.316 1.055 . . . . 0.0 110.038 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.457 ' H ' HG12 ' A' ' 45' ' ' ILE . 5.3 pt -103.62 152.13 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.107 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.629 ' HG2' HG23 ' A' ' 57' ' ' VAL . 30.0 mtp180 -125.85 102.95 7.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 28' ' ' ALA . 2.6 mm? -87.62 137.62 32.17 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -122.13 112.26 17.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.87 144.26 56.83 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.985 ' HG2' HG12 ' A' ' 7' ' ' VAL . 61.7 mtp180 -74.98 -18.96 60.29 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.446 -166.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 -9.62 60.33 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.806 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.3 p -111.86 149.44 31.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.894 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -95.63 18.22 13.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -100.39 139.97 35.31 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.653 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.02 117.37 48.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.696 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.535 ' HA ' HD13 ' A' ' 89' ' ' ILE . 42.3 m-70 -96.85 99.55 11.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.888 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.629 HG23 ' HG2' ' A' ' 46' ' ' ARG . 7.5 p -98.32 127.27 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 1.4 m-85 -137.68 124.02 20.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.01 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 26.7 mtpp -71.13 107.62 4.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.996 160.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.056 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -95.24 145.98 24.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.671 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 19.8 p90 -158.68 143.25 15.88 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.335 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 30.5 mtmt -103.62 124.51 48.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HG2' ' CG ' ' A' ' 39' ' ' LYS . 3.6 tp10 -150.89 154.78 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.297 0.57 . . . . 0.0 111.392 -166.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 92.1 mt -118.44 121.18 66.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.626 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.566 HG23 ' NH2' ' A' ' 71' ' ' ARG . 34.7 m -122.93 151.05 26.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -79.91 -175.56 5.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.875 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -48.5 160.07 0.48 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 125.771 1.628 . . . . 0.0 114.791 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.754 ' HB3' ' HB2' ' A' ' 71' ' ' ARG . 42.1 Cg_endo -67.08 67.49 0.59 Allowed 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 124.116 3.211 . . . . 0.0 116.167 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -93.1 -7.78 44.56 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 161.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -133.51 2.01 3.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.067 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.955 HH22 HD12 ' A' ' 79' ' ' ILE . 67.0 mtt-85 -118.23 167.73 10.84 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -158.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.39 149.88 80.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.207 2.605 . . . . 0.0 109.364 154.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.01 19.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -167.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -95.27 -21.48 18.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.713 ' HB3' ' HD3' ' A' ' 71' ' ' ARG . 10.3 ttm -81.87 130.6 60.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.336 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HD2' HG21 ' A' ' 79' ' ' ILE . 3.0 Cg_endo -74.48 177.47 8.34 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.839 2.36 . . . . 0.0 112.448 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.875 ' HA ' ' HA ' ' A' ' 67' ' ' ALA . 1.9 mp0 -51.81 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.876 0.735 . . . . 0.0 109.036 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -89.54 130.0 35.92 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.436 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.955 HD12 HH22 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.21 151.12 15.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.608 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.611 ' HB3' HG12 ' A' ' 64' ' ' ILE . 9.1 p -124.88 125.74 44.44 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.833 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 73.0 mmtt -159.28 144.26 11.55 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.696 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 3.0 Cg_exo -73.18 96.1 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 0.0 110.493 163.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.526 ' O ' HG13 ' A' ' 84' ' ' VAL . 80.2 m-85 -78.66 172.72 13.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.691 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -173.08 117.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.23 -173.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 118.14 34.56 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.875 157.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 3.6 ptpp? -55.13 139.57 41.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.236 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.9 -31.98 31.18 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.69 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 173.63 -174.68 0.06 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.097 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 56' ' ' HIS . 31.2 mm -127.84 110.02 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.873 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.89 -176.34 2.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.335 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 21.4 mtmt . . . . . 0 C--N 1.312 -1.065 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.604 ' NH1' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -95.76 156.11 16.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.877 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -121.61 132.4 54.65 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.229 -0.295 . . . . 0.0 110.532 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HD1' ' NH2' ' A' ' 4' ' ' ARG . 61.2 m-85 -143.74 134.07 24.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -115.76 133.89 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.784 ' HB2' ' HE2' ' A' ' 19' ' ' PHE . 2.4 tp -66.17 149.36 50.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.44 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.685 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 76.9 mtp180 -118.77 124.16 46.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 163.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.402 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 40.0 t0 -87.03 175.5 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.668 -169.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -44.42 -44.77 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 124.122 0.889 . . . . 0.0 112.965 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -41.54 89.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.456 0.646 . . . . 0.0 110.89 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.05 25.78 2.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.96 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 p30 -110.55 170.37 8.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -95.82 141.89 28.73 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.051 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' HB2' HD23 ' A' ' 8' ' ' LEU . 39.9 m-70 -132.4 -178.99 5.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.823 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -20.26 126.27 0.01 OUTLIER Glycine 0 C--N 1.328 0.135 0 O-C-N 125.876 1.985 . . . . 0.0 114.884 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.09 125.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.253 0.549 . . . . 0.0 109.939 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.784 ' HE2' ' HB2' ' A' ' 8' ' ' LEU . 6.9 m-85 -112.72 149.37 33.04 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -135.8 141.98 44.81 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.3 -175.37 27.19 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.624 -1.275 . . . . 0.0 112.814 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -87.01 -31.79 20.38 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.57 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.604 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 18.6 pt20 -154.15 155.94 31.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 9.3 Cg_endo -50.84 -23.37 11.54 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.154 3.236 . . . . 0.0 114.398 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -58.01 -54.28 48.73 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 123.168 0.292 . . . . 0.0 110.858 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -55.86 -43.97 77.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.263 0.554 . . . . 0.0 111.106 175.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.604 ' HB2' ' NH1' ' A' ' 4' ' ' ARG . . . -55.96 -35.41 66.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.704 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.95 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -89.25 -21.49 23.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.349 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 1.3 mp -64.63 -63.55 1.1 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -39.62 -16.87 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.323 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 29' ' ' LEU . . . -95.53 -50.95 4.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.219 0.533 . . . . 0.0 110.421 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.673 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -63.76 -29.46 70.67 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.412 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -48.42 -4.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -87.2 -59.92 2.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.69 -130.86 6.11 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.043 150.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.3 m 68.05 19.71 9.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.465 0.706 . . . . 0.0 111.886 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.14 146.55 17.84 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.186 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.4 ' CA ' ' HB2' ' A' ' 61' ' ' TRP . 41.0 p -125.37 176.28 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -58.8 -36.0 73.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.195 0.521 . . . . 0.0 110.783 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.92 -25.08 61.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.626 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.57 82.44 3.02 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.764 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.4 Cg_exo -84.8 136.28 6.06 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.245 2.63 . . . . 0.0 111.245 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.62 173.27 9.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.726 HD13 ' HG2' ' A' ' 59' ' ' LYS . 28.9 mm -111.04 118.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.113 0.482 . . . . 0.0 111.125 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.9 pp -122.9 130.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.977 0.894 . . . . 0.0 111.622 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.817 ' HG2' HG22 ' A' ' 57' ' ' VAL . 48.1 mtm180 -105.89 114.32 28.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.961 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 28' ' ' ALA . 3.3 mm? -82.2 164.0 21.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.691 0.758 . . . . 0.0 109.781 168.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.685 ' HD2' ' HD2' ' A' ' 9' ' ' ARG . 51.1 ttt180 -132.22 140.32 48.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 52' ' ' THR . 17.5 tt0 -83.62 72.26 10.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HA ' HG13 ' A' ' 7' ' ' VAL . 26.4 mtm180 47.21 -64.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 111.456 -2.611 . . . . 0.0 113.612 -166.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.94 52.71 0.58 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.993 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.498 ' CG2' ' HB3' ' A' ' 49' ' ' GLU . 8.2 p -95.21 160.16 14.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.556 -0.379 . . . . 0.0 111.417 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.98 -21.95 58.84 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -100.94 111.71 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.062 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 HH11 ' A' ' 9' ' ' ARG . 98.1 t -86.6 132.36 32.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.246 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.474 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 90.0 m-70 -84.82 138.73 32.4 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.817 HG22 ' HG2' ' A' ' 46' ' ' ARG . 86.3 t -130.79 117.34 37.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.101 -171.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.827 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -129.11 139.94 51.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' A' ' 44' ' ' ILE . 24.0 mttp -70.32 161.32 30.63 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 162.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -153.47 142.52 21.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.59 -171.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.513 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 35.8 p90 -162.01 -166.88 1.52 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 87.3 mttt -143.34 136.69 28.14 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.754 ' O ' ' HA ' ' A' ' 80' ' ' SER . 30.9 mm-40 -145.39 171.39 14.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.979 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.53 74.58 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 122.292 1.044 . . . . 0.0 108.223 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HG3' ' A' ' 78' ' ' LYS . 27.5 m -85.6 -167.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.691 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.76 125.05 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.734 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.833 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . . . -120.34 141.24 31.51 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.073 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.95 -165.71 0.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.434 2.756 . . . . 0.0 113.519 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -51.63 -19.78 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -81.78 7.4 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 0.0 110.768 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 8.5 ptt180 -81.22 163.25 55.9 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.323 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 12.6 Cg_exo -68.03 166.1 25.96 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.355 2.037 . . . . 0.0 112.071 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.02 -22.51 20.75 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 60.8 p-90 -74.33 -29.38 61.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.403 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.464 ' HE2' ' HG2' ' A' ' 72' ' ' PRO . 18.4 ttp -99.3 145.94 30.9 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.417 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.4 175.5 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 110.028 168.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.4 mp0 -41.02 -62.68 0.78 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.833 ' HE2' ' HB2' ' A' ' 67' ' ' ALA . 65.8 mmtt -152.01 -173.93 4.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.169 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.642 HD13 ' CG ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -161.56 160.79 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.49 -160.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.754 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -73.34 79.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.756 0.788 . . . . 0.0 109.977 -176.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.642 ' CG ' HD13 ' A' ' 79' ' ' ILE . 66.2 mmtt -113.03 162.08 23.59 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.477 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 25.7 Cg_endo -62.44 119.07 6.0 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.982 2.455 . . . . 0.0 110.903 170.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HE2' ' HB2' ' A' ' 63' ' ' GLU . 23.2 m-85 -107.61 176.25 5.21 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.95 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -165.55 173.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -162.183 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 179.47 99.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.565 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.562 ' HD2' HD11 ' A' ' 89' ' ' ILE . 18.1 ttpp -68.86 103.81 1.89 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.627 0.727 . . . . 0.0 112.225 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 12.4 pt-20 -106.05 2.15 27.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.998 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 10.1 ptm180 -174.77 175.54 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.288 0.566 . . . . 0.0 111.672 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.562 HD11 ' HD2' ' A' ' 86' ' ' LYS . 23.2 mm -132.56 145.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.561 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 8.9 mt-10 -113.95 177.64 4.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 91' ' ' LYS . 1.6 mtmt . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.524 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 29.8 m . . . . . 0 N--CA 1.446 -0.632 0 CA-C-O 121.378 0.608 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -83.76 144.99 28.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.02 0.914 . . . . 0.0 112.182 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -96.14 134.97 38.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.19 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.552 ' HB3' HD12 ' A' ' 47' ' ' LEU . 70.6 m-85 -130.51 146.43 52.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.736 0.779 . . . . 0.0 111.004 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.838 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 9.5 t -96.01 149.01 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.804 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 10.5 tp -113.54 147.79 37.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.99 162.9 37.84 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 170.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.83 -160.58 0.5 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.641 ' OE1' ' HD3' ' A' ' 46' ' ' ARG . 5.3 mm-40 -91.05 0.53 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.79 -16.45 13.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.741 -168.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.455 ' HA2' ' NH2' ' A' ' 9' ' ' ARG . . . 104.62 35.44 3.29 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.472 -1.347 . . . . 0.0 112.249 -176.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.618 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 89.6 m-20 -107.74 101.71 10.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.94 122.54 27.9 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.064 0.459 . . . . 0.0 110.859 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.676 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 92.3 m-70 -110.05 -167.01 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.864 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -52.27 166.33 1.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.873 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 94.6 t -95.36 110.81 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.493 0.664 . . . . 0.0 110.185 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 m-85 -86.55 120.05 27.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.549 1.166 . . . . 0.0 112.225 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.524 ' HB ' ' CG2' ' A' ' 3' ' ' THR . 21.3 p -86.9 142.23 28.17 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.383 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.21 139.23 4.27 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -63.64 -20.18 65.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.846 0.823 . . . . 0.0 110.568 -175.414 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 4.2 pt20 -161.1 165.5 16.94 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.3 Cg_exo -43.85 -51.8 6.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.967 2.445 . . . . 0.0 112.97 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 39.2 ttt180 -51.0 -41.93 60.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' HG3' ' HG3' ' A' ' 22' ' ' LYS . 80.3 mm-40 -78.29 -33.56 49.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 0.0 111.26 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.15 79.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.502 0.667 . . . . 0.0 109.635 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.624 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -69.82 -32.73 71.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.215 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.455 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -55.88 -59.51 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -50.71 -24.34 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.138 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -90.47 -25.11 20.48 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.713 -0.617 . . . . 0.0 110.246 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.75 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -88.63 -16.28 32.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.292 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.0 -15.39 56.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.592 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.51 -28.92 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 110.673 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.38 102.8 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 m -59.12 -41.66 88.73 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.098 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.23 -139.6 0.41 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 123.931 0.77 . . . . 0.0 111.788 -170.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -147.29 171.18 15.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -62.14 -28.2 69.48 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.094 0.474 . . . . 0.0 110.679 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.53 -24.17 25.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.448 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.1 p-10 -143.93 64.6 13.1 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.425 0.631 . . . . 0.0 110.238 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.751 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 19.7 Cg_exo -64.81 150.17 88.53 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.634 2.223 . . . . 0.0 112.599 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.71 124.46 28.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' ' 59' ' ' LYS . 17.5 mm -74.6 117.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.785 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.499 HD11 ' HB1' ' A' ' 28' ' ' ALA . 17.7 pt -107.16 139.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.696 0.76 . . . . 0.0 111.397 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.648 ' O ' HD22 ' A' ' 47' ' ' LEU . 33.7 mmm-85 -94.89 171.54 8.71 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.948 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -154.56 94.74 1.72 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.656 -177.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.838 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.2 ttp180 -78.9 143.39 35.91 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 131.74 54.09 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.01 19.03 7.13 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.279 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.75 -18.05 1.81 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.703 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.2 p -124.32 179.64 4.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.239 0.52 . . . . 0.0 111.326 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -108.11 33.64 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.527 0.68 . . . . 0.0 109.513 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -133.4 123.66 25.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.492 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.579 HG22 ' HG3' ' A' ' 48' ' ' ARG . 50.0 t -94.37 125.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.088 0.47 . . . . 0.0 109.918 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.434 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 33.7 m-70 -81.13 146.79 30.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.517 ' C ' ' HD1' ' A' ' 58' ' ' PHE . 8.3 p -135.13 127.33 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.422 0.629 . . . . 0.0 111.042 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.517 ' HD1' ' C ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -129.55 143.09 50.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 175.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -68.53 171.68 7.19 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.565 159.313 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -171.63 133.05 0.76 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.132 0.491 . . . . 0.0 109.823 -161.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.493 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 41.4 p90 -158.28 -177.48 6.58 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.665 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 55.0 mtmt -131.7 142.75 49.89 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.931 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.686 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 34.0 mt-10 -131.06 175.01 9.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.548 -0.751 . . . . 0.0 108.983 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.906 HD11 ' HB3' ' A' ' 78' ' ' LYS . 9.5 tt -95.53 134.9 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.411 1.1 . . . . 0.0 112.234 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.812 HG21 ' HG3' ' A' ' 81' ' ' LYS . 32.1 m -135.15 -174.4 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.166 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 4.2 p-10 -99.88 165.53 11.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 77' ' ' GLU . . . -142.05 -177.16 0.63 Allowed Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -167.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HD2' ' HD2' ' A' ' 71' ' ' ARG . 58.9 Cg_endo -83.94 148.7 12.19 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.812 1.675 . . . . 0.0 111.236 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -78.29 2.55 18.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.692 -172.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 68' ' ' PRO . 26.1 p-10 -92.07 7.85 40.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.315 0.579 . . . . 0.0 110.825 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.726 ' HD2' ' HD2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -69.24 171.64 6.39 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.633 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 68.6 Cg_exo -53.15 178.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.403 2.735 . . . . 0.0 114.297 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.38 81.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.834 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.457 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 42.5 p-90 -81.37 -39.48 24.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.864 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 44.9 ttm -77.04 115.47 48.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.534 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 74' ' ' TRP . 76.9 Cg_endo -109.3 -155.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.678 2.919 . . . . 0.0 112.026 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.808 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . 4.6 pt-20 -52.11 -59.65 4.12 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.769 167.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.906 ' HB3' HD11 ' A' ' 64' ' ' ILE . 18.6 mmtp -76.64 114.0 14.9 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.195 -172.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -163.79 -178.42 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.29 -175.018 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' ILE . 2.8 p -73.75 158.54 34.43 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.177 0.513 . . . . 0.0 111.968 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.812 ' HG3' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -162.23 136.15 4.87 Favored Pre-proline 0 C--O 1.22 -0.486 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -171.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.665 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 76.3 Cg_exo -52.4 153.98 12.4 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.87 2.38 . . . . 0.0 113.9 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.686 ' CE1' ' HB2' ' A' ' 63' ' ' GLU . 70.2 m-85 -165.93 157.41 13.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.624 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -165.21 169.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -166.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' H ' HG12 ' A' ' 84' ' ' VAL . 59.4 tttp -171.17 98.93 0.21 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.599 0.238 . . . . 0.0 110.519 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.481 ' HE3' HD11 ' A' ' 89' ' ' ILE . 67.2 tttt -53.02 128.26 26.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.523 170.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 3.4 pm0 -130.85 -5.78 4.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.562 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' N ' ' A' ' 89' ' ' ILE . 8.6 ttp180 -171.24 174.56 4.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.37 -166.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.481 HD11 ' HE3' ' A' ' 86' ' ' LYS . 17.4 mm -136.1 137.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.41 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -111.14 176.82 4.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.798 0.809 . . . . 0.0 111.579 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt . . . . . 0 C--N 1.313 -0.984 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.894 -176.032 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 121.163 0.506 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.6 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 27.7 mmm180 -92.76 137.5 32.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.343 1.068 . . . . 0.0 111.208 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 50' ' ' ARG . 1.1 m-80 -106.73 116.65 32.3 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.85 -1.977 . . . . 0.0 111.301 -175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.6 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 91.0 m-85 -129.99 177.32 7.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.567 1.175 . . . . 0.0 112.422 -174.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.889 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 35.2 t -147.68 149.94 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.521 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.8 tp -96.83 158.33 15.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.646 HH11 HG21 ' A' ' 55' ' ' VAL . 49.4 mtp180 -124.79 147.19 48.84 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 12.8 t70 -69.65 -167.65 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.9 0.318 . . . . 0.0 111.015 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.47 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 26.3 mm-40 -61.83 -39.59 92.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 111.435 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.79 -37.61 22.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.474 0.654 . . . . 0.0 109.702 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 9' ' ' ARG . . . 132.51 45.0 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 118.721 -1.705 . . . . 0.0 112.063 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -85.4 -97.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -173.95 137.23 0.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 88.1 m-70 -144.6 166.25 25.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.154 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 34.53 -171.86 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.86 110.89 7.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.792 -1.704 . . . . 0.0 106.638 163.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.04 106.11 16.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.871 1.319 . . . . 0.0 113.364 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.0 p -91.08 117.29 29.48 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.877 170.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.66 169.5 24.59 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 113.776 -1.557 . . . . 0.0 111.947 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.82 -11.28 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.655 0.741 . . . . 0.0 110.293 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -160.82 147.12 11.52 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.391 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 53.8 Cg_exo -43.51 -42.56 11.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.904 . . . . 0.0 113.02 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -60.31 -35.22 75.1 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.457 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 86.2 mm-40 -75.92 -39.03 57.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.631 0.729 . . . . 0.0 109.969 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.5 -33.05 75.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.259 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.8 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -83.26 -26.78 30.4 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.39 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 8.3 tt -64.05 -63.9 1.03 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 172.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 66.6 mmtt -31.99 -27.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.058 164.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.91 -37.67 12.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.54 0.686 . . . . 0.0 110.527 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -69.71 -8.66 49.77 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.716 1.206 . . . . 0.0 113.237 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' OD1' ' HG2' ' A' ' 82' ' ' PRO . 3.1 m-20 -61.96 -51.71 66.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.72 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -63.83 -56.79 12.77 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.914 174.677 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 34' ' ' ARG . . . 83.19 -94.19 1.76 Allowed Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.289 151.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.4 m 63.66 36.77 10.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.217 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.9 159.34 25.98 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.663 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.5 p -125.27 -177.55 3.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.724 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.7 mtmm -72.12 -25.96 61.94 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.62 -28.32 56.06 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.975 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.78 64.53 8.47 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.31 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 7.1 Cg_exo -64.03 134.94 45.17 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.967 1.778 . . . . 0.0 111.182 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.56 176.7 5.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.523 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.554 HG12 ' HE3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -123.77 136.65 59.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -176.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -138.27 136.71 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.739 172.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.57 ' HG3' HG22 ' A' ' 57' ' ' VAL . 66.8 ttt180 -112.08 113.05 25.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.922 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.527 HD11 ' CA ' ' A' ' 28' ' ' ALA . 23.3 mt -101.36 104.52 15.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.153 0.978 . . . . 0.0 112.205 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.889 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 68.7 ttt180 -69.93 153.77 42.83 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.25 172.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.681 ' HG2' ' H ' ' A' ' 51' ' ' GLY . 50.4 tt0 -122.07 129.47 52.42 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -94.61 18.74 10.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.51 0.671 . . . . 0.0 110.507 176.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.681 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -110.98 -58.1 0.48 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.418 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 6.4 p -93.06 175.34 6.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 0.0 110.877 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -93.72 11.3 29.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.542 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 91' ' ' LYS . 94.7 mttt -108.52 133.67 52.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.837 -174.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.892 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 93.6 t -101.59 128.27 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.504 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 22.8 m-70 -94.51 128.63 41.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.57 HG22 ' HG3' ' A' ' 46' ' ' ARG . 39.7 t -111.7 123.54 67.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.043 0.449 . . . . 0.0 110.686 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 1.06 ' HB3' HG12 ' A' ' 84' ' ' VAL . 34.6 m-85 -131.03 126.86 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.266 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.67 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 19.4 mttp -71.13 154.93 41.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.392 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.593 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . . . -135.35 147.06 48.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.494 -170.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.724 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 18.9 p90 -161.51 -179.38 7.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 45.0 mtmt -138.28 136.05 36.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.742 ' O ' ' HA ' ' A' ' 80' ' ' SER . 56.1 mm-40 -151.42 173.15 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.409 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.461 HG23 ' HA ' ' A' ' 79' ' ' ILE . 4.1 mp -109.37 83.34 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.973 0.892 . . . . 0.0 108.609 168.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.715 ' C ' ' HB2' ' A' ' 78' ' ' LYS . 27.2 m -88.59 -162.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -134.02 90.6 2.71 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.898 -168.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 77' ' ' GLU . . . -70.79 154.12 94.47 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.048 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 15.3 Cg_exo -70.71 -158.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.411 2.741 . . . . 0.0 113.565 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -75.05 -23.41 58.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -84.22 17.2 2.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 18.0 ptt-85 -72.89 170.56 13.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.121 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.66 168.45 24.79 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.899 2.399 . . . . 0.0 112.437 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.7 -20.82 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.379 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.94 -27.09 33.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.524 ' HG2' ' HD2' ' A' ' 76' ' ' PRO . 29.7 ttm -94.56 145.02 28.9 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 75' ' ' MET . 14.0 Cg_exo -67.87 -176.96 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.923 1.748 . . . . 0.0 109.849 167.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.626 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 34.9 mt-10 -44.99 -67.37 0.29 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.715 ' HB2' ' C ' ' A' ' 65' ' ' VAL . 20.8 mmtp -151.1 -177.18 5.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.247 167.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.636 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -157.45 173.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.292 -161.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.742 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 12.4 p -64.59 85.53 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.828 1.33 . . . . 0.0 110.855 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.914 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -117.84 167.13 11.79 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.03 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.685 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 7.4 Cg_exo -77.73 128.19 9.21 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.523 2.815 . . . . 0.0 110.57 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.914 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 20.5 m-85 -126.47 123.56 38.11 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.06 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -119.38 128.8 75.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.344 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.9 pttt -106.05 169.9 8.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.6 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -109.44 106.43 16.18 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -171.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HG2' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.57 -6.82 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.829 -172.259 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -176.4 161.94 2.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 12.2 mm -131.81 141.37 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.512 0.673 . . . . 0.0 110.407 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.892 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 69.3 mm-40 -128.1 178.6 6.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.603 -173.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 53.3 mtmt . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.163 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 5.0 ptm180 -93.86 125.47 38.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.26 1.029 . . . . 0.0 111.766 -171.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.8 145.75 25.95 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.389 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.671 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 39.7 m-85 -128.9 170.86 12.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.889 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.747 HG23 ' HG2' ' A' ' 50' ' ' ARG . 15.9 t -130.1 142.41 43.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.631 ' HB3' ' O ' ' A' ' 16' ' ' HIS . 4.0 tp -76.68 124.95 28.42 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.889 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.768 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 6.8 mmm180 -96.62 130.17 43.87 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 14' ' ' ASN . 42.7 p30 -88.34 -171.61 3.43 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.788 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -42.36 -46.69 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.58 -37.23 25.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 111.174 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 9' ' ' ARG . . . 123.0 36.55 0.66 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.731 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 27.2 m-80 -85.98 -178.21 6.5 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.809 0.337 . . . . 0.0 110.294 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' HG11 ' A' ' 7' ' ' VAL . 43.7 mt-10 -105.13 117.99 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.527 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.631 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 79.6 m-70 -137.57 104.27 5.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.911 0.862 . . . . 0.0 111.278 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.75 147.22 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.59 161.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.628 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 80.7 m-85 -150.71 159.59 44.42 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -170.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.0 p -141.25 158.2 44.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.777 0.323 . . . . 0.0 111.254 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.8 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.86 162.61 27.68 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.75 ' H ' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -87.78 0.41 55.8 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.919 0.866 . . . . 0.0 108.889 173.22 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.67 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 30.2 tt0 -161.33 151.58 14.58 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.273 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.67 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 7.9 Cg_exo -43.12 -60.35 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.559 2.173 . . . . 0.0 112.756 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.415 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 38.5 ttt180 -33.89 -42.29 0.11 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.249 167.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.68 -30.35 59.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 117.938 0.336 . . . . 0.0 111.592 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . -63.01 -63.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.906 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -41.05 -39.02 1.12 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.567 165.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.731 ' HB2' ' HA ' ' A' ' 26' ' ' GLN . 1.6 tp -61.78 -14.59 34.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.106 0.479 . . . . 0.0 111.228 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 60.0 mmtt -87.33 -55.45 3.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.61 -30.05 29.27 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.626 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -61.52 -29.5 70.03 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.663 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -62.82 2.15 0.33 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -110.12 -55.02 2.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.564 -162.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.03 -33.8 5.9 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 118.963 -1.589 . . . . 0.0 112.944 165.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 t 73.68 -3.86 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.023 0.529 . . . . 0.0 111.371 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.7 -140.39 0.42 Allowed Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 0.0 112.901 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -150.08 167.72 25.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 165.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -58.79 -31.5 68.47 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.4 0.619 . . . . 0.0 110.4 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.43 27.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.363 -173.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.91 70.42 8.61 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.441 0.639 . . . . 0.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.74 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 25.9 Cg_exo -62.15 166.87 11.82 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.712 2.275 . . . . 0.0 111.477 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -97.2 150.06 21.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.493 HD11 ' HD3' ' A' ' 59' ' ' LYS . 23.0 mm -96.17 102.45 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.895 0.855 . . . . 0.0 112.215 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.7 pp -118.98 142.05 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.076 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -129.32 131.72 46.98 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.773 165.275 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.92 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.4 mm? -90.3 161.12 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.735 0.779 . . . . 0.0 112.118 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.768 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . 18.7 ttp85 -125.01 133.23 53.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.35 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -82.66 72.9 9.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.203 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.747 ' HG2' HG23 ' A' ' 7' ' ' VAL . 35.8 mtp180 30.78 -90.14 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.884 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.61 3.01 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.198 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.842 HG21 ' HE2' ' A' ' 54' ' ' LYS . 54.7 p -138.35 166.29 24.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 110.171 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -112.44 36.46 3.39 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.842 ' HE2' HG21 ' A' ' 52' ' ' THR . 61.0 pttt -124.82 141.23 52.26 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.637 -176.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG21 ' HE ' ' A' ' 9' ' ' ARG . 10.8 t -124.83 144.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.759 0.314 . . . . 0.0 111.71 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.92 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 7.7 p80 -122.53 118.99 29.58 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.887 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.665 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . 60.8 t -85.1 119.83 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.925 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.956 ' HB3' HG12 ' A' ' 84' ' ' VAL . 8.1 m-85 -131.6 124.98 31.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.74 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 16.9 ttpt -85.57 122.57 29.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 84' ' ' VAL . . . -119.57 144.55 47.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -164.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 9.3 p90 -162.55 175.2 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 14.2 mtpp -142.0 107.47 5.05 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.915 173.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 63' ' ' GLU . 7.0 pt-20 177.4 89.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.039 0.936 . . . . 0.0 112.169 159.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.599 HG22 ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -170.28 102.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.242 -1.536 . . . . 0.0 111.951 167.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.847 HG11 ' HE3' ' A' ' 81' ' ' LYS . 2.1 m -142.97 148.51 19.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 120.706 1.594 . . . . 0.0 110.823 164.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.13 72.15 1.64 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.63 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB1' ' HG2' ' A' ' 71' ' ' ARG . . . -54.13 135.71 58.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.495 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.3 Cg_exo -78.28 -148.97 0.03 OUTLIER 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 123.915 3.077 . . . . 0.0 113.078 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -94.81 -42.03 8.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.461 173.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -71.02 31.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.913 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.526 ' HG2' ' HB1' ' A' ' 67' ' ' ALA . 97.9 mtt180 -62.91 162.67 20.35 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.449 0.642 . . . . 0.0 111.981 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 14.1 Cg_exo -72.61 151.11 52.12 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.463 2.775 . . . . 0.0 109.768 163.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.33 64.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.62 -171.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -88.42 -25.38 22.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.626 ' CG ' HG21 ' A' ' 79' ' ' ILE . 41.1 ttm -84.99 125.62 70.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -169.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 79' ' ' ILE . 60.2 Cg_endo -91.07 -162.48 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.253 2.635 . . . . 0.0 112.362 173.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -51.84 -68.84 0.14 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.924 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.5 mmmt -118.38 138.69 52.26 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.626 HG21 ' CG ' ' A' ' 75' ' ' MET . 0.7 OUTLIER -148.01 169.15 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-O 121.21 0.529 . . . . 0.0 109.645 -169.033 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.646 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 33.8 p -99.16 155.49 17.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.155 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.847 ' HE3' HG11 ' A' ' 65' ' ' VAL . 12.5 mmtp -158.34 150.14 17.12 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 52.3 Cg_exo -53.83 91.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 CA-C-N 121.455 1.555 . . . . 0.0 112.899 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.599 ' CE2' HG22 ' A' ' 64' ' ' ILE . 14.4 m-85 -89.78 142.58 27.55 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.267 1.032 . . . . 0.0 111.342 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.956 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -146.51 151.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.08 178.261 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -135.63 103.07 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.728 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 82.8 tttt -66.99 120.37 13.52 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.136 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.64 -15.05 7.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.606 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 2.6 ttm180 -166.95 171.61 11.03 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -170.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.606 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 10.4 mm -137.66 136.2 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.7 mm-40 -116.93 140.02 49.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt . . . . . 0 C--N 1.311 -1.078 0 CA-C-O 121.357 0.598 . . . . 0.0 111.399 -176.122 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.5 ' O ' ' HD2' ' A' ' 4' ' ' ARG . 26.3 m . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.591 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 11.8 mmm180 -126.68 171.51 11.1 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 108.62 7.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 120.973 0.416 . . . . 0.0 110.42 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.591 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 13.8 m-85 -113.16 149.29 33.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.71 0.767 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.02 141.54 19.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.92 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.687 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 19.0 tp -92.59 156.37 17.16 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.426 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HG3' ' HD2' ' A' ' 48' ' ' ARG . 16.7 mtp85 -143.76 113.77 7.26 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.79 170.0 8.16 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.291 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -27.7 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 O-C-N 125.197 1.561 . . . . 0.0 113.048 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.88 -39.36 62.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.636 0.732 . . . . 0.0 111.236 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.05 33.94 6.71 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.485 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 84.8 m-20 -142.5 -174.7 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -82.02 154.19 25.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.583 0.706 . . . . 0.0 110.831 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 9.6 m-70 -135.06 -165.18 1.63 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.404 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -46.3 157.64 0.42 Allowed Glycine 0 CA--C 1.518 0.266 0 O-C-N 123.983 0.802 . . . . 0.0 114.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.55 105.71 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.639 0.733 . . . . 0.0 109.481 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 61.6 m-85 -87.28 113.96 23.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.548 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -95.56 141.88 28.56 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.082 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 164.76 37.97 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -74.0 -19.29 60.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 118.616 1.208 . . . . 0.0 111.259 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 26' ' ' GLN . 26.6 pt20 -157.94 168.89 11.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.7 Cg_exo -45.8 -60.76 0.74 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.686 2.257 . . . . 0.0 112.724 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -39.66 -49.66 2.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.239 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 23' ' ' GLN . 13.1 mm100 -73.12 -24.42 60.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.701 0.286 . . . . 0.0 111.401 -174.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 30' ' ' LYS . . . -74.37 -41.12 61.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.415 0.626 . . . . 0.0 109.666 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -68.98 -35.72 77.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.008 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 9.7 tt -53.78 -55.39 26.91 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 69.6 mmtt -43.7 -43.48 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -73.32 -23.43 60.25 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.85 -0.531 . . . . 0.0 111.549 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -68.0 -11.88 59.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.602 0.715 . . . . 0.0 110.686 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.7 m120 -78.88 3.0 18.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.658 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.4 mmp_? -89.59 -28.37 19.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.93 38.18 49.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.677 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.622 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . 13.8 m -97.48 5.27 49.9 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.173 0.511 . . . . 0.0 109.932 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.25 157.07 26.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.178 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 p -128.45 -177.47 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 12.8 tptm -61.16 -31.8 71.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.997 0.427 . . . . 0.0 110.732 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -38.51 25.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.68 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.24 75.1 75.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 121.116 0.484 . . . . 0.0 110.636 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.698 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 23.3 Cg_exo -67.29 158.12 58.47 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.71 2.274 . . . . 0.0 113.333 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.622 ' OD1' ' HB2' ' A' ' 36' ' ' SER . 15.8 m-20 -71.91 94.12 1.41 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.847 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 tp -72.92 95.65 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.983 0.897 . . . . 0.0 109.372 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.571 HD11 ' HB1' ' A' ' 28' ' ' ALA . 6.2 pt -109.58 152.23 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.914 -172.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.715 ' HB3' HG11 ' A' ' 55' ' ' VAL . 74.3 mtp180 -114.55 118.53 34.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 47' ' ' LEU . 2.4 mm? -111.13 130.87 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.637 0.653 . . . . 0.0 109.412 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.712 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -122.3 118.76 29.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -77.97 107.19 10.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -47.37 102.61 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.296 0 O-C-N 124.019 0.824 . . . . 0.0 111.481 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.4 -25.26 3.01 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.102 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.8 p -92.49 167.47 11.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 24.7 ttmm -111.77 8.97 20.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.216 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -136.89 145.16 44.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.183 0.516 . . . . 0.0 110.96 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.764 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.1 t -101.71 136.41 33.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.958 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 4.4 m-70 -101.0 128.71 46.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 88' ' ' ARG . 12.8 p -114.31 130.55 68.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.549 0.69 . . . . 0.0 110.45 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.753 ' HB2' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -143.13 136.26 28.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.13 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.698 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 53.3 mttp -71.15 109.45 5.21 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.231 163.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.051 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -94.6 145.85 24.54 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 83' ' ' PHE . 13.6 p90 -170.15 146.61 3.02 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.874 ' HE3' ' HG3' ' A' ' 82' ' ' PRO . 11.8 mtpt -101.47 136.23 41.67 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.713 ' O ' ' HA ' ' A' ' 80' ' ' SER . 3.7 tp10 -163.73 158.95 20.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 112.036 -166.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.803 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 39.3 mt -103.54 130.61 53.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.42 150.47 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.484 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.94 93.82 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.914 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HB1' ' HD3' ' A' ' 72' ' ' PRO . . . -51.25 136.27 30.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.404 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HG2' ' HG3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -4.9 -148.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 1 C-N-CA 127.836 5.69 . . . . 0.0 118.22 -165.4 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -51.88 -57.57 8.99 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.503 173.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -132.85 -42.83 0.9 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.304 168.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 71' ' ' ARG . 8.4 mmt180 -144.68 148.04 38.15 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.217 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 1.035 ' HG2' ' HB3' ' A' ' 75' ' ' MET . 5.5 Cg_exo -90.98 166.58 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.434 2.756 . . . . 0.0 108.31 147.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.78 58.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.636 0.731 . . . . 0.0 111.198 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.546 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 58.3 p-90 -109.29 -33.71 6.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.389 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 1.035 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttp -99.44 144.39 28.18 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -167.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.426 ' HD2' HG21 ' A' ' 79' ' ' ILE . 7.0 Cg_exo -73.52 157.18 49.28 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.338 2.692 . . . . 0.0 112.115 169.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 1.7 pm0 -44.19 -48.38 9.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.611 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -138.4 153.67 48.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 175.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.803 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -159.66 -178.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -169.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.713 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 23.1 t -150.72 84.66 1.35 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.394 168.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 26.2 mmtt -97.67 158.16 33.49 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.274 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.874 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 19.9 Cg_exo -63.38 92.44 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.704 1.603 . . . . 0.0 109.31 159.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' HE2' ' O ' ' A' ' 63' ' ' GLU . 35.2 m-85 -78.27 -179.52 6.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.571 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.753 HG12 ' HB2' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -160.92 162.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 79.1 tttt -159.23 98.51 1.43 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.851 0.834 . . . . 0.0 110.709 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HB2' ' HD2' ' A' ' 58' ' ' PHE . 11.9 tmtt? -58.75 113.55 2.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.379 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 12.0 pt-20 -119.63 5.97 11.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.029 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.477 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 39.2 ttp-105 176.24 170.15 0.43 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.015 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -120.24 141.12 41.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.764 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.2 mm-40 -112.14 166.66 11.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.293 0.568 . . . . 0.0 111.174 -173.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.256 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 1.013 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 91.5 m . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 120.782 0.325 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.599 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 1.3 ptm180 -132.77 155.48 48.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -107.15 145.15 32.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.409 0.55 . . . . 0.0 110.306 -174.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.533 ' HB3' HD12 ' A' ' 47' ' ' LEU . 58.5 m-85 -126.49 158.82 35.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.157 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.972 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -127.85 125.12 64.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.742 0.782 . . . . 0.0 109.166 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.768 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.5 OUTLIER -69.67 142.86 53.33 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.923 -1.489 . . . . 0.0 111.581 -168.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.05 142.1 28.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.225 171.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -88.87 -162.07 0.82 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.24 -38.65 66.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.345 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -86.19 -38.95 17.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 9' ' ' ARG . . . 121.25 30.26 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.705 171.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 47.8 m-80 -70.92 128.67 36.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.239 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.41 107.18 2.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.695 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 78.9 m-70 -103.11 -162.8 0.94 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.558 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' A' ' 16' ' ' HIS . . . -56.56 157.1 10.99 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -170.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.9 t -80.62 140.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 12.9 m-85 -124.24 159.25 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 p -128.61 145.75 51.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.092 0.472 . . . . 0.0 110.919 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -178.57 144.01 6.16 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.9 ptmt -70.09 -7.88 44.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.054 0.927 . . . . 0.0 111.549 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.599 ' HA ' ' HD3' ' A' ' 4' ' ' ARG . 10.0 pt20 -159.29 149.71 15.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.14 174.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.29 -8.46 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.661 3.574 . . . . 0.0 115.079 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.433 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 55.9 ttt180 -96.69 -25.26 15.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.62 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 14.7 mm100 -86.84 -8.29 57.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.883 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . . . -89.69 -48.69 7.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.49 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.275 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 26' ' ' GLN . 1.5 tp -57.2 -56.08 26.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.184 173.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 73.7 mmtt -61.54 -5.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.779 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.34 -40.15 9.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 1.024 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -72.97 -11.18 60.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.162 0.982 . . . . 0.0 109.738 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -83.75 -2.22 55.82 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.37 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -107.43 15.62 24.71 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.12 -167.53 24.76 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -172.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 22.9 m -106.04 -33.21 7.96 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.512 0.156 . . . . 0.0 111.291 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 59.16 171.24 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.11 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 40' ' ' ALA . 6.4 m -156.66 128.33 7.17 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 84.7 tttt -65.21 -16.88 64.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.145 0.498 . . . . 0.0 111.965 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.47 ' H ' HG22 ' A' ' 38' ' ' THR . . . -85.26 -22.04 28.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.71 71.96 2.45 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 121.637 0.732 . . . . 0.0 110.283 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 69.8 Cg_exo -54.77 170.0 0.71 Allowed 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.771 2.981 . . . . 0.0 113.943 -176.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.72 123.14 36.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.1 mm -81.55 120.53 33.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.147 0.499 . . . . 0.0 111.211 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.25 141.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.612 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 81.6 mtp180 -113.54 122.56 47.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -91.69 127.53 37.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 70.0 ttt-85 -116.66 99.79 7.37 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 85.1 tt0 -70.69 112.23 6.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.972 ' HG2' HG12 ' A' ' 7' ' ' VAL . 27.0 mtp180 -47.46 -15.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.05 -38.25 6.48 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.755 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 75.1 p -93.85 165.25 12.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.107 0.48 . . . . 0.0 111.561 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -98.85 7.68 45.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.535 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.779 ' HA ' ' CB ' ' A' ' 91' ' ' LYS . 44.9 mtpt -125.24 148.11 48.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 111.215 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.812 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 26.7 t -93.16 135.73 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.713 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.649 ' HA ' HD13 ' A' ' 89' ' ' ILE . 31.7 m-70 -104.18 100.33 10.07 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.664 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.612 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -93.03 134.85 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 25' ' ' ARG . 2.8 m-85 -142.56 118.93 10.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.044 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 15.3 ptpt -67.31 114.57 6.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.531 -1.268 . . . . 0.0 112.251 159.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.024 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -103.07 151.95 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.46 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.59 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 29.0 p90 -161.29 -172.68 3.5 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 44.8 mtmt -136.81 136.39 38.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.669 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 80' ' ' SER . 20.4 mm-40 -137.64 129.38 28.52 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.586 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.802 ' HB ' ' HB3' ' A' ' 80' ' ' SER . 3.3 tt -100.41 109.17 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.843 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.08 144.64 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.767 0.794 . . . . 0.0 110.382 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 21.7 t70 -74.72 103.56 5.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.936 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB1' ' CB ' ' A' ' 71' ' ' ARG . . . -70.19 133.75 87.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.856 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 58.1 Cg_endo -95.47 -160.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.314 3.343 . . . . 0.0 113.333 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -54.61 -56.29 20.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.281 0.562 . . . . 0.0 110.304 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.02 36.26 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.808 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 17.5 ptt180 -94.09 144.5 28.17 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.766 -0.584 . . . . 0.0 109.553 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 49.7 Cg_exo -59.16 159.83 21.03 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.965 2.444 . . . . 0.0 112.2 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.79 8.26 1.59 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.128 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -121.96 -36.44 3.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.588 ' CG ' HD11 ' A' ' 79' ' ' ILE . 36.8 ttm -72.41 114.99 34.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.987 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 81.6 Cg_endo -89.69 -177.91 1.54 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 123.138 2.559 . . . . 0.0 113.704 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 4.3 mm-40 -37.12 -52.42 1.0 Allowed 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 112.235 -2.257 . . . . 0.0 114.015 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -155.34 113.14 3.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.87 0.843 . . . . 0.0 112.059 176.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.613 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -150.0 160.04 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.175 175.224 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.802 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 14.1 p -110.03 93.41 4.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 160.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.669 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 21.2 mmmt -77.36 156.1 81.47 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.23 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.745 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 4.6 Cg_exo -68.32 90.79 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.254 1.302 . . . . 0.0 110.2 169.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.669 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 23.0 m-85 -75.45 175.09 8.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 122.048 0.928 . . . . 0.0 112.081 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 60' ' ' ALA . 1.8 m -165.16 158.68 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.325 -169.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 6.7 tmtm? -148.83 114.15 5.55 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -75.39 123.67 25.79 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.621 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -101.16 -25.92 13.85 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.621 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 8.6 ptt180 -175.73 -173.11 0.58 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.315 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 56' ' ' HIS . 16.2 mm -131.96 103.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.812 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 30.8 mt-10 -118.24 112.66 20.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 118.868 -1.133 . . . . 0.0 113.863 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.779 ' CB ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 mmmt . . . . . 0 N--CA 1.436 -1.155 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.359 163.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.445 -0.687 0 CA-C-O 121.349 0.595 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.7 ptm180 -85.67 145.88 27.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.452 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -84.96 147.09 26.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.554 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 67.2 m-85 -135.59 150.32 49.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.89 136.47 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.1 tp -82.25 124.94 30.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HD3' ' HE ' ' A' ' 46' ' ' ARG . 2.6 mtp180 -101.21 166.92 10.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.513 1.149 . . . . 0.0 114.031 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -134.46 178.1 7.25 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.326 -2.215 . . . . 0.0 108.349 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.02 -35.84 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.62 -39.87 11.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -172.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.44 32.83 1.08 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.845 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -87.04 -173.57 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.293 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.88 107.8 16.52 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.289 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 85.4 m-70 -102.35 75.99 1.52 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.761 0.791 . . . . 0.0 110.053 175.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.65 153.01 0.98 Allowed Glycine 0 C--N 1.302 -1.348 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.865 -172.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.43 139.08 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.514 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 32.6 m-85 -123.89 151.02 43.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.1 p -114.04 145.42 41.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA3' ' HB2' ' A' ' 27' ' ' ALA . . . -154.81 135.71 4.81 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.893 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -71.83 -9.08 57.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.691 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 37.4 tt0 -160.23 149.01 13.64 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.79 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.691 ' HD2' ' HG2' ' A' ' 23' ' ' GLN . 75.0 Cg_exo -43.85 -9.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.956 3.771 . . . . 0.0 115.514 173.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.601 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 26.0 ttt-85 -96.52 -45.2 6.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 43.7 mm-40 -70.02 -16.86 63.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.979 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . . . -89.02 -19.08 26.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -94.37 -27.83 15.86 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.538 ' HB3' ' HA ' ' A' ' 26' ' ' GLN . 7.8 tt -64.89 -46.6 81.08 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.642 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 3.4 mmmp? -62.78 -13.02 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.618 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -88.32 -23.79 23.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.622 0.725 . . . . 0.0 109.046 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.913 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -68.1 -10.47 54.28 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.752 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -92.75 2.77 56.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.339 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' A' ' 34' ' ' ARG . 11.8 mmt85 -100.41 15.17 28.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -173.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 174.5 -147.12 8.96 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -170.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.533 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 72.1 m -149.01 -41.87 0.15 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.008 -1.096 . . . . 0.0 109.166 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.79 5.32 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -168.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.1 p -151.99 177.58 10.32 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.442 ' HE3' ' OE2' ' A' ' 63' ' ' GLU . 20.5 ttmt -67.44 -31.89 72.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.702 0.763 . . . . 0.0 109.859 172.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.02 -39.47 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.503 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.62 75.42 73.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.79 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.422 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 35.9 Cg_exo -63.53 158.54 45.12 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.37 2.047 . . . . 0.0 111.549 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 45' ' ' ILE . 5.2 t70 -88.69 72.68 8.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.587 HG12 ' HG2' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -54.61 130.59 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.396 -174.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.538 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -128.15 152.98 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.84 0.828 . . . . 0.0 110.867 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.771 ' NH1' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.59 127.46 53.05 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.309 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.774 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -118.18 132.55 56.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.632 ' HB2' HH21 ' A' ' 46' ' ' ARG . 41.4 ttt180 -131.03 127.81 39.02 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 30.7 tt0 -71.3 149.77 45.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -67.89 116.18 8.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.351 0.596 . . . . 0.0 111.182 -165.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -8.84 78.92 Favored Glycine 0 C--N 1.318 -0.437 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.247 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 23.1 p -96.86 170.96 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.926 0.393 . . . . 0.0 111.479 -174.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 -8.19 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.229 171.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 57.3 mttp -49.28 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 111.784 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.771 HG13 ' NH1' ' A' ' 46' ' ' ARG . 14.3 t -110.1 101.9 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.774 ' CE1' ' HB3' ' A' ' 47' ' ' LEU . 4.0 p80 -111.3 128.03 55.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.365 172.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' A' ' 46' ' ' ARG . 43.0 t -109.17 115.76 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.817 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.96 131.82 53.37 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.361 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.587 ' HG2' HG12 ' A' ' 44' ' ' ILE . 30.8 mtpt -72.83 117.83 15.02 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.688 1.131 . . . . 0.0 110.869 164.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.913 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -108.61 137.81 45.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.247 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -149.99 -174.43 4.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 32' ' ' ALA . 25.0 mtpt -143.04 122.63 13.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.662 ' HG2' ' CE2' ' A' ' 83' ' ' PHE . 12.1 pt-20 -149.62 174.03 13.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.805 HD11 ' HB3' ' A' ' 78' ' ' LYS . 8.2 tt -115.47 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.33 145.94 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.268 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.673 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 11.2 p-10 -80.3 113.54 18.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.967 170.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.765 ' HB3' ' HA ' ' A' ' 77' ' ' GLU . . . -77.41 129.99 75.8 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.073 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -79.81 -177.33 3.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.955 2.437 . . . . 0.0 111.511 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -49.94 -58.64 5.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 110.04 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.51 31.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 75' ' ' MET . 14.7 ptt85 -64.59 151.14 92.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 118.654 0.661 . . . . 0.0 110.068 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.52 147.07 95.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 111.601 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.68 5.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.449 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.0 p-90 -113.87 -24.72 8.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.655 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.612 ' HG2' HG12 ' A' ' 79' ' ' ILE . 22.8 ttp -101.68 118.94 58.58 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' HG21 ' A' ' 79' ' ' ILE . 12.8 Cg_exo -65.87 144.91 78.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.565 2.177 . . . . 0.0 113.344 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.765 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . 31.0 mp0 -31.43 -54.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.805 1.316 . . . . 0.0 112.322 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.805 ' HB3' HD11 ' A' ' 64' ' ' ILE . 29.5 mmtp -112.22 134.63 53.65 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.462 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.612 HG12 ' HG2' ' A' ' 75' ' ' MET . 1.1 pp -155.22 146.73 13.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.826 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 t -122.5 121.73 37.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 6.2 tppt? -154.64 145.76 16.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.472 -168.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 62' ' ' LYS . 51.0 Cg_exo -52.63 146.86 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.558 1.505 . . . . 0.0 109.474 156.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.758 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 11.2 m-85 -144.44 149.37 35.91 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -169.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -153.01 150.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 19.4 tptm -141.79 105.97 4.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.215 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HE3' HD11 ' A' ' 89' ' ' ILE . 86.8 tttt -73.32 101.89 3.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 4.5 pt-20 -109.63 -36.73 5.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.705 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.478 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 23.9 ttt180 -128.35 152.94 47.57 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.235 0.54 . . . . 0.0 110.455 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.541 HD11 ' HE3' ' A' ' 86' ' ' LYS . 25.5 mm -143.98 159.56 15.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.442 -176.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 20.0 mm-40 -142.26 179.17 7.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 9.9 ptpt . . . . . 0 C--N 1.31 -1.112 0 CA-C-O 122.148 0.975 . . . . 0.0 112.322 -171.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 14.3 m . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.742 0.306 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.674 HH22 ' HG3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -148.94 154.46 39.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -96.76 136.5 37.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.84 0.352 . . . . 0.0 111.759 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.451 ' HZ ' ' NH2' ' A' ' 4' ' ' ARG . 96.7 m-85 -133.14 129.72 38.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.428 0.632 . . . . 0.0 111.73 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.782 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 3.1 t -103.53 100.83 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.978 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.495 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -61.89 144.8 54.4 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.921 173.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 9.6 ptm85 -132.49 132.53 42.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 170.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -115.92 169.44 9.23 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.788 -165.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -23.62 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 O-C-N 126.452 2.345 . . . . 0.0 114.38 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.87 -37.19 86.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.62 35.15 2.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 m120 -138.36 170.54 15.84 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -86.65 156.17 20.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.262 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.473 ' HB2' HD23 ' A' ' 8' ' ' LEU . 27.1 m-70 -142.52 -164.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -38.87 128.11 1.95 Allowed Glycine 0 C--N 1.339 0.697 0 O-C-N 124.473 1.108 . . . . 0.0 113.52 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -80.92 104.52 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.278 1.037 . . . . 0.0 108.231 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.461 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 39.5 m-85 -88.46 113.11 23.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.501 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -88.39 136.15 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.531 -1.668 . . . . 0.0 107.945 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.62 140.66 6.3 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -76.96 -1.27 27.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.476 0.638 . . . . 0.0 111.144 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.712 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 28.3 tt0 -155.61 146.68 16.53 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.712 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 85.3 Cg_exo -47.07 -55.12 4.17 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.456 2.104 . . . . 0.0 112.383 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -45.16 -28.29 0.73 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.613 ' HG2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 mm100 -82.23 -26.22 33.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 19' ' ' PHE . . . -80.14 -40.85 26.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.708 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -58.57 -36.2 73.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.363 169.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.404 HD13 HE22 ' A' ' 26' ' ' GLN . 2.6 tt -66.44 -53.0 40.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -50.31 -19.44 0.82 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.903 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.717 ' O ' ' HG2' ' A' ' 34' ' ' ARG . . . -95.49 -41.09 9.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.475 0.58 . . . . 0.0 109.73 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.525 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -59.79 -20.11 54.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.267 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -56.84 -40.15 75.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.991 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 7.4 ptm180 -84.55 -23.61 29.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.89 0.376 . . . . 0.0 110.937 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.98 70.69 2.87 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.305 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 m -76.67 60.36 1.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.091 0.472 . . . . 0.0 112.196 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.72 40.43 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.3 p -132.09 166.79 20.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.503 0.651 . . . . 0.0 109.74 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -66.54 -14.27 62.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 0.0 111.55 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.97 -18.56 21.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.343 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.447 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -151.78 63.48 5.36 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.976 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 13.3 Cg_exo -68.45 151.98 75.44 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.704 2.269 . . . . 0.0 112.621 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -77.54 122.11 24.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.719 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.777 HD11 ' HE3' ' A' ' 59' ' ' LYS . 17.5 mm -71.22 109.61 3.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.42 0.629 . . . . 0.0 111.064 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 58' ' ' PHE . 2.7 pp -113.75 137.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.515 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.513 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 24.1 mtp180 -124.38 104.87 9.02 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.01 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.578 HD11 ' N ' ' A' ' 28' ' ' ALA . 86.0 mt -88.65 131.0 35.17 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.327 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.782 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -84.27 154.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.452 0.644 . . . . 0.0 109.547 174.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.507 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 34.6 tt0 -116.96 76.98 1.07 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.623 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.671 ' HG2' HG23 ' A' ' 7' ' ' VAL . 6.3 mtp180 -30.66 119.18 0.18 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.059 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.65 -24.21 24.38 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.127 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 10.6 p -114.25 -172.21 2.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.182 0.491 . . . . 0.0 110.201 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -123.17 27.22 7.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 109.534 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -110.08 138.18 46.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.411 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 46' ' ' ARG . 39.9 t -109.8 127.47 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.476 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.649 ' HA ' HD13 ' A' ' 89' ' ' ILE . 62.9 m-70 -88.49 111.71 22.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.711 0.291 . . . . 0.0 110.784 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 46' ' ' ARG . 38.5 t -97.09 108.12 21.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.479 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.846 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -120.06 122.48 41.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.155 172.415 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.976 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 44.1 mttp -68.76 111.77 5.07 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.1 163.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.687 ' HB2' HG13 ' A' ' 84' ' ' VAL . . . -92.92 134.88 34.65 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.011 174.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.591 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 41.6 p90 -144.46 -172.32 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 47.8 mttp -133.8 139.77 46.5 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.208 0.527 . . . . 0.0 110.387 174.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.768 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 18.1 mm-40 -133.09 140.04 47.45 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.365 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.78 143.08 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 79' ' ' ILE . 5.5 m -145.96 -175.35 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.141 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.9 p-10 -162.91 124.17 2.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 168.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -131.74 150.01 75.05 Favored Pre-proline 0 C--N 1.315 -0.925 0 O-C-N 121.613 -0.68 . . . . 0.0 110.675 -167.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.4 Cg_exo -78.0 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.294 1.996 . . . . 0.0 113.833 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 71' ' ' ARG . 59.6 mmtt -93.98 -51.23 4.96 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.64 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 77' ' ' GLU . 22.8 mtm105 -83.04 167.11 31.55 Favored Pre-proline 0 C--N 1.316 -0.885 0 O-C-N 121.219 -0.926 . . . . 0.0 109.998 166.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 15.7 Cg_exo -69.85 170.83 15.77 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 122.197 1.932 . . . . 0.0 110.312 163.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.59 1.33 34.29 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.585 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -120.77 -38.71 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.187 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.627 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 10.1 ttp -74.82 126.93 87.87 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 7.1 Cg_exo -73.71 151.44 46.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.274 2.649 . . . . 0.0 111.861 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 7.2 pt-20 -25.58 -58.57 0.07 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.465 1.506 . . . . 0.0 114.726 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -100.39 119.06 37.88 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.343 -164.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -165.36 164.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.053 -174.551 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 38.2 p -109.06 95.64 5.77 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 20.5 mttt -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.457 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.541 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 4.1 Cg_exo -80.87 96.33 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.642 2.228 . . . . 0.0 111.913 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.768 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 47.4 m-85 -94.36 120.82 35.17 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.371 0.605 . . . . 0.0 110.553 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.846 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -99.29 178.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.422 175.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.733 ' HE2' ' HB3' ' A' ' 87' ' ' GLU . 5.1 tttt -166.18 104.39 0.65 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.125 -173.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.611 ' HE2' HD11 ' A' ' 89' ' ' ILE . 65.8 tttm -61.62 127.7 32.71 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 171.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.733 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 13.5 pt-20 -127.41 -34.03 2.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.271 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 88' ' ' ARG . 15.4 ttp180 -151.74 159.5 43.93 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.712 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 56' ' ' HIS . 21.0 mm -123.23 107.96 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.741 173.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' CD ' ' HE ' ' A' ' 88' ' ' ARG . 6.0 mm-40 -92.5 -177.46 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.122 0.963 . . . . 0.0 113.286 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.882 170.937 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.701 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -93.06 125.3 37.58 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.85 0.833 . . . . 0.0 110.966 -178.187 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -88.82 145.0 25.85 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.858 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.783 ' CE2' ' HG3' ' A' ' 49' ' ' GLU . 82.5 m-85 -130.98 144.59 51.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.536 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 50' ' ' ARG . 47.1 t -112.83 127.92 69.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 16' ' ' HIS . 3.9 tp -66.63 130.01 41.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.216 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 67.1 mtp180 -106.82 128.03 53.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 166.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -87.62 -169.78 2.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -37.57 -48.24 0.99 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.589 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -80.2 -35.07 36.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.595 0.712 . . . . 0.0 110.258 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.6 31.41 1.81 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.641 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.686 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 2.4 m-20 -96.89 148.1 23.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -173.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.77 130.42 38.6 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.784 0.677 . . . . 0.0 111.013 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.631 ' HB2' HD23 ' A' ' 8' ' ' LEU . 92.0 m-70 -138.22 -171.47 3.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.737 -176.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -12.2 130.45 0.01 OUTLIER Glycine 0 N--CA 1.461 0.331 0 O-C-N 126.736 2.522 . . . . 0.0 113.366 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.79 156.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.685 0.278 . . . . 0.0 111.077 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 92.6 m-85 -151.43 156.82 41.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -139.71 158.36 44.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.581 0.229 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.701 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.71 150.63 8.38 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.103 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.52 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 2.7 tppp? -72.79 -6.33 44.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.487 0.643 . . . . 0.0 110.767 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.872 ' HG3' ' HG2' ' A' ' 26' ' ' GLN . 2.6 pt20 -160.46 158.62 25.61 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 11.6 Cg_endo -56.84 -13.48 11.49 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 123.329 2.686 . . . . 0.0 115.233 -171.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 19.4 ttt180 -94.14 -13.67 26.5 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -174.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.872 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 83.2 mm-40 -88.21 -18.08 29.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.061 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 -59.05 2.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.819 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -35.92 -45.58 0.42 Allowed 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 159.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -57.48 -26.07 60.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.425 0.631 . . . . 0.0 111.076 177.756 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.764 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 27.2 mmmt -80.94 -47.89 13.06 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.654 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -69.4 -21.56 63.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.843 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -67.47 -12.85 61.28 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.82 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 1.2 p-10 -66.06 -47.66 73.59 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.82 17.71 2.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.977 170.028 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.29 90.68 1.42 Allowed Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -77.09 49.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 110.281 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.32 -165.62 11.94 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.32 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 40' ' ' ALA . 9.5 t -162.35 171.62 16.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -62.12 -16.42 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.941 0.791 . . . . 0.0 111.029 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 38' ' ' THR . . . -79.85 -30.08 40.24 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.769 . . . . 0.0 110.63 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -165.15 72.74 1.43 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.182 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' A' ' 59' ' ' LYS . 49.4 Cg_exo -56.19 -169.44 0.02 OUTLIER 'Trans proline' 0 CA--C 1.526 0.082 0 C-N-CA 123.386 2.724 . . . . 0.0 114.008 -174.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -119.4 104.14 10.09 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.403 HD11 ' CG2' ' A' ' 57' ' ' VAL . 6.7 tp -79.05 101.52 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.781 0.8 . . . . 0.0 112.391 -167.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.514 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.4 pp -119.12 129.08 75.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.09 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.788 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 42.2 ttm105 -109.44 118.04 35.59 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 8' ' ' LEU . 3.4 mm? -84.88 161.69 19.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.916 0.865 . . . . 0.0 112.687 175.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.646 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 49.5 ttp180 -133.2 130.46 39.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.003 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.783 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 2.4 mt-10 -80.18 88.2 5.47 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HB3' HG23 ' A' ' 7' ' ' VAL . 3.4 ptm180 -51.56 -9.12 0.07 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.86 -32.47 9.96 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.748 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 p -117.99 -169.75 1.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.002 0.43 . . . . 0.0 110.872 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -108.91 41.62 1.57 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.464 0.65 . . . . 0.0 109.599 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -101.32 138.9 37.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.32 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 81.4 t -124.34 129.07 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.589 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 89' ' ' ILE . 71.2 m-70 -134.84 107.93 7.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -172.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 14.9 p -97.0 138.75 21.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.854 ' HB3' HG12 ' A' ' 84' ' ' VAL . 2.9 m-85 -141.52 138.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.966 0.412 . . . . 0.0 110.321 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HG2' ' OE2' ' A' ' 87' ' ' GLU . 55.3 mmtt -71.66 128.5 35.99 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 161.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -126.02 133.01 51.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HZ3' ' HG2' ' A' ' 85' ' ' LYS . 26.9 p90 -151.93 156.37 39.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 6.7 mtpm? -131.58 124.17 29.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.724 0.773 . . . . 0.0 110.943 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.482 ' HG3' ' HE2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 139.87 31.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.003 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -82.23 145.78 8.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.086 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.655 ' H ' HD13 ' A' ' 64' ' ' ILE . 1.5 t -130.19 176.51 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -167.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 25.4 t0 176.79 50.39 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -133.87 118.71 14.45 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.38 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.551 ' HA ' ' HG2' ' A' ' 71' ' ' ARG . 7.3 Cg_exo -74.14 -19.81 19.72 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 C-N-CA 123.697 2.931 . . . . 0.0 113.822 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -71.54 -36.09 70.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.458 -171.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 42.9 m-80 -114.82 33.39 5.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.852 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.852 ' HG3' HH11 ' A' ' 71' ' ' ARG . 5.5 mmt85 -76.21 111.95 18.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.178 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 10.0 Cg_exo -73.76 174.47 12.24 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 123.838 3.025 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.24 8.69 20.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.479 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.565 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.2 p-90 -123.49 -31.79 3.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.319 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.775 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.4 ttp -97.78 141.46 23.02 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.325 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 11.7 Cg_endo -79.68 -148.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.63 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 35.7 mt-10 -91.37 -40.54 11.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.213 -0.304 . . . . 0.0 111.745 -169.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.662 ' HD2' ' HB2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -144.79 118.38 9.15 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -175.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.783 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.19 159.15 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 CA-C-O 120.934 0.397 . . . . 0.0 110.266 -176.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 44.5 t -112.31 126.48 55.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 14.0 tppt? -146.64 135.57 11.22 Favored Pre-proline 0 N--CA 1.438 -1.05 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -164.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.769 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 22.3 Cg_exo -64.67 89.97 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 CA-C-N 119.747 0.945 . . . . 0.0 110.389 172.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.754 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 18.3 m-85 -75.42 139.28 42.22 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.985 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.854 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -150.43 155.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.739 -177.294 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HG2' ' HZ3' ' A' ' 61' ' ' TRP . 3.7 ptmm? -151.78 138.97 19.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.11 0.481 . . . . 0.0 111.637 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.518 ' HD3' HG12 ' A' ' 89' ' ' ILE . 35.9 ttmt -88.98 89.85 8.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.424 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.548 ' OE2' ' HG2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -55.03 -54.63 40.57 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 165.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HG2' HG11 ' A' ' 57' ' ' VAL . 5.0 ptt180 -143.61 171.62 13.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.445 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 56' ' ' HIS . 15.8 mm -145.37 131.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.747 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 32.4 mt-10 -87.77 -158.01 0.44 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.934 1.293 . . . . 0.0 109.17 175.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 46.3 mtmt . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -87.05 124.24 33.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.266 0.555 . . . . 0.0 111.369 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.63 135.48 38.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.187 174.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 24' ' ' PRO . 9.2 m-85 -120.3 160.82 22.24 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.567 HG23 ' HG2' ' A' ' 50' ' ' ARG . 3.5 t -118.5 138.22 49.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.864 HD23 ' HB2' ' A' ' 16' ' ' HIS . 11.5 tp -79.28 134.74 36.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -136.31 121.18 18.66 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 1.9 t70 -65.32 179.03 0.81 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.371 0.605 . . . . 0.0 112.273 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.32 -32.4 71.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -83.37 -38.97 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.689 0.756 . . . . 0.0 109.211 175.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.43 21.12 2.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.878 172.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 40.0 mt-10 -81.88 121.31 26.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.864 ' HB2' HD23 ' A' ' 8' ' ' LEU . 62.0 m-70 -114.61 99.5 7.58 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.376 0.607 . . . . 0.0 111.461 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.46 175.92 27.7 Favored Glycine 0 C--N 1.294 -1.787 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.207 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.17 138.69 50.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 55.0 m-85 -126.69 148.52 49.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.5 p -132.33 144.38 50.52 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.195 -0.316 . . . . 0.0 111.688 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.15 33.69 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.945 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -54.97 -40.43 70.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.529 0.681 . . . . 0.0 109.719 171.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.75 177.68 1.73 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.75 -53.33 7.2 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.925 1.75 . . . . 0.0 112.113 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.427 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 34.2 ttm180 -32.28 -53.38 0.3 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -74.86 -17.41 60.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.114 0.483 . . . . 0.0 111.169 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.01 23.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.629 0.728 . . . . 0.0 109.132 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -95.83 -32.63 12.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 84' ' ' VAL . 4.3 mt -57.3 -40.32 77.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.382 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -70.19 -7.07 38.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.724 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -100.48 -48.25 4.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.616 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -73.58 -11.21 60.36 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.237 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 14.0 p-10 -83.38 -2.19 55.19 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.407 -166.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.6 ptp180 -114.99 15.79 17.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.0 -119.36 2.66 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.661 -171.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m 176.32 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -172.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 46.37 -164.69 0.1 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.539 -175.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.9 p -157.01 141.46 16.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.082 0.553 . . . . 0.0 109.618 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -66.45 -22.47 66.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.761 0.791 . . . . 0.0 110.37 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.03 -43.03 88.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.658 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -157.51 74.41 4.2 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.621 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.854 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 50.4 Cg_exo -52.83 125.57 18.54 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.377 2.718 . . . . 0.0 113.519 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -42.15 127.47 3.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.105 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 44' ' ' ILE . 11.7 mm -80.65 115.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.001 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.8 pp -106.05 154.62 7.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.101 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.551 ' HB3' ' HG3' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -129.71 101.72 6.02 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.034 -178.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.713 HD23 HD13 ' A' ' 45' ' ' ILE . 4.4 mm? -96.25 135.65 37.8 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -132.85 113.04 12.43 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.437 -175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 33.6 mt-10 -59.56 108.92 0.79 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.665 0.386 . . . . 0.0 110.059 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HG2' HG23 ' A' ' 7' ' ' VAL . 12.8 mtp180 -34.08 -43.97 0.16 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 174.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.28 -26.5 71.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.728 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 49' ' ' GLU . 6.9 p -103.43 -177.12 3.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.276 0.56 . . . . 0.0 110.989 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -121.1 4.04 10.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.792 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 25.7 pttm -90.86 133.31 35.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.264 0.554 . . . . 0.0 110.313 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.927 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 19.0 t -103.61 153.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.759 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -128.9 112.29 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.094 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HB ' ' NE ' ' A' ' 46' ' ' ARG . 2.5 p -98.07 126.11 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 122.602 1.191 . . . . 0.0 113.251 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 1.001 ' HB2' HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -114.13 -173.11 2.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.602 -1.636 . . . . 0.0 107.547 174.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.854 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 13.7 ptpt -141.25 121.13 13.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -108.87 140.9 41.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.659 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 10.2 p90 -160.78 -174.33 4.37 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.104 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' ' CA ' ' A' ' 82' ' ' PRO . 88.0 mttt -127.27 153.34 46.26 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 110.542 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.522 ' CG ' ' HE1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -163.77 177.36 8.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -164.191 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.732 ' HB ' ' HG2' ' A' ' 76' ' ' PRO . 18.2 pt -62.37 137.28 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.109 0.957 . . . . 0.0 110.669 167.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 1.043 HG22 HG22 ' A' ' 79' ' ' ILE . 1.4 m -99.75 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 -165.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 36.0 t70 -33.35 -94.18 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 112.02 -2.355 . . . . 0.0 115.945 -166.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 76' ' ' PRO . . . -50.26 150.17 4.68 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -166.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 71.7 Cg_endo -110.34 -102.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 1 C-N-CA 125.963 4.442 . . . . 0.0 115.225 -172.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -83.04 -23.6 33.15 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.33 -168.155 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -64.49 -8.13 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.567 1.175 . . . . 0.0 110.461 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 76' ' ' PRO . 24.3 mmm180 -117.14 170.78 5.6 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.378 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 52.9 Cg_exo -57.69 169.03 2.71 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.778 1.652 . . . . 0.0 112.167 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.45 -47.72 84.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.284 0.564 . . . . 0.0 110.46 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.633 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 43.7 p-90 -82.62 -33.22 27.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.434 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.583 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.8 ttm -94.88 112.0 56.55 Favored Pre-proline 0 C--O 1.223 -0.317 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -170.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.764 ' HG2' HG21 ' A' ' 79' ' ' ILE . 47.0 Cg_exo -65.69 -72.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 123.612 2.875 . . . . 0.0 112.976 169.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 4.7 mm-40 -135.79 -80.44 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HD2' ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -159.92 115.25 2.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 166.404 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.043 HG22 HG22 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -120.22 117.16 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 N-CA-C 119.294 3.072 . . . . 0.0 119.294 -150.228 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -168.69 88.75 0.21 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 110.451 -3.068 . . . . 0.0 109.351 159.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.716 ' HG2' HG11 ' A' ' 65' ' ' VAL . 23.5 mmtt -122.55 155.7 62.29 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 120.113 1.324 . . . . 0.0 111.546 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.576 ' CA ' ' HG2' ' A' ' 62' ' ' LYS . 95.4 Cg_endo -76.14 123.05 6.99 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.255 2.637 . . . . 0.0 111.363 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 33.8 m-85 -124.51 149.41 46.94 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.777 HG23 HD23 ' A' ' 29' ' ' LEU . 1.1 t -122.3 163.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.315 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 86' ' ' LYS . 1.6 tmmm? -148.67 132.71 17.22 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 51.8 tttm -72.99 113.5 10.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.832 0.825 . . . . 0.0 109.116 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -97.52 -45.02 6.58 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.804 -169.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.578 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 27.0 ttp-105 -156.79 -175.73 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.363 0.601 . . . . 0.0 111.048 -171.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.578 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 14.7 mm -128.12 154.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.605 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.927 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -120.28 -171.29 2.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.051 0.94 . . . . 0.0 110.783 -169.511 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 53.6 mtmt . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.35 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.574 0.226 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -91.0 149.0 22.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.052 0.454 . . . . 0.0 110.829 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.3 t -121.58 130.23 53.37 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -82.9 133.29 35.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.545 1.164 . . . . 0.0 113.496 -173.633 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.54 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 31.6 m-20 -78.53 155.21 29.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.339 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.56 176.23 8.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.443 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.46 146.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 2.4 tp -99.43 120.74 40.1 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.265 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.795 ' HB2' ' HB2' ' A' ' 46' ' ' ARG . 53.1 mtp180 -88.72 157.16 18.61 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.469 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 11.9 t70 -102.35 -151.8 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.739 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.461 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 51.1 mm-40 -83.48 -20.37 34.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.868 0.366 . . . . 0.0 110.917 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.25 -6.88 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.477 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.91 50.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.315 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 12.4 m120 -54.63 178.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.653 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.37 160.15 34.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.272 0.558 . . . . 0.0 111.994 -169.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 77.9 m-70 -142.58 -159.59 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.172 -171.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.65 161.2 17.4 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.448 0.467 . . . . 0.0 112.84 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 p -84.25 110.9 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.898 0.856 . . . . 0.0 110.521 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 2.7 m-85 -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.111 175.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 74.2 p -148.24 175.34 11.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.999 0.428 . . . . 0.0 109.865 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 154.69 142.93 3.55 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.565 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -14.41 48.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.241 0.544 . . . . 0.0 110.39 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.428 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 36.4 tt0 -153.83 142.86 14.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.802 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 72.3 Cg_exo -46.96 -18.74 0.61 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.485 3.457 . . . . 0.0 115.492 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -82.81 -12.7 57.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . 13.8 mm100 -77.37 -65.01 1.01 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.914 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -34.46 -37.46 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 164.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.568 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -77.34 -38.97 49.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.34 177.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.856 HD12 HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -63.24 -39.19 93.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -80.87 -1.03 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.943 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . . . -99.06 -20.3 16.78 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.772 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 34' ' ' ARG . . . -72.81 -66.33 0.68 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.621 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.9 OUTLIER -35.06 8.13 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 162.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.61 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 14.8 mmm180 -91.37 -48.27 6.99 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.4 1.0 . . . . 0.0 110.272 -167.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -81.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.142 -1.504 . . . . 0.0 115.055 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -87.26 36.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 0.0 110.204 -168.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 61' ' ' TRP . . . -72.73 92.65 0.62 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.078 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -133.72 144.07 48.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.221 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HD2' ' CD ' ' A' ' 63' ' ' GLU . 68.9 tttt -81.4 -12.81 58.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.256 0.55 . . . . 0.0 110.365 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.6 64.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.047 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -163.9 81.06 1.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.059 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.8 Cg_exo -51.8 140.05 48.26 Favored 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.712 2.941 . . . . 0.0 112.826 -174.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -57.32 99.29 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.924 HD11 ' HE3' ' A' ' 59' ' ' LYS . 19.6 mm -54.9 126.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.355 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.6 pp -135.27 140.93 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.795 ' HB2' ' HB2' ' A' ' 9' ' ' ARG . 72.5 mtp180 -117.29 124.83 49.96 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.521 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 45' ' ' ILE . 1.7 mm? -106.2 158.11 17.08 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -142.5 115.73 8.93 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.3 130.7 43.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 11.2 mtp180 -77.81 8.05 5.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.63 0.729 . . . . 0.0 109.077 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.78 -64.36 0.46 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.607 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 p -91.7 146.66 23.59 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.189 0.519 . . . . 0.0 112.224 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 1.096 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 53.3 pttt -84.03 55.65 3.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.229 1.014 . . . . 0.0 109.808 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -127.98 111.54 13.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.345 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.966 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.7 t -78.68 99.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.562 ' HA ' HD13 ' A' ' 89' ' ' ILE . 51.1 m-70 -69.68 135.51 49.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG11 ' HG2' ' A' ' 90' ' ' GLU . 4.2 p -140.34 104.98 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 122.682 1.23 . . . . 0.0 109.471 -172.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.838 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -104.61 177.54 4.82 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.599 -1.637 . . . . 0.0 107.78 -177.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.924 ' HE3' HD11 ' A' ' 44' ' ' ILE . 45.6 mtpt -123.9 127.44 48.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -127.47 123.79 36.82 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.954 -159.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.583 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . 29.3 p90 -134.64 179.84 6.05 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.621 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 48.2 mtmt -133.84 140.36 46.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.338 174.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.617 ' HB2' ' HE2' ' A' ' 83' ' ' PHE . 38.8 mt-10 -129.56 112.81 14.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.478 173.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 80' ' ' SER . 32.9 mm -79.93 77.97 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.65 ' HA ' ' CB ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -152.24 153.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.873 -177.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.696 ' N ' ' HA ' ' A' ' 78' ' ' LYS . 8.8 t70 157.9 66.44 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.279 1.612 . . . . 0.0 107.932 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -60.59 133.86 91.58 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.266 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.914 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 61.6 Cg_endo -70.37 128.86 16.04 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.853 2.369 . . . . 0.0 115.781 -166.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -95.96 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.322 -1.763 . . . . 0.0 107.621 163.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -124.35 33.83 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.791 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.914 ' HD3' ' HA ' ' A' ' 68' ' ' PRO . 36.9 mtp85 -84.96 163.85 44.24 Favored Pre-proline 0 N--CA 1.464 0.235 0 O-C-N 121.916 -0.49 . . . . 0.0 111.033 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 75' ' ' MET . 18.5 Cg_exo -67.72 160.25 49.05 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.383 2.722 . . . . 0.0 111.458 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.34 -50.15 72.75 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.986 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -59.79 -20.48 57.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.621 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 13.2 ttm -90.18 111.07 44.83 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.454 ' N ' HH21 ' A' ' 71' ' ' ARG . 24.9 Cg_exo -65.24 -135.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 124.19 3.26 . . . . 0.0 115.052 -170.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.827 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.4 mt-10 -117.46 8.47 13.0 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.696 ' HA ' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -160.26 169.43 23.22 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.804 -1.998 . . . . 0.0 106.51 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.083 HD13 ' HD3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -162.7 164.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 169.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 74.9 m -65.3 117.8 8.39 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.765 0.793 . . . . 0.0 111.416 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.083 ' HD3' HD13 ' A' ' 79' ' ' ILE . 4.3 mptp? -142.1 112.71 6.23 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 114.077 -1.42 . . . . 0.0 112.181 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.497 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 2.4 Cg_endo -86.54 124.59 2.34 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 123.28 2.653 . . . . 0.0 109.219 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.722 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 89.1 m-85 -120.82 134.73 55.28 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.856 HG23 HD12 ' A' ' 29' ' ' LEU . 1.5 t -138.81 137.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.926 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -122.45 154.67 37.47 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 27.3 ttmt -99.69 123.37 43.89 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.804 1.638 . . . . 0.0 109.195 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 2.4 pt-20 -89.15 -13.56 38.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.111 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 12.4 ptt-85 174.08 -173.01 0.06 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 56' ' ' HIS . 8.7 mm -138.85 136.22 42.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.784 0.326 . . . . 0.0 110.16 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.966 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.7 mm-40 -107.01 175.04 5.63 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.686 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -126.27 140.17 52.74 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.283 0.563 . . . . 0.0 112.407 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.096 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 13.8 tp -80.85 175.81 10.36 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 164.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.449 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 13.2 mm-40 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.996 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.7 t . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -167.82 135.06 2.22 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.1 m -83.12 131.94 35.12 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.391 0.615 . . . . 0.0 111.934 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.833 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -93.7 133.68 36.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.623 ' HA ' HG22 ' A' ' 20' ' ' THR . 60.6 m-80 -115.6 113.74 23.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.431 . . . . 0.0 111.05 -167.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -117.68 148.09 42.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -175.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 18' ' ' VAL . 3.3 t -113.66 -179.57 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.3 tp -106.56 149.63 26.96 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HD3' ' HB2' ' A' ' 48' ' ' ARG . 24.7 mmm180 -111.05 162.36 14.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t70 -92.74 -162.56 0.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -92.35 -6.62 49.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.073 1.306 . . . . 0.0 108.039 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -110.43 -20.14 12.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.591 -170.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.93 36.53 1.23 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.596 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 65.4 m-80 -111.23 -173.05 2.15 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 87.7 mt-10 -135.9 145.31 46.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 111.092 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 73.9 m-70 -132.57 -166.09 1.69 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.182 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -21.59 130.07 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 125.034 1.459 . . . . 0.0 114.248 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 7' ' ' VAL . 78.4 t -85.53 131.65 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 6' ' ' PHE . 81.5 m-85 -131.4 125.76 33.42 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 5' ' ' ASN . 38.0 p -139.25 140.77 37.78 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.637 ' H ' ' NH1' ' A' ' 4' ' ' ARG . . . -140.78 -164.81 10.06 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.515 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -8.85 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -157.12 139.21 10.25 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.654 -179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HA ' HH21 ' A' ' 4' ' ' ARG . 80.4 Cg_exo -40.91 -47.88 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 124.335 3.356 . . . . 0.0 114.077 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 42.0 ttt180 -53.04 -22.9 6.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.074 0.95 . . . . 0.0 113.341 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 15.0 mm100 -84.05 -50.62 7.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.509 0.671 . . . . 0.0 110.677 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.752 ' CB ' HH22 ' A' ' 4' ' ' ARG . . . -59.07 -31.95 69.34 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.214 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.682 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -83.58 -26.24 30.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.876 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.783 ' HG ' ' HG2' ' A' ' 82' ' ' PRO . 3.7 tt -65.24 -65.52 0.66 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -43.75 -31.29 0.78 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.458 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.88 -39.65 69.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.166 0.507 . . . . 0.0 110.311 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.656 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -70.56 -21.37 62.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.367 0.603 . . . . 0.0 111.184 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' OD1' ' HG3' ' A' ' 82' ' ' PRO . 71.3 m-20 -68.34 -2.83 9.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.965 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.42 ' NH2' ' HE1' ' A' ' 19' ' ' PHE . 8.2 mmt180 -100.06 -13.27 19.09 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.09 82.85 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.84 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.507 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 13.0 p -100.18 -49.52 4.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -126.92 8.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.909 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 160.83 40.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.105 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -62.12 -20.87 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.589 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.64 -25.43 67.36 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.969 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -161.85 67.82 2.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.442 0.639 . . . . 0.0 110.353 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.3 Cg_exo -65.16 130.95 26.95 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.085 1.857 . . . . 0.0 111.592 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.18 139.39 52.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 57' ' ' VAL . 5.6 tp -82.97 105.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.824 0.821 . . . . 0.0 111.249 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.631 HD11 ' HB1' ' A' ' 28' ' ' ALA . 2.7 pp -95.94 123.27 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 122.351 1.072 . . . . 0.0 110.345 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' HD22 ' A' ' 47' ' ' LEU . 77.5 mtp180 -91.79 173.26 7.96 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.446 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.57 ' CB ' ' HB2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -147.47 148.23 31.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.58 ' HB2' ' HD3' ' A' ' 9' ' ' ARG . 11.6 tpt180 -124.18 111.27 15.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.106 0.479 . . . . 0.0 110.169 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 8.4 tp10 -86.27 104.57 15.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.568 ' HD3' ' HB3' ' A' ' 5' ' ' ASN . 2.8 ptm180 -73.05 25.66 0.06 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.434 0.635 . . . . 0.0 111.429 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 49' ' ' GLU . . . -128.63 0.99 6.39 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.325 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 44.6 p -146.65 169.78 18.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.411 0.605 . . . . 0.0 109.825 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -95.21 38.21 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -127.94 132.19 49.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.923 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.852 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 49.1 t -92.47 119.7 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.129 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 47' ' ' LEU . 95.2 m-70 -81.42 131.74 35.3 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.592 HG21 ' HG3' ' A' ' 90' ' ' GLU . 71.3 t -123.15 116.23 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -170.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.65 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -132.25 134.78 45.7 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 87.5 mttt -70.56 170.26 12.52 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 162.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -163.08 133.99 4.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -166.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 36' ' ' SER . 29.9 p90 -150.03 -172.57 4.19 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 35.3 mttp -132.2 136.51 47.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.11 0.481 . . . . 0.0 111.108 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -137.66 137.8 38.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 -178.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 16.0 tt -83.67 94.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.147 1.451 . . . . 0.0 113.877 -166.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 81' ' ' LYS . 35.2 m -112.09 -174.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.523 170.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.996 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 7.3 p-10 -98.88 178.06 5.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 119.453 1.024 . . . . 0.0 110.985 169.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.707 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -125.23 163.87 35.44 Favored Pre-proline 0 C--O 1.239 0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.375 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 67' ' ' ALA . 82.7 Cg_exo -46.3 149.31 2.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.979 2.453 . . . . 0.0 112.636 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -83.83 12.11 6.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.486 0.66 . . . . 0.0 110.309 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -117.31 22.84 12.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.013 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 77' ' ' GLU . 31.3 ptt-85 -63.89 170.2 3.57 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.618 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -56.57 168.95 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.68 2.254 . . . . 0.0 113.108 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.44 -14.87 32.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.265 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.558 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 35.8 p-90 -91.37 -24.36 19.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.111 0.482 . . . . 0.0 111.151 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.558 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 28.6 ttp -101.28 147.46 33.8 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.279 -172.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 75' ' ' MET . 56.1 Cg_endo -83.84 177.4 6.16 Favored 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.499 2.132 . . . . 0.0 110.026 172.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 12.8 pt-20 -74.07 -43.46 57.67 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.145 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.996 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 29.7 mmmt -79.71 114.99 19.06 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 67' ' ' ALA . 1.4 pp -153.54 153.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.355 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 5.3 p -76.33 104.24 6.75 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.226 0.536 . . . . 0.0 110.053 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 21.6 tptt -62.9 136.9 96.75 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.763 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.783 ' HG2' ' HG ' ' A' ' 29' ' ' LEU . 37.9 Cg_endo -68.43 98.32 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.221 1.948 . . . . 0.0 110.491 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 42.3 m-85 -94.31 173.0 7.85 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.682 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -162.59 174.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -162.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' H ' ' HB3' ' A' ' 58' ' ' PHE . 49.5 tptt -175.63 98.23 0.07 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 111.146 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 36.4 ttmt -55.96 93.16 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.825 0.821 . . . . 0.0 111.954 166.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.596 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -82.23 -11.88 58.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.657 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.596 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 7.7 ptm180 -176.84 177.12 1.37 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.347 0.594 . . . . 0.0 111.907 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.531 HD11 ' HE2' ' A' ' 86' ' ' LYS . 20.9 mm -135.83 136.96 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.527 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.852 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 30.4 mt-10 -107.2 151.29 25.62 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.023 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -111.29 166.35 11.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.7 mt -119.44 142.2 48.45 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.161 -171.905 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 120.872 0.368 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -131.75 149.98 52.3 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.491 0.662 . . . . 0.0 110.961 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.425 HG21 ' HB ' ' A' ' 20' ' ' THR . 28.9 m -71.38 137.61 48.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.935 170.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HD3' ' C ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -93.93 126.67 39.27 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.429 0.633 . . . . 0.0 110.557 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.628 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 70.1 m-20 -78.78 143.87 35.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.673 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.844 ' HB3' HD12 ' A' ' 47' ' ' LEU . 66.0 m-85 -131.89 142.09 49.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.411 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 61.7 t -105.17 122.32 58.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.76 133.17 43.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.061 -177.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.866 ' HB3' ' CA ' ' A' ' 13' ' ' GLY . 60.3 mtp180 -85.36 138.84 32.02 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.607 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 5.4 t70 -59.2 -146.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.691 170.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.61 -56.46 4.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -167.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.25 -42.32 68.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 109.088 162.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.866 ' CA ' ' HB3' ' A' ' 9' ' ' ARG . . . 139.36 48.01 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 116.263 -2.875 . . . . 0.0 113.671 169.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.5 m120 -74.01 -152.44 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -97.41 146.67 24.97 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.691 0.758 . . . . 0.0 112.295 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 15.5 m-70 -138.52 -164.56 1.66 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 167.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.95 162.87 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 119.058 -1.544 . . . . 0.0 112.317 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.628 ' CG2' ' HB3' ' A' ' 5' ' ' ASN . 2.7 p -99.22 110.77 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.093 0.949 . . . . 0.0 111.179 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -78.95 178.43 8.0 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.794 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.425 ' HB ' HG21 ' A' ' 3' ' ' THR . 33.1 p -135.09 151.97 51.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.417 -175.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -172.35 160.42 31.76 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -84.04 -10.21 58.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 26' ' ' GLN . 84.1 mt-30 -151.58 165.5 17.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 23' ' ' GLN . 10.8 Cg_endo -60.63 -53.3 2.88 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 CA-C-N 120.283 1.137 . . . . 0.0 111.278 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 75.5 ttt180 -39.9 -36.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.129 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 49.3 mm-40 -84.44 -10.79 57.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.988 0.423 . . . . 0.0 111.535 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.98 -57.07 2.99 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.672 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -45.08 -32.95 1.94 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 165.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' ARG . 7.2 tt -61.41 -19.23 61.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.282 0.563 . . . . 0.0 110.565 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 30' ' ' LYS . 18.4 mtpp -77.85 -53.39 7.53 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -68.37 -16.59 63.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -64.44 -20.46 66.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.317 0.579 . . . . 0.0 110.838 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -68.36 7.1 0.65 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 56.6 mtp180 -99.64 -54.95 2.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.931 -163.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 36' ' ' SER . . . -105.76 -20.8 9.1 Favored Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.164 167.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 61' ' ' TRP . 68.5 m 76.15 -63.95 0.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.54 -160.8 54.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.235 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -160.93 157.14 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.554 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 4.8 ttpm? -63.65 -12.86 37.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.984 0.513 . . . . 0.0 112.065 -171.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.63 -29.92 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.699 0.762 . . . . 0.0 110.162 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.29 70.18 2.95 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.556 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -56.98 166.13 4.34 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.901 2.401 . . . . 0.0 112.84 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.32 118.04 35.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.764 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 ' HZ2' ' A' ' 59' ' ' LYS . 7.0 tp -55.87 158.0 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.04 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -159.19 179.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.784 ' CB ' ' HB2' ' A' ' 9' ' ' ARG . 24.1 mmm-85 -158.29 143.01 16.23 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.826 0.704 . . . . 0.0 109.761 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.844 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -139.84 125.4 19.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.802 0.81 . . . . 0.0 110.567 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 45.3 tpt85 -105.36 114.48 28.68 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.994 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 57.4 tt0 -85.58 78.24 9.68 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -46.47 104.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.997 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.93 -19.47 4.4 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.042 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 26.1 p -127.62 178.48 6.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -115.59 37.26 3.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.929 0.871 . . . . 0.0 109.87 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -127.03 149.09 50.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.906 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 1.052 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 20.9 t -103.92 136.47 36.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.25 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.682 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 90.9 m-70 -103.73 105.99 16.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 43.7 t -95.32 122.38 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.504 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -128.44 162.11 27.91 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.932 176.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.424 ' HZ2' HD13 ' A' ' 44' ' ' ILE . 40.2 mmtm -103.44 133.28 48.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.926 158.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 45' ' ' ILE . . . -110.96 146.26 36.93 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.745 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 32.0 p90 -168.87 151.36 4.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HE2' ' HG3' ' A' ' 82' ' ' PRO . 77.5 mttt -103.18 122.95 45.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.367 0.604 . . . . 0.0 109.932 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.745 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.1 mm-40 -107.71 143.14 36.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.961 172.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 20.7 tt -86.24 143.31 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 163.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 m -141.0 -172.82 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.82 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.3 p-10 -121.16 -179.41 4.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.158 0.504 . . . . 0.0 111.272 -165.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.694 ' HB2' ' HA ' ' A' ' 77' ' ' GLU . . . -110.74 116.59 52.01 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.369 -172.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 71' ' ' ARG . 7.4 Cg_exo -69.0 -173.66 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.3 2.667 . . . . 0.0 111.383 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -95.48 -51.2 4.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.417 0.627 . . . . 0.0 109.334 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.4 t30 -83.97 18.05 2.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.44 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.631 ' HD3' ' HB1' ' A' ' 67' ' ' ALA . 9.8 ptt-85 -59.26 158.01 21.15 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.695 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.5 173.58 10.53 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.517 2.811 . . . . 0.0 114.015 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.15 10.66 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.833 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -123.21 -15.48 7.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.808 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 32.8 ttm -103.05 121.81 47.7 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.532 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 20.4 Cg_endo -88.7 -152.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.124 2.549 . . . . 0.0 112.444 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.694 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 16.6 mm-40 -69.53 -42.04 75.19 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.82 ' HD3' ' HA ' ' A' ' 66' ' ' ASP . 31.9 mmtp -150.03 129.76 13.24 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.613 HD12 HG22 ' A' ' 65' ' ' VAL . 1.2 pp -147.46 147.87 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 118.721 0.691 . . . . 0.0 111.074 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 71.5 p -94.14 153.83 17.9 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.58 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 4.4 tptp -157.38 133.67 6.2 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -168.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.611 ' HG3' ' HE2' ' A' ' 62' ' ' LYS . 14.0 Cg_exo -65.22 89.79 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 CA-C-N 120.651 1.268 . . . . 0.0 111.663 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 27.3 m-85 -83.68 157.78 22.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.517 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.672 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -145.92 162.84 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.079 177.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.557 ' HB3' ' CZ3' ' A' ' 61' ' ' TRP . 5.2 tmtt? -151.72 115.56 4.91 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.316 0.579 . . . . 0.0 110.874 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.52 ' HE2' HD11 ' A' ' 89' ' ' ILE . 33.9 ttmt -60.2 125.65 24.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 20.6 pt-20 -135.41 -13.54 2.03 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.41 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 32.1 ttp85 -157.16 165.83 34.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.52 HD11 ' HE2' ' A' ' 86' ' ' LYS . 22.2 mm -147.1 140.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 1.052 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 52.6 mt-10 -119.93 153.11 36.39 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.06 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -115.67 130.16 56.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD23 HG23 ' A' ' 55' ' ' VAL . 2.1 mm? -109.82 174.71 5.74 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.658 -169.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.249 1.061 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.275 -179.853 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.66 0.267 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -83.0 140.86 32.49 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.4 m -67.16 125.6 26.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.402 0.62 . . . . 0.0 112.123 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' THR . 12.4 mmm180 -88.52 137.47 32.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.336 1.065 . . . . 0.0 111.796 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 36.8 m-80 -104.68 118.05 35.62 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.228 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.501 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 30.3 m-85 -119.27 165.0 14.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.282 1.039 . . . . 0.0 111.599 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.88 130.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.524 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.132 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 13.9 tp -81.26 156.06 25.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.581 ' HD3' HG11 ' A' ' 55' ' ' VAL . 47.9 mtp180 -135.47 143.03 45.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . 6.7 t70 -87.15 -165.04 1.18 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 4.7 mm-40 -83.74 -52.5 6.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.547 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -75.61 0.6 16.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.2 35.94 3.02 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 118.637 -1.744 . . . . 0.0 113.768 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.5 ' HB2' ' CB ' ' A' ' 10' ' ' ASP . 61.5 m-80 -101.75 178.67 4.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -122.72 152.52 40.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.858 0.837 . . . . 0.0 112.255 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 1.132 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 97.3 m-70 -132.18 -158.92 0.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.993 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.78 -172.67 46.55 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 117.84 -2.124 . . . . 0.0 110.936 -158.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 87.1 t -94.23 109.06 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.692 0.758 . . . . 0.0 110.851 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 77.6 m-85 -94.66 111.94 23.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.389 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.8 p -91.08 113.95 26.34 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.74 166.51 21.88 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.423 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HG2' ' HG3' ' A' ' 26' ' ' GLN . 8.9 ptpp? -77.66 -27.25 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.517 0.675 . . . . 0.0 109.58 174.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.608 ' HG2' ' HG3' ' A' ' 22' ' ' LYS . 11.0 pt20 -160.4 163.99 20.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.454 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 33.0 Cg_exo -40.02 -53.3 2.51 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.476 2.784 . . . . 0.0 113.956 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.98 -40.0 69.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.707 ' HG3' ' HG2' ' A' ' 22' ' ' LYS . 21.5 mm-40 -78.56 -31.54 47.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 122.001 -0.437 . . . . 0.0 111.324 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.32 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.588 0.709 . . . . 0.0 109.207 173.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.547 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -70.51 -38.73 74.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.68 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.739 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -56.4 -62.29 1.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 32.1 mmtp -34.81 -48.05 0.37 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.186 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.821 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -66.98 -30.36 70.45 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.162 -0.336 . . . . 0.0 111.512 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -84.7 -18.34 35.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.79 -34.65 20.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 34' ' ' ARG . 28.4 ptt85 -92.21 -20.9 20.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.68 89.75 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.787 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -67.49 -17.1 64.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 31.91 -135.65 0.13 Allowed Glycine 0 C--N 1.344 0.987 0 O-C-N 124.332 1.02 . . . . 0.0 112.843 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -149.46 168.69 22.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 164.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -58.37 -33.64 69.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -81.06 -42.31 21.25 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.294 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.66 65.5 72.32 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.811 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 22.9 Cg_exo -64.45 146.17 89.06 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.485 2.124 . . . . 0.0 112.543 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.92 110.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.539 HD11 ' HE3' ' A' ' 59' ' ' LYS . 30.0 mm -64.1 122.82 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.066 0.46 . . . . 0.0 111.584 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 58' ' ' PHE . 8.0 pt -117.5 132.47 67.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.842 0.83 . . . . 0.0 111.925 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 1.09 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 69.4 mtp180 -122.37 116.47 24.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.866 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.822 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.9 mm? -108.11 123.16 48.29 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.343 0.592 . . . . 0.0 109.922 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.569 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 16.9 ttp180 -112.03 97.29 6.57 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.769 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 4' ' ' ARG . 2.7 tm-20 -61.97 144.14 55.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.07 13.73 7.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -172.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.24 -9.5 2.38 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.408 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.5 p -99.33 172.79 7.12 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.835 -0.215 . . . . 0.0 110.647 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.703 ' HA ' HD22 ' A' ' 92' ' ' LEU . 63.4 tttp -111.76 11.77 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 110.339 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -121.57 142.88 49.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 90.6 t -111.34 101.16 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.822 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 18.6 p80 -86.48 140.31 30.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.28 0.562 . . . . 0.0 111.359 -174.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 1.09 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -125.36 114.57 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.258 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.624 ' O ' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -115.92 147.81 40.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.425 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HE3' HD11 ' A' ' 44' ' ' ILE . 1.5 mmmm -66.29 169.57 7.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.986 160.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -165.31 134.31 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.413 0.149 . . . . 0.0 110.769 -173.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.532 ' HD1' ' HG2' ' A' ' 63' ' ' GLU . 20.1 p90 -161.18 172.74 16.19 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 120.449 0.166 . . . . 0.0 111.15 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 42.2 mtmt -144.32 124.03 13.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.525 0.203 . . . . 0.0 110.706 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.549 ' HG3' ' CG1' ' A' ' 65' ' ' VAL . 7.7 pt-20 -174.09 155.9 2.57 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.698 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -69.99 125.99 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.885 0.766 . . . . 0.0 110.288 173.389 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG23 ' N ' ' A' ' 66' ' ' ASP . 4.2 m -150.75 -167.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -167.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.3 OUTLIER 101.16 -174.65 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 125.395 1.685 . . . . 0.0 110.638 168.192 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 68' ' ' PRO . . . -121.53 179.85 0.88 Allowed Pre-proline 0 N--CA 1.437 -1.099 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.324 -165.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 67' ' ' ALA . 98.1 Cg_exo -50.94 -175.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 123.705 2.937 . . . . 0.0 115.051 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 4.1 mptp? -56.93 -13.05 2.33 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.456 -166.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -76.01 32.67 0.12 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.04 0.447 . . . . 0.0 111.317 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 68' ' ' PRO . 20.3 mmm180 -84.5 167.16 28.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.524 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.6 162.72 30.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.097 1.865 . . . . 0.0 111.191 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.98 62.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.118 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 56.3 p-90 -103.92 -37.51 7.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.895 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.699 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 16.6 ttp -104.57 136.46 19.17 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.706 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 42.7 Cg_endo -92.38 -164.69 0.13 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 122.696 2.264 . . . . 0.0 113.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -86.07 -2.02 57.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.552 -1.658 . . . . 0.0 112.531 -168.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 72.5 mmtt -155.42 119.25 4.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.8 OUTLIER -155.71 144.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.552 0.615 . . . . 0.0 110.087 177.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.0 p -120.71 81.22 1.73 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.004 0.907 . . . . 0.0 111.616 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.842 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -124.74 168.32 13.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.197 176.203 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.739 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 52.2 Cg_exo -57.24 94.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.483 2.122 . . . . 0.0 111.875 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.842 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-85 -86.53 175.6 8.26 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.597 HG12 ' CB ' ' A' ' 58' ' ' PHE . 1.4 t -166.22 173.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -166.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' A' ' 86' ' ' LYS . 16.8 tptm -176.51 99.11 0.06 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.119 0.485 . . . . 0.0 110.7 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.563 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 34.4 ttmt -57.25 134.3 55.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.38 169.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 11.3 pt-20 -167.19 23.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.168 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.488 ' C ' HG13 ' A' ' 57' ' ' VAL . 23.7 ttp180 -168.2 157.03 9.08 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.418 HD11 ' HE2' ' A' ' 86' ' ' LYS . 23.1 mm -140.58 136.31 35.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.534 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -119.36 166.21 13.33 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.452 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -95.16 170.15 9.6 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.818 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.703 HD22 ' HA ' ' A' ' 53' ' ' LYS . 13.3 tp -72.76 157.59 37.21 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.897 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.62 -174.741 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -81.59 74.45 8.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.858 0.837 . . . . 0.0 109.522 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 t -75.8 149.61 37.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.08 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.0 ptm180 -89.34 151.74 21.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.261 1.029 . . . . 0.0 112.642 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -105.08 136.55 44.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.531 -166.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 28.0 m-85 -127.32 122.18 33.07 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.384 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.985 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -97.31 128.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.918 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.5 tp -66.19 139.84 58.14 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.788 -171.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -92.03 171.73 8.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.136 0.97 . . . . 0.0 111.777 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 21.2 t70 -128.43 169.98 13.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.038 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.74 -36.33 80.68 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.744 0.652 . . . . 0.0 111.094 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.09 -39.3 25.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.862 0.839 . . . . 0.0 109.439 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.03 31.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.173 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 6.1 m-20 -77.22 -170.09 1.59 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.773 173.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.29 108.86 9.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.512 0.672 . . . . 0.0 111.083 -170.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.918 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 72.3 m-70 -89.88 -162.17 0.86 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.52 144.11 7.21 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 123.398 0.436 . . . . 0.0 113.434 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 50' ' ' ARG . 97.6 t -83.64 143.82 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -126.71 143.11 51.34 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 p -121.89 135.16 54.87 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.57 -78.59 0.08 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.27 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt 173.36 -33.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 11.1 pt20 -159.68 166.68 15.57 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.312 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 72.5 Cg_exo -45.8 -22.29 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.507 2.805 . . . . 0.0 114.038 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 21.2 ttm-85 -88.1 -35.09 17.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.657 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 20.6 mm-40 -86.34 -14.66 42.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.598 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.0 -47.78 7.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 47' ' ' LEU . . . -57.12 -37.36 71.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.476 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.696 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -49.5 -65.92 0.48 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.426 172.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 74.5 mmtt -35.33 -48.31 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . . . -68.13 -26.78 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.752 0.706 . . . . 0.0 112.067 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.056 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -70.11 -22.95 62.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.226 1.012 . . . . 0.0 111.007 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.665 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 6.2 m-80 -62.45 -0.29 0.57 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -73.54 -63.92 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 116.6 -2.04 . . . . 0.0 109.651 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.13 -50.25 0.25 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 115.282 -3.342 . . . . 0.0 116.622 143.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 38' ' ' THR . 15.2 m -53.77 -25.35 18.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.488 0.644 . . . . 0.0 109.405 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.94 100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.945 164.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 36' ' ' SER . 25.5 p -135.49 -177.97 4.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.143 0.577 . . . . 0.0 110.461 -171.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 23.4 mtmm -65.42 -29.77 70.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.646 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.87 -38.03 79.44 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.157 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -140.38 71.7 32.27 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.21 -178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.8 Cg_exo -67.25 130.44 22.63 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.043 1.162 . . . . 0.0 109.42 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -72.2 107.17 4.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 44' ' ' ILE . 2.9 tp -71.07 96.75 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 122.316 1.055 . . . . 0.0 110.038 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.457 ' H ' HG12 ' A' ' 45' ' ' ILE . 5.3 pt -103.62 152.13 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.107 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.629 ' HG2' HG23 ' A' ' 57' ' ' VAL . 30.0 mtp180 -125.85 102.95 7.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 28' ' ' ALA . 2.6 mm? -87.62 137.62 32.17 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -122.13 112.26 17.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.87 144.26 56.83 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.985 ' HG2' HG12 ' A' ' 7' ' ' VAL . 61.7 mtp180 -74.98 -18.96 60.29 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.446 -166.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 -9.62 60.33 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.806 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.3 p -111.86 149.44 31.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.894 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -95.63 18.22 13.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -100.39 139.97 35.31 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.653 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.02 117.37 48.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.696 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.535 ' HA ' HD13 ' A' ' 89' ' ' ILE . 42.3 m-70 -96.85 99.55 11.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.888 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.629 HG23 ' HG2' ' A' ' 46' ' ' ARG . 7.5 p -98.32 127.27 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 1.4 m-85 -137.68 124.02 20.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.01 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 26.7 mtpp -71.13 107.62 4.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.996 160.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.056 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -95.24 145.98 24.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.671 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 19.8 p90 -158.68 143.25 15.88 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.335 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 30.5 mtmt -103.62 124.51 48.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HG2' ' CG ' ' A' ' 39' ' ' LYS . 3.6 tp10 -150.89 154.78 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.297 0.57 . . . . 0.0 111.392 -166.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 92.1 mt -118.44 121.18 66.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.626 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.566 HG23 ' NH2' ' A' ' 71' ' ' ARG . 34.7 m -122.93 151.05 26.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -79.91 -175.56 5.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.875 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -48.5 160.07 0.48 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 125.771 1.628 . . . . 0.0 114.791 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.754 ' HB3' ' HB2' ' A' ' 71' ' ' ARG . 42.1 Cg_endo -67.08 67.49 0.59 Allowed 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 124.116 3.211 . . . . 0.0 116.167 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -93.1 -7.78 44.56 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 161.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -133.51 2.01 3.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.067 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.955 HH22 HD12 ' A' ' 79' ' ' ILE . 67.0 mtt-85 -118.23 167.73 10.84 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -158.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.39 149.88 80.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.207 2.605 . . . . 0.0 109.364 154.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.01 19.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -167.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -95.27 -21.48 18.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.713 ' HB3' ' HD3' ' A' ' 71' ' ' ARG . 10.3 ttm -81.87 130.6 60.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.336 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HD2' HG21 ' A' ' 79' ' ' ILE . 3.0 Cg_endo -74.48 177.47 8.34 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.839 2.36 . . . . 0.0 112.448 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.875 ' HA ' ' HA ' ' A' ' 67' ' ' ALA . 1.9 mp0 -51.81 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.876 0.735 . . . . 0.0 109.036 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -89.54 130.0 35.92 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.436 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.955 HD12 HH22 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.21 151.12 15.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.608 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.611 ' HB3' HG12 ' A' ' 64' ' ' ILE . 9.1 p -124.88 125.74 44.44 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.833 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 73.0 mmtt -159.28 144.26 11.55 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.696 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 3.0 Cg_exo -73.18 96.1 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 0.0 110.493 163.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.526 ' O ' HG13 ' A' ' 84' ' ' VAL . 80.2 m-85 -78.66 172.72 13.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.691 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -173.08 117.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.23 -173.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 118.14 34.56 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.875 157.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 3.6 ptpp? -55.13 139.57 41.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.236 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.9 -31.98 31.18 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.69 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 173.63 -174.68 0.06 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.097 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 56' ' ' HIS . 31.2 mm -127.84 110.02 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.873 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.89 -176.34 2.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.335 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 21.4 mtmt -110.63 171.06 7.68 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.64 150.37 48.84 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.365 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--N 1.314 -0.96 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.13 -171.767 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.5 t30 62.03 91.1 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.844 0.83 . . . . 0.0 111.307 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.9 m -108.14 108.74 19.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.225 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.604 ' NH1' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -95.76 156.11 16.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.877 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -121.61 132.4 54.65 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.229 -0.295 . . . . 0.0 110.532 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HD1' ' NH2' ' A' ' 4' ' ' ARG . 61.2 m-85 -143.74 134.07 24.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -115.76 133.89 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.784 ' HB2' ' HE2' ' A' ' 19' ' ' PHE . 2.4 tp -66.17 149.36 50.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.44 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.685 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 76.9 mtp180 -118.77 124.16 46.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 163.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.402 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 40.0 t0 -87.03 175.5 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.668 -169.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -44.42 -44.77 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 124.122 0.889 . . . . 0.0 112.965 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -41.54 89.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.456 0.646 . . . . 0.0 110.89 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.05 25.78 2.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.96 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 p30 -110.55 170.37 8.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -95.82 141.89 28.73 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.051 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' HB2' HD23 ' A' ' 8' ' ' LEU . 39.9 m-70 -132.4 -178.99 5.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.823 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -20.26 126.27 0.01 OUTLIER Glycine 0 C--N 1.328 0.135 0 O-C-N 125.876 1.985 . . . . 0.0 114.884 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.09 125.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.253 0.549 . . . . 0.0 109.939 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.784 ' HE2' ' HB2' ' A' ' 8' ' ' LEU . 6.9 m-85 -112.72 149.37 33.04 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -135.8 141.98 44.81 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.3 -175.37 27.19 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.624 -1.275 . . . . 0.0 112.814 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -87.01 -31.79 20.38 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.57 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.604 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 18.6 pt20 -154.15 155.94 31.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 9.3 Cg_endo -50.84 -23.37 11.54 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.154 3.236 . . . . 0.0 114.398 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -58.01 -54.28 48.73 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 123.168 0.292 . . . . 0.0 110.858 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.428 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . 0.6 OUTLIER -55.86 -43.97 77.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.263 0.554 . . . . 0.0 111.106 175.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.604 ' HB2' ' NH1' ' A' ' 4' ' ' ARG . . . -55.96 -35.41 66.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.704 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.95 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -89.25 -21.49 23.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.349 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 1.3 mp -64.63 -63.55 1.1 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -39.62 -16.87 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.323 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 29' ' ' LEU . . . -95.53 -50.95 4.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.219 0.533 . . . . 0.0 110.421 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.673 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -63.76 -29.46 70.67 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.412 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -48.42 -4.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -87.2 -59.92 2.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.69 -130.86 6.11 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.043 150.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.3 m 68.05 19.71 9.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.465 0.706 . . . . 0.0 111.886 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.14 146.55 17.84 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.186 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.4 ' CA ' ' HB2' ' A' ' 61' ' ' TRP . 41.0 p -125.37 176.28 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -58.8 -36.0 73.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.195 0.521 . . . . 0.0 110.783 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.92 -25.08 61.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.626 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.57 82.44 3.02 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.764 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.4 Cg_exo -84.8 136.28 6.06 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.245 2.63 . . . . 0.0 111.245 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.62 173.27 9.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.726 HD13 ' HG2' ' A' ' 59' ' ' LYS . 28.9 mm -111.04 118.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.113 0.482 . . . . 0.0 111.125 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.9 pp -122.9 130.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.977 0.894 . . . . 0.0 111.622 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.817 ' HG2' HG22 ' A' ' 57' ' ' VAL . 48.1 mtm180 -105.89 114.32 28.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.961 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 28' ' ' ALA . 3.3 mm? -82.2 164.0 21.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.691 0.758 . . . . 0.0 109.781 168.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.685 ' HD2' ' HD2' ' A' ' 9' ' ' ARG . 51.1 ttt180 -132.22 140.32 48.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 52' ' ' THR . 17.5 tt0 -83.62 72.26 10.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HA ' HG13 ' A' ' 7' ' ' VAL . 26.4 mtm180 47.21 -64.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 111.456 -2.611 . . . . 0.0 113.612 -166.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.94 52.71 0.58 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.993 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.498 ' CG2' ' HB3' ' A' ' 49' ' ' GLU . 8.2 p -95.21 160.16 14.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.556 -0.379 . . . . 0.0 111.417 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.98 -21.95 58.84 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -100.94 111.71 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.062 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 HH11 ' A' ' 9' ' ' ARG . 98.1 t -86.6 132.36 32.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.246 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.474 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 90.0 m-70 -84.82 138.73 32.4 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.817 HG22 ' HG2' ' A' ' 46' ' ' ARG . 86.3 t -130.79 117.34 37.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.101 -171.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.827 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -129.11 139.94 51.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' A' ' 44' ' ' ILE . 24.0 mttp -70.32 161.32 30.63 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 162.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -153.47 142.52 21.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.59 -171.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.513 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 35.8 p90 -162.01 -166.88 1.52 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 87.3 mttt -143.34 136.69 28.14 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.754 ' O ' ' HA ' ' A' ' 80' ' ' SER . 30.9 mm-40 -145.39 171.39 14.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.979 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.53 74.58 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 122.292 1.044 . . . . 0.0 108.223 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HG3' ' A' ' 78' ' ' LYS . 27.5 m -85.6 -167.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.691 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.76 125.05 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.734 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.833 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . . . -120.34 141.24 31.51 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.073 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.95 -165.71 0.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.434 2.756 . . . . 0.0 113.519 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -51.63 -19.78 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -81.78 7.4 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 0.0 110.768 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 8.5 ptt180 -81.22 163.25 55.9 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.323 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 12.6 Cg_exo -68.03 166.1 25.96 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.355 2.037 . . . . 0.0 112.071 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.02 -22.51 20.75 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 60.8 p-90 -74.33 -29.38 61.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.403 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.464 ' HE2' ' HG2' ' A' ' 72' ' ' PRO . 18.4 ttp -99.3 145.94 30.9 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.417 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.4 175.5 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 110.028 168.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.4 mp0 -41.02 -62.68 0.78 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.833 ' HE2' ' HB2' ' A' ' 67' ' ' ALA . 65.8 mmtt -152.01 -173.93 4.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.169 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.642 HD13 ' CG ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -161.56 160.79 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.49 -160.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.754 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -73.34 79.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.756 0.788 . . . . 0.0 109.977 -176.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.642 ' CG ' HD13 ' A' ' 79' ' ' ILE . 66.2 mmtt -113.03 162.08 23.59 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.477 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 25.7 Cg_endo -62.44 119.07 6.0 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.982 2.455 . . . . 0.0 110.903 170.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HE2' ' HB2' ' A' ' 63' ' ' GLU . 23.2 m-85 -107.61 176.25 5.21 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.95 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -165.55 173.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -162.183 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 179.47 99.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.565 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.562 ' HD2' HD11 ' A' ' 89' ' ' ILE . 18.1 ttpp -68.86 103.81 1.89 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.627 0.727 . . . . 0.0 112.225 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 12.4 pt-20 -106.05 2.15 27.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.998 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 10.1 ptm180 -174.77 175.54 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.288 0.566 . . . . 0.0 111.672 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.562 HD11 ' HD2' ' A' ' 86' ' ' LYS . 23.2 mm -132.56 145.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.561 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 8.9 mt-10 -113.95 177.64 4.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 91' ' ' LYS . 1.6 mtmt -110.5 162.91 14.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -59.95 159.55 9.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.329 173.195 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 34.5 tt0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.728 -1.129 . . . . 0.0 110.147 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.0 m . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.957 0.408 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -107.38 132.83 52.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.942 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.524 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 29.8 m -82.2 98.41 8.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.378 0.608 . . . . 0.0 109.858 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -83.76 144.99 28.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.02 0.914 . . . . 0.0 112.182 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -96.14 134.97 38.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.19 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.552 ' HB3' HD12 ' A' ' 47' ' ' LEU . 70.6 m-85 -130.51 146.43 52.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.736 0.779 . . . . 0.0 111.004 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.838 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 9.5 t -96.01 149.01 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.804 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 10.5 tp -113.54 147.79 37.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.99 162.9 37.84 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 170.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.83 -160.58 0.5 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.641 ' OE1' ' HD3' ' A' ' 46' ' ' ARG . 5.3 mm-40 -91.05 0.53 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.79 -16.45 13.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.741 -168.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' HA2' ' NH2' ' A' ' 9' ' ' ARG . . . 104.62 35.44 3.29 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.472 -1.347 . . . . 0.0 112.249 -176.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.618 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 89.6 m-20 -107.74 101.71 10.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.94 122.54 27.9 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.064 0.459 . . . . 0.0 110.859 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.676 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 92.3 m-70 -110.05 -167.01 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.864 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -52.27 166.33 1.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.873 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 94.6 t -95.36 110.81 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.493 0.664 . . . . 0.0 110.185 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 m-85 -86.55 120.05 27.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.549 1.166 . . . . 0.0 112.225 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.524 ' HB ' ' CG2' ' A' ' 3' ' ' THR . 21.3 p -86.9 142.23 28.17 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.383 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.21 139.23 4.27 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -63.64 -20.18 65.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.846 0.823 . . . . 0.0 110.568 -175.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 4.2 pt20 -161.1 165.5 16.94 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.3 Cg_exo -43.85 -51.8 6.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.967 2.445 . . . . 0.0 112.97 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 39.2 ttt180 -51.0 -41.93 60.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' HG3' ' HG3' ' A' ' 22' ' ' LYS . 80.3 mm-40 -78.29 -33.56 49.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 0.0 111.26 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.15 79.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.502 0.667 . . . . 0.0 109.635 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.624 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -69.82 -32.73 71.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.215 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.455 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.8 OUTLIER -55.88 -59.51 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -50.71 -24.34 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.138 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -90.47 -25.11 20.48 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.713 -0.617 . . . . 0.0 110.246 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.75 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -88.63 -16.28 32.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.292 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -63.0 -15.39 56.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.592 -173.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.51 -28.92 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 110.673 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.38 102.8 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 m -59.12 -41.66 88.73 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.098 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.23 -139.6 0.41 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 123.931 0.77 . . . . 0.0 111.788 -170.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -147.29 171.18 15.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -62.14 -28.2 69.48 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.094 0.474 . . . . 0.0 110.679 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.53 -24.17 25.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.448 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.1 p-10 -143.93 64.6 13.1 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.425 0.631 . . . . 0.0 110.238 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.751 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 19.7 Cg_exo -64.81 150.17 88.53 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.634 2.223 . . . . 0.0 112.599 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.71 124.46 28.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' ' 59' ' ' LYS . 17.5 mm -74.6 117.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.785 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.499 HD11 ' HB1' ' A' ' 28' ' ' ALA . 17.7 pt -107.16 139.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.696 0.76 . . . . 0.0 111.397 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.648 ' O ' HD22 ' A' ' 47' ' ' LEU . 33.7 mmm-85 -94.89 171.54 8.71 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.948 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -154.56 94.74 1.72 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.656 -177.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.838 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.2 ttp180 -78.9 143.39 35.91 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 131.74 54.09 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.01 19.03 7.13 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.279 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.75 -18.05 1.81 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.703 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.2 p -124.32 179.64 4.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.239 0.52 . . . . 0.0 111.326 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' HA ' HD11 ' A' ' 92' ' ' LEU . 64.1 pttt -108.11 33.64 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.527 0.68 . . . . 0.0 109.513 173.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -133.4 123.66 25.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.492 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.579 HG22 ' HG3' ' A' ' 48' ' ' ARG . 50.0 t -94.37 125.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.088 0.47 . . . . 0.0 109.918 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.434 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 33.7 m-70 -81.13 146.79 30.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.517 ' C ' ' HD1' ' A' ' 58' ' ' PHE . 8.3 p -135.13 127.33 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.422 0.629 . . . . 0.0 111.042 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.517 ' HD1' ' C ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -129.55 143.09 50.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 175.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -68.53 171.68 7.19 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.565 159.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -171.63 133.05 0.76 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.132 0.491 . . . . 0.0 109.823 -161.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.493 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 41.4 p90 -158.28 -177.48 6.58 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.665 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 55.0 mtmt -131.7 142.75 49.89 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.931 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.686 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 34.0 mt-10 -131.06 175.01 9.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.548 -0.751 . . . . 0.0 108.983 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.906 HD11 ' HB3' ' A' ' 78' ' ' LYS . 9.5 tt -95.53 134.9 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.411 1.1 . . . . 0.0 112.234 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.812 HG21 ' HG3' ' A' ' 81' ' ' LYS . 32.1 m -135.15 -174.4 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.166 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 4.2 p-10 -99.88 165.53 11.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 77' ' ' GLU . . . -142.05 -177.16 0.63 Allowed Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -167.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HD2' ' HD2' ' A' ' 71' ' ' ARG . 58.9 Cg_endo -83.94 148.7 12.19 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.812 1.675 . . . . 0.0 111.236 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -78.29 2.55 18.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.692 -172.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 68' ' ' PRO . 26.1 p-10 -92.07 7.85 40.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.315 0.579 . . . . 0.0 110.825 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.726 ' HD2' ' HD2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -69.24 171.64 6.39 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.633 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 68.6 Cg_exo -53.15 178.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.403 2.735 . . . . 0.0 114.297 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.38 81.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.834 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.457 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 42.5 p-90 -81.37 -39.48 24.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.864 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 44.9 ttm -77.04 115.47 48.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.534 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 74' ' ' TRP . 76.9 Cg_endo -109.3 -155.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.678 2.919 . . . . 0.0 112.026 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.808 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . 4.6 pt-20 -52.11 -59.65 4.12 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.769 167.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.906 ' HB3' HD11 ' A' ' 64' ' ' ILE . 18.6 mmtp -76.64 114.0 14.9 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.195 -172.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -163.79 -178.42 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.29 -175.018 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' ILE . 2.8 p -73.75 158.54 34.43 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.177 0.513 . . . . 0.0 111.968 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.812 ' HG3' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -162.23 136.15 4.87 Favored Pre-proline 0 C--O 1.22 -0.486 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -171.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.665 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 76.3 Cg_exo -52.4 153.98 12.4 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.87 2.38 . . . . 0.0 113.9 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.686 ' CE1' ' HB2' ' A' ' 63' ' ' GLU . 70.2 m-85 -165.93 157.41 13.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.624 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -165.21 169.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -166.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' H ' HG12 ' A' ' 84' ' ' VAL . 59.4 tttp -171.17 98.93 0.21 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.599 0.238 . . . . 0.0 110.519 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.481 ' HE3' HD11 ' A' ' 89' ' ' ILE . 67.2 tttt -53.02 128.26 26.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.523 170.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 3.4 pm0 -130.85 -5.78 4.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.562 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' N ' ' A' ' 89' ' ' ILE . 8.6 ttp180 -171.24 174.56 4.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.37 -166.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.481 HD11 ' HE3' ' A' ' 86' ' ' LYS . 17.4 mm -136.1 137.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.41 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -111.14 176.82 4.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.798 0.809 . . . . 0.0 111.579 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -103.29 169.09 8.75 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.894 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 53' ' ' LYS . 13.7 mt -76.85 162.09 27.9 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.488 ' HB3' HH12 ' A' ' 9' ' ' ARG . 5.8 tp10 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 120.838 0.351 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.51 147.76 26.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m -64.67 126.62 28.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.163 0.506 . . . . 0.0 110.649 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.6 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 27.7 mmm180 -92.76 137.5 32.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.343 1.068 . . . . 0.0 111.208 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 50' ' ' ARG . 1.1 m-80 -106.73 116.65 32.3 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.85 -1.977 . . . . 0.0 111.301 -175.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.6 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 91.0 m-85 -129.99 177.32 7.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.567 1.175 . . . . 0.0 112.422 -174.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.889 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 35.2 t -147.68 149.94 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.521 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.8 tp -96.83 158.33 15.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.646 HH11 HG21 ' A' ' 55' ' ' VAL . 49.4 mtp180 -124.79 147.19 48.84 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 12.8 t70 -69.65 -167.65 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.9 0.318 . . . . 0.0 111.015 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 26.3 mm-40 -61.83 -39.59 92.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 111.435 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.79 -37.61 22.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.474 0.654 . . . . 0.0 109.702 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 9' ' ' ARG . . . 132.51 45.0 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 118.721 -1.705 . . . . 0.0 112.063 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -85.4 -97.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -173.95 137.23 0.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 88.1 m-70 -144.6 166.25 25.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.154 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 34.53 -171.86 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.86 110.89 7.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.792 -1.704 . . . . 0.0 106.638 163.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.04 106.11 16.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.871 1.319 . . . . 0.0 113.364 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.0 p -91.08 117.29 29.48 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.877 170.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.66 169.5 24.59 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 113.776 -1.557 . . . . 0.0 111.947 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.82 -11.28 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.655 0.741 . . . . 0.0 110.293 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -160.82 147.12 11.52 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.391 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 53.8 Cg_exo -43.51 -42.56 11.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.904 . . . . 0.0 113.02 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -60.31 -35.22 75.1 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.457 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 86.2 mm-40 -75.92 -39.03 57.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.631 0.729 . . . . 0.0 109.969 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.5 -33.05 75.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.259 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.8 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -83.26 -26.78 30.4 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.39 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 8.3 tt -64.05 -63.9 1.03 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 172.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 66.6 mmtt -31.99 -27.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.058 164.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.91 -37.67 12.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.54 0.686 . . . . 0.0 110.527 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.46 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -69.71 -8.66 49.77 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.716 1.206 . . . . 0.0 113.237 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' OD1' ' HG2' ' A' ' 82' ' ' PRO . 3.1 m-20 -61.96 -51.71 66.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.72 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -63.83 -56.79 12.77 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.914 174.677 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 34' ' ' ARG . . . 83.19 -94.19 1.76 Allowed Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.289 151.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.4 m 63.66 36.77 10.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.217 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.9 159.34 25.98 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.663 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.5 p -125.27 -177.55 3.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.724 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.7 mtmm -72.12 -25.96 61.94 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.62 -28.32 56.06 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.975 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.78 64.53 8.47 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.31 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 7.1 Cg_exo -64.03 134.94 45.17 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.967 1.778 . . . . 0.0 111.182 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.56 176.7 5.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.523 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.554 HG12 ' HE3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -123.77 136.65 59.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -176.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -138.27 136.71 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.739 172.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.57 ' HG3' HG22 ' A' ' 57' ' ' VAL . 66.8 ttt180 -112.08 113.05 25.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.922 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.527 HD11 ' CA ' ' A' ' 28' ' ' ALA . 23.3 mt -101.36 104.52 15.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.153 0.978 . . . . 0.0 112.205 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.889 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 68.7 ttt180 -69.93 153.77 42.83 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.25 172.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.681 ' HG2' ' H ' ' A' ' 51' ' ' GLY . 50.4 tt0 -122.07 129.47 52.42 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -94.61 18.74 10.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.51 0.671 . . . . 0.0 110.507 176.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.681 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -110.98 -58.1 0.48 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.418 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 6.4 p -93.06 175.34 6.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 0.0 110.877 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -93.72 11.3 29.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.542 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 91' ' ' LYS . 94.7 mttt -108.52 133.67 52.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.837 -174.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.892 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 93.6 t -101.59 128.27 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.504 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 22.8 m-70 -94.51 128.63 41.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.57 HG22 ' HG3' ' A' ' 46' ' ' ARG . 39.7 t -111.7 123.54 67.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.043 0.449 . . . . 0.0 110.686 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 1.06 ' HB3' HG12 ' A' ' 84' ' ' VAL . 34.6 m-85 -131.03 126.86 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.266 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.67 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 19.4 mttp -71.13 154.93 41.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.392 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.593 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . . . -135.35 147.06 48.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.494 -170.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.724 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 18.9 p90 -161.51 -179.38 7.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 45.0 mtmt -138.28 136.05 36.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.742 ' O ' ' HA ' ' A' ' 80' ' ' SER . 56.1 mm-40 -151.42 173.15 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.409 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.461 HG23 ' HA ' ' A' ' 79' ' ' ILE . 4.1 mp -109.37 83.34 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.973 0.892 . . . . 0.0 108.609 168.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.715 ' C ' ' HB2' ' A' ' 78' ' ' LYS . 27.2 m -88.59 -162.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -134.02 90.6 2.71 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.898 -168.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 77' ' ' GLU . . . -70.79 154.12 94.47 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.048 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 15.3 Cg_exo -70.71 -158.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.411 2.741 . . . . 0.0 113.565 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -75.05 -23.41 58.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -84.22 17.2 2.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 18.0 ptt-85 -72.89 170.56 13.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.121 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.66 168.45 24.79 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.899 2.399 . . . . 0.0 112.437 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.7 -20.82 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.379 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.94 -27.09 33.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.524 ' HG2' ' HD2' ' A' ' 76' ' ' PRO . 29.7 ttm -94.56 145.02 28.9 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 75' ' ' MET . 14.0 Cg_exo -67.87 -176.96 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.923 1.748 . . . . 0.0 109.849 167.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.626 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 34.9 mt-10 -44.99 -67.37 0.29 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.715 ' HB2' ' C ' ' A' ' 65' ' ' VAL . 20.8 mmtp -151.1 -177.18 5.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.247 167.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.636 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -157.45 173.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.292 -161.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.742 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 12.4 p -64.59 85.53 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.828 1.33 . . . . 0.0 110.855 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.914 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -117.84 167.13 11.79 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.03 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.685 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 7.4 Cg_exo -77.73 128.19 9.21 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.523 2.815 . . . . 0.0 110.57 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.914 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 20.5 m-85 -126.47 123.56 38.11 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.06 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -119.38 128.8 75.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.344 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.9 pttt -106.05 169.9 8.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.6 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -109.44 106.43 16.18 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -171.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HG2' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.57 -6.82 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.829 -172.259 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -176.4 161.94 2.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 12.2 mm -131.81 141.37 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.512 0.673 . . . . 0.0 110.407 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.892 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 69.3 mm-40 -128.1 178.6 6.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.603 -173.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 53.3 mtmt -144.53 169.17 18.48 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.163 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt -84.96 168.12 15.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--N 1.315 -0.93 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.581 -179.223 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 121.306 0.574 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -134.91 -178.2 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 t -63.99 159.31 20.31 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 5.0 ptm180 -93.86 125.47 38.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.26 1.029 . . . . 0.0 111.766 -171.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.8 145.75 25.95 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.389 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.671 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 39.7 m-85 -128.9 170.86 12.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.889 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.747 HG23 ' HG2' ' A' ' 50' ' ' ARG . 15.9 t -130.1 142.41 43.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.631 ' HB3' ' O ' ' A' ' 16' ' ' HIS . 4.0 tp -76.68 124.95 28.42 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.889 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.768 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 6.8 mmm180 -96.62 130.17 43.87 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 14' ' ' ASN . 42.7 p30 -88.34 -171.61 3.43 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.788 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -42.36 -46.69 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.58 -37.23 25.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 111.174 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 9' ' ' ARG . . . 123.0 36.55 0.66 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.731 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 27.2 m-80 -85.98 -178.21 6.5 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.809 0.337 . . . . 0.0 110.294 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' HG11 ' A' ' 7' ' ' VAL . 43.7 mt-10 -105.13 117.99 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.527 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.631 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 79.6 m-70 -137.57 104.27 5.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.911 0.862 . . . . 0.0 111.278 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.75 147.22 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.59 161.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.628 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 80.7 m-85 -150.71 159.59 44.42 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -170.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.0 p -141.25 158.2 44.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.777 0.323 . . . . 0.0 111.254 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.8 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.86 162.61 27.68 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.75 ' H ' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -87.78 0.41 55.8 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.919 0.866 . . . . 0.0 108.889 173.22 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.67 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 30.2 tt0 -161.33 151.58 14.58 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.273 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.67 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 7.9 Cg_exo -43.12 -60.35 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.559 2.173 . . . . 0.0 112.756 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.415 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 38.5 ttt180 -33.89 -42.29 0.11 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.249 167.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.68 -30.35 59.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 117.938 0.336 . . . . 0.0 111.592 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . -63.01 -63.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.906 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -41.05 -39.02 1.12 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.567 165.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.731 ' HB2' ' HA ' ' A' ' 26' ' ' GLN . 1.6 tp -61.78 -14.59 34.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.106 0.479 . . . . 0.0 111.228 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 60.0 mmtt -87.33 -55.45 3.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.61 -30.05 29.27 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.626 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -61.52 -29.5 70.03 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.663 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -62.82 2.15 0.33 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -110.12 -55.02 2.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.564 -162.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.03 -33.8 5.9 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 118.963 -1.589 . . . . 0.0 112.944 165.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 t 73.68 -3.86 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.023 0.529 . . . . 0.0 111.371 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.7 -140.39 0.42 Allowed Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 0.0 112.901 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -150.08 167.72 25.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 165.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -58.79 -31.5 68.47 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.4 0.619 . . . . 0.0 110.4 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.43 27.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.363 -173.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.91 70.42 8.61 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.441 0.639 . . . . 0.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.74 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 25.9 Cg_exo -62.15 166.87 11.82 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.712 2.275 . . . . 0.0 111.477 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -97.2 150.06 21.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.493 HD11 ' HD3' ' A' ' 59' ' ' LYS . 23.0 mm -96.17 102.45 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.895 0.855 . . . . 0.0 112.215 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.7 pp -118.98 142.05 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.076 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -129.32 131.72 46.98 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.773 165.275 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.92 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.4 mm? -90.3 161.12 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.735 0.779 . . . . 0.0 112.118 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.768 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . 18.7 ttp85 -125.01 133.23 53.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.35 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -82.66 72.9 9.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.203 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.747 ' HG2' HG23 ' A' ' 7' ' ' VAL . 35.8 mtp180 30.78 -90.14 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.884 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.61 3.01 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.198 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.842 HG21 ' HE2' ' A' ' 54' ' ' LYS . 54.7 p -138.35 166.29 24.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 110.171 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 92' ' ' LEU . 36.0 ttpt -112.44 36.46 3.39 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.842 ' HE2' HG21 ' A' ' 52' ' ' THR . 61.0 pttt -124.82 141.23 52.26 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.637 -176.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG21 ' HE ' ' A' ' 9' ' ' ARG . 10.8 t -124.83 144.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.759 0.314 . . . . 0.0 111.71 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.92 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 7.7 p80 -122.53 118.99 29.58 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.887 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.665 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . 60.8 t -85.1 119.83 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.925 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.956 ' HB3' HG12 ' A' ' 84' ' ' VAL . 8.1 m-85 -131.6 124.98 31.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.74 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 16.9 ttpt -85.57 122.57 29.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 84' ' ' VAL . . . -119.57 144.55 47.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -164.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 9.3 p90 -162.55 175.2 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 14.2 mtpp -142.0 107.47 5.05 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.915 173.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 63' ' ' GLU . 7.0 pt-20 177.4 89.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.039 0.936 . . . . 0.0 112.169 159.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.599 HG22 ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -170.28 102.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.242 -1.536 . . . . 0.0 111.951 167.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG11 ' HE3' ' A' ' 81' ' ' LYS . 2.1 m -142.97 148.51 19.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 120.706 1.594 . . . . 0.0 110.823 164.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.13 72.15 1.64 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.63 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB1' ' HG2' ' A' ' 71' ' ' ARG . . . -54.13 135.71 58.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.495 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.3 Cg_exo -78.28 -148.97 0.03 OUTLIER 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 123.915 3.077 . . . . 0.0 113.078 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -94.81 -42.03 8.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.461 173.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -71.02 31.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.913 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.526 ' HG2' ' HB1' ' A' ' 67' ' ' ALA . 97.9 mtt180 -62.91 162.67 20.35 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.449 0.642 . . . . 0.0 111.981 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 14.1 Cg_exo -72.61 151.11 52.12 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.463 2.775 . . . . 0.0 109.768 163.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.33 64.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.62 -171.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -88.42 -25.38 22.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.626 ' CG ' HG21 ' A' ' 79' ' ' ILE . 41.1 ttm -84.99 125.62 70.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -169.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 79' ' ' ILE . 60.2 Cg_endo -91.07 -162.48 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.253 2.635 . . . . 0.0 112.362 173.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -51.84 -68.84 0.14 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.924 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.5 mmmt -118.38 138.69 52.26 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.626 HG21 ' CG ' ' A' ' 75' ' ' MET . 0.7 OUTLIER -148.01 169.15 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-O 121.21 0.529 . . . . 0.0 109.645 -169.033 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.646 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 33.8 p -99.16 155.49 17.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.155 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.847 ' HE3' HG11 ' A' ' 65' ' ' VAL . 12.5 mmtp -158.34 150.14 17.12 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 52.3 Cg_exo -53.83 91.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 CA-C-N 121.455 1.555 . . . . 0.0 112.899 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.599 ' CE2' HG22 ' A' ' 64' ' ' ILE . 14.4 m-85 -89.78 142.58 27.55 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.267 1.032 . . . . 0.0 111.342 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.956 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -146.51 151.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.08 178.261 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -135.63 103.07 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.728 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 82.8 tttt -66.99 120.37 13.52 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.136 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.64 -15.05 7.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.606 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 2.6 ttm180 -166.95 171.61 11.03 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -170.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.606 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 10.4 mm -137.66 136.2 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.7 mm-40 -116.93 140.02 49.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -142.09 149.42 39.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.357 0.598 . . . . 0.0 111.399 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 40.6 mt -124.38 155.04 39.46 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 163.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.439 -0.977 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.417 -171.572 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 121.28 0.562 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 3' ' ' THR . 62.8 t30 -125.98 -158.92 0.88 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.222 -173.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.5 ' O ' ' HD2' ' A' ' 4' ' ' ARG . 26.3 m -60.6 162.25 6.71 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.941 0.496 . . . . 0.0 111.373 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.591 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 11.8 mmm180 -126.68 171.51 11.1 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 108.62 7.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 120.973 0.416 . . . . 0.0 110.42 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.591 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 13.8 m-85 -113.16 149.29 33.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.71 0.767 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.02 141.54 19.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.92 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.687 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 19.0 tp -92.59 156.37 17.16 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.426 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HG3' ' HD2' ' A' ' 48' ' ' ARG . 16.7 mtp85 -143.76 113.77 7.26 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.79 170.0 8.16 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.291 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -27.7 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 O-C-N 125.197 1.561 . . . . 0.0 113.048 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.88 -39.36 62.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.636 0.732 . . . . 0.0 111.236 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.05 33.94 6.71 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.485 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 84.8 m-20 -142.5 -174.7 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -82.02 154.19 25.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.583 0.706 . . . . 0.0 110.831 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 9.6 m-70 -135.06 -165.18 1.63 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.404 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -46.3 157.64 0.42 Allowed Glycine 0 CA--C 1.518 0.266 0 O-C-N 123.983 0.802 . . . . 0.0 114.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.55 105.71 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.639 0.733 . . . . 0.0 109.481 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 61.6 m-85 -87.28 113.96 23.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.548 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -95.56 141.88 28.56 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.082 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 164.76 37.97 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -174.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -74.0 -19.29 60.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 118.616 1.208 . . . . 0.0 111.259 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 26' ' ' GLN . 26.6 pt20 -157.94 168.89 11.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.7 Cg_exo -45.8 -60.76 0.74 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.686 2.257 . . . . 0.0 112.724 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -39.66 -49.66 2.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.239 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 23' ' ' GLN . 13.1 mm100 -73.12 -24.42 60.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.701 0.286 . . . . 0.0 111.401 -174.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 30' ' ' LYS . . . -74.37 -41.12 61.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.415 0.626 . . . . 0.0 109.666 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -68.98 -35.72 77.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.008 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 9.7 tt -53.78 -55.39 26.91 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 69.6 mmtt -43.7 -43.48 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -73.32 -23.43 60.25 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.85 -0.531 . . . . 0.0 111.549 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -68.0 -11.88 59.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.602 0.715 . . . . 0.0 110.686 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.7 m120 -78.88 3.0 18.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.658 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.4 mmp_? -89.59 -28.37 19.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.93 38.18 49.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.677 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.622 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . 13.8 m -97.48 5.27 49.9 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.173 0.511 . . . . 0.0 109.932 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.25 157.07 26.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.178 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 p -128.45 -177.47 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 12.8 tptm -61.16 -31.8 71.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.997 0.427 . . . . 0.0 110.732 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -38.51 25.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.68 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.24 75.1 75.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 121.116 0.484 . . . . 0.0 110.636 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.698 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 23.3 Cg_exo -67.29 158.12 58.47 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.71 2.274 . . . . 0.0 113.333 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.622 ' OD1' ' HB2' ' A' ' 36' ' ' SER . 15.8 m-20 -71.91 94.12 1.41 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.847 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 tp -72.92 95.65 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.983 0.897 . . . . 0.0 109.372 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.571 HD11 ' HB1' ' A' ' 28' ' ' ALA . 6.2 pt -109.58 152.23 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.914 -172.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.715 ' HB3' HG11 ' A' ' 55' ' ' VAL . 74.3 mtp180 -114.55 118.53 34.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 47' ' ' LEU . 2.4 mm? -111.13 130.87 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.637 0.653 . . . . 0.0 109.412 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.712 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -122.3 118.76 29.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -77.97 107.19 10.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -47.37 102.61 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.296 0 O-C-N 124.019 0.824 . . . . 0.0 111.481 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.4 -25.26 3.01 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.102 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.8 p -92.49 167.47 11.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.789 ' HA ' HD22 ' A' ' 92' ' ' LEU . 24.7 ttmm -111.77 8.97 20.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.216 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -136.89 145.16 44.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.183 0.516 . . . . 0.0 110.96 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.764 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.1 t -101.71 136.41 33.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.958 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 4.4 m-70 -101.0 128.71 46.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 88' ' ' ARG . 12.8 p -114.31 130.55 68.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.549 0.69 . . . . 0.0 110.45 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.753 ' HB2' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -143.13 136.26 28.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.13 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.698 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 53.3 mttp -71.15 109.45 5.21 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.231 163.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.051 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -94.6 145.85 24.54 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 83' ' ' PHE . 13.6 p90 -170.15 146.61 3.02 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.874 ' HE3' ' HG3' ' A' ' 82' ' ' PRO . 11.8 mtpt -101.47 136.23 41.67 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.713 ' O ' ' HA ' ' A' ' 80' ' ' SER . 3.7 tp10 -163.73 158.95 20.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 112.036 -166.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.803 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 39.3 mt -103.54 130.61 53.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.42 150.47 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.484 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.94 93.82 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.914 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HB1' ' HD3' ' A' ' 72' ' ' PRO . . . -51.25 136.27 30.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.404 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HG2' ' HG3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -4.9 -148.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 1 C-N-CA 127.836 5.69 . . . . 0.0 118.22 -165.4 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -51.88 -57.57 8.99 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.503 173.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -132.85 -42.83 0.9 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.304 168.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 71' ' ' ARG . 8.4 mmt180 -144.68 148.04 38.15 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.217 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 1.035 ' HG2' ' HB3' ' A' ' 75' ' ' MET . 5.5 Cg_exo -90.98 166.58 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.434 2.756 . . . . 0.0 108.31 147.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.78 58.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.636 0.731 . . . . 0.0 111.198 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.546 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 58.3 p-90 -109.29 -33.71 6.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.389 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 1.035 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttp -99.44 144.39 28.18 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -167.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' HD2' HG21 ' A' ' 79' ' ' ILE . 7.0 Cg_exo -73.52 157.18 49.28 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.338 2.692 . . . . 0.0 112.115 169.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 1.7 pm0 -44.19 -48.38 9.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -138.4 153.67 48.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 175.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.803 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -159.66 -178.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -169.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.713 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 23.1 t -150.72 84.66 1.35 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.394 168.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 26.2 mmtt -97.67 158.16 33.49 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.274 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.874 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 19.9 Cg_exo -63.38 92.44 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.704 1.603 . . . . 0.0 109.31 159.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' HE2' ' O ' ' A' ' 63' ' ' GLU . 35.2 m-85 -78.27 -179.52 6.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.571 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.753 HG12 ' HB2' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -160.92 162.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 79.1 tttt -159.23 98.51 1.43 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.851 0.834 . . . . 0.0 110.709 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HB2' ' HD2' ' A' ' 58' ' ' PHE . 11.9 tmtt? -58.75 113.55 2.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.379 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 12.0 pt-20 -119.63 5.97 11.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.029 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.477 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 39.2 ttp-105 176.24 170.15 0.43 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.015 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -120.24 141.12 41.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.764 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.2 mm-40 -112.14 166.66 11.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.293 0.568 . . . . 0.0 111.174 -173.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -82.12 159.91 23.26 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.789 HD22 ' HA ' ' A' ' 53' ' ' LYS . 12.5 tp -80.65 140.4 35.69 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--N 1.305 -1.332 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -169.345 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 121.094 0.473 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -154.78 133.31 11.99 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 1.013 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 91.5 m -73.53 149.13 42.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.181 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.599 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 1.3 ptm180 -132.77 155.48 48.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -107.15 145.15 32.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.409 0.55 . . . . 0.0 110.306 -174.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.533 ' HB3' HD12 ' A' ' 47' ' ' LEU . 58.5 m-85 -126.49 158.82 35.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.157 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.972 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -127.85 125.12 64.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.742 0.782 . . . . 0.0 109.166 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.768 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.5 OUTLIER -69.67 142.86 53.33 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.923 -1.489 . . . . 0.0 111.581 -168.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.05 142.1 28.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.225 171.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -88.87 -162.07 0.82 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.24 -38.65 66.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.345 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -86.19 -38.95 17.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 9' ' ' ARG . . . 121.25 30.26 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.705 171.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 47.8 m-80 -70.92 128.67 36.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.239 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.41 107.18 2.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.695 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 78.9 m-70 -103.11 -162.8 0.94 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.558 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' A' ' 16' ' ' HIS . . . -56.56 157.1 10.99 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -170.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.9 t -80.62 140.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 12.9 m-85 -124.24 159.25 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 p -128.61 145.75 51.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.092 0.472 . . . . 0.0 110.919 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -178.57 144.01 6.16 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.9 ptmt -70.09 -7.88 44.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.054 0.927 . . . . 0.0 111.549 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.599 ' HA ' ' HD3' ' A' ' 4' ' ' ARG . 10.0 pt20 -159.29 149.71 15.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.14 174.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.29 -8.46 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.661 3.574 . . . . 0.0 115.079 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.433 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 55.9 ttt180 -96.69 -25.26 15.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.62 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 14.7 mm100 -86.84 -8.29 57.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.883 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . . . -89.69 -48.69 7.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.49 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.275 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 26' ' ' GLN . 1.5 tp -57.2 -56.08 26.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.184 173.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 73.7 mmtt -61.54 -5.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.779 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.34 -40.15 9.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 1.024 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -72.97 -11.18 60.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.162 0.982 . . . . 0.0 109.738 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -83.75 -2.22 55.82 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.37 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -107.43 15.62 24.71 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.12 -167.53 24.76 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -172.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 22.9 m -106.04 -33.21 7.96 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.512 0.156 . . . . 0.0 111.291 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 59.16 171.24 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.11 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 40' ' ' ALA . 6.4 m -156.66 128.33 7.17 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 84.7 tttt -65.21 -16.88 64.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.145 0.498 . . . . 0.0 111.965 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' H ' HG22 ' A' ' 38' ' ' THR . . . -85.26 -22.04 28.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.71 71.96 2.45 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 121.637 0.732 . . . . 0.0 110.283 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 69.8 Cg_exo -54.77 170.0 0.71 Allowed 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.771 2.981 . . . . 0.0 113.943 -176.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.72 123.14 36.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.1 mm -81.55 120.53 33.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.147 0.499 . . . . 0.0 111.211 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.25 141.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.612 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 81.6 mtp180 -113.54 122.56 47.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -91.69 127.53 37.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 70.0 ttt-85 -116.66 99.79 7.37 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 85.1 tt0 -70.69 112.23 6.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.972 ' HG2' HG12 ' A' ' 7' ' ' VAL . 27.0 mtp180 -47.46 -15.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.05 -38.25 6.48 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.755 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 75.1 p -93.85 165.25 12.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.107 0.48 . . . . 0.0 111.561 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -98.85 7.68 45.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.535 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.779 ' HA ' ' CB ' ' A' ' 91' ' ' LYS . 44.9 mtpt -125.24 148.11 48.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 111.215 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.812 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 26.7 t -93.16 135.73 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.713 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.649 ' HA ' HD13 ' A' ' 89' ' ' ILE . 31.7 m-70 -104.18 100.33 10.07 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.664 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.612 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -93.03 134.85 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 25' ' ' ARG . 2.8 m-85 -142.56 118.93 10.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.044 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 15.3 ptpt -67.31 114.57 6.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.531 -1.268 . . . . 0.0 112.251 159.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.024 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -103.07 151.95 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.46 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.59 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 29.0 p90 -161.29 -172.68 3.5 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 44.8 mtmt -136.81 136.39 38.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.669 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 80' ' ' SER . 20.4 mm-40 -137.64 129.38 28.52 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.586 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.802 ' HB ' ' HB3' ' A' ' 80' ' ' SER . 3.3 tt -100.41 109.17 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.843 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.08 144.64 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.767 0.794 . . . . 0.0 110.382 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 21.7 t70 -74.72 103.56 5.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.936 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB1' ' CB ' ' A' ' 71' ' ' ARG . . . -70.19 133.75 87.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.856 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 58.1 Cg_endo -95.47 -160.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.314 3.343 . . . . 0.0 113.333 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -54.61 -56.29 20.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.281 0.562 . . . . 0.0 110.304 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.02 36.26 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.808 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 17.5 ptt180 -94.09 144.5 28.17 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.766 -0.584 . . . . 0.0 109.553 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 49.7 Cg_exo -59.16 159.83 21.03 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.965 2.444 . . . . 0.0 112.2 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.79 8.26 1.59 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.128 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -121.96 -36.44 3.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.588 ' CG ' HD11 ' A' ' 79' ' ' ILE . 36.8 ttm -72.41 114.99 34.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.987 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 81.6 Cg_endo -89.69 -177.91 1.54 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 123.138 2.559 . . . . 0.0 113.704 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 4.3 mm-40 -37.12 -52.42 1.0 Allowed 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 112.235 -2.257 . . . . 0.0 114.015 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -155.34 113.14 3.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.87 0.843 . . . . 0.0 112.059 176.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.613 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -150.0 160.04 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.175 175.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.802 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 14.1 p -110.03 93.41 4.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 160.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.669 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 21.2 mmmt -77.36 156.1 81.47 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.23 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.745 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 4.6 Cg_exo -68.32 90.79 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.254 1.302 . . . . 0.0 110.2 169.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.669 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 23.0 m-85 -75.45 175.09 8.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 122.048 0.928 . . . . 0.0 112.081 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 60' ' ' ALA . 1.8 m -165.16 158.68 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.325 -169.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 6.7 tmtm? -148.83 114.15 5.55 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -75.39 123.67 25.79 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.621 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -101.16 -25.92 13.85 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.621 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 8.6 ptt180 -175.73 -173.11 0.58 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.315 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 56' ' ' HIS . 16.2 mm -131.96 103.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.812 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 30.8 mt-10 -118.24 112.66 20.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 118.868 -1.133 . . . . 0.0 113.863 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.779 ' CB ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 mmmt -144.73 170.75 15.5 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.359 163.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.504 ' H ' ' HD2' ' A' ' 91' ' ' LYS . 79.5 mt -119.88 175.11 6.05 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 112.822 -1.99 . . . . 0.0 110.462 -172.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.525 -176.193 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 121.225 0.536 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -104.57 6.41 34.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.078 0.942 . . . . 0.0 109.642 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -78.1 121.28 24.08 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.749 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.7 ptm180 -85.67 145.88 27.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.452 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.2 m-20 -84.96 147.09 26.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.554 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 67.2 m-85 -135.59 150.32 49.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.89 136.47 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.1 tp -82.25 124.94 30.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HD3' ' HE ' ' A' ' 46' ' ' ARG . 2.6 mtp180 -101.21 166.92 10.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.513 1.149 . . . . 0.0 114.031 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -134.46 178.1 7.25 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.326 -2.215 . . . . 0.0 108.349 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.02 -35.84 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.62 -39.87 11.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -172.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.44 32.83 1.08 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.845 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -87.04 -173.57 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.293 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.88 107.8 16.52 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.289 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 85.4 m-70 -102.35 75.99 1.52 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.761 0.791 . . . . 0.0 110.053 175.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.65 153.01 0.98 Allowed Glycine 0 C--N 1.302 -1.348 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.865 -172.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.43 139.08 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.514 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 32.6 m-85 -123.89 151.02 43.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.1 p -114.04 145.42 41.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 173.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA3' ' HB2' ' A' ' 27' ' ' ALA . . . -154.81 135.71 4.81 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.893 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -71.83 -9.08 57.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.691 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 37.4 tt0 -160.23 149.01 13.64 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.79 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.691 ' HD2' ' HG2' ' A' ' 23' ' ' GLN . 75.0 Cg_exo -43.85 -9.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.956 3.771 . . . . 0.0 115.514 173.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.601 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 26.0 ttt-85 -96.52 -45.2 6.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 43.7 mm-40 -70.02 -16.86 63.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.979 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . . . -89.02 -19.08 26.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -94.37 -27.83 15.86 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.538 ' HB3' ' HA ' ' A' ' 26' ' ' GLN . 7.8 tt -64.89 -46.6 81.08 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.642 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 3.4 mmmp? -62.78 -13.02 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.618 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -88.32 -23.79 23.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.622 0.725 . . . . 0.0 109.046 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.913 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -68.1 -10.47 54.28 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.752 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -92.75 2.77 56.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.339 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' A' ' 34' ' ' ARG . 11.8 mmt85 -100.41 15.17 28.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -173.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 174.5 -147.12 8.96 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -170.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.533 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 72.1 m -149.01 -41.87 0.15 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.008 -1.096 . . . . 0.0 109.166 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.79 5.32 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -168.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.1 p -151.99 177.58 10.32 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.442 ' HE3' ' OE2' ' A' ' 63' ' ' GLU . 20.5 ttmt -67.44 -31.89 72.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.702 0.763 . . . . 0.0 109.859 172.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.02 -39.47 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.503 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.62 75.42 73.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.79 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.422 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 35.9 Cg_exo -63.53 158.54 45.12 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.37 2.047 . . . . 0.0 111.549 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 45' ' ' ILE . 5.2 t70 -88.69 72.68 8.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.587 HG12 ' HG2' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -54.61 130.59 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.396 -174.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.538 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -128.15 152.98 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.84 0.828 . . . . 0.0 110.867 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.771 ' NH1' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.59 127.46 53.05 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.774 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -118.18 132.55 56.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.632 ' HB2' HH21 ' A' ' 46' ' ' ARG . 41.4 ttt180 -131.03 127.81 39.02 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 30.7 tt0 -71.3 149.77 45.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -67.89 116.18 8.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.351 0.596 . . . . 0.0 111.182 -165.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -8.84 78.92 Favored Glycine 0 C--N 1.318 -0.437 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.247 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 23.1 p -96.86 170.96 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.926 0.393 . . . . 0.0 111.479 -174.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.944 ' H ' ' HB3' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.55 -8.19 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.229 171.377 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.826 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 57.3 mttp -49.28 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 111.784 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.771 HG13 ' NH1' ' A' ' 46' ' ' ARG . 14.3 t -110.1 101.9 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.774 ' CE1' ' HB3' ' A' ' 47' ' ' LEU . 4.0 p80 -111.3 128.03 55.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.365 172.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' A' ' 46' ' ' ARG . 43.0 t -109.17 115.76 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.817 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.96 131.82 53.37 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.361 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.587 ' HG2' HG12 ' A' ' 44' ' ' ILE . 30.8 mtpt -72.83 117.83 15.02 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.688 1.131 . . . . 0.0 110.869 164.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.913 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -108.61 137.81 45.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.247 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -149.99 -174.43 4.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 32' ' ' ALA . 25.0 mtpt -143.04 122.63 13.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.662 ' HG2' ' CE2' ' A' ' 83' ' ' PHE . 12.1 pt-20 -149.62 174.03 13.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.805 HD11 ' HB3' ' A' ' 78' ' ' LYS . 8.2 tt -115.47 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.33 145.94 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.268 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.673 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 11.2 p-10 -80.3 113.54 18.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.967 170.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.765 ' HB3' ' HA ' ' A' ' 77' ' ' GLU . . . -77.41 129.99 75.8 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.073 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -79.81 -177.33 3.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.955 2.437 . . . . 0.0 111.511 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -49.94 -58.64 5.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 110.04 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.51 31.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 75' ' ' MET . 14.7 ptt85 -64.59 151.14 92.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 118.654 0.661 . . . . 0.0 110.068 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.52 147.07 95.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 111.601 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.68 5.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.449 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.0 p-90 -113.87 -24.72 8.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.655 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.612 ' HG2' HG12 ' A' ' 79' ' ' ILE . 22.8 ttp -101.68 118.94 58.58 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' HG21 ' A' ' 79' ' ' ILE . 12.8 Cg_exo -65.87 144.91 78.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.565 2.177 . . . . 0.0 113.344 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.765 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . 31.0 mp0 -31.43 -54.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.805 1.316 . . . . 0.0 112.322 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.805 ' HB3' HD11 ' A' ' 64' ' ' ILE . 29.5 mmtp -112.22 134.63 53.65 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.462 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.612 HG12 ' HG2' ' A' ' 75' ' ' MET . 1.1 pp -155.22 146.73 13.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.826 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 t -122.5 121.73 37.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 6.2 tppt? -154.64 145.76 16.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.472 -168.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 62' ' ' LYS . 51.0 Cg_exo -52.63 146.86 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.558 1.505 . . . . 0.0 109.474 156.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.758 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 11.2 m-85 -144.44 149.37 35.91 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -169.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -153.01 150.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 19.4 tptm -141.79 105.97 4.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.215 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HE3' HD11 ' A' ' 89' ' ' ILE . 86.8 tttt -73.32 101.89 3.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 4.5 pt-20 -109.63 -36.73 5.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.705 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.478 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 23.9 ttt180 -128.35 152.94 47.57 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.235 0.54 . . . . 0.0 110.455 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.541 HD11 ' HE3' ' A' ' 86' ' ' LYS . 25.5 mm -143.98 159.56 15.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.442 -176.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 20.0 mm-40 -142.26 179.17 7.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 9.9 ptpt -77.39 113.33 15.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.148 0.975 . . . . 0.0 112.322 -171.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.826 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 24.0 mt -76.25 171.59 14.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.616 -1.629 . . . . 0.0 112.239 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.944 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 7.4 tt0 . . . . . 0 C--O 1.244 0.808 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.102 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 8.6 p . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.156 0.503 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 66.3 t30 -115.56 178.73 4.2 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 14.3 m -61.72 144.26 54.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.742 0.306 . . . . 0.0 111.274 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.674 HH22 ' HG3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -148.94 154.46 39.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -96.76 136.5 37.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.84 0.352 . . . . 0.0 111.759 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.451 ' HZ ' ' NH2' ' A' ' 4' ' ' ARG . 96.7 m-85 -133.14 129.72 38.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.428 0.632 . . . . 0.0 111.73 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.782 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 3.1 t -103.53 100.83 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.978 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.495 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -61.89 144.8 54.4 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.921 173.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 9.6 ptm85 -132.49 132.53 42.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 170.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -115.92 169.44 9.23 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.788 -165.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -23.62 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 O-C-N 126.452 2.345 . . . . 0.0 114.38 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.87 -37.19 86.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.62 35.15 2.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 m120 -138.36 170.54 15.84 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -86.65 156.17 20.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.262 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.473 ' HB2' HD23 ' A' ' 8' ' ' LEU . 27.1 m-70 -142.52 -164.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -38.87 128.11 1.95 Allowed Glycine 0 C--N 1.339 0.697 0 O-C-N 124.473 1.108 . . . . 0.0 113.52 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -80.92 104.52 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.278 1.037 . . . . 0.0 108.231 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.461 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 39.5 m-85 -88.46 113.11 23.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.501 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -88.39 136.15 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.531 -1.668 . . . . 0.0 107.945 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.62 140.66 6.3 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 1' ' ' SER . 30.3 mtmm -76.96 -1.27 27.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.476 0.638 . . . . 0.0 111.144 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.712 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 28.3 tt0 -155.61 146.68 16.53 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.712 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 85.3 Cg_exo -47.07 -55.12 4.17 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.456 2.104 . . . . 0.0 112.383 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -45.16 -28.29 0.73 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.613 ' HG2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 mm100 -82.23 -26.22 33.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 19' ' ' PHE . . . -80.14 -40.85 26.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.708 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -58.57 -36.2 73.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.363 169.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.404 HD13 HE22 ' A' ' 26' ' ' GLN . 2.6 tt -66.44 -53.0 40.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -50.31 -19.44 0.82 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.903 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.717 ' O ' ' HG2' ' A' ' 34' ' ' ARG . . . -95.49 -41.09 9.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.475 0.58 . . . . 0.0 109.73 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.525 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -59.79 -20.11 54.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.267 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -56.84 -40.15 75.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.991 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 7.4 ptm180 -84.55 -23.61 29.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.89 0.376 . . . . 0.0 110.937 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.98 70.69 2.87 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.305 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 m -76.67 60.36 1.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.091 0.472 . . . . 0.0 112.196 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.72 40.43 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.3 p -132.09 166.79 20.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.503 0.651 . . . . 0.0 109.74 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -66.54 -14.27 62.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 0.0 111.55 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.97 -18.56 21.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.343 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.447 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -151.78 63.48 5.36 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.976 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 13.3 Cg_exo -68.45 151.98 75.44 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.704 2.269 . . . . 0.0 112.621 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -77.54 122.11 24.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.719 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.777 HD11 ' HE3' ' A' ' 59' ' ' LYS . 17.5 mm -71.22 109.61 3.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.42 0.629 . . . . 0.0 111.064 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 58' ' ' PHE . 2.7 pp -113.75 137.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.515 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.513 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 24.1 mtp180 -124.38 104.87 9.02 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.01 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.578 HD11 ' N ' ' A' ' 28' ' ' ALA . 86.0 mt -88.65 131.0 35.17 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.327 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.782 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -84.27 154.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.452 0.644 . . . . 0.0 109.547 174.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.507 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 34.6 tt0 -116.96 76.98 1.07 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.623 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.671 ' HG2' HG23 ' A' ' 7' ' ' VAL . 6.3 mtp180 -30.66 119.18 0.18 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.059 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.65 -24.21 24.38 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.127 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 10.6 p -114.25 -172.21 2.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.182 0.491 . . . . 0.0 110.201 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 18.8 pttm -123.17 27.22 7.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 109.534 170.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -110.08 138.18 46.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.411 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG23 ' HA ' ' A' ' 92' ' ' LEU . 39.9 t -109.8 127.47 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.476 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.649 ' HA ' HD13 ' A' ' 89' ' ' ILE . 62.9 m-70 -88.49 111.71 22.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.711 0.291 . . . . 0.0 110.784 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 46' ' ' ARG . 38.5 t -97.09 108.12 21.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.479 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.846 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -120.06 122.48 41.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.155 172.415 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.976 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 44.1 mttp -68.76 111.77 5.07 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.1 163.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.687 ' HB2' HG13 ' A' ' 84' ' ' VAL . . . -92.92 134.88 34.65 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.011 174.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.591 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 41.6 p90 -144.46 -172.32 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 47.8 mttp -133.8 139.77 46.5 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.208 0.527 . . . . 0.0 110.387 174.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.768 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 18.1 mm-40 -133.09 140.04 47.45 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.365 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.78 143.08 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 79' ' ' ILE . 5.5 m -145.96 -175.35 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.141 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.9 p-10 -162.91 124.17 2.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 168.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -131.74 150.01 75.05 Favored Pre-proline 0 C--N 1.315 -0.925 0 O-C-N 121.613 -0.68 . . . . 0.0 110.675 -167.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.4 Cg_exo -78.0 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.294 1.996 . . . . 0.0 113.833 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 71' ' ' ARG . 59.6 mmtt -93.98 -51.23 4.96 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.64 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 77' ' ' GLU . 22.8 mtm105 -83.04 167.11 31.55 Favored Pre-proline 0 C--N 1.316 -0.885 0 O-C-N 121.219 -0.926 . . . . 0.0 109.998 166.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 15.7 Cg_exo -69.85 170.83 15.77 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 122.197 1.932 . . . . 0.0 110.312 163.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.59 1.33 34.29 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.585 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -120.77 -38.71 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.187 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.627 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 10.1 ttp -74.82 126.93 87.87 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 7.1 Cg_exo -73.71 151.44 46.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.274 2.649 . . . . 0.0 111.861 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 7.2 pt-20 -25.58 -58.57 0.07 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.465 1.506 . . . . 0.0 114.726 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -100.39 119.06 37.88 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.343 -164.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -165.36 164.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.053 -174.551 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 38.2 p -109.06 95.64 5.77 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 20.5 mttt -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.457 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.541 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 4.1 Cg_exo -80.87 96.33 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.642 2.228 . . . . 0.0 111.913 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.768 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 47.4 m-85 -94.36 120.82 35.17 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.371 0.605 . . . . 0.0 110.553 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.846 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -99.29 178.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.422 175.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.733 ' HE2' ' HB3' ' A' ' 87' ' ' GLU . 5.1 tttt -166.18 104.39 0.65 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.125 -173.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.611 ' HE2' HD11 ' A' ' 89' ' ' ILE . 65.8 tttm -61.62 127.7 32.71 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 171.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.733 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 13.5 pt-20 -127.41 -34.03 2.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.271 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 88' ' ' ARG . 15.4 ttp180 -151.74 159.5 43.93 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.712 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 56' ' ' HIS . 21.0 mm -123.23 107.96 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.741 173.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' CD ' ' HE ' ' A' ' 88' ' ' ARG . 6.0 mm-40 -92.5 -177.46 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.122 0.963 . . . . 0.0 113.286 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -82.25 169.31 16.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.882 170.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD22 ' HD2' ' A' ' 48' ' ' ARG . 22.6 mt -53.26 151.25 5.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.54 0.686 . . . . 0.0 112.675 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.252 1.198 0 CA-C-N 113.49 -1.686 . . . . 0.0 109.466 -175.711 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.202 0.525 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -123.6 -169.08 1.88 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.367 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 t -70.96 170.37 12.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.989 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.701 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -93.06 125.3 37.58 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.85 0.833 . . . . 0.0 110.966 -178.187 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -88.82 145.0 25.85 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.858 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.783 ' CE2' ' HG3' ' A' ' 49' ' ' GLU . 82.5 m-85 -130.98 144.59 51.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.536 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 50' ' ' ARG . 47.1 t -112.83 127.92 69.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 16' ' ' HIS . 3.9 tp -66.63 130.01 41.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.216 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 67.1 mtp180 -106.82 128.03 53.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 166.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -87.62 -169.78 2.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -37.57 -48.24 0.99 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.589 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -80.2 -35.07 36.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.595 0.712 . . . . 0.0 110.258 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.6 31.41 1.81 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.641 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.686 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 2.4 m-20 -96.89 148.1 23.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -173.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.77 130.42 38.6 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.784 0.677 . . . . 0.0 111.013 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.631 ' HB2' HD23 ' A' ' 8' ' ' LEU . 92.0 m-70 -138.22 -171.47 3.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.737 -176.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -12.2 130.45 0.01 OUTLIER Glycine 0 N--CA 1.461 0.331 0 O-C-N 126.736 2.522 . . . . 0.0 113.366 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.79 156.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.685 0.278 . . . . 0.0 111.077 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 92.6 m-85 -151.43 156.82 41.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -139.71 158.36 44.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.581 0.229 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.701 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.71 150.63 8.38 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.103 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.52 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 2.7 tppp? -72.79 -6.33 44.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.487 0.643 . . . . 0.0 110.767 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.872 ' HG3' ' HG2' ' A' ' 26' ' ' GLN . 2.6 pt20 -160.46 158.62 25.61 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 11.6 Cg_endo -56.84 -13.48 11.49 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 123.329 2.686 . . . . 0.0 115.233 -171.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 19.4 ttt180 -94.14 -13.67 26.5 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -174.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.872 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 83.2 mm-40 -88.21 -18.08 29.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.061 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 -59.05 2.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.819 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -35.92 -45.58 0.42 Allowed 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 159.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -57.48 -26.07 60.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.425 0.631 . . . . 0.0 111.076 177.756 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.764 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 27.2 mmmt -80.94 -47.89 13.06 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.654 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -69.4 -21.56 63.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.843 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -67.47 -12.85 61.28 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.82 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 1.2 p-10 -66.06 -47.66 73.59 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.82 17.71 2.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.977 170.028 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.29 90.68 1.42 Allowed Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -77.09 49.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 110.281 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.32 -165.62 11.94 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.32 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 40' ' ' ALA . 9.5 t -162.35 171.62 16.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -62.12 -16.42 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.941 0.791 . . . . 0.0 111.029 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 38' ' ' THR . . . -79.85 -30.08 40.24 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.769 . . . . 0.0 110.63 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -165.15 72.74 1.43 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.182 -176.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' A' ' 59' ' ' LYS . 49.4 Cg_exo -56.19 -169.44 0.02 OUTLIER 'Trans proline' 0 CA--C 1.526 0.082 0 C-N-CA 123.386 2.724 . . . . 0.0 114.008 -174.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -119.4 104.14 10.09 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.403 HD11 ' CG2' ' A' ' 57' ' ' VAL . 6.7 tp -79.05 101.52 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.781 0.8 . . . . 0.0 112.391 -167.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.514 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.4 pp -119.12 129.08 75.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.09 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.788 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 42.2 ttm105 -109.44 118.04 35.59 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 8' ' ' LEU . 3.4 mm? -84.88 161.69 19.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.916 0.865 . . . . 0.0 112.687 175.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.646 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 49.5 ttp180 -133.2 130.46 39.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.003 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.783 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 2.4 mt-10 -80.18 88.2 5.47 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HB3' HG23 ' A' ' 7' ' ' VAL . 3.4 ptm180 -51.56 -9.12 0.07 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.86 -32.47 9.96 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.748 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 p -117.99 -169.75 1.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.002 0.43 . . . . 0.0 110.872 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -108.91 41.62 1.57 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.464 0.65 . . . . 0.0 109.599 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HD3' ' OXT' ' A' ' 93' ' ' GLU . 67.6 mttm -101.32 138.9 37.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.32 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 81.4 t -124.34 129.07 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.589 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 89' ' ' ILE . 71.2 m-70 -134.84 107.93 7.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -172.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 14.9 p -97.0 138.75 21.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.854 ' HB3' HG12 ' A' ' 84' ' ' VAL . 2.9 m-85 -141.52 138.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.966 0.412 . . . . 0.0 110.321 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HG2' ' OE2' ' A' ' 87' ' ' GLU . 55.3 mmtt -71.66 128.5 35.99 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 161.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -126.02 133.01 51.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HZ3' ' HG2' ' A' ' 85' ' ' LYS . 26.9 p90 -151.93 156.37 39.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 6.7 mtpm? -131.58 124.17 29.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.724 0.773 . . . . 0.0 110.943 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' HG3' ' HE2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 139.87 31.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.003 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -82.23 145.78 8.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.086 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.655 ' H ' HD13 ' A' ' 64' ' ' ILE . 1.5 t -130.19 176.51 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -167.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 25.4 t0 176.79 50.39 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -133.87 118.71 14.45 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.38 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.551 ' HA ' ' HG2' ' A' ' 71' ' ' ARG . 7.3 Cg_exo -74.14 -19.81 19.72 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 C-N-CA 123.697 2.931 . . . . 0.0 113.822 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -71.54 -36.09 70.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.458 -171.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 42.9 m-80 -114.82 33.39 5.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.852 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.852 ' HG3' HH11 ' A' ' 71' ' ' ARG . 5.5 mmt85 -76.21 111.95 18.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.178 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 10.0 Cg_exo -73.76 174.47 12.24 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 123.838 3.025 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.24 8.69 20.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.479 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.565 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.2 p-90 -123.49 -31.79 3.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.319 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.775 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.4 ttp -97.78 141.46 23.02 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.325 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 11.7 Cg_endo -79.68 -148.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.63 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 35.7 mt-10 -91.37 -40.54 11.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.213 -0.304 . . . . 0.0 111.745 -169.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.662 ' HD2' ' HB2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -144.79 118.38 9.15 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -175.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.783 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.19 159.15 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 CA-C-O 120.934 0.397 . . . . 0.0 110.266 -176.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 44.5 t -112.31 126.48 55.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 14.0 tppt? -146.64 135.57 11.22 Favored Pre-proline 0 N--CA 1.438 -1.05 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -164.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.769 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 22.3 Cg_exo -64.67 89.97 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 CA-C-N 119.747 0.945 . . . . 0.0 110.389 172.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.754 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 18.3 m-85 -75.42 139.28 42.22 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.985 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.854 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -150.43 155.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.739 -177.294 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HG2' ' HZ3' ' A' ' 61' ' ' TRP . 3.7 ptmm? -151.78 138.97 19.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.11 0.481 . . . . 0.0 111.637 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.518 ' HD3' HG12 ' A' ' 89' ' ' ILE . 35.9 ttmt -88.98 89.85 8.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.424 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.548 ' OE2' ' HG2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -55.03 -54.63 40.57 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 165.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HG2' HG11 ' A' ' 57' ' ' VAL . 5.0 ptt180 -143.61 171.62 13.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.445 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 93' ' ' GLU . 15.8 mm -145.37 131.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.747 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 32.4 mt-10 -87.77 -158.01 0.44 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.934 1.293 . . . . 0.0 109.17 175.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 46.3 mtmt -57.11 169.42 0.56 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.2 mt -34.6 156.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 117.749 2.5 . . . . 0.0 117.749 -126.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.613 ' HB2' HG21 ' A' ' 89' ' ' ILE . 44.0 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 112.731 -2.032 . . . . 0.0 109.364 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -93.67 98.07 10.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m -72.28 111.95 7.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.393 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -87.05 124.24 33.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.266 0.555 . . . . 0.0 111.369 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.63 135.48 38.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.187 174.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 24' ' ' PRO . 9.2 m-85 -120.3 160.82 22.24 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.567 HG23 ' HG2' ' A' ' 50' ' ' ARG . 3.5 t -118.5 138.22 49.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.864 HD23 ' HB2' ' A' ' 16' ' ' HIS . 11.5 tp -79.28 134.74 36.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -136.31 121.18 18.66 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 1.9 t70 -65.32 179.03 0.81 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.371 0.605 . . . . 0.0 112.273 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.32 -32.4 71.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -83.37 -38.97 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.689 0.756 . . . . 0.0 109.211 175.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.43 21.12 2.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.878 172.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 40.0 mt-10 -81.88 121.31 26.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.864 ' HB2' HD23 ' A' ' 8' ' ' LEU . 62.0 m-70 -114.61 99.5 7.58 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.376 0.607 . . . . 0.0 111.461 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.46 175.92 27.7 Favored Glycine 0 C--N 1.294 -1.787 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.207 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.17 138.69 50.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 55.0 m-85 -126.69 148.52 49.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.5 p -132.33 144.38 50.52 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.195 -0.316 . . . . 0.0 111.688 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.15 33.69 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.945 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -54.97 -40.43 70.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.529 0.681 . . . . 0.0 109.719 171.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.75 177.68 1.73 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.75 -53.33 7.2 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.925 1.75 . . . . 0.0 112.113 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.427 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 34.2 ttm180 -32.28 -53.38 0.3 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -74.86 -17.41 60.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.114 0.483 . . . . 0.0 111.169 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.01 23.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.629 0.728 . . . . 0.0 109.132 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -95.83 -32.63 12.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 84' ' ' VAL . 4.3 mt -57.3 -40.32 77.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.382 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -70.19 -7.07 38.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.724 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -100.48 -48.25 4.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.616 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -73.58 -11.21 60.36 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.237 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 14.0 p-10 -83.38 -2.19 55.19 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.407 -166.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.6 ptp180 -114.99 15.79 17.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.0 -119.36 2.66 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.661 -171.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m 176.32 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -172.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 46.37 -164.69 0.1 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.539 -175.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.9 p -157.01 141.46 16.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.082 0.553 . . . . 0.0 109.618 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -66.45 -22.47 66.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.761 0.791 . . . . 0.0 110.37 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.03 -43.03 88.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.658 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -157.51 74.41 4.2 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.621 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.854 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 50.4 Cg_exo -52.83 125.57 18.54 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.377 2.718 . . . . 0.0 113.519 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -42.15 127.47 3.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.105 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 44' ' ' ILE . 11.7 mm -80.65 115.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.001 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.8 pp -106.05 154.62 7.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.101 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.551 ' HB3' ' HG3' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -129.71 101.72 6.02 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.034 -178.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.713 HD23 HD13 ' A' ' 45' ' ' ILE . 4.4 mm? -96.25 135.65 37.8 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -132.85 113.04 12.43 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.437 -175.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 33.6 mt-10 -59.56 108.92 0.79 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.665 0.386 . . . . 0.0 110.059 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HG2' HG23 ' A' ' 7' ' ' VAL . 12.8 mtp180 -34.08 -43.97 0.16 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 174.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.28 -26.5 71.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.728 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 49' ' ' GLU . 6.9 p -103.43 -177.12 3.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.276 0.56 . . . . 0.0 110.989 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.765 ' HB2' ' HA ' ' A' ' 93' ' ' GLU . 53.6 mtmt -121.1 4.04 10.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.792 169.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 25.7 pttm -90.86 133.31 35.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.264 0.554 . . . . 0.0 110.313 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.927 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 19.0 t -103.61 153.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.759 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -128.9 112.29 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.094 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HB ' ' NE ' ' A' ' 46' ' ' ARG . 2.5 p -98.07 126.11 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 122.602 1.191 . . . . 0.0 113.251 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 1.001 ' HB2' HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -114.13 -173.11 2.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.602 -1.636 . . . . 0.0 107.547 174.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.854 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 13.7 ptpt -141.25 121.13 13.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -108.87 140.9 41.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.659 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 10.2 p90 -160.78 -174.33 4.37 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.104 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' ' CA ' ' A' ' 82' ' ' PRO . 88.0 mttt -127.27 153.34 46.26 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 110.542 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.522 ' CG ' ' HE1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -163.77 177.36 8.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -164.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.732 ' HB ' ' HG2' ' A' ' 76' ' ' PRO . 18.2 pt -62.37 137.28 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.109 0.957 . . . . 0.0 110.669 167.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 1.043 HG22 HG22 ' A' ' 79' ' ' ILE . 1.4 m -99.75 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 -165.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 36.0 t70 -33.35 -94.18 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 112.02 -2.355 . . . . 0.0 115.945 -166.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 76' ' ' PRO . . . -50.26 150.17 4.68 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -166.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 71.7 Cg_endo -110.34 -102.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 1 C-N-CA 125.963 4.442 . . . . 0.0 115.225 -172.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -83.04 -23.6 33.15 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.33 -168.155 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -64.49 -8.13 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.567 1.175 . . . . 0.0 110.461 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 76' ' ' PRO . 24.3 mmm180 -117.14 170.78 5.6 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.378 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 52.9 Cg_exo -57.69 169.03 2.71 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.778 1.652 . . . . 0.0 112.167 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.45 -47.72 84.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.284 0.564 . . . . 0.0 110.46 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.633 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 43.7 p-90 -82.62 -33.22 27.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.434 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.583 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.8 ttm -94.88 112.0 56.55 Favored Pre-proline 0 C--O 1.223 -0.317 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -170.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.764 ' HG2' HG21 ' A' ' 79' ' ' ILE . 47.0 Cg_exo -65.69 -72.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 123.612 2.875 . . . . 0.0 112.976 169.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 4.7 mm-40 -135.79 -80.44 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HD2' ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -159.92 115.25 2.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 166.404 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.043 HG22 HG22 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -120.22 117.16 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 N-CA-C 119.294 3.072 . . . . 0.0 119.294 -150.228 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -168.69 88.75 0.21 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 110.451 -3.068 . . . . 0.0 109.351 159.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.716 ' HG2' HG11 ' A' ' 65' ' ' VAL . 23.5 mmtt -122.55 155.7 62.29 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 120.113 1.324 . . . . 0.0 111.546 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.576 ' CA ' ' HG2' ' A' ' 62' ' ' LYS . 95.4 Cg_endo -76.14 123.05 6.99 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.255 2.637 . . . . 0.0 111.363 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 33.8 m-85 -124.51 149.41 46.94 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.777 HG23 HD23 ' A' ' 29' ' ' LEU . 1.1 t -122.3 163.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.315 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 86' ' ' LYS . 1.6 tmmm? -148.67 132.71 17.22 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 51.8 tttm -72.99 113.5 10.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.832 0.825 . . . . 0.0 109.116 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -97.52 -45.02 6.58 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.804 -169.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.578 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 27.0 ttp-105 -156.79 -175.73 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.363 0.601 . . . . 0.0 111.048 -171.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.578 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 14.7 mm -128.12 154.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.605 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.927 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -120.28 -171.29 2.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.051 0.94 . . . . 0.0 110.783 -169.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 53.6 mtmt -69.02 173.98 4.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.35 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.78 155.56 39.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.088 -152.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.765 ' HA ' ' HB2' ' A' ' 53' ' ' LYS . 1.2 tm-20 . . . . . 0 C--O 1.249 1.044 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.345 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -82.9 133.29 35.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.545 1.164 . . . . 0.0 113.496 -173.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.54 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 31.6 m-20 -78.53 155.21 29.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.339 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.56 176.23 8.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.443 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.46 146.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 2.4 tp -99.43 120.74 40.1 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.265 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.795 ' HB2' ' HB2' ' A' ' 46' ' ' ARG . 53.1 mtp180 -88.72 157.16 18.61 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.469 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 11.9 t70 -102.35 -151.8 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.739 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.461 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 51.1 mm-40 -83.48 -20.37 34.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.868 0.366 . . . . 0.0 110.917 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.25 -6.88 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.477 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.91 50.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.315 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 12.4 m120 -54.63 178.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.653 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.37 160.15 34.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.272 0.558 . . . . 0.0 111.994 -169.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 77.9 m-70 -142.58 -159.59 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.172 -171.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.65 161.2 17.4 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.448 0.467 . . . . 0.0 112.84 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 p -84.25 110.9 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.898 0.856 . . . . 0.0 110.521 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 2.7 m-85 -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.111 175.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 74.2 p -148.24 175.34 11.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.999 0.428 . . . . 0.0 109.865 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 154.69 142.93 3.55 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.565 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -14.41 48.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.241 0.544 . . . . 0.0 110.39 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.428 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 36.4 tt0 -153.83 142.86 14.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.802 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 72.3 Cg_exo -46.96 -18.74 0.61 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.485 3.457 . . . . 0.0 115.492 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -82.81 -12.7 57.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . 23.1 mm-40 -77.37 -65.01 1.01 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.914 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -34.46 -37.46 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 164.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.568 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -77.34 -38.97 49.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.34 177.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.856 HD12 HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -63.24 -39.19 93.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 14.2 mmmm -80.87 -1.03 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.943 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . . . -99.06 -20.3 16.78 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.772 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 34' ' ' ARG . . . -72.81 -66.33 0.68 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.621 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -35.06 8.13 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 162.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.61 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 14.8 mmm180 -91.37 -48.27 6.99 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.4 1.0 . . . . 0.0 110.272 -167.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -81.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.142 -1.504 . . . . 0.0 115.055 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -87.26 36.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 0.0 110.204 -168.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 61' ' ' TRP . . . -72.73 92.65 0.62 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.078 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -133.72 144.07 48.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.221 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HD2' ' CD ' ' A' ' 63' ' ' GLU . 68.9 tttt -81.4 -12.81 58.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.256 0.55 . . . . 0.0 110.365 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.6 64.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.047 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.9 81.06 1.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.059 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.8 Cg_exo -51.8 140.05 48.26 Favored 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.712 2.941 . . . . 0.0 112.826 -174.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -57.32 99.29 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.924 HD11 ' HE3' ' A' ' 59' ' ' LYS . 19.6 mm -54.9 126.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.355 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.6 pp -135.27 140.93 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.795 ' HB2' ' HB2' ' A' ' 9' ' ' ARG . 72.5 mtp180 -117.29 124.83 49.96 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.521 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 45' ' ' ILE . 1.7 mm? -106.2 158.11 17.08 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -142.5 115.73 8.93 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.3 130.7 43.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 11.2 mtp180 -77.81 8.05 5.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.63 0.729 . . . . 0.0 109.077 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.78 -64.36 0.46 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.607 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 p -91.7 146.66 23.59 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.189 0.519 . . . . 0.0 112.224 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -84.03 55.65 3.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.229 1.014 . . . . 0.0 109.808 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -127.98 111.54 13.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.345 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.966 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.7 t -78.68 99.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.562 ' HA ' HD13 ' A' ' 89' ' ' ILE . 51.1 m-70 -69.68 135.51 49.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG11 ' HG2' ' A' ' 90' ' ' GLU . 4.2 p -140.34 104.98 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 122.682 1.23 . . . . 0.0 109.471 -172.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.838 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -104.61 177.54 4.82 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.599 -1.637 . . . . 0.0 107.78 -177.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.924 ' HE3' HD11 ' A' ' 44' ' ' ILE . 45.6 mtpt -123.9 127.44 48.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -127.47 123.79 36.82 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.954 -159.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.583 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . 29.3 p90 -134.64 179.84 6.05 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.621 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 48.2 mtmt -133.84 140.36 46.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.338 174.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.617 ' HB2' ' HE2' ' A' ' 83' ' ' PHE . 38.8 mt-10 -129.56 112.81 14.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.478 173.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 80' ' ' SER . 32.9 mm -79.93 77.97 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.65 ' HA ' ' CB ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -152.24 153.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.873 -177.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.696 ' N ' ' HA ' ' A' ' 78' ' ' LYS . 8.8 t70 157.9 66.44 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.279 1.612 . . . . 0.0 107.932 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -60.59 133.86 91.58 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.266 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.914 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 61.6 Cg_endo -70.37 128.86 16.04 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.853 2.369 . . . . 0.0 115.781 -166.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -95.96 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.322 -1.763 . . . . 0.0 107.621 163.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.35 33.83 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.791 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.914 ' HD3' ' HA ' ' A' ' 68' ' ' PRO . 36.9 mtp85 -84.96 163.85 44.24 Favored Pre-proline 0 N--CA 1.464 0.235 0 O-C-N 121.916 -0.49 . . . . 0.0 111.033 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 75' ' ' MET . 18.5 Cg_exo -67.72 160.25 49.05 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.383 2.722 . . . . 0.0 111.458 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.34 -50.15 72.75 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.986 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -59.79 -20.48 57.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.621 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 13.2 ttm -90.18 111.07 44.83 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.454 ' N ' HH21 ' A' ' 71' ' ' ARG . 24.9 Cg_exo -65.24 -135.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 124.19 3.26 . . . . 0.0 115.052 -170.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.827 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.4 mt-10 -117.46 8.47 13.0 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.696 ' HA ' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -160.26 169.43 23.22 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.804 -1.998 . . . . 0.0 106.51 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.083 HD13 ' HD3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -162.7 164.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 169.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 74.9 m -65.3 117.8 8.39 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.765 0.793 . . . . 0.0 111.416 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 1.083 ' HD3' HD13 ' A' ' 79' ' ' ILE . 4.3 mptp? -142.1 112.71 6.23 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 114.077 -1.42 . . . . 0.0 112.181 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.497 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 2.4 Cg_endo -86.54 124.59 2.34 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 123.28 2.653 . . . . 0.0 109.219 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.722 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 89.1 m-85 -120.82 134.73 55.28 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.856 HG23 HD12 ' A' ' 29' ' ' LEU . 1.5 t -138.81 137.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.926 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -122.45 154.67 37.47 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 27.3 ttmt -99.69 123.37 43.89 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.804 1.638 . . . . 0.0 109.195 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 2.4 pt-20 -89.15 -13.56 38.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.111 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 12.4 ptt-85 174.08 -173.01 0.06 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 56' ' ' HIS . 8.7 mm -138.85 136.22 42.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.784 0.326 . . . . 0.0 110.16 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.966 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.7 mm-40 -107.01 175.04 5.63 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.686 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 121.283 0.563 . . . . 0.0 112.407 -174.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 121.391 0.615 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.833 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -93.7 133.68 36.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.623 ' HA ' HG22 ' A' ' 20' ' ' THR . 60.6 m-80 -115.6 113.74 23.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.431 . . . . 0.0 111.05 -167.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -117.68 148.09 42.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -175.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 18' ' ' VAL . 3.3 t -113.66 -179.57 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.3 tp -106.56 149.63 26.96 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HD3' ' HB2' ' A' ' 48' ' ' ARG . 24.7 mmm180 -111.05 162.36 14.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t70 -92.74 -162.56 0.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -92.35 -6.62 49.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.073 1.306 . . . . 0.0 108.039 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -110.43 -20.14 12.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.591 -170.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.93 36.53 1.23 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.596 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 65.4 m-80 -111.23 -173.05 2.15 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 87.7 mt-10 -135.9 145.31 46.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 111.092 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 73.9 m-70 -132.57 -166.09 1.69 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.182 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -21.59 130.07 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 125.034 1.459 . . . . 0.0 114.248 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 7' ' ' VAL . 78.4 t -85.53 131.65 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 6' ' ' PHE . 81.5 m-85 -131.4 125.76 33.42 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 5' ' ' ASN . 38.0 p -139.25 140.77 37.78 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.637 ' H ' ' NH1' ' A' ' 4' ' ' ARG . . . -140.78 -164.81 10.06 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.515 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -8.85 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.426 HE21 ' HB3' ' A' ' 23' ' ' GLN . 1.2 tt0 -157.12 139.21 10.25 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.654 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HA ' HH21 ' A' ' 4' ' ' ARG . 80.4 Cg_exo -40.91 -47.88 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 124.335 3.356 . . . . 0.0 114.077 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 42.0 ttt180 -53.04 -22.9 6.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.074 0.95 . . . . 0.0 113.341 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 22.9 mm-40 -84.05 -50.62 7.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.509 0.671 . . . . 0.0 110.677 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.752 ' CB ' HH22 ' A' ' 4' ' ' ARG . . . -59.07 -31.95 69.34 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.214 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.682 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -83.58 -26.24 30.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.876 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.783 ' HG ' ' HG2' ' A' ' 82' ' ' PRO . 3.7 tt -65.24 -65.52 0.66 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -43.75 -31.29 0.78 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.458 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.88 -39.65 69.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.166 0.507 . . . . 0.0 110.311 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.656 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -70.56 -21.37 62.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.367 0.603 . . . . 0.0 111.184 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.4 ' OD1' ' HG3' ' A' ' 82' ' ' PRO . 71.3 m-20 -68.34 -2.83 9.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.965 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.42 ' NH2' ' HE1' ' A' ' 19' ' ' PHE . 8.2 mmt180 -100.06 -13.27 19.09 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.09 82.85 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.84 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.507 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 13.0 p -100.18 -49.52 4.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -126.92 8.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.909 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 160.83 40.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.105 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -62.12 -20.87 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.589 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.64 -25.43 67.36 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.969 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.479 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.0 OUTLIER -161.85 67.82 2.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.442 0.639 . . . . 0.0 110.353 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.3 Cg_exo -65.16 130.95 26.95 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.085 1.857 . . . . 0.0 111.592 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.18 139.39 52.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 57' ' ' VAL . 5.6 tp -82.97 105.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.824 0.821 . . . . 0.0 111.249 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.631 HD11 ' HB1' ' A' ' 28' ' ' ALA . 2.7 pp -95.94 123.27 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 122.351 1.072 . . . . 0.0 110.345 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' HD22 ' A' ' 47' ' ' LEU . 77.5 mtp180 -91.79 173.26 7.96 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.446 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.57 ' CB ' ' HB2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -147.47 148.23 31.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.58 ' HB2' ' HD3' ' A' ' 9' ' ' ARG . 11.6 tpt180 -124.18 111.27 15.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.106 0.479 . . . . 0.0 110.169 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 8.4 tp10 -86.27 104.57 15.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.568 ' HD3' ' HB3' ' A' ' 5' ' ' ASN . 2.8 ptm180 -73.05 25.66 0.06 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.434 0.635 . . . . 0.0 111.429 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 49' ' ' GLU . . . -128.63 0.99 6.39 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.325 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 44.6 p -146.65 169.78 18.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.411 0.605 . . . . 0.0 109.825 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -95.21 38.21 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -127.94 132.19 49.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.923 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.852 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 49.1 t -92.47 119.7 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.129 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 47' ' ' LEU . 95.2 m-70 -81.42 131.74 35.3 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.592 HG21 ' HG3' ' A' ' 90' ' ' GLU . 71.3 t -123.15 116.23 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -170.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.65 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -132.25 134.78 45.7 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 87.5 mttt -70.56 170.26 12.52 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 162.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -163.08 133.99 4.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -166.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 36' ' ' SER . 29.9 p90 -150.03 -172.57 4.19 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 35.3 mttp -132.2 136.51 47.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.11 0.481 . . . . 0.0 111.108 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -137.66 137.8 38.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 -178.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 16.0 tt -83.67 94.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.147 1.451 . . . . 0.0 113.877 -166.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 81' ' ' LYS . 35.2 m -112.09 -174.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.523 170.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.996 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 7.3 p-10 -98.88 178.06 5.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 119.453 1.024 . . . . 0.0 110.985 169.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.707 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -125.23 163.87 35.44 Favored Pre-proline 0 C--O 1.239 0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.375 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 67' ' ' ALA . 82.7 Cg_exo -46.3 149.31 2.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.979 2.453 . . . . 0.0 112.636 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -83.83 12.11 6.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.486 0.66 . . . . 0.0 110.309 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -117.31 22.84 12.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.013 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 77' ' ' GLU . 31.3 ptt-85 -63.89 170.2 3.57 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.618 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -56.57 168.95 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.68 2.254 . . . . 0.0 113.108 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.44 -14.87 32.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.265 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.558 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 35.8 p-90 -91.37 -24.36 19.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.111 0.482 . . . . 0.0 111.151 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.558 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 28.6 ttp -101.28 147.46 33.8 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.279 -172.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 75' ' ' MET . 56.1 Cg_endo -83.84 177.4 6.16 Favored 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.499 2.132 . . . . 0.0 110.026 172.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 12.8 pt-20 -74.07 -43.46 57.67 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.145 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.996 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 29.7 mmmt -79.71 114.99 19.06 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 67' ' ' ALA . 1.4 pp -153.54 153.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.355 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 5.3 p -76.33 104.24 6.75 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.226 0.536 . . . . 0.0 110.053 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 21.6 tptt -62.9 136.9 96.75 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.763 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.783 ' HG2' ' HG ' ' A' ' 29' ' ' LEU . 37.9 Cg_endo -68.43 98.32 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.221 1.948 . . . . 0.0 110.491 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 42.3 m-85 -94.31 173.0 7.85 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.682 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -162.59 174.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -162.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' H ' ' HB3' ' A' ' 58' ' ' PHE . 49.5 tptt -175.63 98.23 0.07 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 111.146 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 36.4 ttmt -55.96 93.16 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.825 0.821 . . . . 0.0 111.954 166.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.596 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -82.23 -11.88 58.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.657 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.596 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 7.7 ptm180 -176.84 177.12 1.37 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.347 0.594 . . . . 0.0 111.907 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.531 HD11 ' HE2' ' A' ' 86' ' ' LYS . 20.9 mm -135.83 136.96 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.527 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.852 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 30.4 mt-10 -107.2 151.29 25.62 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.023 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt . . . . . 0 N--CA 1.438 -1.061 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.425 HG21 ' HB ' ' A' ' 20' ' ' THR . 28.9 m . . . . . 0 N--CA 1.441 -0.877 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HD3' ' C ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -93.93 126.67 39.27 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.429 0.633 . . . . 0.0 110.557 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.628 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 12.4 m120 -78.78 143.87 35.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.673 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.844 ' HB3' HD12 ' A' ' 47' ' ' LEU . 66.0 m-85 -131.89 142.09 49.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.411 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 61.7 t -105.17 122.32 58.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.76 133.17 43.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.061 -177.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.866 ' HB3' ' CA ' ' A' ' 13' ' ' GLY . 60.3 mtp180 -85.36 138.84 32.02 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.607 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 5.4 t70 -59.2 -146.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.691 170.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.61 -56.46 4.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -167.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.25 -42.32 68.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 109.088 162.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.866 ' CA ' ' HB3' ' A' ' 9' ' ' ARG . . . 139.36 48.01 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 116.263 -2.875 . . . . 0.0 113.671 169.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.5 m120 -74.01 -152.44 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -97.41 146.67 24.97 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.691 0.758 . . . . 0.0 112.295 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 15.5 m-70 -138.52 -164.56 1.66 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 167.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.95 162.87 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 119.058 -1.544 . . . . 0.0 112.317 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.628 ' CG2' ' HB3' ' A' ' 5' ' ' ASN . 2.7 p -99.22 110.77 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.093 0.949 . . . . 0.0 111.179 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -78.95 178.43 8.0 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.794 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.425 ' HB ' HG21 ' A' ' 3' ' ' THR . 33.1 p -135.09 151.97 51.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.417 -175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -172.35 160.42 31.76 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -84.04 -10.21 58.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 26' ' ' GLN . 17.1 mt-30 -151.58 165.5 17.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 23' ' ' GLN . 10.8 Cg_endo -60.63 -53.3 2.88 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 CA-C-N 120.283 1.137 . . . . 0.0 111.278 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 75.5 ttt180 -39.9 -36.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.129 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 8.2 mm100 -84.44 -10.79 57.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.988 0.423 . . . . 0.0 111.535 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.98 -57.07 2.99 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.672 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -45.08 -32.95 1.94 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 165.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' ARG . 7.2 tt -61.41 -19.23 61.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.282 0.563 . . . . 0.0 110.565 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 30' ' ' LYS . 18.4 mtpp -77.85 -53.39 7.53 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -68.37 -16.59 63.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -64.44 -20.46 66.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.317 0.579 . . . . 0.0 110.838 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.36 7.1 0.65 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 56.6 mtp180 -99.64 -54.95 2.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.931 -163.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 36' ' ' SER . . . -105.76 -20.8 9.1 Favored Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.164 167.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 61' ' ' TRP . 68.5 m 76.15 -63.95 0.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.54 -160.8 54.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.235 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -160.93 157.14 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.554 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 4.8 ttpm? -63.65 -12.86 37.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.984 0.513 . . . . 0.0 112.065 -171.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.63 -29.92 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.699 0.762 . . . . 0.0 110.162 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.29 70.18 2.95 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.556 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -56.98 166.13 4.34 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.901 2.401 . . . . 0.0 112.84 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.32 118.04 35.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.764 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 ' HZ2' ' A' ' 59' ' ' LYS . 7.0 tp -55.87 158.0 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.04 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -159.19 179.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.784 ' CB ' ' HB2' ' A' ' 9' ' ' ARG . 24.1 mmm-85 -158.29 143.01 16.23 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.826 0.704 . . . . 0.0 109.761 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.844 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -139.84 125.4 19.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.802 0.81 . . . . 0.0 110.567 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 45.3 tpt85 -105.36 114.48 28.68 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.994 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 57.4 tt0 -85.58 78.24 9.68 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -46.47 104.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.997 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.93 -19.47 4.4 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.042 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 26.1 p -127.62 178.48 6.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -115.59 37.26 3.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.929 0.871 . . . . 0.0 109.87 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -127.03 149.09 50.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.906 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 1.052 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 20.9 t -103.92 136.47 36.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.25 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.682 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 90.9 m-70 -103.73 105.99 16.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 43.7 t -95.32 122.38 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.504 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -128.44 162.11 27.91 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.932 176.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.424 ' HZ2' HD13 ' A' ' 44' ' ' ILE . 40.2 mmtm -103.44 133.28 48.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.926 158.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 45' ' ' ILE . . . -110.96 146.26 36.93 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.745 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 32.0 p90 -168.87 151.36 4.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HE2' ' HG3' ' A' ' 82' ' ' PRO . 77.5 mttt -103.18 122.95 45.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.367 0.604 . . . . 0.0 109.932 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.745 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.1 mm-40 -107.71 143.14 36.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.961 172.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 20.7 tt -86.24 143.31 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 163.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 m -141.0 -172.82 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.82 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.3 p-10 -121.16 -179.41 4.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.158 0.504 . . . . 0.0 111.272 -165.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.694 ' HB2' ' HA ' ' A' ' 77' ' ' GLU . . . -110.74 116.59 52.01 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.369 -172.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 71' ' ' ARG . 7.4 Cg_exo -69.0 -173.66 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.3 2.667 . . . . 0.0 111.383 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -95.48 -51.2 4.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.417 0.627 . . . . 0.0 109.334 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.4 t30 -83.97 18.05 2.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.44 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.631 ' HD3' ' HB1' ' A' ' 67' ' ' ALA . 9.8 ptt-85 -59.26 158.01 21.15 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.695 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.5 173.58 10.53 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.517 2.811 . . . . 0.0 114.015 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.15 10.66 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.833 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -123.21 -15.48 7.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.808 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 32.8 ttm -103.05 121.81 47.7 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.532 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 20.4 Cg_endo -88.7 -152.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.124 2.549 . . . . 0.0 112.444 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.694 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 16.6 mm-40 -69.53 -42.04 75.19 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.82 ' HD3' ' HA ' ' A' ' 66' ' ' ASP . 31.9 mmtp -150.03 129.76 13.24 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.613 HD12 HG22 ' A' ' 65' ' ' VAL . 1.2 pp -147.46 147.87 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 118.721 0.691 . . . . 0.0 111.074 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 71.5 p -94.14 153.83 17.9 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.58 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 4.4 tptp -157.38 133.67 6.2 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -168.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.611 ' HG3' ' HE2' ' A' ' 62' ' ' LYS . 14.0 Cg_exo -65.22 89.79 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 CA-C-N 120.651 1.268 . . . . 0.0 111.663 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 27.3 m-85 -83.68 157.78 22.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.517 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.672 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -145.92 162.84 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.079 177.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.557 ' HB3' ' CZ3' ' A' ' 61' ' ' TRP . 5.2 tmtt? -151.72 115.56 4.91 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.316 0.579 . . . . 0.0 110.874 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.52 ' HE2' HD11 ' A' ' 89' ' ' ILE . 33.9 ttmt -60.2 125.65 24.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 20.6 pt-20 -135.41 -13.54 2.03 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.41 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 32.1 ttp85 -157.16 165.83 34.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.52 HD11 ' HE2' ' A' ' 86' ' ' LYS . 22.2 mm -147.1 140.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 1.052 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 52.6 mt-10 -119.93 153.11 36.39 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.06 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt . . . . . 0 N--CA 1.443 -0.807 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 -174.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.4 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.402 0.62 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' THR . 12.4 mmm180 -88.52 137.47 32.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.336 1.065 . . . . 0.0 111.796 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 36.8 m-80 -104.68 118.05 35.62 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.228 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.501 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 30.3 m-85 -119.27 165.0 14.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.282 1.039 . . . . 0.0 111.599 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.88 130.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.524 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.132 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 13.9 tp -81.26 156.06 25.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.581 ' HD3' HG11 ' A' ' 55' ' ' VAL . 47.9 mtp180 -135.47 143.03 45.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . 6.7 t70 -87.15 -165.04 1.18 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 4.7 mm-40 -83.74 -52.5 6.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.547 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -75.61 0.6 16.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.2 35.94 3.02 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 118.637 -1.744 . . . . 0.0 113.768 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.5 ' HB2' ' CB ' ' A' ' 10' ' ' ASP . 61.5 m-80 -101.75 178.67 4.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -122.72 152.52 40.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.858 0.837 . . . . 0.0 112.255 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 1.132 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 97.3 m-70 -132.18 -158.92 0.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.993 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.78 -172.67 46.55 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 117.84 -2.124 . . . . 0.0 110.936 -158.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 87.1 t -94.23 109.06 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.692 0.758 . . . . 0.0 110.851 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 77.6 m-85 -94.66 111.94 23.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.389 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.8 p -91.08 113.95 26.34 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.74 166.51 21.88 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.423 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HG2' ' HG3' ' A' ' 26' ' ' GLN . 8.9 ptpp? -77.66 -27.25 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.517 0.675 . . . . 0.0 109.58 174.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.608 ' HG2' ' HG3' ' A' ' 22' ' ' LYS . 11.0 pt20 -160.4 163.99 20.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.454 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 33.0 Cg_exo -40.02 -53.3 2.51 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.476 2.784 . . . . 0.0 113.956 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.98 -40.0 69.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.707 ' HG3' ' HG2' ' A' ' 22' ' ' LYS . 21.5 mm-40 -78.56 -31.54 47.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 122.001 -0.437 . . . . 0.0 111.324 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.32 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.588 0.709 . . . . 0.0 109.207 173.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.547 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -70.51 -38.73 74.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.68 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.739 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -56.4 -62.29 1.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 32.1 mmtp -34.81 -48.05 0.37 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.186 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.821 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -66.98 -30.36 70.45 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.162 -0.336 . . . . 0.0 111.512 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -84.7 -18.34 35.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.79 -34.65 20.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 34' ' ' ARG . 28.4 ptt85 -92.21 -20.9 20.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.68 89.75 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.787 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -67.49 -17.1 64.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 31.91 -135.65 0.13 Allowed Glycine 0 C--N 1.344 0.987 0 O-C-N 124.332 1.02 . . . . 0.0 112.843 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -149.46 168.69 22.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 164.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -58.37 -33.64 69.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -81.06 -42.31 21.25 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.294 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.66 65.5 72.32 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.811 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 22.9 Cg_exo -64.45 146.17 89.06 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.485 2.124 . . . . 0.0 112.543 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.92 110.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.539 HD11 ' HE3' ' A' ' 59' ' ' LYS . 30.0 mm -64.1 122.82 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.066 0.46 . . . . 0.0 111.584 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 58' ' ' PHE . 8.0 pt -117.5 132.47 67.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.842 0.83 . . . . 0.0 111.925 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 1.09 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 69.4 mtp180 -122.37 116.47 24.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.866 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.822 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.9 mm? -108.11 123.16 48.29 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.343 0.592 . . . . 0.0 109.922 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.569 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 16.9 ttp180 -112.03 97.29 6.57 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.769 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 4' ' ' ARG . 2.7 tm-20 -61.97 144.14 55.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.07 13.73 7.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -172.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.24 -9.5 2.38 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.408 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.5 p -99.33 172.79 7.12 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.835 -0.215 . . . . 0.0 110.647 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 63.4 tttp -111.76 11.77 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 110.339 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -121.57 142.88 49.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 90.6 t -111.34 101.16 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.822 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 18.6 p80 -86.48 140.31 30.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.28 0.562 . . . . 0.0 111.359 -174.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 1.09 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -125.36 114.57 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.258 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.624 ' O ' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -115.92 147.81 40.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HE3' HD11 ' A' ' 44' ' ' ILE . 1.5 mmmm -66.29 169.57 7.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.986 160.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -165.31 134.31 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.413 0.149 . . . . 0.0 110.769 -173.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.532 ' HD1' ' HG2' ' A' ' 63' ' ' GLU . 20.1 p90 -161.18 172.74 16.19 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 120.449 0.166 . . . . 0.0 111.15 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 42.2 mtmt -144.32 124.03 13.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.525 0.203 . . . . 0.0 110.706 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.549 ' HG3' ' CG1' ' A' ' 65' ' ' VAL . 7.7 pt-20 -174.09 155.9 2.57 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.698 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -69.99 125.99 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.885 0.766 . . . . 0.0 110.288 173.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.598 HG23 ' N ' ' A' ' 66' ' ' ASP . 4.2 m -150.75 -167.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -167.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.3 OUTLIER 101.16 -174.65 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 125.395 1.685 . . . . 0.0 110.638 168.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 68' ' ' PRO . . . -121.53 179.85 0.88 Allowed Pre-proline 0 N--CA 1.437 -1.099 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.324 -165.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 67' ' ' ALA . 98.1 Cg_exo -50.94 -175.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 123.705 2.937 . . . . 0.0 115.051 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 4.1 mptp? -56.93 -13.05 2.33 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.456 -166.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -76.01 32.67 0.12 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.04 0.447 . . . . 0.0 111.317 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 68' ' ' PRO . 20.3 mmm180 -84.5 167.16 28.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.524 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.6 162.72 30.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.097 1.865 . . . . 0.0 111.191 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.98 62.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.118 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 56.3 p-90 -103.92 -37.51 7.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.895 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.699 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 16.6 ttp -104.57 136.46 19.17 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.706 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 42.7 Cg_endo -92.38 -164.69 0.13 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 122.696 2.264 . . . . 0.0 113.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -86.07 -2.02 57.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.552 -1.658 . . . . 0.0 112.531 -168.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 72.5 mmtt -155.42 119.25 4.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.8 OUTLIER -155.71 144.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.552 0.615 . . . . 0.0 110.087 177.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.0 p -120.71 81.22 1.73 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.004 0.907 . . . . 0.0 111.616 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.842 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -124.74 168.32 13.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.197 176.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.739 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 52.2 Cg_exo -57.24 94.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.483 2.122 . . . . 0.0 111.875 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.842 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-85 -86.53 175.6 8.26 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.597 HG12 ' CB ' ' A' ' 58' ' ' PHE . 1.4 t -166.22 173.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -166.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' A' ' 86' ' ' LYS . 16.8 tptm -176.51 99.11 0.06 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.119 0.485 . . . . 0.0 110.7 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.563 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 34.4 ttmt -57.25 134.3 55.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.38 169.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 11.3 pt-20 -167.19 23.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.168 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.488 ' C ' HG13 ' A' ' 57' ' ' VAL . 23.7 ttp180 -168.2 157.03 9.08 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.418 HD11 ' HE2' ' A' ' 86' ' ' LYS . 23.1 mm -140.58 136.31 35.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.534 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -119.36 166.21 13.33 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.452 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt . . . . . 0 CA--C 1.501 -0.911 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.818 176.753 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.449 -0.525 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.0 ptm180 -89.34 151.74 21.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.261 1.029 . . . . 0.0 112.642 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.8 OUTLIER -105.08 136.55 44.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.531 -166.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 28.0 m-85 -127.32 122.18 33.07 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.384 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.985 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -97.31 128.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.918 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.5 tp -66.19 139.84 58.14 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.788 -171.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -92.03 171.73 8.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.136 0.97 . . . . 0.0 111.777 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 21.2 t70 -128.43 169.98 13.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.038 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.74 -36.33 80.68 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.744 0.652 . . . . 0.0 111.094 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.09 -39.3 25.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.862 0.839 . . . . 0.0 109.439 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.03 31.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.173 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -77.22 -170.09 1.59 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.773 173.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.29 108.86 9.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.512 0.672 . . . . 0.0 111.083 -170.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.918 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 72.3 m-70 -89.88 -162.17 0.86 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.52 144.11 7.21 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 123.398 0.436 . . . . 0.0 113.434 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 50' ' ' ARG . 97.6 t -83.64 143.82 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -126.71 143.11 51.34 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 p -121.89 135.16 54.87 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.57 -78.59 0.08 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.27 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt 173.36 -33.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 11.1 pt20 -159.68 166.68 15.57 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.312 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 72.5 Cg_exo -45.8 -22.29 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.507 2.805 . . . . 0.0 114.038 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 21.2 ttm-85 -88.1 -35.09 17.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.657 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -86.34 -14.66 42.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.598 -178.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.0 -47.78 7.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 47' ' ' LEU . . . -57.12 -37.36 71.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.476 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.696 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -49.5 -65.92 0.48 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.426 172.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 74.5 mmtt -35.33 -48.31 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . . . -68.13 -26.78 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.752 0.706 . . . . 0.0 112.067 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.056 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -70.11 -22.95 62.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.226 1.012 . . . . 0.0 111.007 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.665 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 6.2 m-80 -62.45 -0.29 0.57 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -73.54 -63.92 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 116.6 -2.04 . . . . 0.0 109.651 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.13 -50.25 0.25 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 115.282 -3.342 . . . . 0.0 116.622 143.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 38' ' ' THR . 15.2 m -53.77 -25.35 18.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.488 0.644 . . . . 0.0 109.405 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.94 100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.945 164.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 36' ' ' SER . 25.5 p -135.49 -177.97 4.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.143 0.577 . . . . 0.0 110.461 -171.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 23.4 mtmm -65.42 -29.77 70.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.646 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.87 -38.03 79.44 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.157 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.38 71.7 32.27 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.21 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.8 Cg_exo -67.25 130.44 22.63 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.043 1.162 . . . . 0.0 109.42 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -72.2 107.17 4.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 44' ' ' ILE . 2.9 tp -71.07 96.75 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 122.316 1.055 . . . . 0.0 110.038 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.457 ' H ' HG12 ' A' ' 45' ' ' ILE . 5.3 pt -103.62 152.13 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.107 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.629 ' HG2' HG23 ' A' ' 57' ' ' VAL . 30.0 mtp180 -125.85 102.95 7.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 28' ' ' ALA . 2.6 mm? -87.62 137.62 32.17 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -122.13 112.26 17.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.87 144.26 56.83 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.985 ' HG2' HG12 ' A' ' 7' ' ' VAL . 61.7 mtp180 -74.98 -18.96 60.29 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.446 -166.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 -9.62 60.33 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.806 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.3 p -111.86 149.44 31.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.894 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -95.63 18.22 13.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -100.39 139.97 35.31 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.653 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.02 117.37 48.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.696 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.535 ' HA ' HD13 ' A' ' 89' ' ' ILE . 42.3 m-70 -96.85 99.55 11.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.888 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.629 HG23 ' HG2' ' A' ' 46' ' ' ARG . 7.5 p -98.32 127.27 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 1.4 m-85 -137.68 124.02 20.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.01 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 26.7 mtpp -71.13 107.62 4.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.996 160.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.056 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -95.24 145.98 24.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.671 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 19.8 p90 -158.68 143.25 15.88 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.335 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 30.5 mtmt -103.62 124.51 48.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HG2' ' CG ' ' A' ' 39' ' ' LYS . 3.6 tp10 -150.89 154.78 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.297 0.57 . . . . 0.0 111.392 -166.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 92.1 mt -118.44 121.18 66.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.626 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.566 HG23 ' NH2' ' A' ' 71' ' ' ARG . 34.7 m -122.93 151.05 26.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -79.91 -175.56 5.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.875 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -48.5 160.07 0.48 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 125.771 1.628 . . . . 0.0 114.791 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.754 ' HB3' ' HB2' ' A' ' 71' ' ' ARG . 42.1 Cg_endo -67.08 67.49 0.59 Allowed 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 124.116 3.211 . . . . 0.0 116.167 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -93.1 -7.78 44.56 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 161.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -133.51 2.01 3.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.067 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.955 HH22 HD12 ' A' ' 79' ' ' ILE . 67.0 mtt-85 -118.23 167.73 10.84 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -158.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.39 149.88 80.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.207 2.605 . . . . 0.0 109.364 154.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.01 19.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -167.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -95.27 -21.48 18.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.713 ' HB3' ' HD3' ' A' ' 71' ' ' ARG . 10.3 ttm -81.87 130.6 60.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.336 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HD2' HG21 ' A' ' 79' ' ' ILE . 3.0 Cg_endo -74.48 177.47 8.34 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.839 2.36 . . . . 0.0 112.448 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.875 ' HA ' ' HA ' ' A' ' 67' ' ' ALA . 1.9 mp0 -51.81 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.876 0.735 . . . . 0.0 109.036 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -89.54 130.0 35.92 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.436 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.955 HD12 HH22 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.21 151.12 15.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.611 ' HB3' HG12 ' A' ' 64' ' ' ILE . 9.1 p -124.88 125.74 44.44 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.833 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 73.0 mmtt -159.28 144.26 11.55 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.696 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 3.0 Cg_exo -73.18 96.1 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 0.0 110.493 163.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.526 ' O ' HG13 ' A' ' 84' ' ' VAL . 80.2 m-85 -78.66 172.72 13.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.691 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -173.08 117.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.23 -173.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 118.14 34.56 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.875 157.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 3.6 ptpp? -55.13 139.57 41.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.236 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.9 -31.98 31.18 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.69 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 173.63 -174.68 0.06 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.097 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 56' ' ' HIS . 31.2 mm -127.84 110.02 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.873 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.89 -176.34 2.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.335 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 21.4 mtmt . . . . . 0 C--N 1.312 -1.065 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 N--CA 1.451 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.604 ' NH1' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -95.76 156.11 16.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.877 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -121.61 132.4 54.65 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.229 -0.295 . . . . 0.0 110.532 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HD1' ' NH2' ' A' ' 4' ' ' ARG . 61.2 m-85 -143.74 134.07 24.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -115.76 133.89 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.784 ' HB2' ' HE2' ' A' ' 19' ' ' PHE . 2.4 tp -66.17 149.36 50.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.44 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.685 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 76.9 mtp180 -118.77 124.16 46.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 163.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.402 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 40.0 t0 -87.03 175.5 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.668 -169.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -44.42 -44.77 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 124.122 0.889 . . . . 0.0 112.965 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -41.54 89.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.456 0.646 . . . . 0.0 110.89 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.05 25.78 2.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.96 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 p30 -110.55 170.37 8.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -95.82 141.89 28.73 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.051 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' HB2' HD23 ' A' ' 8' ' ' LEU . 39.9 m-70 -132.4 -178.99 5.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.823 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -20.26 126.27 0.01 OUTLIER Glycine 0 C--N 1.328 0.135 0 O-C-N 125.876 1.985 . . . . 0.0 114.884 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.09 125.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.253 0.549 . . . . 0.0 109.939 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.784 ' HE2' ' HB2' ' A' ' 8' ' ' LEU . 6.9 m-85 -112.72 149.37 33.04 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -135.8 141.98 44.81 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.3 -175.37 27.19 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.624 -1.275 . . . . 0.0 112.814 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -87.01 -31.79 20.38 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.57 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.604 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 18.6 pt20 -154.15 155.94 31.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 9.3 Cg_endo -50.84 -23.37 11.54 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.154 3.236 . . . . 0.0 114.398 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -58.01 -54.28 48.73 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 123.168 0.292 . . . . 0.0 110.858 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.583 HE21 HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -43.97 77.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.263 0.554 . . . . 0.0 111.106 175.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.604 ' HB2' ' NH1' ' A' ' 4' ' ' ARG . . . -55.96 -35.41 66.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.704 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.95 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -89.25 -21.49 23.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.349 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.583 HD22 HE21 ' A' ' 26' ' ' GLN . 1.3 mp -64.63 -63.55 1.1 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -39.62 -16.87 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.323 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 29' ' ' LEU . . . -95.53 -50.95 4.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.219 0.533 . . . . 0.0 110.421 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.673 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -63.76 -29.46 70.67 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.412 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -4.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -87.2 -59.92 2.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.69 -130.86 6.11 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.043 150.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.3 m 68.05 19.71 9.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.465 0.706 . . . . 0.0 111.886 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.14 146.55 17.84 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.186 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.4 ' CA ' ' HB2' ' A' ' 61' ' ' TRP . 41.0 p -125.37 176.28 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -58.8 -36.0 73.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.195 0.521 . . . . 0.0 110.783 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.92 -25.08 61.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.626 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.57 82.44 3.02 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.764 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.4 Cg_exo -84.8 136.28 6.06 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.245 2.63 . . . . 0.0 111.245 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.62 173.27 9.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.726 HD13 ' HG2' ' A' ' 59' ' ' LYS . 28.9 mm -111.04 118.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.113 0.482 . . . . 0.0 111.125 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.9 pp -122.9 130.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.977 0.894 . . . . 0.0 111.622 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.817 ' HG2' HG22 ' A' ' 57' ' ' VAL . 48.1 mtm180 -105.89 114.32 28.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.961 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 28' ' ' ALA . 3.3 mm? -82.2 164.0 21.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.691 0.758 . . . . 0.0 109.781 168.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.685 ' HD2' ' HD2' ' A' ' 9' ' ' ARG . 51.1 ttt180 -132.22 140.32 48.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 52' ' ' THR . 17.5 tt0 -83.62 72.26 10.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HA ' HG13 ' A' ' 7' ' ' VAL . 26.4 mtm180 47.21 -64.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 111.456 -2.611 . . . . 0.0 113.612 -166.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.94 52.71 0.58 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.993 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.498 ' CG2' ' HB3' ' A' ' 49' ' ' GLU . 8.2 p -95.21 160.16 14.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.556 -0.379 . . . . 0.0 111.417 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.98 -21.95 58.84 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -100.94 111.71 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.062 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 HH11 ' A' ' 9' ' ' ARG . 98.1 t -86.6 132.36 32.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.246 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.474 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 90.0 m-70 -84.82 138.73 32.4 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.817 HG22 ' HG2' ' A' ' 46' ' ' ARG . 86.3 t -130.79 117.34 37.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.101 -171.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.827 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -129.11 139.94 51.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' A' ' 44' ' ' ILE . 24.0 mttp -70.32 161.32 30.63 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 162.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -153.47 142.52 21.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.59 -171.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.513 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 35.8 p90 -162.01 -166.88 1.52 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 87.3 mttt -143.34 136.69 28.14 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.754 ' O ' ' HA ' ' A' ' 80' ' ' SER . 30.9 mm-40 -145.39 171.39 14.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.979 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.53 74.58 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 122.292 1.044 . . . . 0.0 108.223 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HG3' ' A' ' 78' ' ' LYS . 27.5 m -85.6 -167.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.691 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.76 125.05 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.734 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.833 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . . . -120.34 141.24 31.51 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.073 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.95 -165.71 0.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.434 2.756 . . . . 0.0 113.519 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -51.63 -19.78 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.78 7.4 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 0.0 110.768 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 8.5 ptt180 -81.22 163.25 55.9 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.323 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 12.6 Cg_exo -68.03 166.1 25.96 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.355 2.037 . . . . 0.0 112.071 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.02 -22.51 20.75 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 60.8 p-90 -74.33 -29.38 61.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.403 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.464 ' HE2' ' HG2' ' A' ' 72' ' ' PRO . 18.4 ttp -99.3 145.94 30.9 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.417 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.4 175.5 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 110.028 168.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.4 mp0 -41.02 -62.68 0.78 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.833 ' HE2' ' HB2' ' A' ' 67' ' ' ALA . 65.8 mmtt -152.01 -173.93 4.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.169 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.642 HD13 ' CG ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -161.56 160.79 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.49 -160.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.754 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -73.34 79.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.756 0.788 . . . . 0.0 109.977 -176.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.642 ' CG ' HD13 ' A' ' 79' ' ' ILE . 66.2 mmtt -113.03 162.08 23.59 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.477 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 25.7 Cg_endo -62.44 119.07 6.0 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.982 2.455 . . . . 0.0 110.903 170.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HE2' ' HB2' ' A' ' 63' ' ' GLU . 23.2 m-85 -107.61 176.25 5.21 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.95 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -165.55 173.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -162.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 179.47 99.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.565 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.562 ' HD2' HD11 ' A' ' 89' ' ' ILE . 18.1 ttpp -68.86 103.81 1.89 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.627 0.727 . . . . 0.0 112.225 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 12.4 pt-20 -106.05 2.15 27.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.998 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 10.1 ptm180 -174.77 175.54 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.288 0.566 . . . . 0.0 111.672 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.562 HD11 ' HD2' ' A' ' 86' ' ' LYS . 23.2 mm -132.56 145.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.561 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 8.9 mt-10 -113.95 177.64 4.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 91' ' ' LYS . 1.6 mtmt . . . . . 0 C--N 1.314 -0.959 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.524 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 29.8 m . . . . . 0 N--CA 1.446 -0.632 0 CA-C-O 121.378 0.608 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -83.76 144.99 28.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.02 0.914 . . . . 0.0 112.182 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -96.14 134.97 38.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.19 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.552 ' HB3' HD12 ' A' ' 47' ' ' LEU . 70.6 m-85 -130.51 146.43 52.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.736 0.779 . . . . 0.0 111.004 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.838 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 9.5 t -96.01 149.01 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.804 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 10.5 tp -113.54 147.79 37.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.99 162.9 37.84 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 170.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.83 -160.58 0.5 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.641 ' OE1' ' HD3' ' A' ' 46' ' ' ARG . 5.3 mm-40 -91.05 0.53 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.79 -16.45 13.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.741 -168.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.455 ' HA2' ' NH2' ' A' ' 9' ' ' ARG . . . 104.62 35.44 3.29 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.472 -1.347 . . . . 0.0 112.249 -176.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.618 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 18.4 m120 -107.74 101.71 10.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.94 122.54 27.9 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.064 0.459 . . . . 0.0 110.859 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.676 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 92.3 m-70 -110.05 -167.01 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.864 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -52.27 166.33 1.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.873 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 94.6 t -95.36 110.81 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.493 0.664 . . . . 0.0 110.185 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 m-85 -86.55 120.05 27.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.549 1.166 . . . . 0.0 112.225 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.524 ' HB ' ' CG2' ' A' ' 3' ' ' THR . 21.3 p -86.9 142.23 28.17 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.383 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.21 139.23 4.27 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -63.64 -20.18 65.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.846 0.823 . . . . 0.0 110.568 -175.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 13.5 pt20 -161.1 165.5 16.94 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.3 Cg_exo -43.85 -51.8 6.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.967 2.445 . . . . 0.0 112.97 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 39.2 ttt180 -51.0 -41.93 60.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.54 HE22 HD22 ' A' ' 29' ' ' LEU . 14.5 mm100 -78.29 -33.56 49.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 0.0 111.26 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.15 79.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.502 0.667 . . . . 0.0 109.635 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.624 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -69.82 -32.73 71.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.215 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.54 HD22 HE22 ' A' ' 26' ' ' GLN . 0.8 OUTLIER -55.88 -59.51 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -50.71 -24.34 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.138 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -90.47 -25.11 20.48 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.713 -0.617 . . . . 0.0 110.246 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.75 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -88.63 -16.28 32.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.292 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -15.39 56.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.592 -173.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.51 -28.92 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 110.673 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.38 102.8 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 m -59.12 -41.66 88.73 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.098 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.23 -139.6 0.41 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 123.931 0.77 . . . . 0.0 111.788 -170.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -147.29 171.18 15.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -62.14 -28.2 69.48 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.094 0.474 . . . . 0.0 110.679 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.53 -24.17 25.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.448 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.1 p-10 -143.93 64.6 13.1 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.425 0.631 . . . . 0.0 110.238 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.751 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 19.7 Cg_exo -64.81 150.17 88.53 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.634 2.223 . . . . 0.0 112.599 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.71 124.46 28.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' ' 59' ' ' LYS . 17.5 mm -74.6 117.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.785 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.499 HD11 ' HB1' ' A' ' 28' ' ' ALA . 17.7 pt -107.16 139.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.696 0.76 . . . . 0.0 111.397 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.648 ' O ' HD22 ' A' ' 47' ' ' LEU . 33.7 mmm-85 -94.89 171.54 8.71 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.948 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -154.56 94.74 1.72 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.656 -177.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.838 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.2 ttp180 -78.9 143.39 35.91 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 131.74 54.09 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.01 19.03 7.13 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.279 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.75 -18.05 1.81 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.703 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.2 p -124.32 179.64 4.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.239 0.52 . . . . 0.0 111.326 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -108.11 33.64 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.527 0.68 . . . . 0.0 109.513 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -133.4 123.66 25.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.492 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.579 HG22 ' HG3' ' A' ' 48' ' ' ARG . 50.0 t -94.37 125.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.088 0.47 . . . . 0.0 109.918 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.434 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 33.7 m-70 -81.13 146.79 30.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.517 ' C ' ' HD1' ' A' ' 58' ' ' PHE . 8.3 p -135.13 127.33 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.422 0.629 . . . . 0.0 111.042 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.517 ' HD1' ' C ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -129.55 143.09 50.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 175.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -68.53 171.68 7.19 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.565 159.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -171.63 133.05 0.76 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.132 0.491 . . . . 0.0 109.823 -161.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.493 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 41.4 p90 -158.28 -177.48 6.58 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.665 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 55.0 mtmt -131.7 142.75 49.89 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.931 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.686 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 34.0 mt-10 -131.06 175.01 9.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.548 -0.751 . . . . 0.0 108.983 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.906 HD11 ' HB3' ' A' ' 78' ' ' LYS . 9.5 tt -95.53 134.9 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.411 1.1 . . . . 0.0 112.234 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.812 HG21 ' HG3' ' A' ' 81' ' ' LYS . 32.1 m -135.15 -174.4 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.166 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 4.2 p-10 -99.88 165.53 11.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 77' ' ' GLU . . . -142.05 -177.16 0.63 Allowed Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -167.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HD2' ' HD2' ' A' ' 71' ' ' ARG . 58.9 Cg_endo -83.94 148.7 12.19 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.812 1.675 . . . . 0.0 111.236 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -78.29 2.55 18.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.692 -172.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 68' ' ' PRO . 26.1 p-10 -92.07 7.85 40.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.315 0.579 . . . . 0.0 110.825 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.726 ' HD2' ' HD2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -69.24 171.64 6.39 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.633 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 68.6 Cg_exo -53.15 178.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.403 2.735 . . . . 0.0 114.297 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.38 81.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.834 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.457 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 42.5 p-90 -81.37 -39.48 24.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.864 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 44.9 ttm -77.04 115.47 48.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.534 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 74' ' ' TRP . 76.9 Cg_endo -109.3 -155.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.678 2.919 . . . . 0.0 112.026 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.808 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . 4.6 pt-20 -52.11 -59.65 4.12 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.769 167.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.906 ' HB3' HD11 ' A' ' 64' ' ' ILE . 18.6 mmtp -76.64 114.0 14.9 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.195 -172.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -163.79 -178.42 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.29 -175.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' ILE . 2.8 p -73.75 158.54 34.43 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.177 0.513 . . . . 0.0 111.968 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.812 ' HG3' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -162.23 136.15 4.87 Favored Pre-proline 0 C--O 1.22 -0.486 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -171.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.665 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 76.3 Cg_exo -52.4 153.98 12.4 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.87 2.38 . . . . 0.0 113.9 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.686 ' CE1' ' HB2' ' A' ' 63' ' ' GLU . 70.2 m-85 -165.93 157.41 13.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.624 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -165.21 169.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -166.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.418 ' H ' HG12 ' A' ' 84' ' ' VAL . 59.4 tttp -171.17 98.93 0.21 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.599 0.238 . . . . 0.0 110.519 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.481 ' HE3' HD11 ' A' ' 89' ' ' ILE . 67.2 tttt -53.02 128.26 26.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.523 170.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 3.4 pm0 -130.85 -5.78 4.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.562 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' N ' ' A' ' 89' ' ' ILE . 8.6 ttp180 -171.24 174.56 4.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.37 -166.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.481 HD11 ' HE3' ' A' ' 86' ' ' LYS . 17.4 mm -136.1 137.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.41 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -111.14 176.82 4.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.798 0.809 . . . . 0.0 111.579 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt . . . . . 0 C--N 1.313 -0.984 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.894 -176.032 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 N--CA 1.449 -0.491 0 CA-C-O 121.163 0.506 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.6 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 27.7 mmm180 -92.76 137.5 32.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.343 1.068 . . . . 0.0 111.208 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 50' ' ' ARG . 1.1 m-80 -106.73 116.65 32.3 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.85 -1.977 . . . . 0.0 111.301 -175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.6 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 91.0 m-85 -129.99 177.32 7.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.567 1.175 . . . . 0.0 112.422 -174.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.889 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 35.2 t -147.68 149.94 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.521 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.8 tp -96.83 158.33 15.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.646 HH11 HG21 ' A' ' 55' ' ' VAL . 49.4 mtp180 -124.79 147.19 48.84 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 12.8 t70 -69.65 -167.65 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.9 0.318 . . . . 0.0 111.015 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.47 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 26.3 mm-40 -61.83 -39.59 92.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 111.435 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.79 -37.61 22.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.474 0.654 . . . . 0.0 109.702 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 9' ' ' ARG . . . 132.51 45.0 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 118.721 -1.705 . . . . 0.0 112.063 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.4 -97.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -173.95 137.23 0.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 88.1 m-70 -144.6 166.25 25.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.154 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 34.53 -171.86 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.86 110.89 7.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.792 -1.704 . . . . 0.0 106.638 163.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.04 106.11 16.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.871 1.319 . . . . 0.0 113.364 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.0 p -91.08 117.29 29.48 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.877 170.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.66 169.5 24.59 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 113.776 -1.557 . . . . 0.0 111.947 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.82 -11.28 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.655 0.741 . . . . 0.0 110.293 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -160.82 147.12 11.52 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.391 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 53.8 Cg_exo -43.51 -42.56 11.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.904 . . . . 0.0 113.02 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -60.31 -35.22 75.1 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.457 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 86.2 mm-40 -75.92 -39.03 57.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.631 0.729 . . . . 0.0 109.969 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.5 -33.05 75.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.259 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.8 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -83.26 -26.78 30.4 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.39 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 8.3 tt -64.05 -63.9 1.03 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 172.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 66.6 mmtt -31.99 -27.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.058 164.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.91 -37.67 12.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.54 0.686 . . . . 0.0 110.527 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -69.71 -8.66 49.77 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.716 1.206 . . . . 0.0 113.237 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.704 ' ND2' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m-80 -61.96 -51.71 66.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.72 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -63.83 -56.79 12.77 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.914 174.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 34' ' ' ARG . . . 83.19 -94.19 1.76 Allowed Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.289 151.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.4 m 63.66 36.77 10.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.217 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.9 159.34 25.98 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.663 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.5 p -125.27 -177.55 3.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.724 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.7 mtmm -72.12 -25.96 61.94 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.62 -28.32 56.06 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.975 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.78 64.53 8.47 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.31 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 7.1 Cg_exo -64.03 134.94 45.17 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.967 1.778 . . . . 0.0 111.182 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.56 176.7 5.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.523 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.554 HG12 ' HE3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -123.77 136.65 59.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -176.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -138.27 136.71 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.739 172.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.57 ' HG3' HG22 ' A' ' 57' ' ' VAL . 66.8 ttt180 -112.08 113.05 25.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.922 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.527 HD11 ' CA ' ' A' ' 28' ' ' ALA . 23.3 mt -101.36 104.52 15.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.153 0.978 . . . . 0.0 112.205 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.889 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 68.7 ttt180 -69.93 153.77 42.83 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.25 172.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.681 ' HG2' ' H ' ' A' ' 51' ' ' GLY . 50.4 tt0 -122.07 129.47 52.42 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -94.61 18.74 10.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.51 0.671 . . . . 0.0 110.507 176.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.681 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -110.98 -58.1 0.48 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.418 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 6.4 p -93.06 175.34 6.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 0.0 110.877 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -93.72 11.3 29.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.542 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 91' ' ' LYS . 94.7 mttt -108.52 133.67 52.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.837 -174.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.892 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 93.6 t -101.59 128.27 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.504 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 22.8 m-70 -94.51 128.63 41.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.57 HG22 ' HG3' ' A' ' 46' ' ' ARG . 39.7 t -111.7 123.54 67.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.043 0.449 . . . . 0.0 110.686 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 1.06 ' HB3' HG12 ' A' ' 84' ' ' VAL . 34.6 m-85 -131.03 126.86 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.266 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.67 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 19.4 mttp -71.13 154.93 41.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.392 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.593 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . . . -135.35 147.06 48.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.494 -170.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.724 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 18.9 p90 -161.51 -179.38 7.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 45.0 mtmt -138.28 136.05 36.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.742 ' O ' ' HA ' ' A' ' 80' ' ' SER . 56.1 mm-40 -151.42 173.15 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.409 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.461 HG23 ' HA ' ' A' ' 79' ' ' ILE . 4.1 mp -109.37 83.34 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.973 0.892 . . . . 0.0 108.609 168.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.715 ' C ' ' HB2' ' A' ' 78' ' ' LYS . 27.2 m -88.59 -162.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -134.02 90.6 2.71 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.898 -168.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 77' ' ' GLU . . . -70.79 154.12 94.47 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.048 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 15.3 Cg_exo -70.71 -158.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.411 2.741 . . . . 0.0 113.565 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -75.05 -23.41 58.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -84.22 17.2 2.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 18.0 ptt-85 -72.89 170.56 13.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.121 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.66 168.45 24.79 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.899 2.399 . . . . 0.0 112.437 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.7 -20.82 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.379 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.94 -27.09 33.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.524 ' HG2' ' HD2' ' A' ' 76' ' ' PRO . 29.7 ttm -94.56 145.02 28.9 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 75' ' ' MET . 14.0 Cg_exo -67.87 -176.96 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.923 1.748 . . . . 0.0 109.849 167.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.626 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 34.9 mt-10 -44.99 -67.37 0.29 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.715 ' HB2' ' C ' ' A' ' 65' ' ' VAL . 20.8 mmtp -151.1 -177.18 5.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.247 167.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.636 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -157.45 173.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.292 -161.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.742 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 12.4 p -64.59 85.53 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.828 1.33 . . . . 0.0 110.855 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.914 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -117.84 167.13 11.79 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.03 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.704 ' HG2' ' ND2' ' A' ' 33' ' ' ASN . 7.4 Cg_exo -77.73 128.19 9.21 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.523 2.815 . . . . 0.0 110.57 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.914 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 20.5 m-85 -126.47 123.56 38.11 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.06 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -119.38 128.8 75.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.344 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.9 pttt -106.05 169.9 8.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.6 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -109.44 106.43 16.18 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -171.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HG2' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.57 -6.82 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.829 -172.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -176.4 161.94 2.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 12.2 mm -131.81 141.37 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.512 0.673 . . . . 0.0 110.407 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.892 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 69.3 mm-40 -128.1 178.6 6.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.603 -173.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 53.3 mtmt . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.163 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 t . . . . . 0 N--CA 1.446 -0.635 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 5.0 ptm180 -93.86 125.47 38.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.26 1.029 . . . . 0.0 111.766 -171.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.9 OUTLIER -87.8 145.75 25.95 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.389 -178.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.671 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 39.7 m-85 -128.9 170.86 12.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.889 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.747 HG23 ' HG2' ' A' ' 50' ' ' ARG . 15.9 t -130.1 142.41 43.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.631 ' HB3' ' O ' ' A' ' 16' ' ' HIS . 4.0 tp -76.68 124.95 28.42 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.889 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.768 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 6.8 mmm180 -96.62 130.17 43.87 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 14' ' ' ASN . 42.7 p30 -88.34 -171.61 3.43 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.788 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -42.36 -46.69 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.58 -37.23 25.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 111.174 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 9' ' ' ARG . . . 123.0 36.55 0.66 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.731 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 27.2 m-80 -85.98 -178.21 6.5 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.809 0.337 . . . . 0.0 110.294 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' HG11 ' A' ' 7' ' ' VAL . 43.7 mt-10 -105.13 117.99 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.527 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.631 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 79.6 m-70 -137.57 104.27 5.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.911 0.862 . . . . 0.0 111.278 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.75 147.22 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.59 161.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.628 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 80.7 m-85 -150.71 159.59 44.42 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -170.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.0 p -141.25 158.2 44.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.777 0.323 . . . . 0.0 111.254 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.8 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.86 162.61 27.68 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.75 ' H ' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -87.78 0.41 55.8 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.919 0.866 . . . . 0.0 108.889 173.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.67 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 27.0 tt0 -161.33 151.58 14.58 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.273 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.67 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 7.9 Cg_exo -43.12 -60.35 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.559 2.173 . . . . 0.0 112.756 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HB3' HE21 ' A' ' 23' ' ' GLN . 38.5 ttt180 -33.89 -42.29 0.11 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.249 167.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.68 -30.35 59.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 117.938 0.336 . . . . 0.0 111.592 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . -63.01 -63.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.906 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -41.05 -39.02 1.12 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.567 165.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.731 ' HB2' ' HA ' ' A' ' 26' ' ' GLN . 1.6 tp -61.78 -14.59 34.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.106 0.479 . . . . 0.0 111.228 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 60.0 mmtt -87.33 -55.45 3.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.61 -30.05 29.27 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.626 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -61.52 -29.5 70.03 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.663 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.82 2.15 0.33 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -110.12 -55.02 2.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.564 -162.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.03 -33.8 5.9 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 118.963 -1.589 . . . . 0.0 112.944 165.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 t 73.68 -3.86 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.023 0.529 . . . . 0.0 111.371 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.7 -140.39 0.42 Allowed Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 0.0 112.901 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -150.08 167.72 25.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 165.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -58.79 -31.5 68.47 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.4 0.619 . . . . 0.0 110.4 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.43 27.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.363 -173.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.91 70.42 8.61 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.441 0.639 . . . . 0.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.74 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 25.9 Cg_exo -62.15 166.87 11.82 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.712 2.275 . . . . 0.0 111.477 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -97.2 150.06 21.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.493 HD11 ' HD3' ' A' ' 59' ' ' LYS . 23.0 mm -96.17 102.45 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.895 0.855 . . . . 0.0 112.215 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.7 pp -118.98 142.05 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.076 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -129.32 131.72 46.98 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.773 165.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.92 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.4 mm? -90.3 161.12 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.735 0.779 . . . . 0.0 112.118 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.768 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . 18.7 ttp85 -125.01 133.23 53.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.35 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -82.66 72.9 9.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.203 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.747 ' HG2' HG23 ' A' ' 7' ' ' VAL . 35.8 mtp180 30.78 -90.14 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.884 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.61 3.01 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.198 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.842 HG21 ' HE2' ' A' ' 54' ' ' LYS . 54.7 p -138.35 166.29 24.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 110.171 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -112.44 36.46 3.39 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.842 ' HE2' HG21 ' A' ' 52' ' ' THR . 61.0 pttt -124.82 141.23 52.26 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.637 -176.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.641 HG21 ' HE ' ' A' ' 9' ' ' ARG . 10.8 t -124.83 144.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.759 0.314 . . . . 0.0 111.71 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.92 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 7.7 p80 -122.53 118.99 29.58 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.887 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.665 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . 60.8 t -85.1 119.83 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.925 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.956 ' HB3' HG12 ' A' ' 84' ' ' VAL . 8.1 m-85 -131.6 124.98 31.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.74 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 16.9 ttpt -85.57 122.57 29.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 84' ' ' VAL . . . -119.57 144.55 47.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -164.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 9.3 p90 -162.55 175.2 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 14.2 mtpp -142.0 107.47 5.05 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.915 173.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 63' ' ' GLU . 7.0 pt-20 177.4 89.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.039 0.936 . . . . 0.0 112.169 159.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.599 HG22 ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -170.28 102.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.242 -1.536 . . . . 0.0 111.951 167.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.847 HG11 ' HE3' ' A' ' 81' ' ' LYS . 2.1 m -142.97 148.51 19.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 120.706 1.594 . . . . 0.0 110.823 164.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.13 72.15 1.64 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.63 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB1' ' HG2' ' A' ' 71' ' ' ARG . . . -54.13 135.71 58.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.495 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.3 Cg_exo -78.28 -148.97 0.03 OUTLIER 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 123.915 3.077 . . . . 0.0 113.078 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -94.81 -42.03 8.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.461 173.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -71.02 31.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.913 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.526 ' HG2' ' HB1' ' A' ' 67' ' ' ALA . 97.9 mtt180 -62.91 162.67 20.35 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.449 0.642 . . . . 0.0 111.981 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 14.1 Cg_exo -72.61 151.11 52.12 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.463 2.775 . . . . 0.0 109.768 163.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.33 64.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.62 -171.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -88.42 -25.38 22.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.626 ' CG ' HG21 ' A' ' 79' ' ' ILE . 41.1 ttm -84.99 125.62 70.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -169.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 79' ' ' ILE . 60.2 Cg_endo -91.07 -162.48 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.253 2.635 . . . . 0.0 112.362 173.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -51.84 -68.84 0.14 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.924 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.5 mmmt -118.38 138.69 52.26 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.626 HG21 ' CG ' ' A' ' 75' ' ' MET . 0.7 OUTLIER -148.01 169.15 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-O 121.21 0.529 . . . . 0.0 109.645 -169.033 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.646 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 33.8 p -99.16 155.49 17.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.155 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.847 ' HE3' HG11 ' A' ' 65' ' ' VAL . 12.5 mmtp -158.34 150.14 17.12 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 52.3 Cg_exo -53.83 91.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 CA-C-N 121.455 1.555 . . . . 0.0 112.899 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.599 ' CE2' HG22 ' A' ' 64' ' ' ILE . 14.4 m-85 -89.78 142.58 27.55 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.267 1.032 . . . . 0.0 111.342 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.956 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -146.51 151.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.08 178.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -135.63 103.07 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.728 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 82.8 tttt -66.99 120.37 13.52 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.136 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.64 -15.05 7.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.606 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 2.6 ttm180 -166.95 171.61 11.03 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -170.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.606 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 10.4 mm -137.66 136.2 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.7 mm-40 -116.93 140.02 49.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt . . . . . 0 C--N 1.311 -1.078 0 CA-C-O 121.357 0.598 . . . . 0.0 111.399 -176.122 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.5 ' O ' ' HD2' ' A' ' 4' ' ' ARG . 26.3 m . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 120.954 0.407 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.591 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 11.8 mmm180 -126.68 171.51 11.1 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 108.62 7.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 120.973 0.416 . . . . 0.0 110.42 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.591 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 13.8 m-85 -113.16 149.29 33.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.71 0.767 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.02 141.54 19.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.92 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.687 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 19.0 tp -92.59 156.37 17.16 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.426 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HG3' ' HD2' ' A' ' 48' ' ' ARG . 16.7 mtp85 -143.76 113.77 7.26 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.79 170.0 8.16 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.291 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -27.7 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 O-C-N 125.197 1.561 . . . . 0.0 113.048 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.88 -39.36 62.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.636 0.732 . . . . 0.0 111.236 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.05 33.94 6.71 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.485 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 84.8 m-20 -142.5 -174.7 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -82.02 154.19 25.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.583 0.706 . . . . 0.0 110.831 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 9.6 m-70 -135.06 -165.18 1.63 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.404 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -46.3 157.64 0.42 Allowed Glycine 0 CA--C 1.518 0.266 0 O-C-N 123.983 0.802 . . . . 0.0 114.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.55 105.71 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.639 0.733 . . . . 0.0 109.481 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 61.6 m-85 -87.28 113.96 23.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.548 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -95.56 141.88 28.56 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.082 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 164.76 37.97 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -74.0 -19.29 60.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 118.616 1.208 . . . . 0.0 111.259 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 26' ' ' GLN . 26.6 pt20 -157.94 168.89 11.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.7 Cg_exo -45.8 -60.76 0.74 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.686 2.257 . . . . 0.0 112.724 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -39.66 -49.66 2.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.239 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 23' ' ' GLN . 13.1 mm100 -73.12 -24.42 60.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.701 0.286 . . . . 0.0 111.401 -174.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 30' ' ' LYS . . . -74.37 -41.12 61.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.415 0.626 . . . . 0.0 109.666 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -68.98 -35.72 77.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.008 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 9.7 tt -53.78 -55.39 26.91 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 69.6 mmtt -43.7 -43.48 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -73.32 -23.43 60.25 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.85 -0.531 . . . . 0.0 111.549 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -68.0 -11.88 59.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.602 0.715 . . . . 0.0 110.686 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.4 m-80 -78.88 3.0 18.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.658 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.4 mmp_? -89.59 -28.37 19.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.93 38.18 49.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.677 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.622 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . 13.8 m -97.48 5.27 49.9 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.173 0.511 . . . . 0.0 109.932 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.25 157.07 26.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.178 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 p -128.45 -177.47 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 12.8 tptm -61.16 -31.8 71.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.997 0.427 . . . . 0.0 110.732 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -38.51 25.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.68 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.24 75.1 75.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 121.116 0.484 . . . . 0.0 110.636 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.698 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 23.3 Cg_exo -67.29 158.12 58.47 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.71 2.274 . . . . 0.0 113.333 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.622 ' OD1' ' HB2' ' A' ' 36' ' ' SER . 15.8 m-20 -71.91 94.12 1.41 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.847 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 tp -72.92 95.65 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.983 0.897 . . . . 0.0 109.372 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.571 HD11 ' HB1' ' A' ' 28' ' ' ALA . 6.2 pt -109.58 152.23 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.914 -172.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.715 ' HB3' HG11 ' A' ' 55' ' ' VAL . 74.3 mtp180 -114.55 118.53 34.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 47' ' ' LEU . 2.4 mm? -111.13 130.87 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.637 0.653 . . . . 0.0 109.412 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.712 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -122.3 118.76 29.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -77.97 107.19 10.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -47.37 102.61 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.296 0 O-C-N 124.019 0.824 . . . . 0.0 111.481 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.4 -25.26 3.01 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.102 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.8 p -92.49 167.47 11.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 53' ' ' LYS . 24.7 ttmm -111.77 8.97 20.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.216 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -136.89 145.16 44.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.183 0.516 . . . . 0.0 110.96 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.764 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.1 t -101.71 136.41 33.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.958 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 4.4 m-70 -101.0 128.71 46.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 88' ' ' ARG . 12.8 p -114.31 130.55 68.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.549 0.69 . . . . 0.0 110.45 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.753 ' HB2' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -143.13 136.26 28.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.13 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.698 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 53.3 mttp -71.15 109.45 5.21 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.231 163.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.051 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -94.6 145.85 24.54 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 83' ' ' PHE . 13.6 p90 -170.15 146.61 3.02 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.874 ' HE3' ' HG3' ' A' ' 82' ' ' PRO . 11.8 mtpt -101.47 136.23 41.67 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.713 ' O ' ' HA ' ' A' ' 80' ' ' SER . 3.7 tp10 -163.73 158.95 20.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 112.036 -166.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.803 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 39.3 mt -103.54 130.61 53.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.42 150.47 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.484 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.94 93.82 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.914 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HB1' ' HD3' ' A' ' 72' ' ' PRO . . . -51.25 136.27 30.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.404 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HG2' ' HG3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -4.9 -148.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 1 C-N-CA 127.836 5.69 . . . . 0.0 118.22 -165.4 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -51.88 -57.57 8.99 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.503 173.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -132.85 -42.83 0.9 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.304 168.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 71' ' ' ARG . 8.4 mmt180 -144.68 148.04 38.15 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.217 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 1.035 ' HG2' ' HB3' ' A' ' 75' ' ' MET . 5.5 Cg_exo -90.98 166.58 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.434 2.756 . . . . 0.0 108.31 147.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.78 58.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.636 0.731 . . . . 0.0 111.198 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.546 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 58.3 p-90 -109.29 -33.71 6.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.389 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 1.035 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttp -99.44 144.39 28.18 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -167.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.426 ' HD2' HG21 ' A' ' 79' ' ' ILE . 7.0 Cg_exo -73.52 157.18 49.28 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.338 2.692 . . . . 0.0 112.115 169.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 1.7 pm0 -44.19 -48.38 9.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.611 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -138.4 153.67 48.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 175.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.803 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -159.66 -178.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -169.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.713 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 23.1 t -150.72 84.66 1.35 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.394 168.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 26.2 mmtt -97.67 158.16 33.49 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.274 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.874 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 19.9 Cg_exo -63.38 92.44 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.704 1.603 . . . . 0.0 109.31 159.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' HE2' ' O ' ' A' ' 63' ' ' GLU . 35.2 m-85 -78.27 -179.52 6.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.571 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.753 HG12 ' HB2' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -160.92 162.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 79.1 tttt -159.23 98.51 1.43 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.851 0.834 . . . . 0.0 110.709 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HB2' ' HD2' ' A' ' 58' ' ' PHE . 11.9 tmtt? -58.75 113.55 2.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.379 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 12.0 pt-20 -119.63 5.97 11.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.029 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.477 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 39.2 ttp-105 176.24 170.15 0.43 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.015 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -120.24 141.12 41.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.764 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.2 mm-40 -112.14 166.66 11.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.293 0.568 . . . . 0.0 111.174 -173.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.256 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 1.013 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 91.5 m . . . . . 0 CA--C 1.532 0.276 0 CA-C-O 120.782 0.325 . . . . 0.0 110.181 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.599 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 1.3 ptm180 -132.77 155.48 48.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -107.15 145.15 32.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.409 0.55 . . . . 0.0 110.306 -174.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.533 ' HB3' HD12 ' A' ' 47' ' ' LEU . 58.5 m-85 -126.49 158.82 35.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.157 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.972 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -127.85 125.12 64.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.742 0.782 . . . . 0.0 109.166 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.768 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.5 OUTLIER -69.67 142.86 53.33 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.923 -1.489 . . . . 0.0 111.581 -168.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.05 142.1 28.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.225 171.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -88.87 -162.07 0.82 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.24 -38.65 66.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.345 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -86.19 -38.95 17.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 9' ' ' ARG . . . 121.25 30.26 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.705 171.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 47.8 m-80 -70.92 128.67 36.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.239 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.41 107.18 2.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.695 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 78.9 m-70 -103.11 -162.8 0.94 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.558 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' A' ' 16' ' ' HIS . . . -56.56 157.1 10.99 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -170.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.9 t -80.62 140.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 12.9 m-85 -124.24 159.25 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 p -128.61 145.75 51.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.092 0.472 . . . . 0.0 110.919 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -178.57 144.01 6.16 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.9 ptmt -70.09 -7.88 44.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.054 0.927 . . . . 0.0 111.549 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.599 ' HA ' ' HD3' ' A' ' 4' ' ' ARG . 10.0 pt20 -159.29 149.71 15.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.14 174.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.29 -8.46 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.661 3.574 . . . . 0.0 115.079 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.433 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 55.9 ttt180 -96.69 -25.26 15.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.62 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 25.3 mm-40 -86.84 -8.29 57.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.883 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . . . -89.69 -48.69 7.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.49 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.275 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.451 HD13 HE22 ' A' ' 26' ' ' GLN . 1.5 tp -57.2 -56.08 26.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.184 173.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 73.7 mmtt -61.54 -5.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.779 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.34 -40.15 9.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 1.024 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -72.97 -11.18 60.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.162 0.982 . . . . 0.0 109.738 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -83.75 -2.22 55.82 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.37 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -107.43 15.62 24.71 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.12 -167.53 24.76 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -172.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 22.9 m -106.04 -33.21 7.96 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.512 0.156 . . . . 0.0 111.291 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 59.16 171.24 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.11 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 40' ' ' ALA . 6.4 m -156.66 128.33 7.17 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 84.7 tttt -65.21 -16.88 64.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.145 0.498 . . . . 0.0 111.965 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.47 ' H ' HG22 ' A' ' 38' ' ' THR . . . -85.26 -22.04 28.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.71 71.96 2.45 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 121.637 0.732 . . . . 0.0 110.283 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 69.8 Cg_exo -54.77 170.0 0.71 Allowed 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.771 2.981 . . . . 0.0 113.943 -176.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.72 123.14 36.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.1 mm -81.55 120.53 33.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.147 0.499 . . . . 0.0 111.211 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.25 141.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.612 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 81.6 mtp180 -113.54 122.56 47.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -91.69 127.53 37.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 70.0 ttt-85 -116.66 99.79 7.37 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 85.1 tt0 -70.69 112.23 6.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.972 ' HG2' HG12 ' A' ' 7' ' ' VAL . 27.0 mtp180 -47.46 -15.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.05 -38.25 6.48 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.755 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 75.1 p -93.85 165.25 12.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.107 0.48 . . . . 0.0 111.561 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -98.85 7.68 45.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.535 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.779 ' HA ' ' CB ' ' A' ' 91' ' ' LYS . 44.9 mtpt -125.24 148.11 48.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 111.215 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.812 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 26.7 t -93.16 135.73 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.713 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.649 ' HA ' HD13 ' A' ' 89' ' ' ILE . 31.7 m-70 -104.18 100.33 10.07 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.664 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.612 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -93.03 134.85 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 25' ' ' ARG . 2.8 m-85 -142.56 118.93 10.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.044 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 15.3 ptpt -67.31 114.57 6.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.531 -1.268 . . . . 0.0 112.251 159.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.024 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -103.07 151.95 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.46 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.59 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 29.0 p90 -161.29 -172.68 3.5 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 44.8 mtmt -136.81 136.39 38.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.669 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 80' ' ' SER . 20.4 mm-40 -137.64 129.38 28.52 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.586 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.802 ' HB ' ' HB3' ' A' ' 80' ' ' SER . 3.3 tt -100.41 109.17 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.843 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.08 144.64 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.767 0.794 . . . . 0.0 110.382 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 21.7 t70 -74.72 103.56 5.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.936 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB1' ' CB ' ' A' ' 71' ' ' ARG . . . -70.19 133.75 87.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.856 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 58.1 Cg_endo -95.47 -160.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.314 3.343 . . . . 0.0 113.333 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -54.61 -56.29 20.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.281 0.562 . . . . 0.0 110.304 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.02 36.26 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.808 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 17.5 ptt180 -94.09 144.5 28.17 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.766 -0.584 . . . . 0.0 109.553 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 49.7 Cg_exo -59.16 159.83 21.03 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.965 2.444 . . . . 0.0 112.2 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.79 8.26 1.59 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.128 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -121.96 -36.44 3.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.588 ' CG ' HD11 ' A' ' 79' ' ' ILE . 36.8 ttm -72.41 114.99 34.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.987 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 81.6 Cg_endo -89.69 -177.91 1.54 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 123.138 2.559 . . . . 0.0 113.704 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 4.3 mm-40 -37.12 -52.42 1.0 Allowed 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 112.235 -2.257 . . . . 0.0 114.015 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -155.34 113.14 3.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.87 0.843 . . . . 0.0 112.059 176.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.613 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -150.0 160.04 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.175 175.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.802 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 14.1 p -110.03 93.41 4.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 160.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.669 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 21.2 mmmt -77.36 156.1 81.47 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.23 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.745 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 4.6 Cg_exo -68.32 90.79 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.254 1.302 . . . . 0.0 110.2 169.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.669 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 23.0 m-85 -75.45 175.09 8.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 122.048 0.928 . . . . 0.0 112.081 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 60' ' ' ALA . 1.8 m -165.16 158.68 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.325 -169.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 6.7 tmtm? -148.83 114.15 5.55 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -75.39 123.67 25.79 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.621 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -101.16 -25.92 13.85 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.621 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 8.6 ptt180 -175.73 -173.11 0.58 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.315 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 56' ' ' HIS . 16.2 mm -131.96 103.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.812 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 30.8 mt-10 -118.24 112.66 20.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 118.868 -1.133 . . . . 0.0 113.863 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.779 ' CB ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 mmmt . . . . . 0 N--CA 1.436 -1.155 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.359 163.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.445 -0.687 0 CA-C-O 121.349 0.595 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.7 ptm180 -85.67 145.88 27.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.452 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.56 HD22 HG22 ' A' ' 20' ' ' THR . 7.6 m120 -84.96 147.09 26.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.554 -172.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 67.2 m-85 -135.59 150.32 49.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.89 136.47 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.1 tp -82.25 124.94 30.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HD3' ' HE ' ' A' ' 46' ' ' ARG . 2.6 mtp180 -101.21 166.92 10.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.513 1.149 . . . . 0.0 114.031 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -134.46 178.1 7.25 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.326 -2.215 . . . . 0.0 108.349 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.02 -35.84 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.62 -39.87 11.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -172.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.44 32.83 1.08 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.845 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.04 -173.57 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.293 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.88 107.8 16.52 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.289 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 85.4 m-70 -102.35 75.99 1.52 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.761 0.791 . . . . 0.0 110.053 175.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.65 153.01 0.98 Allowed Glycine 0 C--N 1.302 -1.348 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.865 -172.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.43 139.08 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.514 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 32.6 m-85 -123.89 151.02 43.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.56 HG22 HD22 ' A' ' 5' ' ' ASN . 22.1 p -114.04 145.42 41.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA3' ' HB2' ' A' ' 27' ' ' ALA . . . -154.81 135.71 4.81 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.893 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -71.83 -9.08 57.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.691 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 5.4 tt0 -160.23 149.01 13.64 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.79 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.691 ' HD2' ' HG2' ' A' ' 23' ' ' GLN . 75.0 Cg_exo -43.85 -9.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.956 3.771 . . . . 0.0 115.514 173.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.601 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 26.0 ttt-85 -96.52 -45.2 6.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 43.7 mm-40 -70.02 -16.86 63.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.979 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . . . -89.02 -19.08 26.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -94.37 -27.83 15.86 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.538 ' HB3' ' HA ' ' A' ' 26' ' ' GLN . 7.8 tt -64.89 -46.6 81.08 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.642 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 3.4 mmmp? -62.78 -13.02 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.618 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -88.32 -23.79 23.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.622 0.725 . . . . 0.0 109.046 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.913 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -68.1 -10.47 54.28 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.752 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -92.75 2.77 56.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.339 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' A' ' 34' ' ' ARG . 11.8 mmt85 -100.41 15.17 28.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -173.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 174.5 -147.12 8.96 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -170.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.533 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 72.1 m -149.01 -41.87 0.15 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.008 -1.096 . . . . 0.0 109.166 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.79 5.32 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -168.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.1 p -151.99 177.58 10.32 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.442 ' HE3' ' OE2' ' A' ' 63' ' ' GLU . 20.5 ttmt -67.44 -31.89 72.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.702 0.763 . . . . 0.0 109.859 172.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.02 -39.47 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.503 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.62 75.42 73.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.79 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.422 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 35.9 Cg_exo -63.53 158.54 45.12 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.37 2.047 . . . . 0.0 111.549 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 45' ' ' ILE . 5.2 t70 -88.69 72.68 8.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.587 HG12 ' HG2' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -54.61 130.59 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.396 -174.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.538 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -128.15 152.98 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.84 0.828 . . . . 0.0 110.867 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.771 ' NH1' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.59 127.46 53.05 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.774 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -118.18 132.55 56.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.632 ' HB2' HH21 ' A' ' 46' ' ' ARG . 41.4 ttt180 -131.03 127.81 39.02 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 30.7 tt0 -71.3 149.77 45.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -67.89 116.18 8.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.351 0.596 . . . . 0.0 111.182 -165.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -8.84 78.92 Favored Glycine 0 C--N 1.318 -0.437 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.247 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 23.1 p -96.86 170.96 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.926 0.393 . . . . 0.0 111.479 -174.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.55 -8.19 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.229 171.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 48' ' ' ARG . 57.3 mttp -49.28 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 111.784 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.771 HG13 ' NH1' ' A' ' 46' ' ' ARG . 14.3 t -110.1 101.9 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.774 ' CE1' ' HB3' ' A' ' 47' ' ' LEU . 4.0 p80 -111.3 128.03 55.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.365 172.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' A' ' 46' ' ' ARG . 43.0 t -109.17 115.76 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.817 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.96 131.82 53.37 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.587 ' HG2' HG12 ' A' ' 44' ' ' ILE . 30.8 mtpt -72.83 117.83 15.02 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.688 1.131 . . . . 0.0 110.869 164.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.913 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -108.61 137.81 45.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.247 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -149.99 -174.43 4.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 32' ' ' ALA . 25.0 mtpt -143.04 122.63 13.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.662 ' HG2' ' CE2' ' A' ' 83' ' ' PHE . 12.1 pt-20 -149.62 174.03 13.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.805 HD11 ' HB3' ' A' ' 78' ' ' LYS . 8.2 tt -115.47 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.33 145.94 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.268 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.673 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 11.2 p-10 -80.3 113.54 18.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.967 170.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.765 ' HB3' ' HA ' ' A' ' 77' ' ' GLU . . . -77.41 129.99 75.8 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.073 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -79.81 -177.33 3.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.955 2.437 . . . . 0.0 111.511 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -49.94 -58.64 5.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 110.04 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.51 31.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 75' ' ' MET . 14.7 ptt85 -64.59 151.14 92.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 118.654 0.661 . . . . 0.0 110.068 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.52 147.07 95.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 111.601 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.68 5.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.449 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.0 p-90 -113.87 -24.72 8.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.655 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.612 ' HG2' HG12 ' A' ' 79' ' ' ILE . 22.8 ttp -101.68 118.94 58.58 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' HG21 ' A' ' 79' ' ' ILE . 12.8 Cg_exo -65.87 144.91 78.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.565 2.177 . . . . 0.0 113.344 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.765 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . 31.0 mp0 -31.43 -54.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.805 1.316 . . . . 0.0 112.322 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.805 ' HB3' HD11 ' A' ' 64' ' ' ILE . 29.5 mmtp -112.22 134.63 53.65 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.462 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.612 HG12 ' HG2' ' A' ' 75' ' ' MET . 1.1 pp -155.22 146.73 13.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.826 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 t -122.5 121.73 37.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 6.2 tppt? -154.64 145.76 16.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.472 -168.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 62' ' ' LYS . 51.0 Cg_exo -52.63 146.86 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.558 1.505 . . . . 0.0 109.474 156.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.758 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 11.2 m-85 -144.44 149.37 35.91 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -169.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -153.01 150.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 19.4 tptm -141.79 105.97 4.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.215 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HE3' HD11 ' A' ' 89' ' ' ILE . 86.8 tttt -73.32 101.89 3.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 4.5 pt-20 -109.63 -36.73 5.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.705 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.478 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 23.9 ttt180 -128.35 152.94 47.57 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.235 0.54 . . . . 0.0 110.455 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.541 HD11 ' HE3' ' A' ' 86' ' ' LYS . 25.5 mm -143.98 159.56 15.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.442 -176.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 20.0 mm-40 -142.26 179.17 7.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 9.9 ptpt . . . . . 0 C--N 1.31 -1.112 0 CA-C-O 122.148 0.975 . . . . 0.0 112.322 -171.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 14.3 m . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.742 0.306 . . . . 0.0 111.274 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.674 HH22 ' HG3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -148.94 154.46 39.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -96.76 136.5 37.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.84 0.352 . . . . 0.0 111.759 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.451 ' HZ ' ' NH2' ' A' ' 4' ' ' ARG . 96.7 m-85 -133.14 129.72 38.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.428 0.632 . . . . 0.0 111.73 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.782 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 3.1 t -103.53 100.83 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.978 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.495 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -61.89 144.8 54.4 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.921 173.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 9.6 ptm85 -132.49 132.53 42.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 170.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -115.92 169.44 9.23 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.788 -165.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -23.62 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 O-C-N 126.452 2.345 . . . . 0.0 114.38 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.87 -37.19 86.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.62 35.15 2.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 m120 -138.36 170.54 15.84 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -86.65 156.17 20.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.262 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.473 ' HB2' HD23 ' A' ' 8' ' ' LEU . 27.1 m-70 -142.52 -164.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -38.87 128.11 1.95 Allowed Glycine 0 C--N 1.339 0.697 0 O-C-N 124.473 1.108 . . . . 0.0 113.52 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -80.92 104.52 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.278 1.037 . . . . 0.0 108.231 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.461 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 39.5 m-85 -88.46 113.11 23.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.501 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -88.39 136.15 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.531 -1.668 . . . . 0.0 107.945 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.62 140.66 6.3 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -76.96 -1.27 27.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.476 0.638 . . . . 0.0 111.144 -175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.712 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 25.2 tt0 -155.61 146.68 16.53 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.712 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 85.3 Cg_exo -47.07 -55.12 4.17 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.456 2.104 . . . . 0.0 112.383 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HB3' HE21 ' A' ' 23' ' ' GLN . 23.8 ttp180 -45.16 -28.29 0.73 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 173.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.613 ' HG2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 mm100 -82.23 -26.22 33.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 19' ' ' PHE . . . -80.14 -40.85 26.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.708 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -58.57 -36.2 73.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.363 169.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.404 HD13 HE22 ' A' ' 26' ' ' GLN . 2.6 tt -66.44 -53.0 40.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -50.31 -19.44 0.82 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.903 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.717 ' O ' ' HG2' ' A' ' 34' ' ' ARG . . . -95.49 -41.09 9.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.475 0.58 . . . . 0.0 109.73 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.525 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -59.79 -20.11 54.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.267 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -40.15 75.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.991 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 7.4 ptm180 -84.55 -23.61 29.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.89 0.376 . . . . 0.0 110.937 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.98 70.69 2.87 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.305 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 m -76.67 60.36 1.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.091 0.472 . . . . 0.0 112.196 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.72 40.43 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.3 p -132.09 166.79 20.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.503 0.651 . . . . 0.0 109.74 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -66.54 -14.27 62.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 0.0 111.55 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.97 -18.56 21.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.343 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.447 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -151.78 63.48 5.36 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.976 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 13.3 Cg_exo -68.45 151.98 75.44 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.704 2.269 . . . . 0.0 112.621 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -77.54 122.11 24.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.719 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.777 HD11 ' HE3' ' A' ' 59' ' ' LYS . 17.5 mm -71.22 109.61 3.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.42 0.629 . . . . 0.0 111.064 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 58' ' ' PHE . 2.7 pp -113.75 137.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.515 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.513 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 24.1 mtp180 -124.38 104.87 9.02 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.01 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.578 HD11 ' N ' ' A' ' 28' ' ' ALA . 86.0 mt -88.65 131.0 35.17 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.327 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.782 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -84.27 154.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.452 0.644 . . . . 0.0 109.547 174.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.507 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 34.6 tt0 -116.96 76.98 1.07 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.623 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.671 ' HG2' HG23 ' A' ' 7' ' ' VAL . 6.3 mtp180 -30.66 119.18 0.18 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.059 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.65 -24.21 24.38 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.127 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 10.6 p -114.25 -172.21 2.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.182 0.491 . . . . 0.0 110.201 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -123.17 27.22 7.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 109.534 170.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -110.08 138.18 46.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.411 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' CG1' ' HB3' ' A' ' 46' ' ' ARG . 39.9 t -109.8 127.47 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.476 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.649 ' HA ' HD13 ' A' ' 89' ' ' ILE . 62.9 m-70 -88.49 111.71 22.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.711 0.291 . . . . 0.0 110.784 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 46' ' ' ARG . 38.5 t -97.09 108.12 21.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.479 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.846 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -120.06 122.48 41.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.155 172.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.976 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 44.1 mttp -68.76 111.77 5.07 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.1 163.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.687 ' HB2' HG13 ' A' ' 84' ' ' VAL . . . -92.92 134.88 34.65 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.011 174.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.591 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 41.6 p90 -144.46 -172.32 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 47.8 mttp -133.8 139.77 46.5 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.208 0.527 . . . . 0.0 110.387 174.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.768 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 18.1 mm-40 -133.09 140.04 47.45 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.365 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.78 143.08 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 79' ' ' ILE . 5.5 m -145.96 -175.35 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.141 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.9 p-10 -162.91 124.17 2.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 168.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -131.74 150.01 75.05 Favored Pre-proline 0 C--N 1.315 -0.925 0 O-C-N 121.613 -0.68 . . . . 0.0 110.675 -167.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.4 Cg_exo -78.0 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.294 1.996 . . . . 0.0 113.833 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 71' ' ' ARG . 59.6 mmtt -93.98 -51.23 4.96 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.64 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 77' ' ' GLU . 22.8 mtm105 -83.04 167.11 31.55 Favored Pre-proline 0 C--N 1.316 -0.885 0 O-C-N 121.219 -0.926 . . . . 0.0 109.998 166.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 15.7 Cg_exo -69.85 170.83 15.77 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 122.197 1.932 . . . . 0.0 110.312 163.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.59 1.33 34.29 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.585 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -120.77 -38.71 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.187 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.627 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 10.1 ttp -74.82 126.93 87.87 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 7.1 Cg_exo -73.71 151.44 46.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.274 2.649 . . . . 0.0 111.861 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 7.2 pt-20 -25.58 -58.57 0.07 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.465 1.506 . . . . 0.0 114.726 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -100.39 119.06 37.88 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.343 -164.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -165.36 164.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.053 -174.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 38.2 p -109.06 95.64 5.77 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 20.5 mttt -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.457 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.541 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 4.1 Cg_exo -80.87 96.33 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.642 2.228 . . . . 0.0 111.913 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.768 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 47.4 m-85 -94.36 120.82 35.17 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.371 0.605 . . . . 0.0 110.553 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.846 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -99.29 178.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.422 175.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.733 ' HE2' ' HB3' ' A' ' 87' ' ' GLU . 5.1 tttt -166.18 104.39 0.65 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.125 -173.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.611 ' HE2' HD11 ' A' ' 89' ' ' ILE . 65.8 tttm -61.62 127.7 32.71 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 171.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.733 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 13.5 pt-20 -127.41 -34.03 2.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.271 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 88' ' ' ARG . 15.4 ttp180 -151.74 159.5 43.93 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.712 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 56' ' ' HIS . 21.0 mm -123.23 107.96 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.741 173.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.428 ' CD ' ' HE ' ' A' ' 88' ' ' ARG . 6.0 mm-40 -92.5 -177.46 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.122 0.963 . . . . 0.0 113.286 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.882 170.937 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.701 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -93.06 125.3 37.58 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.85 0.833 . . . . 0.0 110.966 -178.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -88.82 145.0 25.85 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.858 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.783 ' CE2' ' HG3' ' A' ' 49' ' ' GLU . 82.5 m-85 -130.98 144.59 51.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.536 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 50' ' ' ARG . 47.1 t -112.83 127.92 69.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 16' ' ' HIS . 3.9 tp -66.63 130.01 41.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.216 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 67.1 mtp180 -106.82 128.03 53.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 166.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -87.62 -169.78 2.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -37.57 -48.24 0.99 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.589 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -80.2 -35.07 36.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.595 0.712 . . . . 0.0 110.258 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.6 31.41 1.81 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.641 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.686 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -96.89 148.1 23.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -173.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.77 130.42 38.6 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.784 0.677 . . . . 0.0 111.013 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.631 ' HB2' HD23 ' A' ' 8' ' ' LEU . 92.0 m-70 -138.22 -171.47 3.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.737 -176.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -12.2 130.45 0.01 OUTLIER Glycine 0 N--CA 1.461 0.331 0 O-C-N 126.736 2.522 . . . . 0.0 113.366 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.79 156.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.685 0.278 . . . . 0.0 111.077 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 92.6 m-85 -151.43 156.82 41.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -139.71 158.36 44.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.581 0.229 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.701 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.71 150.63 8.38 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.103 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.52 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 2.7 tppp? -72.79 -6.33 44.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.487 0.643 . . . . 0.0 110.767 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.872 ' HG3' ' HG2' ' A' ' 26' ' ' GLN . 5.5 pt20 -160.46 158.62 25.61 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 11.6 Cg_endo -56.84 -13.48 11.49 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 123.329 2.686 . . . . 0.0 115.233 -171.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 19.4 ttt180 -94.14 -13.67 26.5 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -174.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.872 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 16.9 mm100 -88.21 -18.08 29.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.061 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 -59.05 2.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.819 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -35.92 -45.58 0.42 Allowed 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 159.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -57.48 -26.07 60.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.425 0.631 . . . . 0.0 111.076 177.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.764 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 27.2 mmmt -80.94 -47.89 13.06 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.654 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -69.4 -21.56 63.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.843 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -67.47 -12.85 61.28 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.82 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -66.06 -47.66 73.59 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.82 17.71 2.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.977 170.028 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.29 90.68 1.42 Allowed Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -77.09 49.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 110.281 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.32 -165.62 11.94 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.32 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.463 HG22 ' ND2' ' A' ' 41' ' ' ASN . 9.5 t -162.35 171.62 16.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -62.12 -16.42 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.941 0.791 . . . . 0.0 111.029 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 38' ' ' THR . . . -79.85 -30.08 40.24 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.769 . . . . 0.0 110.63 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.463 ' ND2' HG22 ' A' ' 38' ' ' THR . 0.3 OUTLIER -165.15 72.74 1.43 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.182 -176.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' A' ' 59' ' ' LYS . 49.4 Cg_exo -56.19 -169.44 0.02 OUTLIER 'Trans proline' 0 CA--C 1.526 0.082 0 C-N-CA 123.386 2.724 . . . . 0.0 114.008 -174.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -119.4 104.14 10.09 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.403 HD11 ' CG2' ' A' ' 57' ' ' VAL . 6.7 tp -79.05 101.52 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.781 0.8 . . . . 0.0 112.391 -167.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.514 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.4 pp -119.12 129.08 75.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.09 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.788 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 42.2 ttm105 -109.44 118.04 35.59 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 8' ' ' LEU . 3.4 mm? -84.88 161.69 19.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.916 0.865 . . . . 0.0 112.687 175.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.646 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 49.5 ttp180 -133.2 130.46 39.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.003 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.783 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 2.4 mt-10 -80.18 88.2 5.47 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HB3' HG23 ' A' ' 7' ' ' VAL . 3.4 ptm180 -51.56 -9.12 0.07 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.86 -32.47 9.96 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.748 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 p -117.99 -169.75 1.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.002 0.43 . . . . 0.0 110.872 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -108.91 41.62 1.57 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.464 0.65 . . . . 0.0 109.599 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -101.32 138.9 37.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.32 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 81.4 t -124.34 129.07 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.589 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 89' ' ' ILE . 71.2 m-70 -134.84 107.93 7.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -172.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 14.9 p -97.0 138.75 21.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.854 ' HB3' HG12 ' A' ' 84' ' ' VAL . 2.9 m-85 -141.52 138.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.966 0.412 . . . . 0.0 110.321 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HG2' ' OE2' ' A' ' 87' ' ' GLU . 55.3 mmtt -71.66 128.5 35.99 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 161.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -126.02 133.01 51.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HZ3' ' HG2' ' A' ' 85' ' ' LYS . 26.9 p90 -151.93 156.37 39.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 6.7 mtpm? -131.58 124.17 29.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.724 0.773 . . . . 0.0 110.943 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.482 ' HG3' ' HE2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 139.87 31.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.003 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -82.23 145.78 8.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.655 ' H ' HD13 ' A' ' 64' ' ' ILE . 1.5 t -130.19 176.51 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -167.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 25.4 t0 176.79 50.39 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -133.87 118.71 14.45 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.38 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.551 ' HA ' ' HG2' ' A' ' 71' ' ' ARG . 7.3 Cg_exo -74.14 -19.81 19.72 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 C-N-CA 123.697 2.931 . . . . 0.0 113.822 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -71.54 -36.09 70.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.458 -171.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 42.9 m-80 -114.82 33.39 5.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.852 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.852 ' HG3' HH11 ' A' ' 71' ' ' ARG . 5.5 mmt85 -76.21 111.95 18.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.178 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 10.0 Cg_exo -73.76 174.47 12.24 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 123.838 3.025 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.24 8.69 20.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.479 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.565 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.2 p-90 -123.49 -31.79 3.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.319 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.775 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.4 ttp -97.78 141.46 23.02 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.325 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 11.7 Cg_endo -79.68 -148.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.63 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 35.7 mt-10 -91.37 -40.54 11.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.213 -0.304 . . . . 0.0 111.745 -169.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.662 ' HD2' ' HB2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -144.79 118.38 9.15 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -175.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.783 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.19 159.15 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 CA-C-O 120.934 0.397 . . . . 0.0 110.266 -176.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 44.5 t -112.31 126.48 55.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 14.0 tppt? -146.64 135.57 11.22 Favored Pre-proline 0 N--CA 1.438 -1.05 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -164.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.769 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 22.3 Cg_exo -64.67 89.97 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 CA-C-N 119.747 0.945 . . . . 0.0 110.389 172.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.754 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 18.3 m-85 -75.42 139.28 42.22 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.985 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.854 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -150.43 155.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.739 -177.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HG2' ' HZ3' ' A' ' 61' ' ' TRP . 3.7 ptmm? -151.78 138.97 19.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.11 0.481 . . . . 0.0 111.637 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.518 ' HD3' HG12 ' A' ' 89' ' ' ILE . 35.9 ttmt -88.98 89.85 8.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.424 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.548 ' OE2' ' HG2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -55.03 -54.63 40.57 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 165.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HG2' HG11 ' A' ' 57' ' ' VAL . 5.0 ptt180 -143.61 171.62 13.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.445 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' A' ' 56' ' ' HIS . 15.8 mm -145.37 131.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.747 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 32.4 mt-10 -87.77 -158.01 0.44 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.934 1.293 . . . . 0.0 109.17 175.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 46.3 mtmt . . . . . 0 C--N 1.31 -1.143 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -87.05 124.24 33.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.266 0.555 . . . . 0.0 111.369 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.63 135.48 38.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.187 174.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 24' ' ' PRO . 9.2 m-85 -120.3 160.82 22.24 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.567 HG23 ' HG2' ' A' ' 50' ' ' ARG . 3.5 t -118.5 138.22 49.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.864 HD23 ' HB2' ' A' ' 16' ' ' HIS . 11.5 tp -79.28 134.74 36.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -136.31 121.18 18.66 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 1.9 t70 -65.32 179.03 0.81 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.371 0.605 . . . . 0.0 112.273 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.32 -32.4 71.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -83.37 -38.97 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.689 0.756 . . . . 0.0 109.211 175.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.43 21.12 2.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.878 172.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 40.0 mt-10 -81.88 121.31 26.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.864 ' HB2' HD23 ' A' ' 8' ' ' LEU . 62.0 m-70 -114.61 99.5 7.58 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.376 0.607 . . . . 0.0 111.461 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.46 175.92 27.7 Favored Glycine 0 C--N 1.294 -1.787 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.207 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.17 138.69 50.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 55.0 m-85 -126.69 148.52 49.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.5 p -132.33 144.38 50.52 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.195 -0.316 . . . . 0.0 111.688 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.15 33.69 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.945 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -54.97 -40.43 70.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.529 0.681 . . . . 0.0 109.719 171.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.75 177.68 1.73 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.75 -53.33 7.2 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.925 1.75 . . . . 0.0 112.113 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.427 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 34.2 ttm180 -32.28 -53.38 0.3 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -74.86 -17.41 60.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.114 0.483 . . . . 0.0 111.169 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.01 23.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.629 0.728 . . . . 0.0 109.132 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -95.83 -32.63 12.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 84' ' ' VAL . 4.3 mt -57.3 -40.32 77.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.382 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -70.19 -7.07 38.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.724 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -100.48 -48.25 4.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.616 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -73.58 -11.21 60.36 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.237 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.38 -2.19 55.19 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.407 -166.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.6 ptp180 -114.99 15.79 17.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.0 -119.36 2.66 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.661 -171.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m 176.32 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -172.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 46.37 -164.69 0.1 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.539 -175.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.9 p -157.01 141.46 16.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.082 0.553 . . . . 0.0 109.618 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -66.45 -22.47 66.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.761 0.791 . . . . 0.0 110.37 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.03 -43.03 88.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.658 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.51 74.41 4.2 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.621 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.854 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 50.4 Cg_exo -52.83 125.57 18.54 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.377 2.718 . . . . 0.0 113.519 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -42.15 127.47 3.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.105 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 44' ' ' ILE . 11.7 mm -80.65 115.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.001 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.8 pp -106.05 154.62 7.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.101 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.551 ' HB3' ' HG3' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -129.71 101.72 6.02 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.034 -178.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.713 HD23 HD13 ' A' ' 45' ' ' ILE . 4.4 mm? -96.25 135.65 37.8 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -132.85 113.04 12.43 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.437 -175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 33.6 mt-10 -59.56 108.92 0.79 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.665 0.386 . . . . 0.0 110.059 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HG2' HG23 ' A' ' 7' ' ' VAL . 12.8 mtp180 -34.08 -43.97 0.16 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 174.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.28 -26.5 71.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.728 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 49' ' ' GLU . 6.9 p -103.43 -177.12 3.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.276 0.56 . . . . 0.0 110.989 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -121.1 4.04 10.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.792 169.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 25.7 pttm -90.86 133.31 35.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.264 0.554 . . . . 0.0 110.313 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.927 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 19.0 t -103.61 153.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.759 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -128.9 112.29 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.094 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HB ' ' NE ' ' A' ' 46' ' ' ARG . 2.5 p -98.07 126.11 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 122.602 1.191 . . . . 0.0 113.251 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 1.001 ' HB2' HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -114.13 -173.11 2.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.602 -1.636 . . . . 0.0 107.547 174.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.854 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 13.7 ptpt -141.25 121.13 13.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -108.87 140.9 41.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.659 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 10.2 p90 -160.78 -174.33 4.37 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.104 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' ' CA ' ' A' ' 82' ' ' PRO . 88.0 mttt -127.27 153.34 46.26 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 110.542 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.522 ' CG ' ' HE1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -163.77 177.36 8.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -164.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.732 ' HB ' ' HG2' ' A' ' 76' ' ' PRO . 18.2 pt -62.37 137.28 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.109 0.957 . . . . 0.0 110.669 167.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 1.043 HG22 HG22 ' A' ' 79' ' ' ILE . 1.4 m -99.75 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 -165.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 36.0 t70 -33.35 -94.18 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 112.02 -2.355 . . . . 0.0 115.945 -166.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 76' ' ' PRO . . . -50.26 150.17 4.68 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -166.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 71.7 Cg_endo -110.34 -102.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 1 C-N-CA 125.963 4.442 . . . . 0.0 115.225 -172.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -83.04 -23.6 33.15 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.33 -168.155 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -64.49 -8.13 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.567 1.175 . . . . 0.0 110.461 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 76' ' ' PRO . 24.3 mmm180 -117.14 170.78 5.6 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.378 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 52.9 Cg_exo -57.69 169.03 2.71 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.778 1.652 . . . . 0.0 112.167 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.45 -47.72 84.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.284 0.564 . . . . 0.0 110.46 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.633 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 43.7 p-90 -82.62 -33.22 27.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.434 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.583 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.8 ttm -94.88 112.0 56.55 Favored Pre-proline 0 C--O 1.223 -0.317 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -170.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.764 ' HG2' HG21 ' A' ' 79' ' ' ILE . 47.0 Cg_exo -65.69 -72.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 123.612 2.875 . . . . 0.0 112.976 169.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 4.7 mm-40 -135.79 -80.44 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HD2' ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -159.92 115.25 2.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 166.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.043 HG22 HG22 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -120.22 117.16 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 N-CA-C 119.294 3.072 . . . . 0.0 119.294 -150.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -168.69 88.75 0.21 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 110.451 -3.068 . . . . 0.0 109.351 159.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.716 ' HG2' HG11 ' A' ' 65' ' ' VAL . 23.5 mmtt -122.55 155.7 62.29 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 120.113 1.324 . . . . 0.0 111.546 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.576 ' CA ' ' HG2' ' A' ' 62' ' ' LYS . 95.4 Cg_endo -76.14 123.05 6.99 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.255 2.637 . . . . 0.0 111.363 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 33.8 m-85 -124.51 149.41 46.94 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.777 HG23 HD23 ' A' ' 29' ' ' LEU . 1.1 t -122.3 163.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.315 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 86' ' ' LYS . 1.6 tmmm? -148.67 132.71 17.22 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 51.8 tttm -72.99 113.5 10.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.832 0.825 . . . . 0.0 109.116 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -97.52 -45.02 6.58 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.804 -169.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.578 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 27.0 ttp-105 -156.79 -175.73 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.363 0.601 . . . . 0.0 111.048 -171.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.578 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 14.7 mm -128.12 154.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.605 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.927 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -120.28 -171.29 2.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.051 0.94 . . . . 0.0 110.783 -169.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 53.6 mtmt . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.35 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.6 p . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.574 0.226 . . . . 0.0 111.334 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -91.0 149.0 22.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.052 0.454 . . . . 0.0 110.829 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.3 t -121.58 130.23 53.37 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.527 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.5 OUTLIER -82.9 133.29 35.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.545 1.164 . . . . 0.0 113.496 -173.633 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.54 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 31.6 m-20 -78.53 155.21 29.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.339 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -134.56 176.23 8.82 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 114.857 -1.065 . . . . 0.0 108.443 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.0 t -134.46 146.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 2.4 tp -99.43 120.74 40.1 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.265 -176.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.795 ' HB2' ' HB2' ' A' ' 46' ' ' ARG . 53.1 mtp180 -88.72 157.16 18.61 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.469 177.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.461 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 11.9 t70 -102.35 -151.8 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.739 -174.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.461 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 51.1 mm-40 -83.48 -20.37 34.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.868 0.366 . . . . 0.0 110.917 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -103.25 -6.88 21.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.32 0.581 . . . . 0.0 110.477 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.55 -3.91 50.35 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.397 -0.906 . . . . 0.0 111.315 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.639 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 12.4 m120 -54.63 178.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.192 -0.504 . . . . 0.0 110.653 175.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -130.37 160.15 34.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.272 0.558 . . . . 0.0 111.994 -169.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 77.9 m-70 -142.58 -159.59 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.172 -171.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.65 161.2 17.4 Favored Glycine 0 N--CA 1.45 -0.372 0 O-C-N 123.448 0.467 . . . . 0.0 112.84 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 p -84.25 110.9 19.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.898 0.856 . . . . 0.0 110.521 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 2.7 m-85 -88.65 174.02 8.28 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.111 175.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 5' ' ' ASN . 74.2 p -148.24 175.34 11.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.999 0.428 . . . . 0.0 109.865 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 154.69 142.93 3.55 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.565 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -14.41 48.32 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.241 0.544 . . . . 0.0 110.39 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.428 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 36.4 tt0 -153.83 142.86 14.71 Favored Pre-proline 0 N--CA 1.448 -0.526 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.802 176.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 72.3 Cg_exo -46.96 -18.74 0.61 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 124.485 3.457 . . . . 0.0 115.492 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -82.81 -12.7 57.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.967 0.413 . . . . 0.0 110.024 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . 23.1 mm-40 -77.37 -65.01 1.01 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.914 173.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -34.46 -37.46 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 164.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.568 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -77.34 -38.97 49.25 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.34 177.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.856 HD12 HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -63.24 -39.19 93.91 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.65 0.738 . . . . 0.0 109.786 177.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.405 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 14.2 mmmm -80.87 -1.03 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.943 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . . . -99.06 -20.3 16.78 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.772 173.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' A' ' 34' ' ' ARG . . . -72.81 -66.33 0.68 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.762 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.621 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -35.06 8.13 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 162.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.61 ' HG2' ' HA ' ' A' ' 31' ' ' ALA . 14.8 mmm180 -91.37 -48.27 6.99 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 119.4 1.0 . . . . 0.0 110.272 -167.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.54 -81.31 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.142 -1.504 . . . . 0.0 115.055 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.8 m -87.26 36.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.545 0.688 . . . . 0.0 110.204 -168.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.583 ' CA ' ' HA ' ' A' ' 61' ' ' TRP . . . -72.73 92.65 0.62 Allowed Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.078 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -133.72 144.07 48.88 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.456 -0.872 . . . . 0.0 109.221 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HD2' ' CD ' ' A' ' 63' ' ' GLU . 68.9 tttt -81.4 -12.81 58.84 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.256 0.55 . . . . 0.0 110.365 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.71 -34.6 64.89 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.047 174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.9 81.06 1.44 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.059 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 87.8 Cg_exo -51.8 140.05 48.26 Favored 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 123.712 2.941 . . . . 0.0 112.826 -174.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -57.32 99.29 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 175.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.924 HD11 ' HE3' ' A' ' 59' ' ' LYS . 19.6 mm -54.9 126.51 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.355 176.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.6 pp -135.27 140.93 44.0 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.795 ' HB2' ' HB2' ' A' ' 9' ' ' ARG . 72.5 mtp180 -117.29 124.83 49.96 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.521 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 45' ' ' ILE . 1.7 mm? -106.2 158.11 17.08 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -142.5 115.73 8.93 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -69.3 130.7 43.33 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.54 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 11.2 mtp180 -77.81 8.05 5.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.63 0.729 . . . . 0.0 109.077 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -112.78 -64.36 0.46 Allowed Glycine 0 N--CA 1.44 -1.064 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.607 174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.5 p -91.7 146.66 23.59 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.189 0.519 . . . . 0.0 112.224 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 1.096 ' HB2' ' HB3' ' A' ' 92' ' ' LEU . 53.3 pttt -84.03 55.65 3.39 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.229 1.014 . . . . 0.0 109.808 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -127.98 111.54 13.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.345 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.966 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.7 t -78.68 99.28 2.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.562 ' HA ' HD13 ' A' ' 89' ' ' ILE . 51.1 m-70 -69.68 135.51 49.95 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG11 ' HG2' ' A' ' 90' ' ' GLU . 4.2 p -140.34 104.98 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-O 122.682 1.23 . . . . 0.0 109.471 -172.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.838 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -104.61 177.54 4.82 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 113.599 -1.637 . . . . 0.0 107.78 -177.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.924 ' HE3' HD11 ' A' ' 44' ' ' ILE . 45.6 mtpt -123.9 127.44 48.0 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 172.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -127.47 123.79 36.82 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.587 -0.845 . . . . 0.0 110.954 -159.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.583 ' HA ' ' CA ' ' A' ' 37' ' ' GLY . 29.3 p90 -134.64 179.84 6.05 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.72 -178.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.621 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 48.2 mtmt -133.84 140.36 46.83 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.338 174.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.617 ' HB2' ' HE2' ' A' ' 83' ' ' PHE . 38.8 mt-10 -129.56 112.81 14.1 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 114.756 -1.111 . . . . 0.0 108.478 173.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 80' ' ' SER . 32.9 mm -79.93 77.97 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.97 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 174.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.65 ' HA ' ' CB ' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -152.24 153.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.873 -177.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.696 ' N ' ' HA ' ' A' ' 78' ' ' LYS . 8.8 t70 157.9 66.44 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 O-C-N 125.279 1.612 . . . . 0.0 107.932 172.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.708 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -60.59 133.86 91.58 Favored Pre-proline 0 C--N 1.312 -1.052 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.266 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.914 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 61.6 Cg_endo -70.37 128.86 16.04 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 C-N-CA 122.853 2.369 . . . . 0.0 115.781 -166.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -95.96 -63.02 1.19 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.322 -1.763 . . . . 0.0 107.621 163.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -124.35 33.83 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.791 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.914 ' HD3' ' HA ' ' A' ' 68' ' ' PRO . 36.9 mtp85 -84.96 163.85 44.24 Favored Pre-proline 0 N--CA 1.464 0.235 0 O-C-N 121.916 -0.49 . . . . 0.0 111.033 -172.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 75' ' ' MET . 18.5 Cg_exo -67.72 160.25 49.05 Favored 'Trans proline' 0 CA--C 1.512 -0.611 0 C-N-CA 123.383 2.722 . . . . 0.0 111.458 173.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.34 -50.15 72.75 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.986 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -59.79 -20.48 57.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.621 ' HG2' ' NH2' ' A' ' 71' ' ' ARG . 13.2 ttm -90.18 111.07 44.83 Favored Pre-proline 0 N--CA 1.451 -0.403 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.454 ' N ' HH21 ' A' ' 71' ' ' ARG . 24.9 Cg_exo -65.24 -135.98 0.01 OUTLIER 'Trans proline' 0 N--CA 1.485 1.027 0 C-N-CA 124.19 3.26 . . . . 0.0 115.052 -170.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.827 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 11.4 mt-10 -117.46 8.47 13.0 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.696 ' HA ' ' N ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -160.26 169.43 23.22 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.804 -1.998 . . . . 0.0 106.51 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.083 HD13 ' HD3' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -162.7 164.54 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 169.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.502 ' O ' ' HD2' ' A' ' 81' ' ' LYS . 74.9 m -65.3 117.8 8.39 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.765 0.793 . . . . 0.0 111.416 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.083 ' HD3' HD13 ' A' ' 79' ' ' ILE . 4.3 mptp? -142.1 112.71 6.23 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 114.077 -1.42 . . . . 0.0 112.181 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.497 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 2.4 Cg_endo -86.54 124.59 2.34 Favored 'Trans proline' 0 N--CA 1.439 -1.719 0 C-N-CA 123.28 2.653 . . . . 0.0 109.219 167.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.722 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 89.1 m-85 -120.82 134.73 55.28 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.856 HG23 HD12 ' A' ' 29' ' ' LEU . 1.5 t -138.81 137.76 42.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.926 179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -122.45 154.67 37.47 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 173.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 27.3 ttmt -99.69 123.37 43.89 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 120.804 1.638 . . . . 0.0 109.195 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.495 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 2.4 pt-20 -89.15 -13.56 38.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.302 -0.559 . . . . 0.0 111.111 -174.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.495 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 12.4 ptt-85 174.08 -173.01 0.06 Allowed 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -174.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.562 HD13 ' HA ' ' A' ' 56' ' ' HIS . 8.7 mm -138.85 136.22 42.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 120.784 0.326 . . . . 0.0 110.16 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.966 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.7 mm-40 -107.01 175.04 5.63 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.686 ' HD2' ' H ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -126.27 140.17 52.74 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.283 0.563 . . . . 0.0 112.407 -174.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.096 ' HB3' ' HB2' ' A' ' 53' ' ' LYS . 13.8 tp -80.85 175.81 10.36 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 164.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.449 ' H ' ' HG ' ' A' ' 92' ' ' LEU . 13.2 mm-40 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.996 -168.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.7 t . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -167.82 135.06 2.22 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.1 m -83.12 131.94 35.12 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.391 0.615 . . . . 0.0 111.934 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.833 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -93.7 133.68 36.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 170.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.623 ' HA ' HG22 ' A' ' 20' ' ' THR . 60.6 m-80 -115.6 113.74 23.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.004 0.431 . . . . 0.0 111.05 -167.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.833 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 0.4 OUTLIER -117.68 148.09 42.3 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 -175.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.785 HG13 HG22 ' A' ' 18' ' ' VAL . 3.3 t -113.66 -179.57 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 160.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.659 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.3 tp -106.56 149.63 26.96 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HD3' ' HB2' ' A' ' 48' ' ' ARG . 24.7 mmm180 -111.05 162.36 14.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 175.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.611 ' HB2' ' HB2' ' A' ' 14' ' ' ASN . 8.4 t70 -92.74 -162.56 0.94 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -92.35 -6.62 49.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 120.073 1.306 . . . . 0.0 108.039 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -110.43 -20.14 12.7 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.214 -1.812 . . . . 0.0 110.591 -170.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 114.93 36.53 1.23 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 119.455 -1.355 . . . . 0.0 112.596 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.611 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 65.4 m-80 -111.23 -173.05 2.15 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 87.7 mt-10 -135.9 145.31 46.18 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.253 0.549 . . . . 0.0 111.092 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 73.9 m-70 -132.57 -166.09 1.69 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.182 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -21.59 130.07 0.01 OUTLIER Glycine 0 C--N 1.332 0.341 0 O-C-N 125.034 1.459 . . . . 0.0 114.248 169.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.785 HG22 HG13 ' A' ' 7' ' ' VAL . 78.4 t -85.53 131.65 33.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.54 ' O ' ' HB2' ' A' ' 6' ' ' PHE . 81.5 m-85 -131.4 125.76 33.42 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 5' ' ' ASN . 38.0 p -139.25 140.77 37.78 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.637 ' H ' ' NH1' ' A' ' 4' ' ' ARG . . . -140.78 -164.81 10.06 Favored Glycine 0 C--N 1.301 -1.369 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.515 -171.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 -8.85 21.84 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 165.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.426 HE21 ' HB3' ' A' ' 23' ' ' GLN . 1.2 tt0 -157.12 139.21 10.25 Favored Pre-proline 0 N--CA 1.454 -0.227 0 CA-C-N 115.101 -0.954 . . . . 0.0 111.654 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HA ' HH21 ' A' ' 4' ' ' ARG . 80.4 Cg_exo -40.91 -47.88 4.77 Favored 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 124.335 3.356 . . . . 0.0 114.077 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.557 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 42.0 ttt180 -53.04 -22.9 6.47 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.074 0.95 . . . . 0.0 113.341 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 22.9 mm-40 -84.05 -50.62 7.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.509 0.671 . . . . 0.0 110.677 -177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.752 ' CB ' HH22 ' A' ' 4' ' ' ARG . . . -59.07 -31.95 69.34 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.685 -1.143 . . . . 0.0 111.214 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.682 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -83.58 -26.24 30.2 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.876 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.783 ' HG ' ' HG2' ' A' ' 82' ' ' PRO . 3.7 tt -65.24 -65.52 0.66 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 172.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -43.75 -31.29 0.78 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.003 -0.998 . . . . 0.0 112.458 169.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.88 -39.65 69.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.166 0.507 . . . . 0.0 110.311 177.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.656 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -70.56 -21.37 62.7 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.367 0.603 . . . . 0.0 111.184 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.4 ' OD1' ' HG3' ' A' ' 82' ' ' PRO . 71.3 m-20 -68.34 -2.83 9.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.965 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.42 ' NH2' ' HE1' ' A' ' 19' ' ' PHE . 8.2 mmt180 -100.06 -13.27 19.09 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -175.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.09 82.85 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.119 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.84 176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.507 ' HB3' ' HB1' ' A' ' 32' ' ' ALA . 13.0 p -100.18 -49.52 4.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.35 -126.92 8.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.909 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -144.88 160.83 40.67 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.105 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -62.12 -20.87 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.589 -170.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.64 -25.43 67.36 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.969 176.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.479 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.0 OUTLIER -161.85 67.82 2.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.442 0.639 . . . . 0.0 110.353 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.3 Cg_exo -65.16 130.95 26.95 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.085 1.857 . . . . 0.0 111.592 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.18 139.39 52.34 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.59 HD11 HG13 ' A' ' 57' ' ' VAL . 5.6 tp -82.97 105.96 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 CA-C-O 121.824 0.821 . . . . 0.0 111.249 -175.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.631 HD11 ' HB1' ' A' ' 28' ' ' ALA . 2.7 pp -95.94 123.27 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 122.351 1.072 . . . . 0.0 110.345 177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' HD22 ' A' ' 47' ' ' LEU . 77.5 mtp180 -91.79 173.26 7.96 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.446 175.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.57 ' CB ' ' HB2' ' A' ' 56' ' ' HIS . 0.3 OUTLIER -147.47 148.23 31.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.58 ' HB2' ' HD3' ' A' ' 9' ' ' ARG . 11.6 tpt180 -124.18 111.27 15.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.106 0.479 . . . . 0.0 110.169 -175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 56' ' ' HIS . 8.4 tp10 -86.27 104.57 15.93 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.568 ' HD3' ' HB3' ' A' ' 5' ' ' ASN . 2.8 ptm180 -73.05 25.66 0.06 Allowed 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.434 0.635 . . . . 0.0 111.429 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 49' ' ' GLU . . . -128.63 0.99 6.39 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.325 172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 44.6 p -146.65 169.78 18.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 117.411 0.605 . . . . 0.0 109.825 -175.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -95.21 38.21 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -127.94 132.19 49.27 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.923 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.852 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 49.1 t -92.47 119.7 40.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.129 174.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 47' ' ' LEU . 95.2 m-70 -81.42 131.74 35.3 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.592 HG21 ' HG3' ' A' ' 90' ' ' GLU . 71.3 t -123.15 116.23 47.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -170.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.65 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -132.25 134.78 45.7 Favored 'General case' 0 C--O 1.223 -0.299 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 87.5 mttt -70.56 170.26 12.52 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 162.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.656 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -163.08 133.99 4.74 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -166.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.446 ' HA ' ' HB2' ' A' ' 36' ' ' SER . 29.9 p90 -150.03 -172.57 4.19 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.664 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 35.3 mttp -132.2 136.51 47.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.11 0.481 . . . . 0.0 111.108 176.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -137.66 137.8 38.79 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.421 -178.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.688 ' HA ' ' HA ' ' A' ' 80' ' ' SER . 16.0 tt -83.67 94.73 3.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 123.147 1.451 . . . . 0.0 113.877 -166.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 81' ' ' LYS . 35.2 m -112.09 -174.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 112.739 -2.028 . . . . 0.0 108.523 170.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.996 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 7.3 p-10 -98.88 178.06 5.07 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 119.453 1.024 . . . . 0.0 110.985 169.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.707 ' HB2' HD11 ' A' ' 79' ' ' ILE . . . -125.23 163.87 35.44 Favored Pre-proline 0 C--O 1.239 0.525 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.375 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.43 ' HD2' ' HB1' ' A' ' 67' ' ' ALA . 82.7 Cg_exo -46.3 149.31 2.67 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.979 2.453 . . . . 0.0 112.636 176.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -83.83 12.11 6.56 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.486 0.66 . . . . 0.0 110.309 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -117.31 22.84 12.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.013 174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.428 ' NH1' ' HB3' ' A' ' 77' ' ' GLU . 31.3 ptt-85 -63.89 170.2 3.57 Favored Pre-proline 0 C--O 1.237 0.4 0 CA-C-N 114.19 -1.368 . . . . 0.0 111.618 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -56.57 168.95 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.68 2.254 . . . . 0.0 113.108 171.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.44 -14.87 32.0 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.265 -169.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.558 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 35.8 p-90 -91.37 -24.36 19.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.111 0.482 . . . . 0.0 111.151 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.558 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 28.6 ttp -101.28 147.46 33.8 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.279 -172.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 75' ' ' MET . 56.1 Cg_endo -83.84 177.4 6.16 Favored 'Trans proline' 0 N--CA 1.438 -1.761 0 C-N-CA 122.499 2.132 . . . . 0.0 110.026 172.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 12.8 pt-20 -74.07 -43.46 57.67 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.145 177.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.996 ' HD2' ' HB3' ' A' ' 66' ' ' ASP . 29.7 mmmt -79.71 114.99 19.06 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 67' ' ' ALA . 1.4 pp -153.54 153.83 8.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 114.334 -1.303 . . . . 0.0 109.355 -178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.688 ' HA ' ' HA ' ' A' ' 64' ' ' ILE . 5.3 p -76.33 104.24 6.75 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.226 0.536 . . . . 0.0 110.053 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.664 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 21.6 tptt -62.9 136.9 96.75 Favored Pre-proline 0 CA--C 1.514 -0.425 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.763 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.783 ' HG2' ' HG ' ' A' ' 29' ' ' LEU . 37.9 Cg_endo -68.43 98.32 0.56 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.221 1.948 . . . . 0.0 110.491 169.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 81' ' ' LYS . 42.3 m-85 -94.31 173.0 7.85 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.682 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -162.59 174.04 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -162.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' H ' ' HB3' ' A' ' 58' ' ' PHE . 49.5 tptt -175.63 98.23 0.07 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.762 0.315 . . . . 0.0 111.146 179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 36.4 ttmt -55.96 93.16 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.825 0.821 . . . . 0.0 111.954 166.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.596 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -82.23 -11.88 58.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.44 -1.254 . . . . 0.0 111.657 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.596 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 7.7 ptm180 -176.84 177.12 1.37 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.347 0.594 . . . . 0.0 111.907 -173.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.531 HD11 ' HE2' ' A' ' 86' ' ' LYS . 20.9 mm -135.83 136.96 49.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.527 177.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.852 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 30.4 mt-10 -107.2 151.29 25.62 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.023 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -111.29 166.35 11.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 166.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 14.7 mt -119.44 142.2 48.45 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 171.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.251 1.179 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.161 -171.905 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.5 p . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 120.872 0.368 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -131.75 149.98 52.3 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.491 0.662 . . . . 0.0 110.961 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.425 HG21 ' HB ' ' A' ' 20' ' ' THR . 28.9 m -71.38 137.61 48.52 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.935 170.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.478 ' HD3' ' C ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -93.93 126.67 39.27 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.429 0.633 . . . . 0.0 110.557 -179.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.628 ' HB3' ' CG2' ' A' ' 18' ' ' VAL . 12.4 m120 -78.78 143.87 35.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.673 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.844 ' HB3' HD12 ' A' ' 47' ' ' LEU . 66.0 m-85 -131.89 142.09 49.56 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.411 176.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 61.7 t -105.17 122.32 58.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.7 OUTLIER -73.76 133.17 43.24 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.061 -177.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.866 ' HB3' ' CA ' ' A' ' 13' ' ' GLY . 60.3 mtp180 -85.36 138.84 32.02 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.607 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 5.4 t70 -59.2 -146.77 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.691 170.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.61 -56.46 4.59 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 -167.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.25 -42.32 68.97 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.631 0.729 . . . . 0.0 109.088 162.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.866 ' CA ' ' HB3' ' A' ' 9' ' ' ARG . . . 139.36 48.01 0.06 OUTLIER Glycine 0 N--CA 1.437 -1.245 0 C-N-CA 116.263 -2.875 . . . . 0.0 113.671 169.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 3.5 m120 -74.01 -152.44 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -97.41 146.67 24.97 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.691 0.758 . . . . 0.0 112.295 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 15.5 m-70 -138.52 -164.56 1.66 Allowed 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 167.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.95 162.87 41.95 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 119.058 -1.544 . . . . 0.0 112.317 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.628 ' CG2' ' HB3' ' A' ' 5' ' ' ASN . 2.7 p -99.22 110.77 27.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 122.093 0.949 . . . . 0.0 111.179 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -78.95 178.43 8.0 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 114.334 -1.303 . . . . 0.0 111.794 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.425 ' HB ' HG21 ' A' ' 3' ' ' THR . 33.1 p -135.09 151.97 51.22 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.417 -175.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -172.35 160.42 31.76 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.478 ' C ' ' HD3' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -84.04 -10.21 58.03 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 171.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.495 ' H ' ' HB2' ' A' ' 26' ' ' GLN . 17.1 mt-30 -151.58 165.5 17.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 174.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 23' ' ' GLN . 10.8 Cg_endo -60.63 -53.3 2.88 Favored 'Trans proline' 0 C--O 1.22 -0.423 0 CA-C-N 120.283 1.137 . . . . 0.0 111.278 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 75.5 ttt180 -39.9 -36.49 0.46 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.129 166.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HB2' ' H ' ' A' ' 23' ' ' GLN . 8.2 mm100 -84.44 -10.79 57.2 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.988 0.423 . . . . 0.0 111.535 179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.98 -57.07 2.99 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.672 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -45.08 -32.95 1.94 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 165.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' ARG . 7.2 tt -61.41 -19.23 61.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.282 0.563 . . . . 0.0 110.565 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.47 ' HE3' ' HB3' ' A' ' 30' ' ' LYS . 18.4 mtpp -77.85 -53.39 7.53 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 175.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -68.37 -16.59 63.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -169.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -64.44 -20.46 66.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.317 0.579 . . . . 0.0 110.838 177.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.36 7.1 0.65 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 56.6 mtp180 -99.64 -54.95 2.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 119.174 -1.011 . . . . 0.0 109.931 -163.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 36' ' ' SER . . . -105.76 -20.8 9.1 Favored Glycine 0 CA--C 1.489 -1.57 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.164 167.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 61' ' ' TRP . 68.5 m 76.15 -63.95 0.37 Allowed 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.54 -160.8 54.19 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.293 -0.956 . . . . 0.0 111.235 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -160.93 157.14 25.96 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.554 ' NZ ' ' HB3' ' A' ' 39' ' ' LYS . 4.8 ttpm? -63.65 -12.86 37.34 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 122.984 0.513 . . . . 0.0 112.065 -171.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.63 -29.92 63.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.699 0.762 . . . . 0.0 110.162 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -160.29 70.18 2.95 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.556 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -56.98 166.13 4.34 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.901 2.401 . . . . 0.0 112.84 -174.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -104.32 118.04 35.67 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.764 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.424 HD13 ' HZ2' ' A' ' 59' ' ' LYS . 7.0 tp -55.87 158.0 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.04 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -159.19 179.92 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 178.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.784 ' CB ' ' HB2' ' A' ' 9' ' ' ARG . 24.1 mmm-85 -158.29 143.01 16.23 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 123.826 0.704 . . . . 0.0 109.761 -173.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.844 HD12 ' HB3' ' A' ' 6' ' ' PHE . 0.5 OUTLIER -139.84 125.4 19.22 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.802 0.81 . . . . 0.0 110.567 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 45.3 tpt85 -105.36 114.48 28.68 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 114.263 -1.335 . . . . 0.0 107.994 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 57.4 tt0 -85.58 78.24 9.68 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -171.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -46.47 104.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.997 173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 132.93 -19.47 4.4 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.042 -171.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 26.1 p -127.62 178.48 6.09 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 175.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -115.59 37.26 3.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.929 0.871 . . . . 0.0 109.87 174.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -127.03 149.09 50.06 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.906 176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 1.052 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 20.9 t -103.92 136.47 36.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.25 176.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.682 ' HB3' ' CE1' ' A' ' 58' ' ' PHE . 90.9 m-70 -103.73 105.99 16.38 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.154 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' A' ' 88' ' ' ARG . 43.7 t -95.32 122.38 46.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.504 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.682 ' CE1' ' HB3' ' A' ' 56' ' ' HIS . 0.9 OUTLIER -128.44 162.11 27.91 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.932 176.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.424 ' HZ2' HD13 ' A' ' 44' ' ' ILE . 40.2 mmtm -103.44 133.28 48.75 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.926 158.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 45' ' ' ILE . . . -110.96 146.26 36.93 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.745 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 32.0 p90 -168.87 151.36 4.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.611 ' HE2' ' HG3' ' A' ' 82' ' ' PRO . 77.5 mttt -103.18 122.95 45.78 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.367 0.604 . . . . 0.0 109.932 173.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.745 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.1 mm-40 -107.71 143.14 36.64 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.961 172.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 20.7 tt -86.24 143.31 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 163.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' A' ' 78' ' ' LYS . 20.4 m -141.0 -172.82 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -171.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.82 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 6.3 p-10 -121.16 -179.41 4.03 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.158 0.504 . . . . 0.0 111.272 -165.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.694 ' HB2' ' HA ' ' A' ' 77' ' ' GLU . . . -110.74 116.59 52.01 Favored Pre-proline 0 N--CA 1.443 -0.813 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.369 -172.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 71' ' ' ARG . 7.4 Cg_exo -69.0 -173.66 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 C-N-CA 123.3 2.667 . . . . 0.0 111.383 168.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.404 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 0.9 OUTLIER -95.48 -51.2 4.66 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.417 0.627 . . . . 0.0 109.334 178.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 67.4 t30 -83.97 18.05 2.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.44 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.631 ' HD3' ' HB1' ' A' ' 67' ' ' ALA . 9.8 ptt-85 -59.26 158.01 21.15 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.695 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -69.5 173.58 10.53 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.517 2.811 . . . . 0.0 114.015 -175.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.15 10.66 9.66 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.299 -1.319 . . . . 0.0 111.833 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -123.21 -15.48 7.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.808 -178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.43 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 32.8 ttm -103.05 121.81 47.7 Favored Pre-proline 0 N--CA 1.451 -0.38 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.532 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 20.4 Cg_endo -88.7 -152.52 0.04 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 123.124 2.549 . . . . 0.0 112.444 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.694 ' HA ' ' HB2' ' A' ' 67' ' ' ALA . 16.6 mm-40 -69.53 -42.04 75.19 Favored 'General case' 0 C--N 1.328 -0.37 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.82 ' HD3' ' HA ' ' A' ' 66' ' ' ASP . 31.9 mmtp -150.03 129.76 13.24 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -176.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.613 HD12 HG22 ' A' ' 65' ' ' VAL . 1.2 pp -147.46 147.87 17.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 118.721 0.691 . . . . 0.0 111.074 -178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 71.5 p -94.14 153.83 17.9 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 171.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.58 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 4.4 tptp -157.38 133.67 6.2 Favored Pre-proline 0 N--CA 1.441 -0.888 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -168.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.611 ' HG3' ' HE2' ' A' ' 62' ' ' LYS . 14.0 Cg_exo -65.22 89.79 0.2 Allowed 'Trans proline' 0 CA--C 1.533 0.467 0 CA-C-N 120.651 1.268 . . . . 0.0 111.663 176.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.624 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 27.3 m-85 -83.68 157.78 22.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.97 -1.014 . . . . 0.0 112.517 176.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.672 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -145.92 162.84 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.079 177.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.557 ' HB3' ' CZ3' ' A' ' 61' ' ' TRP . 5.2 tmtt? -151.72 115.56 4.91 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.316 0.579 . . . . 0.0 110.874 -177.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.52 ' HE2' HD11 ' A' ' 89' ' ' ILE . 33.9 ttmt -60.2 125.65 24.49 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 173.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.466 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 20.6 pt-20 -135.41 -13.54 2.03 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.41 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.406 ' HB3' ' HB ' ' A' ' 57' ' ' VAL . 32.1 ttp85 -157.16 165.83 34.89 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.52 HD11 ' HE2' ' A' ' 86' ' ' LYS . 22.2 mm -147.1 140.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 1.052 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 52.6 mt-10 -119.93 153.11 36.39 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.06 -175.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -115.67 130.16 56.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.183 -174.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD23 HG23 ' A' ' 55' ' ' VAL . 2.1 mm? -109.82 174.71 5.74 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.658 -169.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.249 1.061 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.275 -179.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.476 0.832 0 CA-C-O 120.66 0.267 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -83.0 140.86 32.49 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 99.4 m -67.16 125.6 26.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.402 0.62 . . . . 0.0 112.123 -174.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.561 ' O ' ' HA ' ' A' ' 20' ' ' THR . 12.4 mmm180 -88.52 137.47 32.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 122.336 1.065 . . . . 0.0 111.796 175.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 50' ' ' ARG . 36.8 m-80 -104.68 118.05 35.62 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 112.984 -1.916 . . . . 0.0 110.228 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.501 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 30.3 m-85 -119.27 165.0 14.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.282 1.039 . . . . 0.0 111.599 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -126.88 130.1 71.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 113.224 -1.807 . . . . 0.0 108.524 170.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.132 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 13.9 tp -81.26 156.06 25.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.581 ' HD3' HG11 ' A' ' 55' ' ' VAL . 47.9 mtp180 -135.47 143.03 45.64 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' CB ' ' HB2' ' A' ' 14' ' ' ASN . 6.7 t70 -87.15 -165.04 1.18 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 11' ' ' GLU . 4.7 mm-40 -83.74 -52.5 6.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.547 -171.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -75.61 0.6 16.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.2 35.94 3.02 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 118.637 -1.744 . . . . 0.0 113.768 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.5 ' HB2' ' CB ' ' A' ' 10' ' ' ASP . 61.5 m-80 -101.75 178.67 4.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -122.72 152.52 40.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.858 0.837 . . . . 0.0 112.255 -174.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 1.132 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 97.3 m-70 -132.18 -158.92 0.92 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.993 177.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.78 -172.67 46.55 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 117.84 -2.124 . . . . 0.0 110.936 -158.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 87.1 t -94.23 109.06 21.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.692 0.758 . . . . 0.0 110.851 178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.821 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 77.6 m-85 -94.66 111.94 23.7 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.389 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.8 p -91.08 113.95 26.34 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 113.598 -1.637 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -129.74 166.51 21.88 Favored Glycine 0 C--N 1.313 -0.731 0 CA-C-N 113.683 -1.598 . . . . 0.0 113.423 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.707 ' HG2' ' HG3' ' A' ' 26' ' ' GLN . 8.9 ptpp? -77.66 -27.25 50.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.517 0.675 . . . . 0.0 109.58 174.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.608 ' HG2' ' HG3' ' A' ' 22' ' ' LYS . 11.0 pt20 -160.4 163.99 20.54 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.454 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 33.0 Cg_exo -40.02 -53.3 2.51 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 123.476 2.784 . . . . 0.0 113.956 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -54.98 -40.0 69.58 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.707 ' HG3' ' HG2' ' A' ' 22' ' ' LYS . 21.5 mm-40 -78.56 -31.54 47.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 O-C-N 122.001 -0.437 . . . . 0.0 111.324 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.02 -32.32 73.73 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.588 0.709 . . . . 0.0 109.207 173.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.547 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -70.51 -38.73 74.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.68 175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.739 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -56.4 -62.29 1.82 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 172.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 32.1 mmtp -34.81 -48.05 0.37 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.172 -1.376 . . . . 0.0 112.186 168.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.821 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -66.98 -30.36 70.45 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.162 -0.336 . . . . 0.0 111.512 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.796 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -84.7 -18.34 35.56 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -49.79 -34.65 20.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.852 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 34' ' ' ARG . 28.4 ptt85 -92.21 -20.9 20.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.143 0.497 . . . . 0.0 110.538 -175.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -122.68 89.75 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.787 -174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.6 t -67.49 -17.1 64.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 -178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 31.91 -135.65 0.13 Allowed Glycine 0 C--N 1.344 0.987 0 O-C-N 124.332 1.02 . . . . 0.0 112.843 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 35.2 p -149.46 168.69 22.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 164.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -58.37 -33.64 69.81 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.394 0.616 . . . . 0.0 111.117 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' C ' ' HD3' ' A' ' 42' ' ' PRO . . . -81.06 -42.31 21.25 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.294 -172.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -128.66 65.5 72.32 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.811 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.49 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 22.9 Cg_exo -64.45 146.17 89.06 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.485 2.124 . . . . 0.0 112.543 -172.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.92 110.63 1.84 Allowed 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 176.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.539 HD11 ' HE3' ' A' ' 59' ' ' LYS . 30.0 mm -64.1 122.82 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.066 0.46 . . . . 0.0 111.584 -177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.624 HG12 ' O ' ' A' ' 58' ' ' PHE . 8.0 pt -117.5 132.47 67.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 121.842 0.83 . . . . 0.0 111.925 177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 1.09 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 69.4 mtp180 -122.37 116.47 24.08 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.866 174.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.822 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.9 mm? -108.11 123.16 48.29 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.343 0.592 . . . . 0.0 109.922 -176.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.569 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 16.9 ttp180 -112.03 97.29 6.57 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.769 177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 4' ' ' ARG . 2.7 tm-20 -61.97 144.14 55.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 5' ' ' ASN . 0.0 OUTLIER -86.07 13.73 7.29 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -172.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -132.24 -9.5 2.38 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 121.252 -0.499 . . . . 0.0 112.408 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 78.5 p -99.33 172.79 7.12 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 122.835 -0.215 . . . . 0.0 110.647 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.703 ' HA ' HD22 ' A' ' 92' ' ' LEU . 63.4 tttp -111.76 11.77 20.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.598 0.713 . . . . 0.0 110.339 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -121.57 142.88 49.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.721 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 90.6 t -111.34 101.16 12.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 173.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.822 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 18.6 p80 -86.48 140.31 30.07 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.28 0.562 . . . . 0.0 111.359 -174.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 1.09 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -125.36 114.57 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.258 -177.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.624 ' O ' HG12 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -115.92 147.81 40.71 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 175.425 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.539 ' HE3' HD11 ' A' ' 44' ' ' ILE . 1.5 mmmm -66.29 169.57 7.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.68 -1.208 . . . . 0.0 108.986 160.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.796 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -165.31 134.31 3.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.413 0.149 . . . . 0.0 110.769 -173.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.532 ' HD1' ' HG2' ' A' ' 63' ' ' GLU . 20.1 p90 -161.18 172.74 16.19 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 120.449 0.166 . . . . 0.0 111.15 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.72 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 42.2 mtmt -144.32 124.03 13.35 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.525 0.203 . . . . 0.0 110.706 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.549 ' HG3' ' CG1' ' A' ' 65' ' ' VAL . 7.7 pt-20 -174.09 155.9 2.57 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.698 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -69.99 125.99 29.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 118.885 0.766 . . . . 0.0 110.288 173.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.598 HG23 ' N ' ' A' ' 66' ' ' ASP . 4.2 m -150.75 -167.49 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -167.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.598 ' N ' HG23 ' A' ' 65' ' ' VAL . 0.3 OUTLIER 101.16 -174.65 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.972 0 O-C-N 125.395 1.685 . . . . 0.0 110.638 168.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 68' ' ' PRO . . . -121.53 179.85 0.88 Allowed Pre-proline 0 N--CA 1.437 -1.099 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.324 -165.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.692 ' HD2' ' HB1' ' A' ' 67' ' ' ALA . 98.1 Cg_exo -50.94 -175.26 0.01 OUTLIER 'Trans proline' 0 N--CA 1.484 0.966 0 C-N-CA 123.705 2.937 . . . . 0.0 115.051 173.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 69' ' ' LYS . 4.1 mptp? -56.93 -13.05 2.33 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.456 -166.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -76.01 32.67 0.12 Allowed 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.04 0.447 . . . . 0.0 111.317 179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 68' ' ' PRO . 20.3 mmm180 -84.5 167.16 28.65 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.524 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -64.6 162.72 30.05 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.097 1.865 . . . . 0.0 111.191 174.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.98 62.11 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.118 -176.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.699 ' CE3' ' HB2' ' A' ' 75' ' ' MET . 56.3 p-90 -103.92 -37.51 7.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.895 -177.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.699 ' HB2' ' CE3' ' A' ' 74' ' ' TRP . 16.6 ttp -104.57 136.46 19.17 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.706 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 42.7 Cg_endo -92.38 -164.69 0.13 Allowed 'Trans proline' 0 N--CA 1.438 -1.769 0 C-N-CA 122.696 2.264 . . . . 0.0 113.122 178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -86.07 -2.02 57.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.552 -1.658 . . . . 0.0 112.531 -168.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 72.5 mmtt -155.42 119.25 4.52 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 -176.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.8 OUTLIER -155.71 144.53 12.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 118.552 0.615 . . . . 0.0 110.087 177.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 74.0 p -120.71 81.22 1.73 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.004 0.907 . . . . 0.0 111.616 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.842 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -124.74 168.32 13.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.197 176.203 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.739 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 52.2 Cg_exo -57.24 94.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.483 2.122 . . . . 0.0 111.875 174.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.842 ' CE1' ' HG3' ' A' ' 81' ' ' LYS . 11.0 m-85 -86.53 175.6 8.26 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.597 HG12 ' CB ' ' A' ' 58' ' ' PHE . 1.4 t -166.22 173.49 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -166.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.563 ' HE2' ' O ' ' A' ' 86' ' ' LYS . 16.8 tptm -176.51 99.11 0.06 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.119 0.485 . . . . 0.0 110.7 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.563 ' O ' ' HE2' ' A' ' 85' ' ' LYS . 34.4 ttmt -57.25 134.3 55.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.38 169.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 11.3 pt-20 -167.19 23.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.629 -1.169 . . . . 0.0 112.168 175.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.488 ' C ' HG13 ' A' ' 57' ' ' VAL . 23.7 ttp180 -168.2 157.03 9.08 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 172.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.418 HD11 ' HE2' ' A' ' 86' ' ' LYS . 23.1 mm -140.58 136.31 35.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.534 -176.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.721 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -119.36 166.21 13.33 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.452 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.0 ptpt -95.16 170.15 9.6 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.818 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.703 HD22 ' HA ' ' A' ' 53' ' ' LYS . 13.3 tp -72.76 157.59 37.21 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.897 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.343 -0.837 . . . . 0.0 109.62 -174.741 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -81.59 74.45 8.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.858 0.837 . . . . 0.0 109.522 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.1 t -75.8 149.61 37.89 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.08 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.513 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.0 ptm180 -89.34 151.74 21.91 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.261 1.029 . . . . 0.0 112.642 -175.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.8 OUTLIER -105.08 136.55 44.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.531 -166.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 28.0 m-85 -127.32 122.18 33.07 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.384 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.985 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -97.31 128.92 48.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.918 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.5 tp -66.19 139.84 58.14 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.788 -171.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 0.7 OUTLIER -92.03 171.73 8.91 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 122.136 0.97 . . . . 0.0 111.777 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 14' ' ' ASN . 21.2 t70 -128.43 169.98 13.67 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.409 -1.723 . . . . 0.0 109.038 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -61.74 -36.33 80.68 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 123.744 0.652 . . . . 0.0 111.094 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.09 -39.3 25.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.862 0.839 . . . . 0.0 109.439 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.03 31.05 1.04 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.173 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' H ' ' HB3' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -77.22 -170.09 1.59 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.437 -0.881 . . . . 0.0 108.773 173.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -132.29 108.86 9.49 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 121.512 0.672 . . . . 0.0 111.083 -170.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.918 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 72.3 m-70 -89.88 -162.17 0.86 Allowed 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.007 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -48.52 144.11 7.21 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 123.398 0.436 . . . . 0.0 113.434 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG13 ' HD2' ' A' ' 50' ' ' ARG . 97.6 t -83.64 143.82 11.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 174.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -126.71 143.11 51.34 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.7 p -121.89 135.16 54.87 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.57 -78.59 0.08 OUTLIER Glycine 0 C--N 1.312 -0.785 0 C-N-CA 119.516 -1.326 . . . . 0.0 111.27 -177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt 173.36 -33.03 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 11.1 pt20 -159.68 166.68 15.57 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.621 -1.172 . . . . 0.0 109.312 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 72.5 Cg_exo -45.8 -22.29 1.2 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 123.507 2.805 . . . . 0.0 114.038 178.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.6 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 21.2 ttm-85 -88.1 -35.09 17.66 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.657 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.601 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 0.0 OUTLIER -86.34 -14.66 42.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.598 -178.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.0 -47.78 7.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HA ' HD21 ' A' ' 47' ' ' LEU . . . -57.12 -37.36 71.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.476 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.696 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -49.5 -65.92 0.48 Allowed 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.426 172.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 74.5 mmtt -35.33 -48.31 0.46 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.443 ' HB3' ' CD1' ' A' ' 45' ' ' ILE . . . -68.13 -26.78 65.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 118.752 0.706 . . . . 0.0 112.067 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.056 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -70.11 -22.95 62.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.226 1.012 . . . . 0.0 111.007 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.665 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 6.2 m-80 -62.45 -0.29 0.57 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 116.509 2.04 . . . . 0.0 116.509 -171.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.7 mpp_? -73.54 -63.92 1.1 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 116.6 -2.04 . . . . 0.0 109.651 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 167.13 -50.25 0.25 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 115.282 -3.342 . . . . 0.0 116.622 143.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.537 ' O ' HG23 ' A' ' 38' ' ' THR . 15.2 m -53.77 -25.35 18.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.488 0.644 . . . . 0.0 109.405 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.94 100.34 0.01 OUTLIER Glycine 0 CA--C 1.524 0.652 0 CA-C-N 113.705 -1.589 . . . . 0.0 111.945 164.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 36' ' ' SER . 25.5 p -135.49 -177.97 4.9 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.143 0.577 . . . . 0.0 110.461 -171.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 23.4 mtmm -65.42 -29.77 70.5 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 119.759 -0.776 . . . . 0.0 109.646 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.87 -38.03 79.44 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.157 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.38 71.7 32.27 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.21 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.657 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 6.8 Cg_exo -67.25 130.44 22.63 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.043 1.162 . . . . 0.0 109.42 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -72.2 107.17 4.71 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.4 HG22 ' H ' ' A' ' 44' ' ' ILE . 2.9 tp -71.07 96.75 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-O 122.316 1.055 . . . . 0.0 110.038 -175.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.457 ' H ' HG12 ' A' ' 45' ' ' ILE . 5.3 pt -103.62 152.13 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.107 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.629 ' HG2' HG23 ' A' ' 57' ' ' VAL . 30.0 mtp180 -125.85 102.95 7.52 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 28' ' ' ALA . 2.6 mm? -87.62 137.62 32.17 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -122.13 112.26 17.99 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.87 144.26 56.83 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.472 -1.306 . . . . 0.0 107.472 -177.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.985 ' HG2' HG12 ' A' ' 7' ' ' VAL . 61.7 mtp180 -74.98 -18.96 60.29 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.446 -166.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.25 -9.62 60.33 Favored Glycine 0 N--CA 1.433 -1.565 0 C-N-CA 120.129 -1.034 . . . . 0.0 111.806 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.3 p -111.86 149.44 31.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 121.017 0.437 . . . . 0.0 110.894 179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -95.63 18.22 13.32 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -100.39 139.97 35.31 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.653 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.02 117.37 48.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.696 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.535 ' HA ' HD13 ' A' ' 89' ' ' ILE . 42.3 m-70 -96.85 99.55 11.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.888 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.629 HG23 ' HG2' ' A' ' 46' ' ' ARG . 7.5 p -98.32 127.27 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 86' ' ' LYS . 1.4 m-85 -137.68 124.02 20.64 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 119.15 -0.452 . . . . 0.0 110.01 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.657 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 26.7 mtpp -71.13 107.62 4.25 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.996 160.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.056 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -95.24 145.98 24.67 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.671 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 19.8 p90 -158.68 143.25 15.88 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.335 177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.665 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 30.5 mtmt -103.62 124.51 48.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HG2' ' CG ' ' A' ' 39' ' ' LYS . 3.6 tp10 -150.89 154.78 37.83 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-O 121.297 0.57 . . . . 0.0 111.392 -166.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 92.1 mt -118.44 121.18 66.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.626 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.566 HG23 ' NH2' ' A' ' 71' ' ' ARG . 34.7 m -122.93 151.05 26.96 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -79.91 -175.56 5.0 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -175.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.875 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . . . -48.5 160.07 0.48 Allowed Pre-proline 0 N--CA 1.471 0.595 0 C-N-CA 125.771 1.628 . . . . 0.0 114.791 -172.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.754 ' HB3' ' HB2' ' A' ' 71' ' ' ARG . 42.1 Cg_endo -67.08 67.49 0.59 Allowed 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 124.116 3.211 . . . . 0.0 116.167 -169.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -93.1 -7.78 44.56 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 161.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -133.51 2.01 3.46 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 113.37 -1.741 . . . . 0.0 111.067 -171.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.955 HH22 HD12 ' A' ' 79' ' ' ILE . 67.0 mtt-85 -118.23 167.73 10.84 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 113.215 0.821 . . . . 0.0 113.215 -158.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -67.39 149.88 80.72 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.207 2.605 . . . . 0.0 109.364 154.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.82 0.01 19.54 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 113.609 0.966 . . . . 0.0 113.609 -167.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -95.27 -21.48 18.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.898 0.38 . . . . 0.0 110.808 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.713 ' HB3' ' HD3' ' A' ' 71' ' ' ARG . 10.3 ttm -81.87 130.6 60.11 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.336 -176.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.448 ' HD2' HG21 ' A' ' 79' ' ' ILE . 3.0 Cg_endo -74.48 177.47 8.34 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.839 2.36 . . . . 0.0 112.448 -175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.875 ' HA ' ' HA ' ' A' ' 67' ' ' ALA . 1.9 mp0 -51.81 -81.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 123.876 0.735 . . . . 0.0 109.036 176.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -89.54 130.0 35.92 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.736 -0.385 . . . . 0.0 111.436 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.955 HD12 HH22 ' A' ' 71' ' ' ARG . 0.0 OUTLIER -145.21 151.12 15.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 171.608 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.611 ' HB3' HG12 ' A' ' 64' ' ' ILE . 9.1 p -124.88 125.74 44.44 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.833 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 73.0 mmtt -159.28 144.26 11.55 Favored Pre-proline 0 N--CA 1.465 0.294 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -173.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.696 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 3.0 Cg_exo -73.18 96.1 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.044 1.829 . . . . 0.0 110.493 163.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.526 ' O ' HG13 ' A' ' 84' ' ' VAL . 80.2 m-85 -78.66 172.72 13.29 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.691 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -173.08 117.24 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.23 -173.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.11 118.14 34.56 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.299 -1.36 . . . . 0.0 109.875 157.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 3.6 ptpp? -55.13 139.57 41.26 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.236 168.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -81.9 -31.98 31.18 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.69 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 173.63 -174.68 0.06 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.097 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 56' ' ' HIS . 31.2 mm -127.84 110.02 21.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.873 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -113.89 -176.34 2.88 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.335 -177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 91' ' ' LYS . 21.4 mtmt -110.63 171.06 7.68 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 15.1 tp -67.64 150.37 48.84 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.365 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 . . . . . 0 C--N 1.314 -0.96 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.13 -171.767 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.5 t30 62.03 91.1 0.07 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.844 0.83 . . . . 0.0 111.307 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 89.9 m -108.14 108.74 19.94 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.225 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.604 ' NH1' ' HB2' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -95.76 156.11 16.47 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.877 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -121.61 132.4 54.65 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 122.229 -0.295 . . . . 0.0 110.532 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.56 ' HD1' ' NH2' ' A' ' 4' ' ' ARG . 61.2 m-85 -143.74 134.07 24.59 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG13 ' HA ' ' A' ' 50' ' ' ARG . 0.7 OUTLIER -115.76 133.89 60.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 171.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.784 ' HB2' ' HE2' ' A' ' 19' ' ' PHE . 2.4 tp -66.17 149.36 50.43 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.44 -172.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.685 ' HD2' ' HD2' ' A' ' 48' ' ' ARG . 76.9 mtp180 -118.77 124.16 46.57 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 163.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.402 ' HB2' ' CD2' ' A' ' 16' ' ' HIS . 40.0 t0 -87.03 175.5 8.08 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.668 -169.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -44.42 -44.77 8.64 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 124.122 0.889 . . . . 0.0 112.965 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -41.54 89.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.456 0.646 . . . . 0.0 110.89 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.05 25.78 2.43 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.96 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.627 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 p30 -110.55 170.37 8.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -95.82 141.89 28.73 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.051 -174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' HB2' HD23 ' A' ' 8' ' ' LEU . 39.9 m-70 -132.4 -178.99 5.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.823 -177.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -20.26 126.27 0.01 OUTLIER Glycine 0 C--N 1.328 0.135 0 O-C-N 125.876 1.985 . . . . 0.0 114.884 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -80.09 125.62 39.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.253 0.549 . . . . 0.0 109.939 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.784 ' HE2' ' HB2' ' A' ' 8' ' ' LEU . 6.9 m-85 -112.72 149.37 33.04 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -135.8 141.98 44.81 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.3 -175.37 27.19 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 119.624 -1.275 . . . . 0.0 112.814 -173.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -87.01 -31.79 20.38 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.0 -0.6 . . . . 0.0 110.57 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.604 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 18.6 pt20 -154.15 155.94 31.44 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 9.3 Cg_endo -50.84 -23.37 11.54 Favored 'Trans proline' 0 C--N 1.355 0.91 0 C-N-CA 124.154 3.236 . . . . 0.0 114.398 -169.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -58.01 -54.28 48.73 Favored 'General case' 0 C--O 1.215 -0.749 0 O-C-N 123.168 0.292 . . . . 0.0 110.858 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.583 HE21 HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -55.86 -43.97 77.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.263 0.554 . . . . 0.0 111.106 175.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.604 ' HB2' ' NH1' ' A' ' 4' ' ' ARG . . . -55.96 -35.41 66.66 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.704 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.95 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -89.25 -21.49 23.19 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.349 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.583 HD22 HE21 ' A' ' 26' ' ' GLN . 1.3 mp -64.63 -63.55 1.1 Allowed 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -39.62 -16.87 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.323 166.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' N ' ' C ' ' A' ' 29' ' ' LEU . . . -95.53 -50.95 4.75 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.219 0.533 . . . . 0.0 110.421 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.673 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -63.76 -29.46 70.67 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.125 -0.943 . . . . 0.0 112.412 -177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.42 -4.53 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -87.2 -59.92 2.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.69 -130.86 6.11 Favored Glycine 0 N--CA 1.437 -1.268 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.043 150.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 56.3 m 68.05 19.71 9.22 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 123.465 0.706 . . . . 0.0 111.886 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -141.14 146.55 17.84 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.457 -0.878 . . . . 0.0 113.186 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.4 ' CA ' ' HB2' ' A' ' 61' ' ' TRP . 41.0 p -125.37 176.28 6.9 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -58.8 -36.0 73.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.195 0.521 . . . . 0.0 110.783 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.92 -25.08 61.76 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.626 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -157.57 82.44 3.02 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.764 -175.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 5.4 Cg_exo -84.8 136.28 6.06 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.245 2.63 . . . . 0.0 111.245 -176.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -73.62 173.27 9.97 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.726 HD13 ' HG2' ' A' ' 59' ' ' LYS . 28.9 mm -111.04 118.76 58.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.113 0.482 . . . . 0.0 111.125 -174.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.9 pp -122.9 130.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.977 0.894 . . . . 0.0 111.622 177.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.817 ' HG2' HG22 ' A' ' 57' ' ' VAL . 48.1 mtm180 -105.89 114.32 28.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.961 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 28' ' ' ALA . 3.3 mm? -82.2 164.0 21.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.691 0.758 . . . . 0.0 109.781 168.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.685 ' HD2' ' HD2' ' A' ' 9' ' ' ARG . 51.1 ttt180 -132.22 140.32 48.64 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HB3' ' CG2' ' A' ' 52' ' ' THR . 17.5 tt0 -83.62 72.26 10.32 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HA ' HG13 ' A' ' 7' ' ' VAL . 26.4 mtm180 47.21 -64.46 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 111.456 -2.611 . . . . 0.0 113.612 -166.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.94 52.71 0.58 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.993 -177.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.498 ' CG2' ' HB3' ' A' ' 49' ' ' GLU . 8.2 p -95.21 160.16 14.68 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 122.556 -0.379 . . . . 0.0 111.417 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -74.98 -21.95 58.84 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -100.94 111.71 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.062 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 HH11 ' A' ' 9' ' ' ARG . 98.1 t -86.6 132.36 32.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.246 177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.474 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 90.0 m-70 -84.82 138.73 32.4 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -175.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.817 HG22 ' HG2' ' A' ' 46' ' ' ARG . 86.3 t -130.79 117.34 37.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.101 -171.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.827 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -129.11 139.94 51.76 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 177.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.726 ' HG2' HD13 ' A' ' 44' ' ' ILE . 24.0 mttp -70.32 161.32 30.63 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 162.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.673 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -153.47 142.52 21.3 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.59 -171.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.513 ' O ' ' HA ' ' A' ' 82' ' ' PRO . 35.8 p90 -162.01 -166.88 1.52 Allowed 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.654 -0.128 . . . . 0.0 110.654 -177.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 87.3 mttt -143.34 136.69 28.14 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 173.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.754 ' O ' ' HA ' ' A' ' 80' ' ' SER . 30.9 mm-40 -145.39 171.39 14.68 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.979 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.53 74.58 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 122.292 1.044 . . . . 0.0 108.223 172.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' HG3' ' A' ' 78' ' ' LYS . 27.5 m -85.6 -167.6 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 113.86 -1.518 . . . . 0.0 114.691 -171.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -131.76 125.05 30.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.712 -1.585 . . . . 0.0 111.734 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.833 ' HB2' ' HE2' ' A' ' 78' ' ' LYS . . . -120.34 141.24 31.51 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.073 176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.95 -165.71 0.36 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 123.434 2.756 . . . . 0.0 113.519 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -51.63 -19.78 1.7 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -166.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -81.78 7.4 12.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.631 0.729 . . . . 0.0 110.768 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.477 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 8.5 ptt180 -81.22 163.25 55.9 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.323 176.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.468 ' O ' ' HG3' ' A' ' 71' ' ' ARG . 12.6 Cg_exo -68.03 166.1 25.96 Favored 'Trans proline' 0 CA--C 1.508 -0.783 0 C-N-CA 122.355 2.037 . . . . 0.0 112.071 173.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.02 -22.51 20.75 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.46 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 60.8 p-90 -74.33 -29.38 61.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.403 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.464 ' HE2' ' HG2' ' A' ' 72' ' ' PRO . 18.4 ttp -99.3 145.94 30.9 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.417 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -62.4 175.5 2.08 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.427 2.085 . . . . 0.0 110.028 168.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 2.4 mp0 -41.02 -62.68 0.78 Allowed 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.833 ' HE2' ' HB2' ' A' ' 67' ' ' ALA . 65.8 mmtt -152.01 -173.93 4.7 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.169 170.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.642 HD13 ' CG ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -161.56 160.79 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 113.331 -1.759 . . . . 0.0 110.49 -160.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.754 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -73.34 79.94 1.36 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.756 0.788 . . . . 0.0 109.977 -176.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.642 ' CG ' HD13 ' A' ' 79' ' ' ILE . 66.2 mmtt -113.03 162.08 23.59 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 114.456 -1.247 . . . . 0.0 113.477 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.513 ' HA ' ' O ' ' A' ' 61' ' ' TRP . 25.7 Cg_endo -62.44 119.07 6.0 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.982 2.455 . . . . 0.0 110.903 170.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.556 ' HE2' ' HB2' ' A' ' 63' ' ' GLU . 23.2 m-85 -107.61 176.25 5.21 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.95 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -165.55 173.65 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -162.183 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 58' ' ' PHE . 0.0 OUTLIER 179.47 99.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.565 -176.255 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.562 ' HD2' HD11 ' A' ' 89' ' ' ILE . 18.1 ttpp -68.86 103.81 1.89 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.627 0.727 . . . . 0.0 112.225 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 12.4 pt-20 -106.05 2.15 27.01 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.998 177.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.519 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 10.1 ptm180 -174.77 175.54 2.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.288 0.566 . . . . 0.0 111.672 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.562 HD11 ' HD2' ' A' ' 86' ' ' LYS . 23.2 mm -132.56 145.75 33.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.561 178.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 8.9 mt-10 -113.95 177.64 4.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 175.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HE3' ' HB2' ' A' ' 91' ' ' LYS . 1.6 mtmt -110.5 162.91 14.22 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 93' ' ' GLU . 0.0 OUTLIER -59.95 159.55 9.08 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.329 173.195 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.549 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 34.5 tt0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.728 -1.129 . . . . 0.0 110.147 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 57.0 m . . . . . 0 N--CA 1.476 0.831 0 CA-C-O 120.957 0.408 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -107.38 132.83 52.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.942 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.524 ' CG2' ' HB ' ' A' ' 20' ' ' THR . 29.8 m -82.2 98.41 8.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.378 0.608 . . . . 0.0 109.858 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 15.2 mtp180 -83.76 144.99 28.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 122.02 0.914 . . . . 0.0 112.182 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -96.14 134.97 38.57 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 113.654 -1.612 . . . . 0.0 110.19 -175.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.552 ' HB3' HD12 ' A' ' 47' ' ' LEU . 70.6 m-85 -130.51 146.43 52.04 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.736 0.779 . . . . 0.0 111.004 177.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.838 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 9.5 t -96.01 149.01 4.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.804 176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 10.5 tp -113.54 147.79 37.31 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.618 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.99 162.9 37.84 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 170.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -84.83 -160.58 0.5 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 171.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.641 ' OE1' ' HD3' ' A' ' 46' ' ' ARG . 5.3 mm-40 -91.05 0.53 57.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -111.79 -16.45 13.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.112 -1.404 . . . . 0.0 111.741 -168.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' HA2' ' NH2' ' A' ' 9' ' ' ARG . . . 104.62 35.44 3.29 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 119.472 -1.347 . . . . 0.0 112.249 -176.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.618 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 18.4 m120 -107.74 101.71 10.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.94 122.54 27.9 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.064 0.459 . . . . 0.0 110.859 -173.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.676 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 92.3 m-70 -110.05 -167.01 1.14 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.864 -173.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -52.27 166.33 1.11 Allowed Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 114.436 -1.256 . . . . 0.0 114.873 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 94.6 t -95.36 110.81 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.493 0.664 . . . . 0.0 110.185 177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 11.6 m-85 -86.55 120.05 27.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.549 1.166 . . . . 0.0 112.225 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.524 ' HB ' ' CG2' ' A' ' 3' ' ' THR . 21.3 p -86.9 142.23 28.17 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 113.043 -1.89 . . . . 0.0 109.383 176.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.21 139.23 4.27 Favored Glycine 0 N--CA 1.441 -1.032 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 -171.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.485 ' HG3' ' HG3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -63.64 -20.18 65.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.846 0.823 . . . . 0.0 110.568 -175.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.537 ' HB2' ' HD2' ' A' ' 24' ' ' PRO . 13.5 pt20 -161.1 165.5 16.94 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.3 Cg_exo -43.85 -51.8 6.04 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.967 2.445 . . . . 0.0 112.97 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.423 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 39.2 ttt180 -51.0 -41.93 60.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 176.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.54 HE22 HD22 ' A' ' 29' ' ' LEU . 14.5 mm100 -78.29 -33.56 49.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.671 0.272 . . . . 0.0 111.26 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.62 -35.15 79.49 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.502 0.667 . . . . 0.0 109.635 173.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.624 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -69.82 -32.73 71.31 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.215 177.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.54 HD22 HE22 ' A' ' 26' ' ' GLN . 0.8 OUTLIER -55.88 -59.51 4.78 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 173.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -50.71 -24.34 3.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.138 173.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -90.47 -25.11 20.48 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.713 -0.617 . . . . 0.0 110.246 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.75 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -88.63 -16.28 32.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.292 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -15.39 56.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.592 -173.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -93.51 -28.92 15.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.979 0.418 . . . . 0.0 110.673 -174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.38 102.8 1.22 Allowed Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -175.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.8 m -59.12 -41.66 88.73 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.389 -0.405 . . . . 0.0 111.098 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.23 -139.6 0.41 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 123.931 0.77 . . . . 0.0 111.788 -170.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 67.0 p -147.29 171.18 15.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -62.14 -28.2 69.48 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.094 0.474 . . . . 0.0 110.679 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.53 -24.17 25.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.505 -172.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.448 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.1 p-10 -143.93 64.6 13.1 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 121.425 0.631 . . . . 0.0 110.238 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.751 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 19.7 Cg_exo -64.81 150.17 88.53 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.634 2.223 . . . . 0.0 112.599 -177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -79.71 124.46 28.6 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.631 HD13 ' HA ' ' A' ' 59' ' ' LYS . 17.5 mm -74.6 117.13 18.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.785 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.499 HD11 ' HB1' ' A' ' 28' ' ' ALA . 17.7 pt -107.16 139.24 29.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.696 0.76 . . . . 0.0 111.397 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.648 ' O ' HD22 ' A' ' 47' ' ' LEU . 33.7 mmm-85 -94.89 171.54 8.71 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.948 174.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.648 HD22 ' O ' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -154.56 94.74 1.72 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.656 -177.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.838 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 32.2 ttp180 -78.9 143.39 35.91 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.69 131.74 54.09 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.01 19.03 7.13 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.279 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.75 -18.05 1.81 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.703 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.2 p -124.32 179.64 4.83 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.239 0.52 . . . . 0.0 111.326 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.534 ' HA ' HD11 ' A' ' 92' ' ' LEU . 64.1 pttt -108.11 33.64 4.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.527 0.68 . . . . 0.0 109.513 173.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -133.4 123.66 25.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.492 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.579 HG22 ' HG3' ' A' ' 48' ' ' ARG . 50.0 t -94.37 125.61 46.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.088 0.47 . . . . 0.0 109.918 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.434 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 33.7 m-70 -81.13 146.79 30.38 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.517 ' C ' ' HD1' ' A' ' 58' ' ' PHE . 8.3 p -135.13 127.33 47.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 121.422 0.629 . . . . 0.0 111.042 175.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.517 ' HD1' ' C ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -129.55 143.09 50.68 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 175.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -68.53 171.68 7.19 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 118.477 -1.289 . . . . 0.0 108.565 159.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.75 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -171.63 133.05 0.76 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.132 0.491 . . . . 0.0 109.823 -161.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.493 ' HE3' ' HB3' ' A' ' 42' ' ' PRO . 41.4 p90 -158.28 -177.48 6.58 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -173.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.665 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 55.0 mtmt -131.7 142.75 49.89 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.931 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.686 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 34.0 mt-10 -131.06 175.01 9.44 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.548 -0.751 . . . . 0.0 108.983 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.906 HD11 ' HB3' ' A' ' 78' ' ' LYS . 9.5 tt -95.53 134.9 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 122.411 1.1 . . . . 0.0 112.234 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.812 HG21 ' HG3' ' A' ' 81' ' ' LYS . 32.1 m -135.15 -174.4 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.166 -177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' HB2' ' HB2' ' A' ' 77' ' ' GLU . 4.2 p-10 -99.88 165.53 11.51 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 167.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.808 ' HB3' ' HA ' ' A' ' 77' ' ' GLU . . . -142.05 -177.16 0.63 Allowed Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 -167.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.726 ' HD2' ' HD2' ' A' ' 71' ' ' ARG . 58.9 Cg_endo -83.94 148.7 12.19 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.812 1.675 . . . . 0.0 111.236 173.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -78.29 2.55 18.11 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.692 -172.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.446 ' OD1' ' HB2' ' A' ' 68' ' ' PRO . 26.1 p-10 -92.07 7.85 40.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.315 0.579 . . . . 0.0 110.825 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.726 ' HD2' ' HD2' ' A' ' 68' ' ' PRO . 0.4 OUTLIER -69.24 171.64 6.39 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.633 177.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.864 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 68.6 Cg_exo -53.15 178.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 123.403 2.735 . . . . 0.0 114.297 -178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -48.38 81.89 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.834 177.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.457 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 42.5 p-90 -81.37 -39.48 24.97 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.391 -176.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.864 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 44.9 ttm -77.04 115.47 48.95 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.534 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 74' ' ' TRP . 76.9 Cg_endo -109.3 -155.99 0.02 OUTLIER 'Trans proline' 0 N--CA 1.432 -2.117 0 C-N-CA 123.678 2.919 . . . . 0.0 112.026 170.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.808 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . 4.6 pt-20 -52.11 -59.65 4.12 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.136 -0.938 . . . . 0.0 112.769 167.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.906 ' HB3' HD11 ' A' ' 64' ' ' ILE . 18.6 mmtp -76.64 114.0 14.9 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 118.783 -1.167 . . . . 0.0 110.195 -172.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -163.79 -178.42 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 CA-C-N 114.754 -1.112 . . . . 0.0 108.29 -175.018 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 79' ' ' ILE . 2.8 p -73.75 158.54 34.43 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.177 0.513 . . . . 0.0 111.968 174.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.812 ' HG3' HG21 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -162.23 136.15 4.87 Favored Pre-proline 0 C--O 1.22 -0.486 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -171.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.665 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 76.3 Cg_exo -52.4 153.98 12.4 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.87 2.38 . . . . 0.0 113.9 175.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.686 ' CE1' ' HB2' ' A' ' 63' ' ' GLU . 70.2 m-85 -165.93 157.41 13.87 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 -175.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.624 HG11 ' HB1' ' A' ' 28' ' ' ALA . 0.8 OUTLIER -165.21 169.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -166.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.418 ' H ' HG12 ' A' ' 84' ' ' VAL . 59.4 tttp -171.17 98.93 0.21 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.599 0.238 . . . . 0.0 110.519 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.481 ' HE3' HD11 ' A' ' 89' ' ' ILE . 67.2 tttt -53.02 128.26 26.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.523 170.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.544 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 3.4 pm0 -130.85 -5.78 4.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.562 -178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HG2' ' N ' ' A' ' 89' ' ' ILE . 8.6 ttp180 -171.24 174.56 4.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.955 0.407 . . . . 0.0 110.37 -166.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.481 HD11 ' HE3' ' A' ' 86' ' ' LYS . 17.4 mm -136.1 137.68 48.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.41 173.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -111.14 176.82 4.87 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.798 0.809 . . . . 0.0 111.579 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -103.29 169.09 8.75 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.543 -1.208 . . . . 0.0 109.894 -176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.534 HD11 ' HA ' ' A' ' 53' ' ' LYS . 13.7 mt -76.85 162.09 27.9 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 173.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.488 ' HB3' HH12 ' A' ' 9' ' ' ARG . 5.8 tp10 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 120.838 0.351 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.51 147.76 26.29 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.5 m -64.67 126.62 28.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.163 0.506 . . . . 0.0 110.649 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.6 ' HB3' ' CE2' ' A' ' 6' ' ' PHE . 27.7 mmm180 -92.76 137.5 32.31 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.343 1.068 . . . . 0.0 111.208 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 50' ' ' ARG . 1.1 m-80 -106.73 116.65 32.3 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 112.85 -1.977 . . . . 0.0 111.301 -175.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.6 ' CE2' ' HB3' ' A' ' 4' ' ' ARG . 91.0 m-85 -129.99 177.32 7.37 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 122.567 1.175 . . . . 0.0 112.422 -174.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.889 ' HB ' ' HB3' ' A' ' 48' ' ' ARG . 35.2 t -147.68 149.94 14.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 112.255 -2.248 . . . . 0.0 108.521 -177.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.733 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 14.8 tp -96.83 158.33 15.48 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 171.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.646 HH11 HG21 ' A' ' 55' ' ' VAL . 49.4 mtp180 -124.79 147.19 48.84 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 11' ' ' GLU . 12.8 t70 -69.65 -167.65 0.15 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.9 0.318 . . . . 0.0 111.015 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.47 ' H ' ' CG ' ' A' ' 10' ' ' ASP . 26.3 mm-40 -61.83 -39.59 92.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.859 0.361 . . . . 0.0 111.435 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -83.79 -37.61 22.35 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.474 0.654 . . . . 0.0 109.702 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA2' ' HB3' ' A' ' 9' ' ' ARG . . . 132.51 45.0 0.14 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 118.721 -1.705 . . . . 0.0 112.063 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.4 -97.91 0.07 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -174.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -173.95 137.23 0.56 Allowed 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.733 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 88.1 m-70 -144.6 166.25 25.7 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.154 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 34.53 -171.86 0.01 OUTLIER Glycine 0 CA--C 1.522 0.474 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -177.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -137.86 110.89 7.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 112.792 -1.704 . . . . 0.0 106.638 163.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.04 106.11 16.46 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.871 1.319 . . . . 0.0 113.364 -173.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 4' ' ' ARG . 19.0 p -91.08 117.29 29.48 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.877 170.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -139.66 169.5 24.59 Favored Glycine 0 C--O 1.222 -0.651 0 CA-C-N 113.776 -1.557 . . . . 0.0 111.947 178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -88.82 -11.28 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.655 0.741 . . . . 0.0 110.293 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -160.82 147.12 11.52 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.391 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 53.8 Cg_exo -43.51 -42.56 11.0 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.157 1.904 . . . . 0.0 113.02 177.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -60.31 -35.22 75.1 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.457 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 86.2 mm-40 -75.92 -39.03 57.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.631 0.729 . . . . 0.0 109.969 178.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.5 -33.05 75.02 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.259 175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.8 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -83.26 -26.78 30.4 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.39 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.685 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 8.3 tt -64.05 -63.9 1.03 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 172.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 30' ' ' LYS . 66.6 mmtt -31.99 -27.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.058 164.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -92.91 -37.67 12.12 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.54 0.686 . . . . 0.0 110.527 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.46 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -69.71 -8.66 49.77 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.716 1.206 . . . . 0.0 113.237 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.704 ' ND2' ' HG2' ' A' ' 82' ' ' PRO . 1.1 m-80 -61.96 -51.71 66.99 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.72 ' H ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -63.83 -56.79 12.77 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.682 -0.807 . . . . 0.0 108.914 174.677 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.544 ' H ' ' HG2' ' A' ' 34' ' ' ARG . . . 83.19 -94.19 1.76 Allowed Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.289 151.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.4 m 63.66 36.77 10.59 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.415 0.626 . . . . 0.0 110.217 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -139.9 159.34 25.98 Favored Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.663 178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.5 p -125.27 -177.55 3.91 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.724 ' HG2' ' CD1' ' A' ' 61' ' ' TRP . 19.7 mtmm -72.12 -25.96 61.94 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 119.196 -1.001 . . . . 0.0 108.913 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.62 -28.32 56.06 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.975 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.78 64.53 8.47 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.31 -176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 7.1 Cg_exo -64.03 134.94 45.17 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.967 1.778 . . . . 0.0 111.182 -177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -72.56 176.7 5.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.523 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.554 HG12 ' HE3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -123.77 136.65 59.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.049 0.452 . . . . 0.0 111.829 -176.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.593 ' CD1' ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -138.27 136.71 44.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.739 172.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.57 ' HG3' HG22 ' A' ' 57' ' ' VAL . 66.8 ttt180 -112.08 113.05 25.1 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.922 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.527 HD11 ' CA ' ' A' ' 28' ' ' ALA . 23.3 mt -101.36 104.52 15.51 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-O 122.153 0.978 . . . . 0.0 112.205 -174.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.889 ' HB3' ' HB ' ' A' ' 7' ' ' VAL . 68.7 ttt180 -69.93 153.77 42.83 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.921 -1.491 . . . . 0.0 108.25 172.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.681 ' HG2' ' H ' ' A' ' 51' ' ' GLY . 50.4 tt0 -122.07 129.47 52.42 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' HG3' ' HB3' ' A' ' 5' ' ' ASN . 0.1 OUTLIER -94.61 18.74 10.93 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.51 0.671 . . . . 0.0 110.507 176.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.681 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -110.98 -58.1 0.48 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.418 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 6.4 p -93.06 175.34 6.82 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 0.0 110.877 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -93.72 11.3 29.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.542 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 91' ' ' LYS . 94.7 mttt -108.52 133.67 52.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.837 -174.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.892 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 93.6 t -101.59 128.27 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.504 177.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 58' ' ' PHE . 22.8 m-70 -94.51 128.63 41.23 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.57 HG22 ' HG3' ' A' ' 46' ' ' ARG . 39.7 t -111.7 123.54 67.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.043 0.449 . . . . 0.0 110.686 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 1.06 ' HB3' HG12 ' A' ' 84' ' ' VAL . 34.6 m-85 -131.03 126.86 37.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.266 -175.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.67 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 19.4 mttp -71.13 154.93 41.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.392 156.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.593 ' HB2' ' CD1' ' A' ' 45' ' ' ILE . . . -135.35 147.06 48.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.494 -170.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.724 ' CD1' ' HG2' ' A' ' 39' ' ' LYS . 18.9 p90 -161.51 -179.38 7.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 172.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 45.0 mtmt -138.28 136.05 36.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.207 0.527 . . . . 0.0 111.009 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.742 ' O ' ' HA ' ' A' ' 80' ' ' SER . 56.1 mm-40 -151.42 173.15 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.808 -1.087 . . . . 0.0 111.409 -170.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.461 HG23 ' HA ' ' A' ' 79' ' ' ILE . 4.1 mp -109.37 83.34 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.973 0.892 . . . . 0.0 108.609 168.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.715 ' C ' ' HB2' ' A' ' 78' ' ' LYS . 27.2 m -88.59 -162.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -169.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -134.02 90.6 2.71 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 113.871 -1.513 . . . . 0.0 111.898 -168.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 77' ' ' GLU . . . -70.79 154.12 94.47 Favored Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 120.639 -0.424 . . . . 0.0 112.048 170.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 15.3 Cg_exo -70.71 -158.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.411 2.741 . . . . 0.0 113.565 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -75.05 -23.41 58.1 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -84.22 17.2 2.62 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -172.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CD ' ' HA ' ' A' ' 77' ' ' GLU . 18.0 ptt-85 -72.89 170.56 13.02 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.121 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.66 168.45 24.79 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.899 2.399 . . . . 0.0 112.437 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.7 -20.82 22.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.379 -179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.94 -27.09 33.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.93 0.395 . . . . 0.0 110.035 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.524 ' HG2' ' HD2' ' A' ' 76' ' ' PRO . 29.7 ttm -94.56 145.02 28.9 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HD2' ' HG2' ' A' ' 75' ' ' MET . 14.0 Cg_exo -67.87 -176.96 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 121.923 1.748 . . . . 0.0 109.849 167.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.626 ' O ' ' HB3' ' A' ' 67' ' ' ALA . 34.9 mt-10 -44.99 -67.37 0.29 Allowed 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 173.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.715 ' HB2' ' C ' ' A' ' 65' ' ' VAL . 20.8 mmtp -151.1 -177.18 5.88 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.247 167.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.636 ' N ' HD13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -157.45 173.58 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.881 -1.054 . . . . 0.0 109.292 -161.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.742 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 12.4 p -64.59 85.53 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.828 1.33 . . . . 0.0 110.855 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.914 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -117.84 167.13 11.79 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-N 114.397 -1.274 . . . . 0.0 112.03 176.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.704 ' HG2' ' ND2' ' A' ' 33' ' ' ASN . 7.4 Cg_exo -77.73 128.19 9.21 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 123.523 2.815 . . . . 0.0 110.57 169.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.914 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 20.5 m-85 -126.47 123.56 38.11 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -175.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.06 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.8 OUTLIER -119.38 128.8 75.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.344 -174.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 41.9 pttt -106.05 169.9 8.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.6 178.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -109.44 106.43 16.18 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 -171.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HG2' HD11 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -100.57 -6.82 24.78 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.829 -172.259 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.5 ttp-105 -176.4 161.94 2.29 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 89' ' ' ILE . 12.2 mm -131.81 141.37 45.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.512 0.673 . . . . 0.0 110.407 173.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.892 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 69.3 mm-40 -128.1 178.6 6.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.603 -173.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 53.3 mtmt -144.53 169.17 18.48 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.05 -1.432 . . . . 0.0 107.163 176.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt -84.96 168.12 15.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--N 1.315 -0.93 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.581 -179.223 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 121.306 0.574 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -134.91 -178.2 4.97 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.1 t -63.99 159.31 20.31 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 169.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.8 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 5.0 ptm180 -93.86 125.47 38.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.26 1.029 . . . . 0.0 111.766 -171.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.9 OUTLIER -87.8 145.75 25.95 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.492 -1.685 . . . . 0.0 110.389 -178.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.671 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 39.7 m-85 -128.9 170.86 12.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.889 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.747 HG23 ' HG2' ' A' ' 50' ' ' ARG . 15.9 t -130.1 142.41 43.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 170.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.631 ' HB3' ' O ' ' A' ' 16' ' ' HIS . 4.0 tp -76.68 124.95 28.42 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.889 178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.768 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 6.8 mmm180 -96.62 130.17 43.87 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 14' ' ' ASN . 42.7 p30 -88.34 -171.61 3.43 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.788 178.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -42.36 -46.69 4.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -82.58 -37.23 25.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.045 0.45 . . . . 0.0 111.174 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.44 ' O ' ' HD2' ' A' ' 9' ' ' ARG . . . 123.0 36.55 0.66 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.139 -1.029 . . . . 0.0 112.731 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.634 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 27.2 m-80 -85.98 -178.21 6.5 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.809 0.337 . . . . 0.0 110.294 -177.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' HG11 ' A' ' 7' ' ' VAL . 43.7 mt-10 -105.13 117.99 35.4 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.527 178.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.631 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 79.6 m-70 -137.57 104.27 5.28 Favored 'General case' 0 CA--C 1.497 -1.091 0 CA-C-O 121.911 0.862 . . . . 0.0 111.278 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.75 147.22 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 CA-C-N 113.798 -1.546 . . . . 0.0 112.038 -178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.59 161.22 2.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.628 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 80.7 m-85 -150.71 159.59 44.42 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -170.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.0 p -141.25 158.2 44.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.777 0.323 . . . . 0.0 111.254 -176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.8 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.86 162.61 27.68 Favored Glycine 0 N--CA 1.434 -1.458 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.75 ' H ' ' HD2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -87.78 0.41 55.8 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.919 0.866 . . . . 0.0 108.889 173.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.67 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 27.0 tt0 -161.33 151.58 14.58 Favored Pre-proline 0 N--CA 1.448 -0.556 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.273 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.67 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 7.9 Cg_exo -43.12 -60.35 0.78 Allowed 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.559 2.173 . . . . 0.0 112.756 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.622 ' HB3' HE21 ' A' ' 23' ' ' GLN . 38.5 ttt180 -33.89 -42.29 0.11 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.249 167.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.731 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -75.68 -30.35 59.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 117.938 0.336 . . . . 0.0 111.592 179.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 6' ' ' PHE . . . -63.01 -63.35 1.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 172.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.906 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -41.05 -39.02 1.12 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.567 165.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.731 ' HB2' ' HA ' ' A' ' 26' ' ' GLN . 1.6 tp -61.78 -14.59 34.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.106 0.479 . . . . 0.0 111.228 177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 60.0 mmtt -87.33 -55.45 3.8 Favored 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 172.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.61 -30.05 29.27 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -173.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.626 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -61.52 -29.5 70.03 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.663 -178.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.82 2.15 0.33 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -110.12 -55.02 2.51 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.564 -162.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -97.03 -33.8 5.9 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 118.963 -1.589 . . . . 0.0 112.944 165.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 62' ' ' LYS . 39.5 t 73.68 -3.86 2.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 123.023 0.529 . . . . 0.0 111.371 178.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 37.7 -140.39 0.42 Allowed Glycine 0 C--N 1.342 0.907 0 O-C-N 123.562 0.539 . . . . 0.0 112.901 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.0 p -150.08 167.72 25.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 165.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 38.6 tptt -58.79 -31.5 68.47 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.4 0.619 . . . . 0.0 110.4 173.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -83.67 -29.43 27.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.363 -173.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.91 70.42 8.61 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-O 121.441 0.639 . . . . 0.0 111.218 -176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.74 ' HB2' ' CG ' ' A' ' 59' ' ' LYS . 25.9 Cg_exo -62.15 166.87 11.82 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.712 2.275 . . . . 0.0 111.477 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -97.2 150.06 21.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -176.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.493 HD11 ' HD3' ' A' ' 59' ' ' LYS . 23.0 mm -96.17 102.45 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 121.895 0.855 . . . . 0.0 112.215 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.457 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.7 pp -118.98 142.05 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.076 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.665 ' HB3' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -129.32 131.72 46.98 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.773 165.275 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.92 ' HB2' ' CE1' ' A' ' 56' ' ' HIS . 3.4 mm? -90.3 161.12 15.8 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.735 0.779 . . . . 0.0 112.118 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.768 ' HB2' ' HG3' ' A' ' 9' ' ' ARG . 18.7 ttp85 -125.01 133.23 53.07 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 113.652 -1.613 . . . . 0.0 107.35 176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -82.66 72.9 9.73 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.203 -174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.747 ' HG2' HG23 ' A' ' 7' ' ' VAL . 35.8 mtp180 30.78 -90.14 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 112.882 -1.963 . . . . 0.0 113.884 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.87 44.61 3.01 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.692 -0.766 . . . . 0.0 113.198 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.842 HG21 ' HE2' ' A' ' 54' ' ' LYS . 54.7 p -138.35 166.29 24.61 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.973 0.416 . . . . 0.0 110.171 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.415 ' HE3' ' O ' ' A' ' 92' ' ' LEU . 36.0 ttpt -112.44 36.46 3.39 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 177.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.842 ' HE2' HG21 ' A' ' 52' ' ' THR . 61.0 pttt -124.82 141.23 52.26 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.637 -176.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.641 HG21 ' HE ' ' A' ' 9' ' ' ARG . 10.8 t -124.83 144.55 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 120.759 0.314 . . . . 0.0 111.71 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.92 ' CE1' ' HB2' ' A' ' 47' ' ' LEU . 7.7 p80 -122.53 118.99 29.58 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.795 0.331 . . . . 0.0 111.887 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.665 ' HA ' ' HB3' ' A' ' 46' ' ' ARG . 60.8 t -85.1 119.83 34.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.925 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.956 ' HB3' HG12 ' A' ' 84' ' ' VAL . 8.1 m-85 -131.6 124.98 31.11 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.74 ' CG ' ' HB2' ' A' ' 42' ' ' PRO . 16.9 ttpt -85.57 122.57 29.89 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.857 ' HB2' HG13 ' A' ' 84' ' ' VAL . . . -119.57 144.55 47.02 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -164.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.423 ' HB3' ' HB3' ' A' ' 42' ' ' PRO . 9.3 p90 -162.55 175.2 11.68 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.646 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 14.2 mtpp -142.0 107.47 5.05 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.915 173.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 63' ' ' GLU . 7.0 pt-20 177.4 89.54 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.039 0.936 . . . . 0.0 112.169 159.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.599 HG22 ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -170.28 102.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.242 -1.536 . . . . 0.0 111.951 167.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG11 ' HE3' ' A' ' 81' ' ' LYS . 2.1 m -142.97 148.51 19.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 120.706 1.594 . . . . 0.0 110.823 164.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.13 72.15 1.64 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.63 170.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB1' ' HG2' ' A' ' 71' ' ' ARG . . . -54.13 135.71 58.85 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.495 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.3 Cg_exo -78.28 -148.97 0.03 OUTLIER 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 123.915 3.077 . . . . 0.0 113.078 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.0 OUTLIER -94.81 -42.03 8.92 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.461 173.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.0 m-20 -71.02 31.33 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.913 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.526 ' HG2' ' HB1' ' A' ' 67' ' ' ALA . 97.9 mtt180 -62.91 162.67 20.35 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.449 0.642 . . . . 0.0 111.981 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 14.1 Cg_exo -72.61 151.11 52.12 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.463 2.775 . . . . 0.0 109.768 163.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.53 -21.33 64.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.62 -171.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 67.9 p-90 -88.42 -25.38 22.69 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.626 ' CG ' HG21 ' A' ' 79' ' ' ILE . 41.1 ttm -84.99 125.62 70.08 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -169.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CG2' ' A' ' 79' ' ' ILE . 60.2 Cg_endo -91.07 -162.48 0.11 Allowed 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 123.253 2.635 . . . . 0.0 112.362 173.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -51.84 -68.84 0.14 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 114.755 -1.111 . . . . 0.0 111.924 -176.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.669 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 3.5 mmmt -118.38 138.69 52.26 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -175.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.626 HG21 ' CG ' ' A' ' 75' ' ' MET . 0.7 OUTLIER -148.01 169.15 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.514 0 CA-C-O 121.21 0.529 . . . . 0.0 109.645 -169.033 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.646 ' HB2' ' HB3' ' A' ' 62' ' ' LYS . 33.8 p -99.16 155.49 17.45 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.198 -0.91 . . . . 0.0 112.155 -176.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.847 ' HE3' HG11 ' A' ' 65' ' ' VAL . 12.5 mmtp -158.34 150.14 17.12 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 102.311 -3.218 . . . . 0.0 102.311 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 52.3 Cg_exo -53.83 91.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 CA-C-N 121.455 1.555 . . . . 0.0 112.899 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.599 ' CE2' HG22 ' A' ' 64' ' ' ILE . 14.4 m-85 -89.78 142.58 27.55 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.267 1.032 . . . . 0.0 111.342 173.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.956 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.3 OUTLIER -146.51 151.7 14.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.08 178.261 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -135.63 103.07 5.31 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.728 ' HB2' ' CE2' ' A' ' 58' ' ' PHE . 82.8 tttt -66.99 120.37 13.52 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.136 178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -123.64 -15.05 7.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -170.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.606 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 2.6 ttm180 -166.95 171.61 11.03 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -170.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.606 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 10.4 mm -137.66 136.2 45.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.447 ' HB2' ' CG1' ' A' ' 55' ' ' VAL . 43.7 mm-40 -116.93 140.02 49.95 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -142.09 149.42 39.85 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.357 0.598 . . . . 0.0 111.399 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' O ' ' HE3' ' A' ' 53' ' ' LYS . 40.6 mt -124.38 155.04 39.46 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 163.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 . . . . . 0 N--CA 1.439 -0.977 0 CA-C-O 118.145 -0.931 . . . . 0.0 110.417 -171.572 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 121.28 0.562 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.468 ' CG ' ' H ' ' A' ' 3' ' ' THR . 62.8 t30 -125.98 -158.92 0.88 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.222 -173.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.5 ' O ' ' HD2' ' A' ' 4' ' ' ARG . 26.3 m -60.6 162.25 6.71 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.941 0.496 . . . . 0.0 111.373 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.591 ' HB2' ' HE1' ' A' ' 6' ' ' PHE . 11.8 mmm180 -126.68 171.51 11.1 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -135.51 108.62 7.7 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-O 120.973 0.416 . . . . 0.0 110.42 -175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.591 ' HE1' ' HB2' ' A' ' 4' ' ' ARG . 13.8 m-85 -113.16 149.29 33.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.71 0.767 . . . . 0.0 111.823 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.1 t -104.02 141.54 19.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.92 170.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.687 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 19.0 tp -92.59 156.37 17.16 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.426 -175.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.561 ' HG3' ' HD2' ' A' ' 48' ' ' ARG . 16.7 mtp85 -143.76 113.77 7.26 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -105.79 170.0 8.16 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.291 -170.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -27.7 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.254 0 O-C-N 125.197 1.561 . . . . 0.0 113.048 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.88 -39.36 62.59 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.636 0.732 . . . . 0.0 111.236 177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.05 33.94 6.71 Favored Glycine 0 CA--C 1.503 -0.685 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.485 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 84.8 m-20 -142.5 -174.7 4.21 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -172.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -82.02 154.19 25.8 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.583 0.706 . . . . 0.0 110.831 174.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.687 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 9.6 m-70 -135.06 -165.18 1.63 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.404 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -46.3 157.64 0.42 Allowed Glycine 0 CA--C 1.518 0.266 0 O-C-N 123.983 0.802 . . . . 0.0 114.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -90.55 105.71 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.639 0.733 . . . . 0.0 109.481 174.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 61.6 m-85 -87.28 113.96 23.46 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.548 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 18.3 p -95.56 141.88 28.56 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 113.36 -1.745 . . . . 0.0 109.082 176.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 164.76 37.97 Favored Glycine 0 N--CA 1.443 -0.875 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 -174.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.3 ttpt -74.0 -19.29 60.7 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 118.616 1.208 . . . . 0.0 111.259 -175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 26' ' ' GLN . 26.6 pt20 -157.94 168.89 11.55 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 82.7 Cg_exo -45.8 -60.76 0.74 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.686 2.257 . . . . 0.0 112.724 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.0 ttm180 -39.66 -49.66 2.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.239 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HG2' ' HG2' ' A' ' 23' ' ' GLN . 13.1 mm100 -73.12 -24.42 60.62 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.701 0.286 . . . . 0.0 111.401 -174.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 30' ' ' LYS . . . -74.37 -41.12 61.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.415 0.626 . . . . 0.0 109.666 177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -68.98 -35.72 77.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.008 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 9.7 tt -53.78 -55.39 26.91 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 171.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 69.6 mmtt -43.7 -43.48 5.95 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 169.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -73.32 -23.43 60.25 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.85 -0.531 . . . . 0.0 111.549 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.051 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -68.0 -11.88 59.72 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.602 0.715 . . . . 0.0 110.686 177.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 30' ' ' LYS . 7.4 m-80 -78.88 3.0 18.17 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.658 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 3.4 mmp_? -89.59 -28.37 19.6 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -175.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.93 38.18 49.2 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 114.215 -1.357 . . . . 0.0 114.677 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.622 ' HB2' ' OD1' ' A' ' 43' ' ' ASP . 13.8 m -97.48 5.27 49.9 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.173 0.511 . . . . 0.0 109.932 175.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -143.25 157.07 26.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.592 -0.813 . . . . 0.0 113.178 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.1 p -128.45 -177.47 4.18 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 39' ' ' LYS . 12.8 tptm -61.16 -31.8 71.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.997 0.427 . . . . 0.0 110.732 177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -81.59 -38.51 25.97 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.68 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.24 75.1 75.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-O 121.116 0.484 . . . . 0.0 110.636 177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.698 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 23.3 Cg_exo -67.29 158.12 58.47 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.71 2.274 . . . . 0.0 113.333 -175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.622 ' OD1' ' HB2' ' A' ' 36' ' ' SER . 15.8 m-20 -71.91 94.12 1.41 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.847 172.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 tp -72.92 95.65 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.983 0.897 . . . . 0.0 109.372 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.571 HD11 ' HB1' ' A' ' 28' ' ' ALA . 6.2 pt -109.58 152.23 11.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.914 -172.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.715 ' HB3' HG11 ' A' ' 55' ' ' VAL . 74.3 mtp180 -114.55 118.53 34.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 47' ' ' LEU . 2.4 mm? -111.13 130.87 55.49 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 118.637 0.653 . . . . 0.0 109.412 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.712 ' HG2' HG22 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -122.3 118.76 29.27 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -77.97 107.19 10.33 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -47.37 102.61 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.296 0 O-C-N 124.019 0.824 . . . . 0.0 111.481 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.4 -25.26 3.01 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.102 -173.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 76.8 p -92.49 167.47 11.93 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.789 ' HA ' HD22 ' A' ' 92' ' ' LEU . 24.7 ttmm -111.77 8.97 20.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.216 -175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -136.89 145.16 44.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.183 0.516 . . . . 0.0 110.96 -176.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.764 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 58.1 t -101.71 136.41 33.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.958 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 4.4 m-70 -101.0 128.71 46.9 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 88' ' ' ARG . 12.8 p -114.31 130.55 68.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.549 0.69 . . . . 0.0 110.45 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.753 ' HB2' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -143.13 136.26 28.06 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.13 -177.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.698 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 53.3 mttp -71.15 109.45 5.21 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.231 163.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.051 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -94.6 145.85 24.54 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 175.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 83' ' ' PHE . 13.6 p90 -170.15 146.61 3.02 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.874 ' HE3' ' HG3' ' A' ' 82' ' ' PRO . 11.8 mtpt -101.47 136.23 41.67 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.713 ' O ' ' HA ' ' A' ' 80' ' ' SER . 3.7 tp10 -163.73 158.95 20.86 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.973 0.416 . . . . 0.0 112.036 -166.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.803 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 39.3 mt -103.54 130.61 53.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 171.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.6 m -132.42 150.47 33.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.484 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -77.94 93.82 4.48 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.43 -0.804 . . . . 0.0 109.914 173.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.548 ' HB1' ' HD3' ' A' ' 72' ' ' PRO . . . -51.25 136.27 30.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.404 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.422 ' HG2' ' HG3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -4.9 -148.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.227 1 C-N-CA 127.836 5.69 . . . . 0.0 118.22 -165.4 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -51.88 -57.57 8.99 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.503 173.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -132.85 -42.83 0.9 Allowed 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.336 -0.945 . . . . 0.0 111.304 168.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 71' ' ' ARG . 8.4 mmt180 -144.68 148.04 38.15 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 113.977 -1.465 . . . . 0.0 114.217 -175.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 1.035 ' HG2' ' HB3' ' A' ' 75' ' ' MET . 5.5 Cg_exo -90.98 166.58 3.77 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 123.434 2.756 . . . . 0.0 108.31 147.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.38 -16.78 58.68 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.636 0.731 . . . . 0.0 111.198 -176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.546 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 58.3 p-90 -109.29 -33.71 6.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.515 -1.221 . . . . 0.0 112.389 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 1.035 ' HB3' ' HG2' ' A' ' 72' ' ' PRO . 10.0 ttp -99.44 144.39 28.18 Favored Pre-proline 0 N--CA 1.464 0.266 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -167.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.426 ' HD2' HG21 ' A' ' 79' ' ' ILE . 7.0 Cg_exo -73.52 157.18 49.28 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 123.338 2.692 . . . . 0.0 112.115 169.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.476 ' CD ' ' H ' ' A' ' 77' ' ' GLU . 1.7 pm0 -44.19 -48.38 9.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -176.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.611 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.1 OUTLIER -138.4 153.67 48.91 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 175.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.803 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -159.66 -178.93 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.893 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -169.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.713 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 23.1 t -150.72 84.66 1.35 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.394 168.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 26.2 mmtt -97.67 158.16 33.49 Favored Pre-proline 0 CA--C 1.501 -0.926 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.274 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.874 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 19.9 Cg_exo -63.38 92.44 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.704 1.603 . . . . 0.0 109.31 159.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' HE2' ' O ' ' A' ' 63' ' ' GLU . 35.2 m-85 -78.27 -179.52 6.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.571 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.753 HG12 ' HB2' ' A' ' 58' ' ' PHE . 0.6 OUTLIER -160.92 162.59 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 79.1 tttt -159.23 98.51 1.43 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.851 0.834 . . . . 0.0 110.709 177.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.587 ' HB2' ' HD2' ' A' ' 58' ' ' PHE . 11.9 tmtt? -58.75 113.55 2.1 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.952 -1.476 . . . . 0.0 110.379 171.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 12.0 pt-20 -119.63 5.97 11.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.029 -175.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.477 ' HB3' ' CG1' ' A' ' 57' ' ' VAL . 39.2 ttp-105 176.24 170.15 0.43 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.015 -176.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.1 mm -120.24 141.12 41.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 170.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.764 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 6.2 mm-40 -112.14 166.66 11.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.293 0.568 . . . . 0.0 111.174 -173.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -82.12 159.91 23.26 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.789 HD22 ' HA ' ' A' ' 53' ' ' LYS . 12.5 tp -80.65 140.4 35.69 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--N 1.305 -1.332 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -169.345 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 121.094 0.473 . . . . 0.0 110.292 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.2 t-20 -154.78 133.31 11.99 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 1.013 ' HA ' ' HA ' ' A' ' 22' ' ' LYS . 91.5 m -73.53 149.13 42.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.181 177.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.599 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 1.3 ptm180 -132.77 155.48 48.83 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -107.15 145.15 32.88 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 118.409 0.55 . . . . 0.0 110.306 -174.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.533 ' HB3' HD12 ' A' ' 47' ' ' LEU . 58.5 m-85 -126.49 158.82 35.11 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.157 -179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.972 HG12 ' HG2' ' A' ' 50' ' ' ARG . 0.2 OUTLIER -127.85 125.12 64.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.742 0.782 . . . . 0.0 109.166 169.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.768 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 0.5 OUTLIER -69.67 142.86 53.33 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 113.923 -1.489 . . . . 0.0 111.581 -168.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.621 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 13.4 ptm180 -146.05 142.1 28.26 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.225 171.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -88.87 -162.07 0.82 Allowed 'General case' 0 C--O 1.236 0.367 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.24 -38.65 66.0 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.345 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -86.19 -38.95 17.14 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 9' ' ' ARG . . . 121.25 30.26 1.34 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.705 171.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 47.8 m-80 -70.92 128.67 36.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.239 . . . . 0.0 110.6 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.41 107.18 2.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.695 -176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.768 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 78.9 m-70 -103.11 -162.8 0.94 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.558 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.405 ' H ' ' HB3' ' A' ' 16' ' ' HIS . . . -56.56 157.1 10.99 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 115.155 0.822 . . . . 0.0 115.155 -170.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 89.9 t -80.62 140.95 15.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.532 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 12.9 m-85 -124.24 159.25 30.6 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -176.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.0 p -128.61 145.75 51.05 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.092 0.472 . . . . 0.0 110.919 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.572 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . -178.57 144.01 6.16 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 1.013 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 3.9 ptmt -70.09 -7.88 44.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 118.054 0.927 . . . . 0.0 111.549 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.599 ' HA ' ' HD3' ' A' ' 4' ' ' ARG . 10.0 pt20 -159.29 149.71 15.56 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.14 174.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.29 -8.46 0.22 Allowed 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.661 3.574 . . . . 0.0 115.079 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.433 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 55.9 ttt180 -96.69 -25.26 15.61 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.62 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 25.3 mm-40 -86.84 -8.29 57.45 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.883 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . . . -89.69 -48.69 7.11 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.59 -35.49 68.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.275 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.451 HD13 HE22 ' A' ' 26' ' ' GLN . 1.5 tp -57.2 -56.08 26.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.184 173.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.62 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 73.7 mmtt -61.54 -5.73 2.0 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.779 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -96.34 -40.15 9.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -176.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 1.024 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -72.97 -11.18 60.47 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 122.162 0.982 . . . . 0.0 109.738 174.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -83.75 -2.22 55.82 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.37 -175.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -107.43 15.62 24.71 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -164.12 -167.53 24.76 Favored Glycine 0 N--CA 1.417 -2.618 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -172.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 22.9 m -106.04 -33.21 7.96 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.512 0.156 . . . . 0.0 111.291 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 59.16 171.24 0.37 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.11 -174.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.47 HG22 ' H ' ' A' ' 40' ' ' ALA . 6.4 m -156.66 128.33 7.17 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.408 ' HD2' ' HG3' ' A' ' 63' ' ' GLU . 84.7 tttt -65.21 -16.88 64.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.145 0.498 . . . . 0.0 111.965 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.47 ' H ' HG22 ' A' ' 38' ' ' THR . . . -85.26 -22.04 28.78 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.824 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.71 71.96 2.45 Favored Pre-proline 0 N--CA 1.447 -0.61 0 CA-C-O 121.637 0.732 . . . . 0.0 110.283 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.641 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 69.8 Cg_exo -54.77 170.0 0.71 Allowed 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.771 2.981 . . . . 0.0 113.943 -176.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.72 123.14 36.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.1 mm -81.55 120.53 33.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-O 121.147 0.499 . . . . 0.0 111.211 -176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.25 141.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.612 ' HG2' ' HB ' ' A' ' 57' ' ' VAL . 81.6 mtp180 -113.54 122.56 47.61 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 175.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.533 HD12 ' HB3' ' A' ' 6' ' ' PHE . 1.0 OUTLIER -91.69 127.53 37.18 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 70.0 ttt-85 -116.66 99.79 7.37 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 85.1 tt0 -70.69 112.23 6.76 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -172.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.972 ' HG2' HG12 ' A' ' 7' ' ' VAL . 27.0 mtp180 -47.46 -15.4 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.05 -38.25 6.48 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.755 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 75.1 p -93.85 165.25 12.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.107 0.48 . . . . 0.0 111.561 -178.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -98.85 7.68 45.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.535 179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.779 ' HA ' ' CB ' ' A' ' 91' ' ' LYS . 44.9 mtpt -125.24 148.11 48.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 111.215 -177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.812 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 26.7 t -93.16 135.73 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.713 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.649 ' HA ' HD13 ' A' ' 89' ' ' ILE . 31.7 m-70 -104.18 100.33 10.07 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.664 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.612 ' HB ' ' HG2' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -93.03 134.85 29.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -176.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.433 ' CE2' ' HA ' ' A' ' 25' ' ' ARG . 2.8 m-85 -142.56 118.93 10.88 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.044 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 15.3 ptpt -67.31 114.57 6.13 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 118.531 -1.268 . . . . 0.0 112.251 159.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.024 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -103.07 151.95 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.46 -179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.59 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 29.0 p90 -161.29 -172.68 3.5 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 176.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' A' ' 82' ' ' PRO . 44.8 mtmt -136.81 136.39 38.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.208 0.528 . . . . 0.0 110.669 173.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 80' ' ' SER . 20.4 mm-40 -137.64 129.38 28.52 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.586 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.802 ' HB ' ' HB3' ' A' ' 80' ' ' SER . 3.3 tt -100.41 109.17 24.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.843 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.5 m -138.08 144.64 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 121.767 0.794 . . . . 0.0 110.382 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.614 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 21.7 t70 -74.72 103.56 5.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.022 -1.444 . . . . 0.0 109.936 174.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.602 ' HB1' ' CB ' ' A' ' 71' ' ' ARG . . . -70.19 133.75 87.51 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.856 -176.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 58.1 Cg_endo -95.47 -160.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.314 3.343 . . . . 0.0 113.333 -174.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -54.61 -56.29 20.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.281 0.562 . . . . 0.0 110.304 177.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -70.02 36.26 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.808 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.602 ' CB ' ' HB1' ' A' ' 67' ' ' ALA . 17.5 ptt180 -94.09 144.5 28.17 Favored Pre-proline 0 C--O 1.236 0.372 0 O-C-N 121.766 -0.584 . . . . 0.0 109.553 179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 49.7 Cg_exo -59.16 159.83 21.03 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 122.965 2.444 . . . . 0.0 112.2 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.79 8.26 1.59 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.128 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -121.96 -36.44 3.0 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.588 ' CG ' HD11 ' A' ' 79' ' ' ILE . 36.8 ttm -72.41 114.99 34.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.987 176.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.613 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 81.6 Cg_endo -89.69 -177.91 1.54 Allowed 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 123.138 2.559 . . . . 0.0 113.704 175.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 66' ' ' ASP . 4.3 mm-40 -37.12 -52.42 1.0 Allowed 'General case' 0 C--O 1.211 -0.957 0 CA-C-N 112.235 -2.257 . . . . 0.0 114.015 -172.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.521 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -155.34 113.14 3.38 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.87 0.843 . . . . 0.0 112.059 176.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.613 ' CG1' ' HD2' ' A' ' 76' ' ' PRO . 0.8 OUTLIER -150.0 160.04 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 115.239 -0.891 . . . . 0.0 113.175 175.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.802 ' HB3' ' HB ' ' A' ' 64' ' ' ILE . 14.1 p -110.03 93.41 4.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.959 0.409 . . . . 0.0 111.215 160.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.669 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . 21.2 mmmt -77.36 156.1 81.47 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.23 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.745 ' HA ' ' HG2' ' A' ' 62' ' ' LYS . 4.6 Cg_exo -68.32 90.79 0.39 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.254 1.302 . . . . 0.0 110.2 169.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.669 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 23.0 m-85 -75.45 175.09 8.79 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-O 122.048 0.928 . . . . 0.0 112.081 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' A' ' 60' ' ' ALA . 1.8 m -165.16 158.68 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.325 -169.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 59' ' ' LYS . 6.7 tmtm? -148.83 114.15 5.55 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -75.39 123.67 25.79 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.621 ' HG3' ' HG2' ' A' ' 88' ' ' ARG . 11.2 pt-20 -101.16 -25.92 13.85 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.621 ' HG2' ' HG3' ' A' ' 87' ' ' GLU . 8.6 ptt180 -175.73 -173.11 0.58 Allowed 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.315 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 56' ' ' HIS . 16.2 mm -131.96 103.57 7.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 175.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.812 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 30.8 mt-10 -118.24 112.66 20.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 118.868 -1.133 . . . . 0.0 113.863 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.779 ' CB ' ' HA ' ' A' ' 54' ' ' LYS . 2.5 mmmt -144.73 170.75 15.5 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.359 163.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.504 ' H ' ' HD2' ' A' ' 91' ' ' LYS . 79.5 mt -119.88 175.11 6.05 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 112.822 -1.99 . . . . 0.0 110.462 -172.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.525 -176.193 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 121.225 0.536 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -104.57 6.41 34.58 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 122.078 0.942 . . . . 0.0 109.642 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.3 t -78.1 121.28 24.08 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.749 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.434 ' HG3' ' CE1' ' A' ' 6' ' ' PHE . 6.7 ptm180 -85.67 145.88 27.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.452 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.56 HD22 HG22 ' A' ' 20' ' ' THR . 7.6 m120 -84.96 147.09 26.9 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.539 -1.21 . . . . 0.0 111.554 -172.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 4' ' ' ARG . 67.2 m-85 -135.59 150.32 49.64 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 174.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.89 136.47 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 16' ' ' HIS . 6.1 tp -82.25 124.94 30.39 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -176.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.465 ' HD3' ' HE ' ' A' ' 46' ' ' ARG . 2.6 mtp180 -101.21 166.92 10.53 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.513 1.149 . . . . 0.0 114.031 -168.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -134.46 178.1 7.25 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 112.326 -2.215 . . . . 0.0 108.349 175.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -46.02 -35.84 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -92.62 -39.87 11.08 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -172.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.44 32.83 1.08 Allowed Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.845 176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -87.04 -173.57 4.5 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.764 0.316 . . . . 0.0 110.293 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -112.88 107.8 16.52 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.289 -176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . 85.4 m-70 -102.35 75.99 1.52 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.761 0.791 . . . . 0.0 110.053 175.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.65 153.01 0.98 Allowed Glycine 0 C--N 1.302 -1.348 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.865 -172.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -97.43 139.08 20.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 171.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.514 ' CE2' ' HA ' ' A' ' 31' ' ' ALA . 32.6 m-85 -123.89 151.02 43.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -175.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.56 HG22 HD22 ' A' ' 5' ' ' ASN . 22.1 p -114.04 145.42 41.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 173.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.516 ' HA3' ' HB2' ' A' ' 27' ' ' ALA . . . -154.81 135.71 4.81 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.052 -1.07 . . . . 0.0 110.893 175.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -71.83 -9.08 57.8 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.691 ' HG2' ' HD2' ' A' ' 24' ' ' PRO . 5.4 tt0 -160.23 149.01 13.64 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-N 114.272 -1.331 . . . . 0.0 107.79 173.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.691 ' HD2' ' HG2' ' A' ' 23' ' ' GLN . 75.0 Cg_exo -43.85 -9.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.956 3.771 . . . . 0.0 115.514 173.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.601 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 26.0 ttt-85 -96.52 -45.2 6.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 30' ' ' LYS . 43.7 mm-40 -70.02 -16.86 63.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.398 -1.274 . . . . 0.0 110.979 175.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HB2' ' HA3' ' A' ' 21' ' ' GLY . . . -89.02 -19.08 26.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -94.37 -27.83 15.86 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 173.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.538 ' HB3' ' HA ' ' A' ' 26' ' ' GLN . 7.8 tt -64.89 -46.6 81.08 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.352 -1.294 . . . . 0.0 109.642 176.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 3.4 mmmp? -62.78 -13.02 28.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.618 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.514 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -88.32 -23.79 23.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.622 0.725 . . . . 0.0 109.046 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.913 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -68.1 -10.47 54.28 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.752 173.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -92.75 2.77 56.56 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.339 -171.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' A' ' 34' ' ' ARG . 11.8 mmt85 -100.41 15.17 28.69 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -173.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 174.5 -147.12 8.96 Favored Glycine 0 N--CA 1.425 -2.059 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 -170.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.533 ' HA ' ' HB2' ' A' ' 62' ' ' LYS . 72.1 m -149.01 -41.87 0.15 Allowed 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.008 -1.096 . . . . 0.0 109.166 174.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 46.68 -142.79 5.32 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -168.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.1 p -151.99 177.58 10.32 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.442 ' HE3' ' OE2' ' A' ' 63' ' ' GLU . 20.5 ttmt -67.44 -31.89 72.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.702 0.763 . . . . 0.0 109.859 172.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.02 -39.47 65.97 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.503 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -132.62 75.42 73.38 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.79 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.422 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 35.9 Cg_exo -63.53 158.54 45.12 Favored 'Trans proline' 0 C--O 1.237 0.443 0 C-N-CA 122.37 2.047 . . . . 0.0 111.549 178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.434 ' O ' HG23 ' A' ' 45' ' ' ILE . 5.2 t70 -88.69 72.68 8.63 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 176.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.587 HG12 ' HG2' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -54.61 130.59 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.396 -174.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.538 ' N ' HD13 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -128.15 152.98 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 121.84 0.828 . . . . 0.0 110.867 -179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.771 ' NH1' HG13 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -105.59 127.46 53.05 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.774 ' HB3' ' CE1' ' A' ' 56' ' ' HIS . 0.0 OUTLIER -118.18 132.55 56.32 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -174.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.632 ' HB2' HH21 ' A' ' 46' ' ' ARG . 41.4 ttt180 -131.03 127.81 39.02 Favored 'General case' 0 C--N 1.309 -1.152 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 30.7 tt0 -71.3 149.77 45.82 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.4 mtm180 -67.89 116.18 8.26 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.351 0.596 . . . . 0.0 111.182 -165.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.17 -8.84 78.92 Favored Glycine 0 C--N 1.318 -0.437 0 CA-C-N 114.778 -1.101 . . . . 0.0 113.247 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.508 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 23.1 p -96.86 170.96 8.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.926 0.393 . . . . 0.0 111.479 -174.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.944 ' H ' ' HB3' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.55 -8.19 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.229 171.377 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.826 ' HA ' ' HA ' ' A' ' 92' ' ' LEU . 57.3 mttp -49.28 103.09 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.469 0.652 . . . . 0.0 111.784 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.771 HG13 ' NH1' ' A' ' 46' ' ' ARG . 14.3 t -110.1 101.9 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.685 178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.774 ' CE1' ' HB3' ' A' ' 47' ' ' LEU . 4.0 p80 -111.3 128.03 55.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.365 172.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' A' ' 46' ' ' ARG . 43.0 t -109.17 115.76 50.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.741 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.817 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -124.96 131.82 53.37 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.587 ' HG2' HG12 ' A' ' 44' ' ' ILE . 30.8 mtpt -72.83 117.83 15.02 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.688 1.131 . . . . 0.0 110.869 164.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.913 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -108.61 137.81 45.94 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.247 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -149.99 -174.43 4.71 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 174.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.627 ' HD3' ' O ' ' A' ' 32' ' ' ALA . 25.0 mtpt -143.04 122.63 13.25 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 176.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.662 ' HG2' ' CE2' ' A' ' 83' ' ' PHE . 12.1 pt-20 -149.62 174.03 13.0 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.805 HD11 ' HB3' ' A' ' 78' ' ' LYS . 8.2 tt -115.47 109.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 169.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.8 m -91.33 145.94 6.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.268 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.673 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 11.2 p-10 -80.3 113.54 18.55 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.967 170.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.765 ' HB3' ' HA ' ' A' ' 77' ' ' GLU . . . -77.41 129.99 75.8 Favored Pre-proline 0 C--N 1.315 -0.904 0 CA-C-N 114.397 -1.274 . . . . 0.0 109.073 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 2.4 Cg_endo -79.81 -177.33 3.76 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.955 2.437 . . . . 0.0 111.511 -174.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -49.94 -58.64 5.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.057 0.456 . . . . 0.0 110.04 176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.51 31.79 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.474 ' HD2' ' O ' ' A' ' 75' ' ' MET . 14.7 ptt85 -64.59 151.14 92.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 118.654 0.661 . . . . 0.0 110.068 174.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.52 147.07 95.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.074 1.85 . . . . 0.0 111.601 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.71 4.68 5.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.449 -172.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.0 p-90 -113.87 -24.72 8.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.655 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.612 ' HG2' HG12 ' A' ' 79' ' ' ILE . 22.8 ttp -101.68 118.94 58.58 Favored Pre-proline 0 N--CA 1.454 -0.27 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.562 ' HD2' HG21 ' A' ' 79' ' ' ILE . 12.8 Cg_exo -65.87 144.91 78.79 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.565 2.177 . . . . 0.0 113.344 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.765 ' HA ' ' HB3' ' A' ' 67' ' ' ALA . 31.0 mp0 -31.43 -54.5 0.25 Allowed 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.805 1.316 . . . . 0.0 112.322 -178.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.805 ' HB3' HD11 ' A' ' 64' ' ' ILE . 29.5 mmtp -112.22 134.63 53.65 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.462 175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.612 HG12 ' HG2' ' A' ' 75' ' ' MET . 1.1 pp -155.22 146.73 13.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.826 -174.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.7 t -122.5 121.73 37.24 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.758 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 6.2 tppt? -154.64 145.76 16.49 Favored Pre-proline 0 C--N 1.314 -0.945 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.472 -168.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.599 ' HA ' ' HG3' ' A' ' 62' ' ' LYS . 51.0 Cg_exo -52.63 146.86 32.76 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 121.558 1.505 . . . . 0.0 109.474 156.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.758 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 11.2 m-85 -144.44 149.37 35.91 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -169.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -153.01 150.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -174.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 58' ' ' PHE . 19.4 tptm -141.79 105.97 4.79 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.215 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.541 ' HE3' HD11 ' A' ' 89' ' ' ILE . 86.8 tttt -73.32 101.89 3.55 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.469 -0.787 . . . . 0.0 108.908 175.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.52 ' OE1' ' HD2' ' A' ' 59' ' ' LYS . 4.5 pt-20 -109.63 -36.73 5.87 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.705 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.478 ' N ' ' HG3' ' A' ' 87' ' ' GLU . 23.9 ttt180 -128.35 152.94 47.57 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.235 0.54 . . . . 0.0 110.455 -179.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.541 HD11 ' HE3' ' A' ' 86' ' ' LYS . 25.5 mm -143.98 159.56 15.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.442 -176.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.645 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 20.0 mm-40 -142.26 179.17 7.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 91' ' ' LYS . 9.9 ptpt -77.39 113.33 15.07 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.148 0.975 . . . . 0.0 112.322 -171.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.826 ' HA ' ' HA ' ' A' ' 54' ' ' LYS . 24.0 mt -76.25 171.59 14.28 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.616 -1.629 . . . . 0.0 112.239 -176.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.944 ' HB3' ' H ' ' A' ' 53' ' ' LYS . 7.4 tt0 . . . . . 0 C--O 1.244 0.808 0 CA-C-N 114.788 -1.097 . . . . 0.0 109.102 177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 22' ' ' LYS . 8.6 p . . . . . 0 N--CA 1.474 0.756 0 CA-C-O 121.156 0.503 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' LYS . 66.3 t30 -115.56 178.73 4.2 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 175.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.529 ' O ' ' HG3' ' A' ' 4' ' ' ARG . 14.3 m -61.72 144.26 54.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.742 0.306 . . . . 0.0 111.274 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.674 HH22 ' HG3' ' A' ' 24' ' ' PRO . 0.0 OUTLIER -148.94 154.46 39.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -96.76 136.5 37.21 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.84 0.352 . . . . 0.0 111.759 -177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.451 ' HZ ' ' NH2' ' A' ' 4' ' ' ARG . 96.7 m-85 -133.14 129.72 38.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.428 0.632 . . . . 0.0 111.73 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.782 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 3.1 t -103.53 100.83 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.978 175.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.495 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -61.89 144.8 54.4 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.365 -1.288 . . . . 0.0 110.921 173.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 9.6 ptm85 -132.49 132.53 42.78 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 170.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -115.92 169.44 9.23 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.788 -165.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -23.62 -39.03 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 O-C-N 126.452 2.345 . . . . 0.0 114.38 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -64.87 -37.19 86.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.62 35.15 2.9 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 -176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 11.6 m120 -138.36 170.54 15.84 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -169.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -86.65 156.17 20.11 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.262 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.473 ' HB2' HD23 ' A' ' 8' ' ' LEU . 27.1 m-70 -142.52 -164.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -174.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -38.87 128.11 1.95 Allowed Glycine 0 C--N 1.339 0.697 0 O-C-N 124.473 1.108 . . . . 0.0 113.52 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -80.92 104.52 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-O 122.278 1.037 . . . . 0.0 108.231 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.461 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 39.5 m-85 -88.46 113.11 23.71 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.501 -176.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -88.39 136.15 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 113.531 -1.668 . . . . 0.0 107.945 167.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.62 140.66 6.3 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 1' ' ' SER . 30.3 mtmm -76.96 -1.27 27.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.476 0.638 . . . . 0.0 111.144 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.712 ' HG3' ' HD2' ' A' ' 24' ' ' PRO . 25.2 tt0 -155.61 146.68 16.53 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 174.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.712 ' HD2' ' HG3' ' A' ' 23' ' ' GLN . 85.3 Cg_exo -47.07 -55.12 4.17 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.456 2.104 . . . . 0.0 112.383 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HB3' HE21 ' A' ' 23' ' ' GLN . 23.8 ttp180 -45.16 -28.29 0.73 Allowed 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 173.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.613 ' HG2' ' HB3' ' A' ' 23' ' ' GLN . 12.0 mm100 -82.23 -26.22 33.46 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.082 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB1' ' HB2' ' A' ' 19' ' ' PHE . . . -80.14 -40.85 26.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.708 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -58.57 -36.2 73.57 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.363 169.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.404 HD13 HE22 ' A' ' 26' ' ' GLN . 2.6 tt -66.44 -53.0 40.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -50.31 -19.44 0.82 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.903 173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.717 ' O ' ' HG2' ' A' ' 34' ' ' ARG . . . -95.49 -41.09 9.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.475 0.58 . . . . 0.0 109.73 171.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.525 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -59.79 -20.11 54.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.267 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -40.15 75.56 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.991 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 7.4 ptm180 -84.55 -23.61 29.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.89 0.376 . . . . 0.0 110.937 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.98 70.69 2.87 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.305 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 32.1 m -76.67 60.36 1.67 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.091 0.472 . . . . 0.0 112.196 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.0 -164.72 40.43 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 171.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 33.3 p -132.09 166.79 20.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 117.503 0.651 . . . . 0.0 109.74 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -66.54 -14.27 62.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.053 0.454 . . . . 0.0 111.55 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.97 -18.56 21.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.343 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.447 ' N ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -151.78 63.48 5.36 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.919 -178.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.976 ' HB2' ' HB3' ' A' ' 59' ' ' LYS . 13.3 Cg_exo -68.45 151.98 75.44 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.704 2.269 . . . . 0.0 112.621 -175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -77.54 122.11 24.81 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.719 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.777 HD11 ' HE3' ' A' ' 59' ' ' LYS . 17.5 mm -71.22 109.61 3.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.42 0.629 . . . . 0.0 111.064 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 58' ' ' PHE . 2.7 pp -113.75 137.05 48.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.515 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.513 ' HB3' ' CG1' ' A' ' 55' ' ' VAL . 24.1 mtp180 -124.38 104.87 9.02 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.01 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.578 HD11 ' N ' ' A' ' 28' ' ' ALA . 86.0 mt -88.65 131.0 35.17 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.327 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.782 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 1.0 OUTLIER -84.27 154.47 22.96 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-O 121.452 0.644 . . . . 0.0 109.547 174.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.507 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 34.6 tt0 -116.96 76.98 1.07 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.623 -175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.671 ' HG2' HG23 ' A' ' 7' ' ' VAL . 6.3 mtp180 -30.66 119.18 0.18 Allowed 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.635 -1.62 . . . . 0.0 112.059 177.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.65 -24.21 24.38 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.295 -0.866 . . . . 0.0 113.127 -175.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 49' ' ' GLU . 10.6 p -114.25 -172.21 2.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.182 0.491 . . . . 0.0 110.201 -176.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.558 ' HA ' ' HG ' ' A' ' 92' ' ' LEU . 18.8 pttm -123.17 27.22 7.68 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.283 0.563 . . . . 0.0 109.534 170.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -110.08 138.18 46.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.411 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG23 ' HA ' ' A' ' 92' ' ' LEU . 39.9 t -109.8 127.47 66.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.476 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.649 ' HA ' HD13 ' A' ' 89' ' ' ILE . 62.9 m-70 -88.49 111.71 22.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.711 0.291 . . . . 0.0 110.784 -178.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 46' ' ' ARG . 38.5 t -97.09 108.12 21.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.479 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.846 ' HB3' HG12 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -120.06 122.48 41.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.155 172.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.976 ' HB3' ' HB2' ' A' ' 42' ' ' PRO . 44.1 mttp -68.76 111.77 5.07 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.1 163.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.687 ' HB2' HG13 ' A' ' 84' ' ' VAL . . . -92.92 134.88 34.65 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 115.554 -0.748 . . . . 0.0 113.011 174.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.591 ' CD1' ' HG2' ' A' ' 63' ' ' GLU . 41.6 p90 -144.46 -172.32 3.78 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.604 178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 81' ' ' LYS . 47.8 mttp -133.8 139.77 46.5 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.208 0.527 . . . . 0.0 110.387 174.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.768 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . 18.1 mm-40 -133.09 140.04 47.45 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.365 -177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.1 mp -74.78 143.08 13.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 79' ' ' ILE . 5.5 m -145.96 -175.35 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.141 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 78' ' ' LYS . 4.9 p-10 -162.91 124.17 2.48 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 168.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -131.74 150.01 75.05 Favored Pre-proline 0 C--N 1.315 -0.925 0 O-C-N 121.613 -0.68 . . . . 0.0 110.675 -167.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 5.4 Cg_exo -78.0 -87.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.294 1.996 . . . . 0.0 113.833 -177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 71' ' ' ARG . 59.6 mmtt -93.98 -51.23 4.96 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -61.64 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.873 1.435 . . . . 0.0 114.873 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.475 ' HD3' ' HA ' ' A' ' 77' ' ' GLU . 22.8 mtm105 -83.04 167.11 31.55 Favored Pre-proline 0 C--N 1.316 -0.885 0 O-C-N 121.219 -0.926 . . . . 0.0 109.998 166.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.627 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 15.7 Cg_exo -69.85 170.83 15.77 Favored 'Trans proline' 0 CA--C 1.506 -0.892 0 C-N-CA 122.197 1.932 . . . . 0.0 110.312 163.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.59 1.33 34.29 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.585 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -120.77 -38.71 2.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.187 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.627 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 10.1 ttp -74.82 126.93 87.87 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 75' ' ' MET . 7.1 Cg_exo -73.71 151.44 46.4 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.274 2.649 . . . . 0.0 111.861 175.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 71' ' ' ARG . 7.2 pt-20 -25.58 -58.57 0.07 Allowed 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 125.465 1.506 . . . . 0.0 114.726 177.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -100.39 119.06 37.88 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.343 -164.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -165.36 164.07 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.053 -174.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 63' ' ' GLU . 38.2 p -109.06 95.64 5.77 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.473 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 62' ' ' LYS . 20.5 mttt -82.8 158.57 65.0 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.457 -177.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.541 ' HG3' ' HE3' ' A' ' 62' ' ' LYS . 4.1 Cg_exo -80.87 96.33 0.98 Allowed 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.642 2.228 . . . . 0.0 111.913 175.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.768 ' CE2' ' HB2' ' A' ' 63' ' ' GLU . 47.4 m-85 -94.36 120.82 35.17 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.371 0.605 . . . . 0.0 110.553 178.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.846 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -99.29 178.35 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.422 175.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.733 ' HE2' ' HB3' ' A' ' 87' ' ' GLU . 5.1 tttt -166.18 104.39 0.65 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.125 -173.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.611 ' HE2' HD11 ' A' ' 89' ' ' ILE . 65.8 tttm -61.62 127.7 32.71 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.076 171.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.733 ' HB3' ' HE2' ' A' ' 85' ' ' LYS . 13.5 pt-20 -127.41 -34.03 2.3 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.271 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 88' ' ' ARG . 15.4 ttp180 -151.74 159.5 43.93 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 119.8 -0.76 . . . . 0.0 111.712 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 56' ' ' HIS . 21.0 mm -123.23 107.96 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.741 173.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' CD ' ' HE ' ' A' ' 88' ' ' ARG . 6.0 mm-40 -92.5 -177.46 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 122.122 0.963 . . . . 0.0 113.286 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -82.25 169.31 16.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.882 170.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.617 HD22 ' HD2' ' A' ' 48' ' ' ARG . 22.6 mt -53.26 151.25 5.41 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.54 0.686 . . . . 0.0 112.675 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--O 1.252 1.198 0 CA-C-N 113.49 -1.686 . . . . 0.0 109.466 -175.711 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.202 0.525 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -123.6 -169.08 1.88 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.367 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.4 t -70.96 170.37 12.89 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.989 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.701 ' HG2' ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -93.06 125.3 37.58 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.85 0.833 . . . . 0.0 110.966 -178.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -88.82 145.0 25.85 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.858 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.783 ' CE2' ' HG3' ' A' ' 49' ' ' GLU . 82.5 m-85 -130.98 144.59 51.59 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.536 -177.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 50' ' ' ARG . 47.1 t -112.83 127.92 69.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.765 174.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 16' ' ' HIS . 3.9 tp -66.63 130.01 41.75 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.216 -175.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.686 ' HA ' ' O ' ' A' ' 14' ' ' ASN . 67.1 mtp180 -106.82 128.03 53.91 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 166.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -87.62 -169.78 2.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -174.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -37.57 -48.24 0.99 Allowed 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.109 -0.951 . . . . 0.0 112.589 174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -80.2 -35.07 36.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.595 0.712 . . . . 0.0 110.258 -178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.6 31.41 1.81 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.641 176.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.686 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.7 OUTLIER -96.89 148.1 23.28 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -173.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.77 130.42 38.6 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 123.784 0.677 . . . . 0.0 111.013 -178.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.631 ' HB2' HD23 ' A' ' 8' ' ' LEU . 92.0 m-70 -138.22 -171.47 3.04 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.737 -176.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -12.2 130.45 0.01 OUTLIER Glycine 0 N--CA 1.461 0.331 0 O-C-N 126.736 2.522 . . . . 0.0 113.366 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.79 156.14 4.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 120.685 0.278 . . . . 0.0 111.077 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 92.6 m-85 -151.43 156.82 41.44 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 -174.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.3 p -139.71 158.36 44.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.581 0.229 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.701 ' O ' ' HG2' ' A' ' 4' ' ' ARG . . . 176.71 150.63 8.38 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.103 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.52 ' O ' ' HD3' ' A' ' 4' ' ' ARG . 2.7 tppp? -72.79 -6.33 44.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.487 0.643 . . . . 0.0 110.767 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.872 ' HG3' ' HG2' ' A' ' 26' ' ' GLN . 5.5 pt20 -160.46 158.62 25.61 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 171.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 23' ' ' GLN . 11.6 Cg_endo -56.84 -13.48 11.49 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 123.329 2.686 . . . . 0.0 115.233 -171.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 19.4 ttt180 -94.14 -13.67 26.5 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -174.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.872 ' HG2' ' HG3' ' A' ' 23' ' ' GLN . 16.9 mm100 -88.21 -18.08 29.45 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.061 -178.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.9 -59.05 2.88 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 171.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.819 ' HB1' HG11 ' A' ' 84' ' ' VAL . . . -35.92 -45.58 0.42 Allowed 'General case' 0 CA--C 1.519 -0.228 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 159.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -57.48 -26.07 60.7 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.425 0.631 . . . . 0.0 111.076 177.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.764 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 27.2 mmmt -80.94 -47.89 13.06 Favored 'General case' 0 N--CA 1.426 -1.67 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.654 ' O ' ' HG3' ' A' ' 34' ' ' ARG . . . -69.4 -21.56 63.76 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.843 ' HB2' ' HB1' ' A' ' 60' ' ' ALA . . . -67.47 -12.85 61.28 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.82 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.643 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 0.5 OUTLIER -66.06 -47.66 73.59 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 177.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.82 17.71 2.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.977 170.028 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.29 90.68 1.42 Allowed Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.3 m -77.09 49.65 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.276 0.56 . . . . 0.0 110.281 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -127.32 -165.62 11.94 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.32 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.463 HG22 ' ND2' ' A' ' 41' ' ' ASN . 9.5 t -162.35 171.62 16.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -62.12 -16.42 52.38 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.941 0.791 . . . . 0.0 111.029 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.41 ' H ' HG23 ' A' ' 38' ' ' THR . . . -79.85 -30.08 40.24 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.714 0.769 . . . . 0.0 110.63 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.463 ' ND2' HG22 ' A' ' 38' ' ' THR . 0.3 OUTLIER -165.15 72.74 1.43 Allowed Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.182 -176.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' A' ' 59' ' ' LYS . 49.4 Cg_exo -56.19 -169.44 0.02 OUTLIER 'Trans proline' 0 CA--C 1.526 0.082 0 C-N-CA 123.386 2.724 . . . . 0.0 114.008 -174.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -119.4 104.14 10.09 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.403 HD11 ' CG2' ' A' ' 57' ' ' VAL . 6.7 tp -79.05 101.52 4.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.781 0.8 . . . . 0.0 112.391 -167.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.514 HD12 ' O ' ' A' ' 45' ' ' ILE . 2.4 pp -119.12 129.08 75.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.09 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.788 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 42.2 ttm105 -109.44 118.04 35.59 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.517 HD13 ' HA ' ' A' ' 8' ' ' LEU . 3.4 mm? -84.88 161.69 19.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.916 0.865 . . . . 0.0 112.687 175.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.646 ' HD3' ' HD2' ' A' ' 9' ' ' ARG . 49.5 ttp180 -133.2 130.46 39.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.003 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.783 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 2.4 mt-10 -80.18 88.2 5.47 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.589 ' HB3' HG23 ' A' ' 7' ' ' VAL . 3.4 ptm180 -51.56 -9.12 0.07 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 113.974 1.101 . . . . 0.0 113.974 177.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -89.86 -32.47 9.96 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.601 -0.809 . . . . 0.0 111.748 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 p -117.99 -169.75 1.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.002 0.43 . . . . 0.0 110.872 -176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -108.91 41.62 1.57 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.464 0.65 . . . . 0.0 109.599 171.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HD3' ' OXT' ' A' ' 93' ' ' GLU . 67.6 mttm -101.32 138.9 37.73 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.32 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 90' ' ' GLU . 81.4 t -124.34 129.07 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.665 0.269 . . . . 0.0 110.589 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.541 ' HA ' ' CD1' ' A' ' 89' ' ' ILE . 71.2 m-70 -134.84 107.93 7.65 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -172.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 46' ' ' ARG . 14.9 p -97.0 138.75 21.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.854 ' HB3' HG12 ' A' ' 84' ' ' VAL . 2.9 m-85 -141.52 138.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.966 0.412 . . . . 0.0 110.321 176.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HG2' ' OE2' ' A' ' 87' ' ' GLU . 55.3 mmtt -71.66 128.5 35.99 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 161.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.843 ' HB1' ' HB2' ' A' ' 32' ' ' ALA . . . -126.02 133.01 51.87 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HZ3' ' HG2' ' A' ' 85' ' ' LYS . 26.9 p90 -151.93 156.37 39.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.643 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 6.7 mtpm? -131.58 124.17 29.44 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.724 0.773 . . . . 0.0 110.943 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.482 ' HG3' ' HE2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 139.87 31.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.003 177.52 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.783 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -82.23 145.78 8.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 173.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.655 ' H ' HD13 ' A' ' 64' ' ' ILE . 1.5 t -130.19 176.51 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -167.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 77' ' ' GLU . 25.4 t0 176.79 50.39 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . . . -133.87 118.71 14.45 Favored Pre-proline 0 C--N 1.321 -0.647 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.38 -170.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.551 ' HA ' ' HG2' ' A' ' 71' ' ' ARG . 7.3 Cg_exo -74.14 -19.81 19.72 Favored 'Trans proline' 0 CA--C 1.514 -0.481 0 C-N-CA 123.697 2.931 . . . . 0.0 113.822 -167.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.9 mmmt -71.54 -36.09 70.86 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.458 -171.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 42.9 m-80 -114.82 33.39 5.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.852 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.852 ' HG3' HH11 ' A' ' 71' ' ' ARG . 5.5 mmt85 -76.21 111.95 18.16 Favored Pre-proline 0 C--N 1.33 -0.253 0 C-N-CA 120.489 -0.485 . . . . 0.0 110.178 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.775 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 10.0 Cg_exo -73.76 174.47 12.24 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 123.838 3.025 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.24 8.69 20.2 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.479 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.565 ' CZ3' ' HB2' ' A' ' 75' ' ' MET . 65.2 p-90 -123.49 -31.79 3.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.319 176.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.775 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.4 ttp -97.78 141.46 23.02 Favored Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.325 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' O ' ' HD2' ' A' ' 71' ' ' ARG . 11.7 Cg_endo -79.68 -148.16 0.03 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.63 176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 78' ' ' LYS . 35.7 mt-10 -91.37 -40.54 11.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 122.213 -0.304 . . . . 0.0 111.745 -169.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.662 ' HD2' ' HB2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -144.79 118.38 9.15 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -175.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.783 ' O ' ' HA ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -151.19 159.15 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 CA-C-O 120.934 0.397 . . . . 0.0 110.266 -176.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 44.5 t -112.31 126.48 55.3 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.754 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 14.0 tppt? -146.64 135.57 11.22 Favored Pre-proline 0 N--CA 1.438 -1.05 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -164.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.769 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . 22.3 Cg_exo -64.67 89.97 0.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 CA-C-N 119.747 0.945 . . . . 0.0 110.389 172.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.754 ' CE1' ' HB3' ' A' ' 81' ' ' LYS . 18.3 m-85 -75.42 139.28 42.22 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.985 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.854 HG12 ' HB3' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -150.43 155.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.739 -177.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.506 ' HG2' ' HZ3' ' A' ' 61' ' ' TRP . 3.7 ptmm? -151.78 138.97 19.25 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.11 0.481 . . . . 0.0 111.637 177.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.518 ' HD3' HG12 ' A' ' 89' ' ' ILE . 35.9 ttmt -88.98 89.85 8.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.424 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.548 ' OE2' ' HG2' ' A' ' 59' ' ' LYS . 0.8 OUTLIER -55.03 -54.63 40.57 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 165.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.491 ' HG2' HG11 ' A' ' 57' ' ' VAL . 5.0 ptt180 -143.61 171.62 13.93 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.687 -0.805 . . . . 0.0 111.445 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.613 HG21 ' HB2' ' A' ' 93' ' ' GLU . 15.8 mm -145.37 131.41 14.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.747 178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 55' ' ' VAL . 32.4 mt-10 -87.77 -158.01 0.44 Allowed 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 124.934 1.293 . . . . 0.0 109.17 175.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.432 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 46.3 mtmt -57.11 169.42 0.56 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -174.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 95.2 mt -34.6 156.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 117.749 2.5 . . . . 0.0 117.749 -126.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.613 ' HB2' HG21 ' A' ' 89' ' ' ILE . 44.0 tt0 . . . . . 0 C--O 1.248 1.014 0 CA-C-N 112.731 -2.032 . . . . 0.0 109.364 174.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -93.67 98.07 10.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.962 0.411 . . . . 0.0 111.039 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m -72.28 111.95 7.93 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.393 173.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 -87.05 124.24 33.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.266 0.555 . . . . 0.0 111.369 -176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.63 135.48 38.13 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.187 174.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 24' ' ' PRO . 9.2 m-85 -120.3 160.82 22.24 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.567 HG23 ' HG2' ' A' ' 50' ' ' ARG . 3.5 t -118.5 138.22 49.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.864 HD23 ' HB2' ' A' ' 16' ' ' HIS . 11.5 tp -79.28 134.74 36.63 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 175.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.551 ' HG3' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -136.31 121.18 18.66 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.436 ' HB3' ' OD1' ' A' ' 12' ' ' ASP . 1.9 t70 -65.32 179.03 0.81 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.371 0.605 . . . . 0.0 112.273 -175.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -60.32 -32.4 71.19 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.113 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 10' ' ' ASP . 0.6 OUTLIER -83.37 -38.97 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.689 0.756 . . . . 0.0 109.211 175.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 123.43 21.12 2.54 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.878 172.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -78.21 129.21 34.83 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 172.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 8' ' ' LEU . 40.0 mt-10 -81.88 121.31 26.31 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.118 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.864 ' HB2' HD23 ' A' ' 8' ' ' LEU . 62.0 m-70 -114.61 99.5 7.58 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.376 0.607 . . . . 0.0 111.461 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 72.46 175.92 27.7 Favored Glycine 0 C--N 1.294 -1.787 0 CA-C-N 114.946 -1.025 . . . . 0.0 113.207 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 48.1 t -121.17 138.69 50.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.509 ' CE1' ' HB2' ' A' ' 8' ' ' LEU . 55.0 m-85 -126.69 148.52 49.84 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -172.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.5 p -132.33 144.38 50.52 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 122.195 -0.316 . . . . 0.0 111.688 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.68 160.15 33.69 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.31 -0.948 . . . . 0.0 112.945 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.8 tptt -54.97 -40.43 70.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.529 0.681 . . . . 0.0 109.719 171.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -143.75 177.68 1.73 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.512 ' HG3' ' CE2' ' A' ' 6' ' ' PHE . 75.0 Cg_exo -51.75 -53.33 7.2 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.925 1.75 . . . . 0.0 112.113 177.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.427 ' HA ' ' CE2' ' A' ' 58' ' ' PHE . 34.2 ttm180 -32.28 -53.38 0.3 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 169.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -74.86 -17.41 60.59 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.114 0.483 . . . . 0.0 111.169 -175.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.61 -13.01 23.17 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.629 0.728 . . . . 0.0 109.132 -178.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' C ' HG21 ' A' ' 84' ' ' VAL . . . -95.83 -32.63 12.59 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.777 HD23 HG23 ' A' ' 84' ' ' VAL . 4.3 mt -57.3 -40.32 77.6 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.382 171.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -70.19 -7.07 38.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.724 176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . . . -100.48 -48.25 4.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -174.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.616 ' CB ' ' HB1' ' A' ' 60' ' ' ALA . . . -73.58 -11.21 60.36 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 114.274 -1.33 . . . . 0.0 112.237 -178.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -83.38 -2.19 55.19 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.407 -166.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HG2' ' O ' ' A' ' 31' ' ' ALA . 14.6 ptp180 -114.99 15.79 17.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -176.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.0 -119.36 2.66 Favored Glycine 0 CA--C 1.497 -1.073 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.661 -171.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 27.0 m 176.32 -47.1 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 -172.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.659 ' HA3' ' HA ' ' A' ' 61' ' ' TRP . . . 46.37 -164.69 0.1 Allowed Glycine 0 CA--C 1.524 0.631 0 CA-C-N 114.974 -1.012 . . . . 0.0 113.539 -175.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.9 p -157.01 141.46 16.62 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.082 0.553 . . . . 0.0 109.618 176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -66.45 -22.47 66.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.761 0.791 . . . . 0.0 110.37 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.03 -43.03 88.78 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.658 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -157.51 74.41 4.2 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.621 -178.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.854 ' HB2' ' HB2' ' A' ' 59' ' ' LYS . 50.4 Cg_exo -52.83 125.57 18.54 Favored 'Trans proline' 0 CA--C 1.515 -0.444 0 C-N-CA 123.377 2.718 . . . . 0.0 113.519 -178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -42.15 127.47 3.52 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.105 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 44' ' ' ILE . 11.7 mm -80.65 115.75 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.996 178.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.001 HD11 ' HB2' ' A' ' 58' ' ' PHE . 2.8 pp -106.05 154.62 7.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.101 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.551 ' HB3' ' HG3' ' A' ' 9' ' ' ARG . 0.8 OUTLIER -129.71 101.72 6.02 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.034 -178.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.713 HD23 HD13 ' A' ' 45' ' ' ILE . 4.4 mm? -96.25 135.65 37.8 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -132.85 113.04 12.43 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.437 -175.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HB2' ' OG1' ' A' ' 52' ' ' THR . 33.6 mt-10 -59.56 108.92 0.79 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 122.665 0.386 . . . . 0.0 110.059 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.567 ' HG2' HG23 ' A' ' 7' ' ' VAL . 12.8 mtp180 -34.08 -43.97 0.16 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 174.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.28 -26.5 71.93 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.728 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 49' ' ' GLU . 6.9 p -103.43 -177.12 3.28 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.276 0.56 . . . . 0.0 110.989 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.765 ' HB2' ' HA ' ' A' ' 93' ' ' GLU . 53.6 mtmt -121.1 4.04 10.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.792 169.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 91' ' ' LYS . 25.7 pttm -90.86 133.31 35.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.264 0.554 . . . . 0.0 110.313 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.927 ' HB ' ' HB3' ' A' ' 90' ' ' GLU . 19.0 t -103.61 153.53 5.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.759 -174.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -128.9 112.29 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.094 -178.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.529 ' HB ' ' NE ' ' A' ' 46' ' ' ARG . 2.5 p -98.07 126.11 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 122.602 1.191 . . . . 0.0 113.251 -178.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 1.001 ' HB2' HD11 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -114.13 -173.11 2.22 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 113.602 -1.636 . . . . 0.0 107.547 174.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.854 ' HB2' ' HB2' ' A' ' 42' ' ' PRO . 13.7 ptpt -141.25 121.13 13.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.128 -1.804 . . . . 0.0 106.128 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.616 ' HB1' ' CB ' ' A' ' 32' ' ' ALA . . . -108.87 140.9 41.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -164.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.659 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 10.2 p90 -160.78 -174.33 4.37 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.104 -177.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HG2' ' CA ' ' A' ' 82' ' ' PRO . 88.0 mttt -127.27 153.34 46.26 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 120.671 0.272 . . . . 0.0 110.542 172.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.522 ' CG ' ' HE1' ' A' ' 61' ' ' TRP . 0.0 OUTLIER -163.77 177.36 8.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -164.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.732 ' HB ' ' HG2' ' A' ' 76' ' ' PRO . 18.2 pt -62.37 137.28 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.109 0.957 . . . . 0.0 110.669 167.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 1.043 HG22 HG22 ' A' ' 79' ' ' ILE . 1.4 m -99.75 -163.4 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 -165.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 77' ' ' GLU . 36.0 t70 -33.35 -94.18 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 112.02 -2.355 . . . . 0.0 115.945 -166.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 76' ' ' PRO . . . -50.26 150.17 4.68 Favored Pre-proline 0 N--CA 1.479 1.008 0 N-CA-C 116.736 2.124 . . . . 0.0 116.736 -166.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 67' ' ' ALA . 71.7 Cg_endo -110.34 -102.77 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.255 1 C-N-CA 125.963 4.442 . . . . 0.0 115.225 -172.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' C ' ' H ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -83.04 -23.6 33.15 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.33 -168.155 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -64.49 -8.13 12.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 122.567 1.175 . . . . 0.0 110.461 174.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.681 ' HG3' ' O ' ' A' ' 76' ' ' PRO . 24.3 mmm180 -117.14 170.78 5.6 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 113.239 -1.801 . . . . 0.0 109.378 -178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.583 ' HD2' ' HB3' ' A' ' 75' ' ' MET . 52.9 Cg_exo -57.69 169.03 2.71 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 121.778 1.652 . . . . 0.0 112.167 177.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.45 -47.72 84.41 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.284 0.564 . . . . 0.0 110.46 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.633 ' O ' ' HD3' ' A' ' 76' ' ' PRO . 43.7 p-90 -82.62 -33.22 27.98 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.442 -0.799 . . . . 0.0 112.434 -177.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.583 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 18.8 ttm -94.88 112.0 56.55 Favored Pre-proline 0 C--O 1.223 -0.317 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -170.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.764 ' HG2' HG21 ' A' ' 79' ' ' ILE . 47.0 Cg_exo -65.69 -72.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 123.612 2.875 . . . . 0.0 112.976 169.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.535 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 4.7 mm-40 -135.79 -80.44 0.42 Allowed 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -178.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HD2' ' C ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -159.92 115.25 2.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.06 -3.311 . . . . 0.0 102.06 166.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.043 HG22 HG22 ' A' ' 65' ' ' VAL . 0.2 OUTLIER -120.22 117.16 52.55 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.38 0 N-CA-C 119.294 3.072 . . . . 0.0 119.294 -150.228 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -168.69 88.75 0.21 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 110.451 -3.068 . . . . 0.0 109.351 159.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.716 ' HG2' HG11 ' A' ' 65' ' ' VAL . 23.5 mmtt -122.55 155.7 62.29 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 120.113 1.324 . . . . 0.0 111.546 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.576 ' CA ' ' HG2' ' A' ' 62' ' ' LYS . 95.4 Cg_endo -76.14 123.05 6.99 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.255 2.637 . . . . 0.0 111.363 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.594 ' CE1' ' HB2' ' A' ' 81' ' ' LYS . 33.8 m-85 -124.51 149.41 46.94 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.777 HG23 HD23 ' A' ' 29' ' ' LEU . 1.1 t -122.3 163.36 20.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.315 173.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.536 ' HD2' ' N ' ' A' ' 86' ' ' LYS . 1.6 tmmm? -148.67 132.71 17.22 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 51.8 tttm -72.99 113.5 10.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 121.832 0.825 . . . . 0.0 109.116 -177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.453 ' H ' ' HA ' ' A' ' 58' ' ' PHE . 0.4 OUTLIER -97.52 -45.02 6.58 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.804 -169.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.578 ' HG2' ' H ' ' A' ' 89' ' ' ILE . 27.0 ttp-105 -156.79 -175.73 5.59 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.363 0.601 . . . . 0.0 111.048 -171.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.578 ' H ' ' HG2' ' A' ' 88' ' ' ARG . 14.7 mm -128.12 154.6 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.605 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.927 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -120.28 -171.29 2.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 124.051 0.94 . . . . 0.0 110.783 -169.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 53.6 mtmt -69.02 173.98 4.96 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.35 -173.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.7 mp -124.78 155.56 39.16 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.088 -152.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.765 ' HA ' ' HB2' ' A' ' 53' ' ' LYS . 1.2 tm-20 . . . . . 0 C--O 1.249 1.044 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.345 174.076 . . . . . . . . 1 1 . 1 stop_ save_